VAERS Datenanalyse und Statistik
VAERS DatenanalyseSuche nach Chargen, Symptomen, Reports und Statistiken
Zurueck zur Suche

Reporte zur Charge EN 6198

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

500Reporte angezeigt
208Todesfaelle
288Hospitalisiert
40Lebensbedrohlich
20Bleibende Schaeden
KY 52 TX 39 CA 37 MI 28 TN 27 FL 26 WA 19 VA 13 PA 12 IN 12 MN 11 OH 9

VAERS 2723128

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6198

kritisch
Staat
-
Alter
73,0
Geschlecht
F
Eingang
12.12.2023
Impfdatum
24.03.2021
Beginn
02.12.2023
Tage bis Beginn
983,0
Dosis
2
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acinetobacter test Acute kidney injury Alanine aminotransferase normal Angiogram cerebral normal Anion gap Antimicrobial susceptibility test Aspartate aminotransferase normal Asthenia Bacillus test positive Bacterial test negative Bacterial test positive Basophil count normal Basophil percentage Blood albumin decreased Blood alkaline phosphatase increased Blood bilirubin normal Blood calcium decreased Blood chloride normal

Symptomtext

Document Type: Internal Medicine IP Progress Note Document Subject: Progress Note Comprehensive Performed By: MD on December 05, 2023 12:40 Verified By: MD on December 05, 2023 12:40 Encounter Info: Hospital, Inpatient, 12/02/23 - * Final Report * Subjective Admission Date: 12/02/2023 18:45 LOS: 3 Days 75 year old woman w/ bipolar d/o, myasthenia gravis, T2DM and seizures who presents from facility after a episode of unresponsiveness seen and evaluated by her bedside E.coli bacteremia, repeat blood cx sent- negative VSS CM to discuss NH options with family. Family does not want to send her back to where she is coming from for safety concerns 12/5/23: no new complaints. Review of Systems All 13 point review of systems were reviewed with the patient and are negative except as specified in the HPI Objective Vitals and Measurements Vitals & Measurements most recent past 24 hours T: 36.3 ?C (Axillary) TMIN: 36.3 ?C (Axillary) TMAX: 36.6 ?C (Oral) BP: 179/79 HR: 80 (Monitored) RR: 15 SpO2: 92% Oxygen Therapy: Room air WT: 73.4 kg Hemodynamics Neurologic Glasgow Coma Score: 14 Patient Weight Current Daily Weight: 73.4 kg 12/05/23 Previous Daily Weight: 72.4 kg 12/04/23 Difference from Previous: 1.000 kg Patient Height Intake/Output I/O TOTALS ONLY - Last 24 hrs (0600-0559) from 12/04 - 12/05 Total Intake 200.00 mL Total Output 1425.00 mL Balance -1225.00 mL Physical Exam General: Alert and oriented, No Acute distress Eye: Pupils are equal, round and reactive to light HEENT: Normocephalic, atraumatic Neck: Supple, normal range of motion, no nuchal rigidity Oropharynx: No erythema or drainage. Respiratory: Lungs are clear to auscultation. No added sounds Cardiovascular: Normal rate, Regular rhythm. s1 s2 positive Gastrointestinal: Soft, Non-tender. BS present all 4 quadrants, no rebound tenderness Musculoskeletal: Normal range of motion, No focal tenderness Integumentary: Warm, Dry, no obvious rashes Neurologic: No focal weakness. Sensation intact. Normal mood and affect. cranial nerves grossly intact. Assessment/Plan 1. UTI (urinary tract infection) N39.0 c/w current treatment. same bacteria in blood. 2. E coli bacteremia R78.81 Will need few days of IV abx. will need to repeat blood cultures. 3. CVA (cerebrovascular accident) I63.9 -Subacute -Had w/u including TTE a few weeks for an acute lacunar infarct. CTA at that time showed no significant obstruction -Continue statin and DAPT -PT OT ST - AKI is improving 4. AKI (acute kidney injury) N17.9 Improving. 5. Weakness R53.1 Noted PT OT evaluation. 6. Diabetes E11.9 continue with regimen. 7. Hypertension I10 controlled. 8. Myasthenia gravis G70.00 9. COVID U07.1 NO need for treatments. Code Status Resuscitation Status - Ordered -- 12/02/23 18:23:00, Full Code Medications Active Scheduled Inpatient Medications aspirin (Aspirin Enteric Coated), Tab, Delayed Rel, 81 mg, Orally, Daily, Start: 12/03/23 09:00:00 atorvastatin, Tablet, 40 mg, Orally, Daily, Start: 12/03/23 09:00:00 busPIRone, Tablet, 30 mg, Orally, BID, Start: 12/02/23 21:00:00 carBAMazepine, Tab, Chewable, 100 mg, Orally, Daily, Start: 12/03/23 09:00:00 ceftRIAXone, Injection, 1 GM, IVPB, Q24H, Indication: Bacteremia - Source Unknown, Start: 12/03/23 15:00:00 cholecalciferol, Tablet, 125 mCg, Orally, Daily, Start: 12/03/23 09:00:00 clopidogrel, Tablet, 75 mg, Orally, Daily, Start: 12/03/23 09:00:00 cyanocobalamin, Tablet, 500 mCg, Orally, Daily, Start: 12/03/23 09:00:00 enoxaparin, Injection, 40 mg, Subcutaneous, Q24H, Start: 12/03/23 18:00:00 insulin glargine (Lantus (insulin glargine) 100 units/mL subcutaneous solution), Injection, 10 Units, Subcutaneous, Daily, Start: 12/03/23 09:00:00 lamoTRIgine, Tablet, 200 mg, Orally, At Bedtime, Start: 12/02/23 21:00:00 olanzapine, Tab, Oral Disintegrating, 10 mg, Orally, At Bedtime, Start: 12/02/23 21:00:00 pantoprazole, Tab, Delayed Rel, 20 mg, Orally, Daily, Start: 12/03/23 09:00:00 primidone, Tablet, 50 mg, Orally, BID, Start: 12/02/23 21:00:00 PYRIDostigmine, Tablet, 90 mg, Orally, TID, Start: 12/02/23 21:00:00 traZODONE, Tablet, 100 mg, Orally, At Bedtime, Start: 12/02/23 21:00:00 vilazodone (Viibryd), Tablet, 20 mg, Orally, QAM, Start: 12/03/23 09:00:00 Lactated Ringers 1,000 mL IV Continuous 100 mL/hr 0 12/03/23 Dextrose 10% in Water 500 mL IV Continuous Per Core Diabetes App - See Comments One-Time Medications Given 12/04/23 00:00:00 TO 12/05/23 12:39:55 None Reported PRN Medications (0600 - 0559) from 12/04 - 12/05 acetaminophen, 650 mg, Orally, Q6H, 2 Dose(s) glucagon, 1 mg, IM, Unscheduled, 0 Dose(s) glucose, Per Core Diabetes App , IV Push, Unscheduled, 0 Dose(s) insulin lispro, Per Core Diabetes App , Subcutaneous, Unscheduled, 1 Dose(s) Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 7.7 k/cumm (12/05/23 03:23:00) RBC: 2.6 million/cumm Low (12/05/23 03:23:00) Hgb: 7.2 GM/dL Low (12/05/23 03:23:00) Hct: 20.9 % Low (12/05/23 03:23:00) MCV: 81 fL (12/05/23 03:23:00) MCH: 27.8 pg (12/05/23 03:23:00) MCHC: 34.5 GM/dL (12/05/23 03:23:00) RDW: 17.8 % High (12/05/23 03:23:00) Platelet: 262 k/cumm (12/05/23 03:23:00) MPV: 7 fL (12/05/23 03:23:00) Neutrophils %: 71 % (12/05/23 03:23:00) Lymphocytes %: 13 % (12/05/23 03:23:00) Monocytes %: 11 % (12/05/23 03:23:00) Eosinophils %: 4 % (12/05/23 03:23:00) Basophils %: 1 % (12/05/23 03:23:00) Absolute Neutrophil: 5.5 k/cumm (12/05/23 03:23:00) Absolute Lymphocyte: 1 k/cumm (12/05/23 03:23:00) Absolute Monocyte: 0.9 k/cumm (12/05/23 03:23:00) Absolute Eosinophil: 0.3 k/cumm (12/05/23 03:23:00) Absolute Basophil: 0.1 k/cumm (12/05/23 03:23:00) Chemistry: Sodium SerPl QN: 129 mmol/L Low (12/05/23 03:23:00) Potassium SerPl QN: 3.7 mmol/L (12/05/23 03:23:00) Chloride SerPl QN: 99 mmol/L (12/05/23 03:23:00) Carbon Dioxide SerPl QN: 26 mmol/L (12/05/23 03:23:00) Anion Gap: 4 mmol/L (12/05/23 03:23:00) BUN SerPl QN: 10 mg/dL (12/05/23 03:23:00) Creatinine SerPl QN: 1.01 mg/dL (12/05/23 03:23:00) Estimated GFR (CKD-EPI, no race): 58 mL/min/1.73m2 Low (12/05/23 03:23:00) Estimated CRCL (CG): 52 mL/min Low (12/05/23 03:23:00) Glucose SerPl QN: 78 mg/dL (12/05/23 03:23:00) Calcium Total SerPl QN: 7.7 mg/dL Low (12/05/23 03:23:00) Phosphorus SerPl QN: 3.5 mg/dL (12/05/23 03:23:00) Alkaline Phos SerPl QN: 142 Units/L High (12/05/23 03:23:00) ALT SerPl QN: 8 Units/L (12/05/23 03:23:00) AST SerPl QN: 13 Units/L (12/05/23 03:23:00) Bilirubin Total SerPl QN: 0.2 mg/dL (12/05/23 03:23:00) Total Protein SerPl QN: 5.3 GM/dL Low (12/05/23 03:23:00) Albumin SerPl QN: 2.5 GM/dL Low (12/05/23 03:23:00) Magnesium SerPl QN: 1.7 mg/dL (12/05/23 03:23:00) Gluc-Strip, POC: 90 mg/dL (12/05/23 10:49:00) Micro - Last 7 days Staphylococcus spp: Not Detect (11/30/23 14:42:00) Staphylococcus aureus: Not Detect (11/30/23 14:42:00) Staphylococcus epidermidis: Not Detect (11/30/23 14:42:00) Staphylococcus lugdunensis: Not Detect (11/30/23 14:42:00) Streptococcus spp: Not Detect (11/30/23 14:42:00) Streptococcus agalactiae (Group B): Not Detect (11/30/23 14:42:00) Streptococcus pneumoniae: Not Detect (11/30/23 14:42:00) Streptococcus pyogenes (Group A): Not Detect (11/30/23 14:42:00) Enterococcus faecalis: Not Detect (11/30/23 14:42:00) Enterococcus faecium: Not Detect (11/30/23 14:42:00) Listeria monocytogenes: Not Detect (11/30/23 14:42:00) Enteric gram-negative bacilli: Detect Abnormal (11/30/23 14:42:00) Enterobacter cloacae cmplx: Not Detect (11/30/23 14:42:00) Escherichia coli: Detect Abnormal (11/30/23 14:42:00) Klebsiella aerogenes: Not Detect (11/30/23 14:42:00) Klebsiella oxytoca: Not Detect (11/30/23 14:42:00) Klebsiella pneumoniae grp: Not Detect (11/30/23 14:42:00) Proteus spp: Not Detect (11/30/23 14:42:00) Salmonella spp: Not Detect (11/30/23 14:42:00) Serratia marcescens: Not Detect (11/30/23 14:42:00) Haemophilus influenzae: Not Detect (11/30/23 14:42:00) Neisseria meningitidis: Not Detect (11/30/23 14:42:00) Pseudomonas aeruginosa: Not Detect (11/30/23 14:42:00) Stenotrophomonas maltophilia: Not Detect (11/30/23 14:42:00) Acinetobacter baumannii cmplx: Not Detect (11/30/23 14:42:00) Bacteroides fragilis: Not Detect (11/30/23 14:42:00) CTX-M: Not Detect (11/30/23 14:42:00) IMP: Not Detect (11/30/23 14:42:00) KPC: Not Detect (11/30/23 14:42:00) mcr-1: Not Detect (11/30/23 14:42:00) mecA/C: Test Not Performed (11/30/23 14:42:00) mecA/C and MREJ (MRSA): Test Not Performed (11/30/23 14:42:00) NDM: Not Detect (11/30/23 14:42:00) OXA-48-like: Not Detect (11/30/23 14:42:00) vanA/B: Test Not Performed (11/30/23 14:42:00) VIM: Not Detect (11/30/23 14:42:00) Candida albicans: Not Detect (11/30/23 14:42:00) Candida auris: Not Detect (11/30/23 14:42:00) Candida glabrata: Not Detect (11/30/23 14:42:00) Candida krusei: Not Detect (11/30/23 14:42:00) Candida parapsilosis: Not Detect (11/30/23 14:42:00) Candida tropicalis: Not Detect (11/30/23 14:42:00) Cryptococcus neoformans/gattii: Not Detect (11/30/23 14:42:00) Blood Pathogen Interp: Blood Pathogen Interp (11/30/23 14:42:00) Blood CX: POS Critical (11/30/23 14:42:00) Urine CX: NEG (12/01/23 16:41:00) Diagnostics Radiology Results - Last 24 hours Across Visits No radiology results found in the last 24 hours. Signature Line Electronically Signed on 12/05/23 12:40 ________________________________________________________ MD

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
covid positive
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2720614

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
FL
Alter
80,0
Geschlecht
F
Eingang
04.12.2023
Impfdatum
02.02.2021
Beginn
01.04.2021
Tage bis Beginn
58,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Biopsy Fibrosarcoma Pathology test

Symptomtext

developed spindle cell neoplasm consistent with fibroblastic sarcoma grade2/3

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fibrosarcoma
Hospital-Tage
10,0
Labordaten
needle core biopsy surgical pathology report 8/22/22
Aktuelle Erkrankungen
chronic but stable heart disease but no history of any form of cancer ever.
Vorgeschichte
heart disease
Andere Medikamente
atorvastatin 40mg alprazolam .25mg 2x carvedilol 12.5mg 2x eliquist 2.5mg 2x levothyroxine 25mg losartan 50mg ezetimibide 10mg welexa 200mcg Tramadol as needed
Allergien
norvastin
Vorherige Impfungen
-

VAERS 2719960

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
91,0
Geschlecht
M
Eingang
01.12.2023
Impfdatum
23.02.2021
Beginn
09.11.2021
Tage bis Beginn
259,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 Fibrin D dimer

Symptomtext

Patient presented to the ER with recent diagnosis of Covid-19 infection. Patient diagnosed with acute respiratory failure requiring 2L oxygen. D-dimer 8.53. Patient was started on Azithromycin, Ceftriaxone, Dexamethasone, vitamin supplements. Timeline was not in favor of initiating Remdesivir. Patient was transferred to an acute hospital.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2705694

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
85,0
Geschlecht
M
Eingang
15.11.2023
Impfdatum
30.03.2021
Beginn
23.10.2023
Tage bis Beginn
937,0
Dosis
1
Route/Site
SYR / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Breakthrough COVID-19 Death

Symptomtext

Covid-19 Breakthrough Infection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Anemia, Arthritis, AFIB, BPH, Cataracts, CKD Stage 3, Colon Cancer, DM Type 2, HTN, HLD, Prostate Cancer
Andere Medikamente
Albuterol, Cefdinir, Diltiazem, Haloperidol, Quetiapine, Silodosin. Tamsulosin.
Allergien
NKA
Vorherige Impfungen
-

VAERS 2705694

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
85,0
Geschlecht
M
Eingang
15.11.2023
Impfdatum
30.03.2021
Beginn
23.10.2023
Tage bis Beginn
937,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Breakthrough COVID-19 Death

Symptomtext

Covid-19 Breakthrough Infection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Anemia, Arthritis, AFIB, BPH, Cataracts, CKD Stage 3, Colon Cancer, DM Type 2, HTN, HLD, Prostate Cancer
Andere Medikamente
Albuterol, Cefdinir, Diltiazem, Haloperidol, Quetiapine, Silodosin. Tamsulosin.
Allergien
NKA
Vorherige Impfungen
-

VAERS 2708870

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
63,0
Geschlecht
M
Eingang
02.11.2023
Impfdatum
23.02.2021
Beginn
26.10.2023
Tage bis Beginn
975,0
Dosis
UNK
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

tested + for covid 10-08-2023 at Hosp deceased 10-26-23

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
tested + for covid 10-08-2023 by PCR
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2695527

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
69,0
Geschlecht
M
Eingang
13.10.2023
Impfdatum
20.02.2021
Beginn
04.11.2021
Tage bis Beginn
257,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 pneumonia Dyspnoea Fatigue Sepsis

Symptomtext

Presented with SOB, fatigue; admitted with sepsis and acute respiratory failure due to COVID19 associated pneumonia. He was started on iv abx, iv steroids and remdesivir. Also rec'd actemra and lovenox; breathing gradually improved; oxygen was weaned down to 2 L by NC. home oxygen has been arranged.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
13,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2689411

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MN
Alter
98,0
Geschlecht
F
Eingang
02.10.2023
Impfdatum
02.11.2022
Beginn
30.09.2023
Tage bis Beginn
332,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Patient expired 9/30/2023.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Unknown
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Aortic stenosis, DM type 2, CAD
Andere Medikamente
Unknown
Allergien
Morphine
Vorherige Impfungen
-

VAERS 2679578

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
93,0
Geschlecht
F
Eingang
06.09.2023
Impfdatum
23.02.2021
Beginn
25.12.2021
Tage bis Beginn
305,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal pain Acute myocardial infarction C-reactive protein COVID-19 Fibrin D dimer Myocardial ischaemia Serum ferritin normal Vitamin D

Symptomtext

Presented with abd pain; dx Type 2 NSTEMI due to demand iscemia from Covid 19 infection; Labs: D dimer 1.27; CRP 0.45, Ferritin 121; Tx: Vit D3, Decadron, lovenox, singulair, zinc; O2 remained on room air

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2677733

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
FL
Alter
44,0
Geschlecht
F
Eingang
29.08.2023
Impfdatum
20.03.2021
Beginn
06.10.2021
Tage bis Beginn
200,0
Dosis
2
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Anticoagulant therapy Atrial septal defect Blood test Cardiac imaging procedure normal Catheterisation cardiac abnormal Cerebrovascular accident Dysgraphia Echocardiogram Fine motor skill dysfunction Impaired work ability Implantable cardiac monitor insertion Intracardiac thrombus Laboratory test Language disorder Magnetic resonance imaging Thrombosis

Symptomtext

10/06/2021, I suffered several strokes with no history or risk. I was admitted to the hospital the following day and received multiple tests. I have confirmed tests offering no evidence or explanation for multiple thrombus generation, other than the Pfizer COVID vaccine. I have no blood clot disorders, neither genetic or otherwise. I have zero atrial fibrillation events, confirmed via lync loop recorder since Oct 2021. Due to multiple tests, doctors discovered I have a PFO. In Dec 2021, PFO occluder was successfully inserted via heart catheterization. I was started on heavy blood thinners in Oct of 2021. In May of 2022, doctors confirmed the final thrombus noted in my lower heart chamber was gone via cardiac MRI. All blood thinners medications were stopped in May of 2022, however I continue ?baby? aspirin as a safety precaution due to my new medical history. My language processing was severely adversely affected by the strokes, as well as fine motor skills, such as handwriting. I work as a professional Sign Language interpreter, and I am nationally certified. Due to language processing affects of the strokes, work is extremely difficult and ability and effective language processing is unpredictable at best. Some days are just ?bad? and nothing makes sense.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
3,0
Labordaten
Blood tests, lab work, MRIs, CT scans, TEE, echocardiograms, etc.
Aktuelle Erkrankungen
None
Vorgeschichte
None prior to event
Andere Medikamente
-
Allergien
Bactrim
Vorherige Impfungen
DTP, as a toddler

VAERS 2567588

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
86,0
Geschlecht
F
Eingang
04.08.2023
Impfdatum
03.03.2021
Beginn
22.01.2023
Tage bis Beginn
690,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Breakthrough COVID-19 Death

Symptomtext

Covid Breakthrough Infection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
AFIB, HTN, Coronary Atherosclerosis, Dementia
Andere Medikamente
Amiodarone, Apixaban, Diltiazem, Docusate, Lisinopril, Furosemide, Multivitamin, Potassium Chloride, Rosuvastatin
Allergien
Cephalexin, Doxycycline,
Vorherige Impfungen
-

VAERS 2567588

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
86,0
Geschlecht
F
Eingang
04.08.2023
Impfdatum
03.03.2021
Beginn
22.01.2023
Tage bis Beginn
690,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Breakthrough COVID-19 Death

Symptomtext

Covid Breakthrough Infection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
AFIB, HTN, Coronary Atherosclerosis, Dementia
Andere Medikamente
Amiodarone, Apixaban, Diltiazem, Docusate, Lisinopril, Furosemide, Multivitamin, Potassium Chloride, Rosuvastatin
Allergien
Cephalexin, Doxycycline,
Vorherige Impfungen
-

VAERS 2663486

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
78,0
Geschlecht
F
Eingang
31.07.2023
Impfdatum
26.02.2021
Beginn
13.01.2022
Tage bis Beginn
321,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 Chronic obstructive pulmonary disease Death Intensive care Pneumonia aspiration Septic shock

Symptomtext

Admitted for septic shock; treated in the ICU for acute respiratory failure due to aspiration pneumonia and COPD exacerbation; Patient also was diagnosed with COVID-19; tx w/abx & steroids; despite treatment, prognosis remained poor; family opted for comfort care & pt expired 1/16.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2622191

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
98,0
Geschlecht
F
Eingang
27.04.2023
Impfdatum
01.03.2021
Beginn
01.10.2022
Tage bis Beginn
579,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Asthenia Atrial fibrillation COVID-19 Cardiac flutter Death Decreased appetite Dyspnoea Fall Pain Rib fracture SARS-CoV-2 test positive Skin abrasion

Symptomtext

pt to hospital 10/15/22 with c/o weakness, pain after fall at home; 1 wk ago pt experienced difficulty breathing and feelings of heart fluttering; poor appetite; multiple abrasions, fx ribs; found to be positive for COVID; given O2 supplementation and dexamethasone; atrial fibrillation with RVR; family did not want aggressive interventions; DNR/DNI; 10/26/22 pt dc'd to SNF where she later passed away

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
11,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
COPD, HLD, HTN, OSTEOPOROSIS, DMT2
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2603352

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
86,0
Geschlecht
F
Eingang
24.03.2023
Impfdatum
06.10.2021
Beginn
22.11.2022
Tage bis Beginn
412,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had a breakthrough infection and passed away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
32,0
Labordaten
Positive COVID test on 10/23/2022.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2598552

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
80,0
Geschlecht
F
Eingang
17.03.2023
Impfdatum
07.10.2021
Beginn
04.11.2022
Tage bis Beginn
393,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had a breakthrough infection and passed away..

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Positive COVID test on 9/7/2022.
Aktuelle Erkrankungen
Unknown
Vorgeschichte
DM2 HTN Ischemic Stroke
Andere Medikamente
Citalopram Memantine XR Donepezil Cholecalciferol Cyanocobalamin Valsartan Aspirin Nifedipine XL Mirtazapine Quetiapine Macrobid Isosorbide Mononitrate
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2594342

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WA
Alter
68,0
Geschlecht
M
Eingang
09.03.2023
Impfdatum
09.03.2021
Beginn
28.02.2023
Tage bis Beginn
721,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure COVID-19 pneumonia Cardiac failure congestive SARS-CoV-2 test positive

Symptomtext

Patient received Pfizer COVID vaccine on 2/12/21 and 3/9/21. On 2/28/23, patient admitted to our inpatient facility (med/surg unit) with acute hypoxic respiratory failure secondary to acute CHF and COVID-19 pneumonia. Patient discharged home on 3/6/23.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
6,0
Labordaten
COVID status positive 2/28/23.
Aktuelle Erkrankungen
-
Vorgeschichte
morbidly obese male with history of A-fib, diabetes, coronary artery disease, polymyalgia rheumatica on chronic prednisone, hypertension, diabetes, dyslipidemia, BPH, complex sleep apnea syndrome
Andere Medikamente
acetaminophen, apixaban, vitamin c, aspirin, atorvastatin, vitamin d3, citalopram, vitamin b12, diltiazem, dulaglutide inj, folic acid, glipizide, hydroxychloroquine, lidocaine patch, metformin, methocarbamol, metoclopramide, oxycodone, pa
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2584446

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
88,0
Geschlecht
F
Eingang
20.02.2023
Impfdatum
05.02.2021
Beginn
20.05.2022
Tage bis Beginn
469,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

UNKNOWN

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
SPECIMEN COLLECTION FOR COVID-19 PCR TESTING ON 5/9/2022 - POSITIVE ON 5/11/2022 FOR COVID-19 RNA.
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
UNKNOWN; WAS AT A LTCF AT TIME OF DEATH
Andere Medikamente
UNKNOWN
Allergien
UNKNOWN
Vorherige Impfungen
-

VAERS 2578126

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
71,0
Geschlecht
F
Eingang
08.02.2023
Impfdatum
07.03.2021
Beginn
04.10.2022
Tage bis Beginn
576,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

Patient expired due to COVID related infection.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2569346

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
88,0
Geschlecht
M
Eingang
27.01.2023
Impfdatum
01.03.2021
Beginn
11.08.2022
Tage bis Beginn
528,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death

Symptomtext

PATIENT DIED OF COVID 08/18/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2568773

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MN
Alter
84,0
Geschlecht
F
Eingang
26.01.2023
Impfdatum
17.11.2022
Beginn
21.11.2022
Tage bis Beginn
4,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Abdominal pain Acute respiratory failure Bradycardia COVID-19 Cardiac failure congestive Chronic left ventricular failure Condition aggravated Cough SARS-CoV-2 test positive

Symptomtext

Patient seen in the ED on 11/21/22 with abdominal pain for the past two weeks and cough that began the night prior. She recently received her second booster on 11/17/22. In the ED, her O2 sats were at 89-90%, so she was placed on 1L O2 by nasal cannula. COVID-19 PCR test was done in the ED which resulted positive. Ultimately, she was admitted 11/21 for acute hypoxic respiratory failure likely due to a combination of COVID-19 and CHF, acute exacerbation of chronic diastolic heart failure, and bradycardia. Patient discharged 11/24/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2567812

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
83,0
Geschlecht
M
Eingang
25.01.2023
Impfdatum
21.11.2021
Beginn
13.08.2022
Tage bis Beginn
265,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had a breakthrough infection and passed away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
5,0
Labordaten
Positive COVID test on 9/8/2022.
Aktuelle Erkrankungen
Unknown
Vorgeschichte
SAH COPD CAD HTN Hyperlipidemia
Andere Medikamente
Finasteride Atorvastatin Ferrous sulfate Pantoprazole Acetaminophen Aluminum-mag hydroxide-simethicone Bisacodyl Hydroxyzine HCL Melatonin Metoprolol tartrate Nystatin Ranolazine Warfarin
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2567604

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
71,0
Geschlecht
F
Eingang
25.01.2023
Impfdatum
25.02.2021
Beginn
08.08.2022
Tage bis Beginn
529,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had breakthrough infection and expired.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
6,0
Labordaten
Positive COVID test on 8/3/2022.
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2567595

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
LA
Alter
75,0
Geschlecht
F
Eingang
25.01.2023
Impfdatum
19.10.2021
Beginn
08.08.2022
Tage bis Beginn
293,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had breakthrough infection and passed away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
1,0
Labordaten
Positive COVID test on 7/28/2022 and 8/5/2022.
Aktuelle Erkrankungen
Unknow
Vorgeschichte
Dementia DM 2 HTN Dyslipidemia
Andere Medikamente
Metformin Lisinopril Estradiol Pravastatin Sodium Gabapentin Mirabegron Metoprolol Tartrate Amlodipine Aspirin Ascorbic Acid Cholecalciferol Cyanocobalamin
Allergien
Adhesive tape Latex
Vorherige Impfungen
-

VAERS 2567326

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
71,0
Geschlecht
F
Eingang
24.01.2023
Impfdatum
26.02.2021
Beginn
12.12.2021
Tage bis Beginn
289,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Atrial fibrillation COVID-19 Dyspnoea Pneumonia SARS-CoV-2 test positive Septic shock

Symptomtext

PERSON WAS ADMITTED TO HOSPITAL ON 12/5/2021 WITH COMPLAINT OF SHORTNESS OF BREATH. DURING HOSPITALIZATION, PERSON HAD ACUTE HYPOXEMIC RESPIRATORY FAILURE WITH PNEUMONIA AS WELL AS NEW ATRIAL FIBRILLATION WITH RVR, SEPTIC SHOCK.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
7,0
Labordaten
COVID-19 SPECIMEN COLLECTION ON 12/4/2021, TESTED POSITIVE VIA PCR
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
DEMENTIA; HTN; HLD; ASTHMA; GERD; ACUTE RENAL FAILURE; HYPOTHYROIDISM; ANEMIA; HISTORY OF BREAST & SKIN CANCER; ANXIETY; DEPRESSION;
Andere Medikamente
GABAPENTIN; ONDANSETRON; POTASSIUM GLUCONATE; PROCHLORPERAZINE MALEATE; DEXAMETHASONE; HYDROCODONE-ACETAMINOPHEN; LEVOTHYROXINE
Allergien
BENZODIAZEPINES
Vorherige Impfungen
-

VAERS 2533229

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MI
Alter
70,0
Geschlecht
M
Eingang
15.12.2022
Impfdatum
19.03.2021
Beginn
09.12.2021
Tage bis Beginn
265,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute kidney injury Acute respiratory failure Angiogram abnormal Asthenia Blood albumin decreased Blood creatine phosphokinase MB Blood creatine phosphokinase normal Blood creatinine increased Blood culture negative Blood folate normal Blood glucose normal Blood lactate dehydrogenase increased Blood potassium increased Blood urea increased Blood urea nitrogen/creatinine ratio Blood uric acid increased COVID-19 COVID-19 pneumonia

Symptomtext

Patient is a 71-year-old obese male, with known history of hypertension, CAD, status post myocardial infarction, a recent bout of COVID-19 infection, who presents essentially 13 days post discharge after he was admitted because of signs and symptoms of acute respiratory failure related to COVID-19 infection. The patient was presumably started back up on nifedipine for blood pressure control. Per family member, Patient has had in the past problems with calcium channel blockers while they may come retain more fluid. The patient reported return and worsening of difficulty in breathing, reason why he decided to come back into the hospital for evaluation. Workup in the emergency room does find the patient moderately hypertensive with a blood pressure 183/94, tachypneic, respiratory rate 36, otherwise afebrile. Saturating down to 81% on room air. ER stay was complicated by requiring BiPAP. He has now been successfully weaned off. Further workup in the emergency room does include a CMP that shows a BUN and creatinine are 37 and 1.7 respectively with a glucose of 116. Albumin 2.2. Potassium 5.7 from presumably a slightly hemolyzed sample. BUN and creatinine ratio is 22. Troponin is 9.1. CK and CK-MB 60 and less than 2.5. LDH 268. Ferritin 776.1. D-dimer is 1234. CBC with differential shows no concerns for infection. COVID-19 testing still positive. Influenza panel respiratory syncytial virus negative. Duplex of the left upper extremity negative for DVTs. One view of the chest ordered and pending. Because of the above findings, the patient did go on to receive Lasix, Solu-Medrol, as well as tramadol and gabapentin and Hospital Medicine was then called to admit the patient to the hospital for further monitoring, workup, and treatment." Patient was admitted to medical telemetry. He was notably anasarcus with fluid retention from toes up to abdomen with notable scrotal swelling. Cardiology, Nephrology consulted. Aggressive diuresis initiated. The patient initially with good diuresis and then plateau. He has been transitioned to Lasix 40 mg p.o. On discharge. Continued daily weights with monitoring of intake and output with fluid restriction is recommended. Cardiology was able to adjust medications given elevated blood pressures. He will need follow up with Dr. Findings for COVID-19 pneumonia on admission was ruled out. It is noted the patient does have historical COVID-19 pneumonia dating back to December 9, 2021. Despite no leukocytosis nor growth on blood cultures, urinalysis was abnormal with nitrates and leukocyte esterase. Repeat UA confirmed similar. Cultures obtained. He had two culture growths of E. coli. Renal ultrasound revealed a persistent right renal stone which is the likely etiology in combination with self catheterization due to neurogenic bladder due to history of back injury, status post surgical intervention. PSA was not elevated. Patient was treated with Cipro-which was renal dosed.. This should be continued for a full 14 days. Surveillance for UTIs is recommended noting the patient's kidney stone is nonobstructing and will not likely resolved. Additionally given his neurogenic bladder he is at risk for UTIs. He will need regular follow-up with Dr. MD It is noted that he was given Ultram which did not help his pain. He was given Remeron which did not help asleep. Both of these medications did make him groggy and alter his mentation with episode of him hallucinating that his roommates diagnosis for his. Additionally he was given Flexeril and remained very groggy for at least 6 hr after dosing. He had been on Ultram outpatient. He was also on Benadryl. These were both stopped due to the potential for urinary retention. Additionally Benadryl has anticholinergic affects which could be negatively affecting his mentation. Hyper start an was held due to potassium sparing affects and presentation with hyperkalemia. This was not resumed. AKI on admission in setting of chronic kidney disease stage IIIB with AKI following CTA 12/28/21 and with secondary hyperparathyroidism due to Renal osteodystrophy. He was started on calcitriol 3 times weekly-Monday, Wednesday and Friday. Hypercalcemia treated with calcium carbonate/Tums. With chronic kidney disease Rolaids should be avoided due to aluminum content. He is continued thusly on times daily. He is encouraged to eat a low-sodium diet of 2 g low-potassium diet of 2 g as well as maintain a 2 L fluid restriction. Apresoline was increased from 50-75 mg t.i.d. Uric acid elevated at 8.1 - He will require follow-up with nephrology. Macrocytosis appreciated with low B12. Repletion with cyanocobalamin started and is recommended lifelong. Folate was low normal. Folate repletion also started given synergistic action. Patient was able to taper oxygen to 4 L via nasal cannula from Bipap for treatment of presenting hypoxia measured at 81% on Room Air. At baseline he reports no home supplemental oxygen use. On discharge he has new diagnosis of chronic respiratory failure with hypoxia. CT- chest 12/28 did reveal bilateral pulmonary effusions. These could be re-evaluated in the future if anasarca recurs. Given his frail nature with severe deconditioning and multiple allergies. Thoracentesis was not considered. In the future, with continued diuresis if these have not resolved, He may benefit from thoracentesis He participated in PT and OT with acknowledgement that at home he generally furniture walks and is severely deconditioned. He is discharging to skilled nursing facility for continued multi disciplinary therapy. He will need close specialist follow-up and urine surveillance given recurrence of UTI.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
6,0
Labordaten
Positive COVID 19 test on 12/09/2021
Aktuelle Erkrankungen
-
Vorgeschichte
01/24/2017 Coronary atherosclerosis 5/13/13 Hydrocele Date Unknown Anxiety Date Unknown Asthma Date Unknown Atrial fibrillation Date Unknown CKD (chronic kidney disease), stage III Date Unknown COPD (chronic obstructive pulmonary disease) Date Unknown GERD (gastroesophageal reflux disease) Date Unknown Heart disease Date Unknown HTN (hypertension) Date Unknown Hyperlipidemia Date Unknown MI (myocardial infarction) Date Unknown Neurogenic bladder Date Unknown Sciatic pain Date Unknown Self-catheterizes urinary bladder
Andere Medikamente
aspirin (HALFPRIN) 81 MG tablet bumetanide (BUMEX) 1 MG tablet Cholecalciferol (VITAMIN D3) 2000 UNIT capsule Cyanocobalamin (B-12) 5000 MCG CAPS gabapentin (NEURONTIN) 300 MG capsule hydrlazine (APRESOLINE) 100 MG tablet isosorbide mononit
Allergien
Ace InhibitorsShortness of Breath Calcium Channel BlockersShortness of Breath ClonidineOther (Add Comment) Celexa Hallucinations Fish Oil Unknown Lipitor [Atorvastatin Calcium] Unknown Losartan Wheezing Norvasc [Amlodipine]Shortness of Breath, Swelling
Vorherige Impfungen
-

VAERS 2531208

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
86,0
Geschlecht
M
Eingang
14.12.2022
Impfdatum
10.03.2021
Beginn
01.06.2022
Tage bis Beginn
448,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death Respiratory failure SARS-CoV-2 test positive

Symptomtext

pt had a recent hospitalization for hypoxic respiratory failure; found to be positive for COVID; On O2 supplementation via NC; recent CVA, too; dc'd to SNF (local Care Center); DNR; comfort care; pt passed away in the SNF

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CVA, basal cell CA, colon CA, GERD
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2511641

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
73,0
Geschlecht
F
Eingang
18.11.2022
Impfdatum
25.02.2021
Beginn
27.09.2022
Tage bis Beginn
579,0
Dosis
UNK
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Acute kidney injury Anaemia Atrial fibrillation Blood test abnormal COVID-19 Death Gastrointestinal haemorrhage Haematochezia Hypotension Mechanical ventilation Respiratory failure SARS-CoV-2 test positive Septic shock Serratia test positive Sputum test Transfusion Troponin increased

Symptomtext

TESTED + FOR COVID ON 08/29/2022. TRANSFERRED ON 9-9-22 with septic shock, resp failure, covid, acute kidney injury, elevated troponin, anemia and GI bleed. She had multiple specialty consults including pulmonary, cardiology, infectious disease, nephrology. Had complicated course with being on ventilator, on levophed , given merrem antibiotics, dexamethason and baricitinib, had serratia in sputum and blood, developed afib with rapid ventricular response with hypotension. amiodarone and pressure support , had bloody stools, anemia ,t ransfusions . Deceased 9-27-22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CAD WITH STENT, GERD, THYROID DISEASE, MASS OF LEFT BREAST, H/O VENTRICULAR SEPTAL DEFECT S/P SURGERY, HOME MEDS INCLUDED TWO BP MEDS SO SHE MAY HAVE HAD HTN
Andere Medikamente
-
Allergien
KEFLEX (RASH BREATHING) ;IODINATED CONTRAST (RASH HIVES BREATHING); LEVOFLOXACIN (RASH, HIVES , BREATHING); AMOXICILLIN AND CLAVULANIC ACID (AUGMENTIN - RASH); BUPROPRION (HIVES): SULFA (RASH HIVES); MONTELUKAST FROM SINGULAIR (RASH)
Vorherige Impfungen
-

VAERS 2499246

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
70,0
Geschlecht
M
Eingang
04.11.2022
Impfdatum
01.03.2021
Beginn
27.09.2022
Tage bis Beginn
575,0
Dosis
2
Route/Site
SYR / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death Vaccine breakthrough infection

Symptomtext

COVID related death, breakthrough case

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
chronic lymphoid leukemia, coronary atherosclerosis, hypertension, sleep apnea
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2491480

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MI
Alter
85,0
Geschlecht
F
Eingang
27.10.2022
Impfdatum
24.03.2021
Beginn
10.12.2021
Tage bis Beginn
261,0
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure Angiogram pulmonary abnormal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Decreased appetite Dyspnoea Echocardiogram normal Ejection fraction Fatigue Haemoglobin Headache Hypoxia Malaise Pain Respiration abnormal Respiratory tract congestion

Symptomtext

Patient presented to the ED via MMR accompanied by her grandson for evaluation of increased shortness of breath. According to her grandson patient was diagnosed with COVID-19 last week and started with some congestion, cough, headache, body aches fatigue, decreased appetite and shortness of breath which has worsened in the last few days and decided to come to ER for further evaluation. Per her grandson patient was admitted overnight 7 days ago at hospital where she was started on steroid and oxygen and discharged home but patient continued having symptoms and he brought her for further evaluation. No recent fall or injury. Patient denies any chest pain or leg edema. Denies any history of coronary artery disease or congestive heart failure. Upon arrival to ER patient was hypoxic in the 80s and was placed on oxygen Her vitals shows blood pressure 172/70 heart rate 64 temperature 99.8? respiratory rate 18 pulse ox improved to 94% on room air Chest x-ray showed COVID-19 pneumonia Her lab showed white count at 7.4 hemoglobin. She was diagnosed with sepsis due to covid pneumonia with associated acute hypoxic respiratory failure at time of admission. Patient was admitted on 3 L of oxygen via nasal cannula. Breathing declined and oxygen demand maxed at 6 L via nasal cannula. she was tapered to 1L via NC after high-dose steroids and Remdesivir. She declined Baracitinib. She continues on Decadron which has been tapered to 2mg po daily and can be tapered off this week. Patient's oxygen saturations with demand plateaued at 6 L for approximately 4-5 days. Subsequent CTA for evaluation of PE showed incidental finding of thyroid mass which needs further follow-up outpatient. The patient has been advised. There was no findings of PE. Echocardiogram also completed without any significant abnormalities nor acute findings. LVEF is preserved. Again incidental finding during chart review of hepatocellular disease On 11/2020 imaging without known history of liver affected cancer. Patient is medically cleared for discharge to skilled nursing facility for continued multi disciplinary care in improved condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
18,0
Labordaten
Positive COVID 19 test 12/10/2021
Aktuelle Erkrankungen
-
Vorgeschichte
Date Unknown Acid reflux Date Unknown Anemia Date Unknown Anxiety Date Unknown Arthritis Date Unknown Breast cancer (HCC) Date Unknown Colon cancer (HCC) Date Unknown Depression Date Unknown Diabetes mellitus (HCC) Date Unknown Diverticulitis Date Unknown High cholesterol Date Unknown Hypertension Date Unknown Leg edema
Andere Medikamente
B Complex Vitamins (B COMPLEX 1 PO) Calcium Carb-Cholecalciferol 600-800 MG-UNIT TABS Cinnamon 500 MG capsule glucose blood strip (BLOOD GLUCOSE TEST STRIP) box hydrochlorothiazide (HYDRODIURIL) 25 MG tablet HYDROcodone-acetaminophen (
Allergien
NSAID
Vorherige Impfungen
-

VAERS 2484345

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
FL
Alter
59,0
Geschlecht
M
Eingang
20.10.2022
Impfdatum
18.03.2021
Beginn
18.09.2022
Tage bis Beginn
549,0
Dosis
2
Route/Site
SYR / AR
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein
Blindness unilateral Carotid artery aneurysm Cerebrovascular accident Computerised tomogram Fatigue Intracranial aneurysm Joint swelling Laboratory test Magnetic resonance imaging Scan with contrast X-ray

Symptomtext

chronic fatigue, swollen joints shortly after 2nd dose. Then Sept 18, 2022 lost vision in left eye went to ER was admitted due to a stroke. Further testing showed a previous stroke along with a Brain and Carotid Artery Aneurysm

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
2,0
Labordaten
Labs, CT Scans, MRI w/contrast Sept 19-20, 2022 and several xrays
Aktuelle Erkrankungen
None
Vorgeschichte
removal of squamous cell skin cancers
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2478371

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
89,0
Geschlecht
M
Eingang
14.10.2022
Impfdatum
04.03.2021
Beginn
29.09.2021
Tage bis Beginn
209,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
COVID-19 Cardiac arrest Death Decreased appetite Encephalopathy Failure to thrive Hypoxia SARS-CoV-2 test positive Viral sepsis Weight decreased

Symptomtext

pt presented to hospital with viral sepsis, encephalopathy, positive COVID test, hypoxia due to COVID; failure to thrive (wt loss of 100# in past year with poor appetite; ABX; Remdesivir; Dexamethasone; O2 supplementation intermittently; pt had a cardiac arrest and passed away in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CAD, CHRONIC VENOUS INSUFFICIENCY
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2470654

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
98,0
Geschlecht
F
Eingang
06.10.2022
Impfdatum
24.02.2021
Beginn
19.02.2022
Tage bis Beginn
360,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient had a positive COVID test on 1/22/22 and 2/7/22. They expired on 2/19/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
30,0
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
AKI CHF Peripheral neuropathy hypothyroidism hyponatremia
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2470633

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
81,0
Geschlecht
M
Eingang
06.10.2022
Impfdatum
02.12.2021
Beginn
19.02.2022
Tage bis Beginn
79,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient had a positive COVID test on 2/07/2022 and expired on 2/19/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CVA Dementia Atrial fibrillation CAD HTN Hyperlipidemia MI DM type 2 Rheumatoid arthritis
Andere Medikamente
Duloxetine Metoprolol tartrate Furosemide Methocarbamol
Allergien
Niacin Penicillins
Vorherige Impfungen
-

VAERS 2470097

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
93,0
Geschlecht
F
Eingang
05.10.2022
Impfdatum
24.02.2021
Beginn
17.02.2022
Tage bis Beginn
358,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient had a positive COVID test on 1/31/2022 and expired on 2/17/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2467781

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
86,0
Geschlecht
M
Eingang
03.10.2022
Impfdatum
23.02.2021
Beginn
22.02.2022
Tage bis Beginn
364,0
Dosis
1
Route/Site
SYR / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

tested + for covid initally on 2-9-22 and on same date + at Med Center 2-9-22 and 2-17-22. Deceased 2-22-22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2450866

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
89,0
Geschlecht
M
Eingang
19.09.2022
Impfdatum
28.02.2021
Beginn
01.06.2022
Tage bis Beginn
458,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death Inappropriate schedule of product administration SARS-CoV-2 test positive

Symptomtext

PFIZER COVID VACCINE #3 GIVEN 6/27/2021, LOT #FF2587; pt passed away at home; pt had a positive COVID test 6/15/22; no medical records on this patient; PCP is unknown

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2436376

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
78,0
Geschlecht
F
Eingang
09.09.2022
Impfdatum
04.02.2021
Beginn
19.08.2022
Tage bis Beginn
561,0
Dosis
2
Route/Site
- / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Chest pain Death Dyspnoea

Symptomtext

SOB, weakness, chest pain. Pt expired 08/19/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Stage IV metastatic squamous cell carcinoma of the lung; hypertension
Andere Medikamente
Benazepril; cyclobenzaprine
Allergien
N/A
Vorherige Impfungen
-

VAERS 2433664

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MI
Alter
67,0
Geschlecht
F
Eingang
08.09.2022
Impfdatum
08.02.2021
Beginn
22.08.2022
Tage bis Beginn
560,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 pneumonia Chest tube insertion Death Dyspnoea Endotracheal intubation Haemodynamic instability Hypoxia Mechanical ventilation Oxygen saturation decreased Pneumothorax Respiratory distress SARS-CoV-2 antibody test SARS-CoV-2 antibody test positive

Symptomtext

68y.o. female with PMH pertinent for seronegative RA on chronic prednisone recent COVID PNA presented for worsening SOB. In the ER, patient was hypoxic requiring HFNC 100% FiO2/50 L and a nonrebreather maintaining SPO2 in the early 90s. Significant increase in work of breathing. Patient was intubated. On 8/28, the patient developed resp distress. Patient had a needle decompression and then chest tube placement for right sided tension pneumothorax. Patient was unable to be weaned off ventilator and on 9/5 had a drop in SpO2 with increased WOB. Patient required multiple pressors for hemodynamic instability. Patient transitioned to comfort care, and passed peacefully that evening.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
15,0
Labordaten
8/23/22 SARS-CoV-2 IgG (Anti-Spike) -- positive
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2425215

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MI
Alter
82,0
Geschlecht
M
Eingang
31.08.2022
Impfdatum
02.03.2021
Beginn
30.08.2022
Tage bis Beginn
546,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure COVID-19 Exposure to SARS-CoV-2 Fatigue Malaise

Symptomtext

Pt arrives with fatigue and malaise. Pt reports that his wife lives in a nursing home and he has had a COVID exposure there. Pt was admitted with acute hypoxic respiratory failure and COVID-19.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2422754

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
100,0
Geschlecht
M
Eingang
29.08.2022
Impfdatum
07.03.2021
Beginn
01.02.2022
Tage bis Beginn
331,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
COVID-19 Death Dyspnoea Haemoptysis Inappropriate schedule of product administration SARS-CoV-2 test positive Tachycardia Tachypnoea

Symptomtext

PFIZER COVID VACCINE #3 GIVEN 10/1/21, LOT #30145BA; 2/11/22 pt brought to ED with hemoptysis and SOB; was on hospice for CHF; pt had a positive COVID test on 1/30/22; DNR/DNI; pt in hospital became tachycardic and tachypneic; comfort measures put in place and pt expired in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CHF, DEMENTIA, PVD, BEDBOUND
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2418303

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
67,0
Geschlecht
M
Eingang
23.08.2022
Impfdatum
25.02.2021
Beginn
22.02.2022
Tage bis Beginn
362,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Cough Death Dyspnoea Hypoxia Lung infiltration

Symptomtext

deceased 02/22/2022; admitted 2/4/2022 with 3 days of cough, shortness of breath and weakness. Developed hypoxia and progression of diffuse b/l infiltrates

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CAD s/p CABG; aortic stenosis s/p TAVR, Diabetes, Htn, Chronic kidney disease
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2415852

UNKNOWN MANUFACTURER · COVID19 (COVID19 (UNKNOWN)) · Charge EN6198

kritisch
Staat
KY
Alter
77,0
Geschlecht
M
Eingang
19.08.2022
Impfdatum
26.02.2021
Beginn
27.12.2021
Tage bis Beginn
304,0
Dosis
1
Route/Site
UN / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

deceased 12/27/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2415824

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
82,0
Geschlecht
M
Eingang
19.08.2022
Impfdatum
06.03.2021
Beginn
01.01.2022
Tage bis Beginn
301,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute kidney injury Asthenia COVID-19 COVID-19 pneumonia Chest X-ray abnormal Death Fall Herpes simplex Herpes simplex meningitis Hypophagia Inappropriate schedule of product administration Lung opacity SARS-CoV-2 test positive Seizure

Symptomtext

PFIZER COVID VACCINE #3 GIVEN 12/29/21, LOT #FJ8757; 1/4/22 pt had a positive COVID test from Urgent Care; 1/9 - 1/19/22 pt had a hospitalization (name of hosp unknown) with COVID pneumonia; 2/7 - 2/26/22 pt brought to hospital again with increasing weakness, falling, and poor oral intake; CXR showed improvements, still with bilateral interstitial and patchy alveolar opacities; AKI; pt had a seizure in the hospital; found to have HSV-2 meningitis; treated with Acyclovir; seizure medications given for seizures; poor prognosis; transitioned to comfort care; dc'd to Life Care Center on hospice; pt expired in the Life Care Center

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
31,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
DM, HTN, CAD, SKIN CA
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2415822

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6198

kritisch
Staat
FL
Alter
69,0
Geschlecht
M
Eingang
19.08.2022
Impfdatum
24.12.2021
Beginn
09.08.2022
Tage bis Beginn
228,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure COVID-19 pneumonia Hypotension Metabolic encephalopathy

Symptomtext

Patient admitted for COVID-19 pneumonia, hypotension, metabolic encephalopathy, acute hypoxemic respiratory failure. Treated with decadron and remdesivir and inhalers. Once stable pt d/c home

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
hypertension, hyperlipidemia, coronary artery disease status post 5 stents, status post CABG x5, 3 years ago, depressi
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2412320

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
73,0
Geschlecht
M
Eingang
16.08.2022
Impfdatum
10.03.2021
Beginn
09.02.2022
Tage bis Beginn
336,0
Dosis
2
Route/Site
SYR / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Atrial fibrillation COVID-19 Death Endotracheal intubation General physical health deterioration Lacunar infarction Pulmonary oedema Resuscitation Syncope Unresponsive to stimuli

Symptomtext

Patient was diagnosed with Covid-19 on 02/09/2022. He drove himself to ED and collapsed in the parking lot and was found down, he was taken to ED and CPR initiated, and he was intubated. Patient was found to have Lacunar Infarct, Pulmonary edema, Afib with RVR. Patient was admitted to hospital services. Family eventually elected DNR/Comfort Care. Patient was extubated. Patient was transferred to Hospice. Patient was unresponsive and actively dying. Patient expired on 03/18/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2411321

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6198

kritisch
Staat
IN
Alter
66,0
Geschlecht
M
Eingang
15.08.2022
Impfdatum
12.04.2021
Beginn
27.12.2021
Tage bis Beginn
259,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Alanine aminotransferase normal Angiogram pulmonary abnormal Anion gap Aspartate aminotransferase increased Back pain Basophil count decreased Basophil percentage decreased Blood albumin decreased Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium decreased Blood chloride normal Blood creatinine normal Blood glucose normal Blood group A Blood potassium normal Blood sodium normal Blood test

Symptomtext

67 year old male presents to the ED via private vehicle complaining of cough onset PTA. pt reports coughing up blood recently and is trying to cough now but cant. Pt was recently diagnosed with COVID-19 on 12/13/21. Pt c/o of dyspnea, chest pain, back pain ,nasal congestion and headache. Pt reports that the chest pain is a stabbing pain that is worse with deep inspiration. he reports feeling better from COVID-19 but is still having symptoms. He denies fever, dysuria or hematuria. Review of Systems Constitutional: no fever Eyes: no eye pain ENMT: no sore throat, +nasal congestion Cardiovascular: +chest pain Respiratory: +shortness of breath, +cough Gastrointestinal: no abdominal pain Genitourinary: no dysuria Musculoskeletal: +back pain Skin: no rash Neurologic: +headache Physical Exam/Objective Vitals & Measurements last 24 hours VITAL SIGNS Temp C: 36.9 DegC Heart Rate: 84 bpm Resp Rate: 32 br/min BP #1: 110 / 72 mmHg SpO2 (%): 90 % O2 Flow (l/min): 2 L/min O2 Device: Nasal Cannula Height CM: 180 cm Weight KG: 83.2 kg Ideal Body Weight: 74.99 kg I have reviewed the triage vital signs General: mild distress, Eye: no conjunctival injection Cardiovascular: rhythm regular, S1S2 within normal limits Respiratory: lungs clear, tachypneic but speaking in full sentences Gastrointestinal: soft, non-distended, nontender, no guarding Msk: NC/AT, extremities without deformity Skin: warm, dry, no cyanosis Psych: appropriate mood and affect Neurological: Alert, conversant, speech normal Medical Decision Making 67 year old year old male presents with cough. Pt was in ED 12/21 for emesis and nausea. Diagnosed with COVID-19 on 12/13. Pt arrived hypoxic to 89%. He was placed on 2L NC. Found to have pulmonary embolism. Nasal cannula was escalated to HHFNC due to tachypnea. Labs: reviewed Radiology: reviewed EKG: 1319. Rate: 80. Rhythm: sinus. Axis: normal. Intervals: normal. ST segments: no ST depression or elevation Re-Assessment 12/27/21 13:04:05 Pt is 94% on 2L. 12/27/21 17:53:10 Requested high flow cannula, respiratory rate is in 30-40 range Condition Stable Disposition: 12/27/21 18:05:06 Transferred care of pt to Dr., MD Counseled patient regarding diagnosis, regarding diagnostic results, regarding treatment plan. Patient indicated understanding of instructions. Assessment/Plan 1. Pulmonary emboli I26.99 2. Hemoptysis R04.2 3. Chest pain R07.9 4. COVID-19 U07.1 5. Leukocytosis D72.829 Chronic Problem List Procedure/Surgical History ?Diabetic retinal eye exam (05/07/2021) ?Septo/Turbs (11/17/2020) ?septoplasty, turbinate reduction with Dr. on 11/17/2020 (11/17/2020) ?Diabetic retinal eye exam (01/16/2020) ?Diabetic retinal eye exam (01/24/2019) ?Teeth Extraction (2013) ?egd (01/10/2006) ?laparotomy with small bowel resection for gunshot wound (1974) ?Splenectomy (removal of spleen) (1974) ?Fracture repair (1966) ?Ingrown toenail removal both feet. Medications Home Medications (28) Active Accu-Chek Guide Blood Glucose Meter Not Applicable, Other, Unscheduled Accu-Chek Guide Test Strips Check 2 times daily, Other, Unscheduled Accu-Chek Softclix Lancets Check 2 times daily, Other, Unscheduled, Dispense QS 90 days albuterol 0.63 mg/3 mL (0.021%) inhalation solution 0.63 mg = 3 mL, PRN, Neb Inhal, Q6H aspirin 81 mg oral tablet 81 mg = 1 Tablet, Orally, Every Other Day, Do not take aspirin for 10 days atorvastatin 80 mg oral tablet 80 mg = 1 Tablet, Orally, Daily Atrovent Nasal 42 mCg/spray 2 Spray, intraNASAL, TID docusate sodium 100 mg oral capsule 100 mg = 1 Capsule, Orally, Daily Dulera 100 mCg-5 mCg/inh inhalation aerosol 2 Puff, Inhalation, BID Glucophage XR 500 mg oral tablet, extended release 1,000 mg = 2 Tablet, Orally, BID Jardiance 10 mg oral tablet 10 mg = 1 Tablet, Orally, QAM Keppra 1000 mg oral tablet 1,000 mg = 1 Tablet, Orally, BID losartan 25 mg oral tablet 25 mg = 1 Tablet, Orally, Daily Nebulizer - Standard Small Volume (ONCE) Not Applicable, Other, Unscheduled Neurontin 300 mg oral capsule 600 mg = 2 Capsule, Orally, At Bedtime ondansetron 4 mg oral tablet, disintegrating 4 mg = 1 Tablet, PRN, Orally, Q6H Pen Needles - Insulin (4mm x 32G) Use daily, Other, Unscheduled, Dispense QS 90 days;needs pen needles for Victoza pens Prilosec 20 mg oral delayed release capsule 20 mg = 1 Capsule, Orally, Daily ProAir HFA 90 mCg/inh inhalation aerosol 1 Puff, PRN, Inhalation, 4 Times Daily promethazine 25 mg oral tablet 25 mg = 1 Tablet, PRN, Orally, Q4H propranolol 40 mg oral tablet See Instructions, take 2 tablets in AM and 1 tablet in PM rizatriptan 5 mg oral tablet, disintegrating 5 mg = 1 Tablet, Orally, Daily, may repeat dose once in 2 hours Singulair 10 mg oral tablet 10 mg = 1 Tablet, Orally, Daily tamsulosin 0.4 mg oral capsule 0.8 mg = 2 Capsule, Orally, QHS topiramate 50 mg oral tablet 50 mg = 1 Tablet, Orally, BID Victoza 18 mg/3 mL subcutaneous solution 1.8 mg, Subcutaneous, Daily, Please dispense 90 day supply Vitamin D3 2,000 intl units (50 mCg) oral capsule 50 mCg = 1 Capsule, Orally, Daily, OTC Voltaren Topical 1% topical gel 2 GM, Topical, 4 Times Daily, not to exceed 8 grams/day/single joint of upper extremitiesnot to exceed 32 grams/day Tobacco Use: Former Smoker. Cigarettes, 0.25 packs per day. 50 year(s). Family History Brain cancer 02-JUL-2017 11:19:02<$>: Mother and Father. Heart disease..: Mother, Father and Brother. Lab Results Hemogram-Platelets-WBC Differential FS LATEST RESULTS HISTORICAL RESULTS WBC 12/27/21 14:02 16.8 High 12/21/21 8.2 RBC 12/27/21 14:02 4.49 12/21/21 4.81 Hgb 12/27/21 14:02 13.4 12/21/21 14.7 Hct 12/27/21 14:02 41.8 12/21/21 44.4 MCV 12/27/21 14:02 93 12/21/21 92 MCH 12/27/21 14:02 29.8 12/21/21 30.6 MCHC 12/27/21 14:02 32.0 12/21/21 33.2 RDW 12/27/21 14:02 13.7 12/21/21 14.3 Platelet 12/27/21 14:02 221 12/21/21 276 MPV 12/27/21 14:02 7.5 12/21/21 7.2 Neutrophils % 12/27/21 14:02 78 12/21/21 72 Lymphocytes % 12/27/21 14:02 9 12/21/21 16 Monocytes % 12/27/21 14:02 12 12/21/21 11 Eosinophils % 12/27/21 14:02 0 12/21/21 0 Basophils % 12/27/21 14:02 0 12/21/21 0 Absolute Neutrophil 12/27/21 14:02 13.1 High 12/21/21 5.9 Absolute Lymphocyte 12/27/21 14:02 1.5 12/21/21 1.3 Absolute Monocyte 12/27/21 14:02 2.0 High 12/21/21 0.9 Absolute Eosinophil 12/27/21 14:02 0.0 12/21/21 0.0 Absolute Basophil 12/27/21 14:02 0.1 12/21/21 0.0 Routine Coagulation Studies FS LATEST RESULTS HISTORICAL RESULTS PT 12/27/21 14:02 16.6 High INR 12/27/21 14:02 1.43 High D-Dimer Pl QN 12/27/21 14:02 6028 High 12/21/21 484 High Routine Serum/Plasma Chemistry Tests FS LATEST RESULTS HISTORICAL RESULTS Sodium SerPl QN 12/27/21 14:02 137 12/21/21 136 Potassium SerPl QN 12/27/21 14:02 4.3 12/21/21 4.0 Chloride SerPl QN 12/27/21 14:02 101 12/21/21 104 Carbon Dioxide SerPl QN 12/27/21 14:02 22 12/21/21 22 Anion Gap 12/27/21 14:02 14 High 12/21/21 10 BUN SerPl QN 12/27/21 14:02 24 High 12/21/21 21 High Creatinine SerPl QN 12/27/21 14:02 1.03 12/21/21 1.07 Estimated GFR (CKD-EPI) 12/27/21 14:02 75 12/21/21 71 Estimated CRCL (CG) 12/27/21 14:02 77 12/21/21 71 Glucose SerPl QN 12/27/21 14:02 111 High 12/21/21 96 Calcium Total SerPl QN 12/27/21 14:02 8.6 12/21/21 8.9 Alkaline Phos SerPl QN 12/27/21 14:02 99 12/21/21 77 ALT SerPl QN 12/27/21 14:02 21 12/21/21 33 AST SerPl QN 12/27/21 14:02 25 12/21/21 49 High Bilirubin Total SerPl QN 12/27/21 14:02 1.0 12/21/21 1.0 Total Protein SerPl QN 12/27/21 14:02 7.2 12/21/21 7.5 Albumin SerPl QN 12/27/21 14:02 3.2 Low 12/21/21 3.8 Troponin-I High Sensitivity 12/27/21 14:02 4 12/21/21 7 BNP Pl QN 12/27/21 14:02 87 Blood Bank Testing LATEST RESULTS ABO Rh 12/27/21 14:02 A Pos IAT Interp 12/27/21 14:02 Neg Diagnostic Results XR Chest PA or AP Portable 12/27/21 13:42:08 IMPRESSION: Patchy bilateral pulmonary infiltrates are increased compared to 12/21/2021. The appearance is nonspecific but consistent with COVID-19 infection. Electronically Signed by: Signed By: MD ************************************************** CTA Chest Pulm Embolism W/IV Contrast 12/27/21 16:33:51 IMPRESSION: Bilateral and predominantly posterior pulmonary infiltrates and/or pulmonary hemorrhage have progressed slightly since 12/21/2021. Interval development of a large pulmonary embolus to the right middle and lower lobe pulmonary artery segments.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
CTA Chest Pulm Embolism W/IV Contrast 12/27/21 16:33:51 IMPRESSION: Bilateral and predominantly posterior pulmonary infiltrates and/or pulmonary hemorrhage have progressed slightly since 12/21/2021. Interval development of a large pulmonary embolus to the right middle and lower lobe pulmonary artery segments. 12/27/21 13:42:08 IMPRESSION: Patchy bilateral pulmonary infiltrates are increased compared to 12/21/2021. The appearance is nonspecific but consistent with COVID-19 infection.
Aktuelle Erkrankungen
no acute illnesses
Vorgeschichte
Pt has hx of COPD. Pt has not been on O2 before. Chronic atrophic gastritis without bleeding COPD (chronic obstructive pulmonary disease) Diabetic neuropathy History of alcohol abuse Hyperlipidemia Left renal artery stenosis Nasal congestion with rhinorrhea Nasal obstruction Non-insulin treated type 2 diabetes mellitus Routine health maintenance Seizure disorder Sleep apnea Vasomotor rhinitis
Andere Medikamente
-
Allergien
advair diskus
Vorherige Impfungen
-

VAERS 2399369

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
50,0
Geschlecht
F
Eingang
02.08.2022
Impfdatum
26.02.2021
Beginn
29.07.2022
Tage bis Beginn
518,0
Dosis
2
Route/Site
IM / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acidosis Acute respiratory distress syndrome Acute respiratory failure COVID-19 COVID-19 pneumonia Death Dialysis Dyspnoea Endotracheal intubation Inappropriate schedule of product administration Mechanical ventilation Oxygen saturation decreased SARS-CoV-2 test positive Superinfection

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer BioNTECH vaccine on 1/28/21 and 2/26/21. Tested covid + at home 7/1 was initially admitted to OSF 7/14 for SOB and COVID PNA. Intubated, started on ATBs for superimposed PNA, and transferred 7/20. Severe ARDS and requiring fio2 100% and pressors. Req'd dialysis 7/25. Resp status cont to decline req max vent support. Unable to maintain sats > 92% became increasingly acidotic req'd add'l vasopressors and bicarb for pH correction. Cont'd to decompensate. On 7/28 O2 dropped to consistently < 80%. Transitioned to comfort care. Tx'd with vanc, micafungin, decadron, and cefepime. Expired on 7/29/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
10,0
Labordaten
Covid + 7/13/22 - This sample was analyzed using the Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification(NAA)technology.
Aktuelle Erkrankungen
-
Vorgeschichte
CKD4, kidney transplant (2001), HTN, HLD, chronic pain, migraines, gout, depression
Andere Medikamente
albuterol, allopurinol, atorvastatin, azithromycin, calcitriol
Allergien
Ibuprofen
Vorherige Impfungen
-

VAERS 2396373

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MN
Alter
80,0
Geschlecht
F
Eingang
29.07.2022
Impfdatum
01.11.2021
Beginn
03.07.2022
Tage bis Beginn
244,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure Asthenia COVID-19 Cough Escherichia bacteraemia Fall SARS-CoV-2 test positive Septic shock Vaccine breakthrough infection

Symptomtext

Patient with history of COPD. She was brought into the ED on 7/3 by EMS for weakness and a fall. She additionally reported a cough. She was hypoxic per the paramedics and was placed on supplemental O2. COVID-19 PCR test was done in the ED which was positive. Patient admitted from 7/3-7/12, discharge diagnoses included septic shock secondary to E. coli bacteremia and acute hypoxic respiratory failure secondary to COVID infection, among others. This meets criteria for vaccine breakthrough case review.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
9,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2393354

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
91,0
Geschlecht
M
Eingang
27.07.2022
Impfdatum
27.02.2021
Beginn
01.08.2021
Tage bis Beginn
155,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute respiratory failure Anticoagulant therapy Asthenia COVID-19 COVID-19 pneumonia Chest tube insertion Cough Death Deep vein thrombosis Myalgia Pneumothorax Positive airway pressure therapy Pyrexia SARS-CoV-2 test positive

Symptomtext

EMS called to pt's house due to fever, generalized weakness, cough, myalgias; O2 saturation 88% on RA; O2 supplement; found to be positive for COVID; admitted; AHRF secondary to COVID pneumonia; Decadron; US showed DVT left peroneal; started on Eliquis; placed on BiPAP; developed left pneumothorax, Chest tube placed; pt changed status to DNR/DNI, comfort measures only; pt expired in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
17,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, HLD, GERD, CKD
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2393161

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MI
Alter
79,0
Geschlecht
M
Eingang
27.07.2022
Impfdatum
23.03.2021
Beginn
17.01.2022
Tage bis Beginn
300,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Anticoagulant therapy Bacteraemia Bacterial test positive Blood culture positive COVID-19 Cough Culture urine positive Dehydration Escherichia infection Escherichia test positive Mental status changes Pulmonary embolism SARS-CoV-2 test positive Tachypnoea Toxic encephalopathy Urinary tract infection

Symptomtext

Patient was admitted for acute metabolic encephalopathy , UTI, right lobar PE, Gram-negative bacteremia with altered mentation last known status was 2-3 weeks ago. Pt was boderline febrile. Tachypnic with a cough. He tested positive for COVID-19 without any acute pulmonary process. Patient was treated for acute toxic metabolic encephalopathy. His toxic metabolic encephalopathy was likely secondary to a complicated urinary tract infection in combination with a pulmonary embolism. Additionally patient was found to have dehydration. With regard to his urinary tract infection, use found to have E coli which grew on a urine culture. Additionally found to have Roseomonas which grew on blood culture. Infectious Disease consulted. Ultimately patient was treated with ceftriaxone and transitioned to ciprofloxacin for which he must complete doses on outpatient basis. Patient was initially treated with heparin drip for pulmonary embolism and then transitioned to Eliquis. Patient to finish Eliquis for total of 11 weeks. He was eventually discharged in stable conditions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
9,0
Labordaten
Positive COVID 19 test on 01/17/2022
Aktuelle Erkrankungen
unknown
Vorgeschichte
Hypertension, AAA , hyperlipidemia, type 2 diabetic, hx prostate cancer, CAD
Andere Medikamente
amLODIPine (NORVASC) 10 MG tablet hydrochlorothiazide (HYDRODIURIL) 25 MG tablet metFORMIN (GLUCOPHAGE) 500 MG tablet polyethylene glycol (MIRALAX) 17 g/packet packet atorvastatin (LIPITOR) 80 MG tablet cetirizine (ZYRTEC) 10 MG tab
Allergien
No known drug allergies
Vorherige Impfungen
-

VAERS 2377404

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WA
Alter
70,0
Geschlecht
M
Eingang
22.07.2022
Impfdatum
01.03.2021
Beginn
12.07.2022
Tage bis Beginn
498,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure COVID-19 Inappropriate schedule of product administration Pneumonia bacterial SARS-CoV-2 test positive

Symptomtext

Patient received Pfizer COVID vaccine on 2/1/21 and 3/1/21. On 7/12/22, patient admitted to our inpatient facility (med/surg unit) with acute respiratory failure with hypoxia due to COVID-19 and secondary bacterial pneumonia. Patient was discharged back to nursing facility/ short term rehab on 7/21/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
9,0
Labordaten
COVID status positive 7/12/22.
Aktuelle Erkrankungen
-
Vorgeschichte
history of PAF not on anticoagulation due to falls, dementia, chronic hydrocephalus, OSA, RA, right foot amputation for osteomyelitis
Andere Medikamente
acetaminophen, baby aspirin, atorvastatin, bupropion xl, vitamin d3, vitamin b12, digoxin, duloxetine, entecavir, etanercept sq, folic acid, gabapentin, lidocaine patch, meloxicam, methotrexate im, metoprolol, mirtazapine, polyethylene glyc
Allergien
codeine, tetracyclines
Vorherige Impfungen
-

VAERS 2370272

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
79,0
Geschlecht
M
Eingang
14.07.2022
Impfdatum
05.02.2021
Beginn
25.02.2022
Tage bis Beginn
385,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
COVID-19 Death

Symptomtext

Narrative: PATIENT PASSED AWAY DUE TO COVID-19. HE WAS HOSPITALIZED AND HAD RECEIVED THE COVID-19 VACCINE.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2315524

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
74,0
Geschlecht
M
Eingang
10.06.2022
Impfdatum
03.03.2021
Beginn
01.12.2021
Tage bis Beginn
273,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Asthenia COVID-19 Confusional state Cough Death Intensive care Myalgia Pyrexia SARS-CoV-2 test positive

Symptomtext

Pfizer COVID vaccine # 3 given 12/3/21, lot # 33130BA; pt presented to ED on 12/27/21 with fever, confusion and weakness; hx of cough, myalgias, weakness x 3 days; positive for COVID in ED; on O2 supplementation; given ABX, dexamethasone, remdesivir; pt did not improve; transferred to ICU where he passed away on 1/2/22

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
6,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
leukemia, A Fib,
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2308415

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
92,0
Geschlecht
M
Eingang
03.06.2022
Impfdatum
23.02.2021
Beginn
26.10.2021
Tage bis Beginn
245,0
Dosis
2
Route/Site
UN / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute kidney injury Blood creatinine increased Bronchitis COVID-19 Cardiac arrest Death Dialysis Fall Haemoglobin decreased Oxygen saturation decreased Pneumonia Positive airway pressure therapy Red blood cell transfusion SARS-CoV-2 test positive X-ray abnormal

Symptomtext

Pt readmitted from 10/16 - 10/21 stay for AKI & falls; returned d/t worsening creatinine of 5.0; admitted for AKI, acute bronchitis; pt COVID+ & xray showed pneumonia; tx w/Azithromycin, Cefipime, Vit C, steroids & zinc; 10/20 - started 5 day course of remdesivir; O2 status & creatinine worsened and pt started dialysis 10/30; Hgb dropped to 5.7 w/ no evidence of bleeding; 2 U PRBCs transfused; pt did not improve w/ dialysis & oxygenation status continued to deteriorate and required OptiFlow & BiPAP. Pt made DNR, went into asystole 11/4 and subsequently passed away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
10,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2284754

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WI
Alter
70,0
Geschlecht
M
Eingang
19.05.2022
Impfdatum
18.02.2021
Beginn
08.05.2022
Tage bis Beginn
444,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

Death related to COVID-19 infection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
OSC: COPD; DM2; a-fib; CAD; HTN; HLD; dementia
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2280726

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
63,0
Geschlecht
F
Eingang
17.05.2022
Impfdatum
12.03.2021
Beginn
12.04.2022
Tage bis Beginn
396,0
Dosis
1
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

Death and COVID pos S/p COVID vaccination

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
7,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
COPD Hypertension
Andere Medikamente
loratadine methotrexate montelukast prednisone folic acid
Allergien
amoxicillin codeine
Vorherige Impfungen
-

VAERS 2275907

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
81,0
Geschlecht
M
Eingang
13.05.2022
Impfdatum
26.08.2021
Beginn
14.02.2022
Tage bis Beginn
172,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had breakthrough infection and passed away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Positive COVID-29 test on 1/28/2022.
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2275895

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
82,0
Geschlecht
F
Eingang
13.05.2022
Impfdatum
26.10.2021
Beginn
01.02.2022
Tage bis Beginn
98,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had breakthrough infection and passed away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
1,0
Labordaten
Positive COVID-19 test on 2/1/22.
Aktuelle Erkrankungen
-
Vorgeschichte
Advance dementia rheumatoid arthritis supraventricular tachycardia
Andere Medikamente
Methotrexate levothyroxine multivitamin omeprazole methylcellulose Cymbalta Vitamin D3 Folic acid Orencia Tylenol Colace Plaquenil Neurontin Ferrous sulfate plavix toprol XL Amiodarone Lipitor Albuteral Melatonin
Allergien
Penicillins codeine red dye horse/equine containing products
Vorherige Impfungen
-

VAERS 2268902

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
69,0
Geschlecht
M
Eingang
10.05.2022
Impfdatum
23.02.2021
Beginn
05.10.2021
Tage bis Beginn
224,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Balance disorder COVID-19 Chest tube insertion Computerised tomogram thorax abnormal Cough Dyspnoea Feeling abnormal Gait disturbance Loss of personal independence in daily activities Near death experience Pneumothorax Pulmonary embolism Pulmonary pain SARS-CoV-2 test positive Vaccine breakthrough infection Vena cava filter insertion

Symptomtext

COVID -19 Break Through Case. I received my 2nd vaccine on the 02/23/2021. My adverse event started on COVID-19 Break Through Case. I received my 2nd vaccine on the 02/23/2021. My adverse event started on 10/05/2021. I was having a severe cough and my lungs hurt really bad. I got a rapid COVID-19 test which came back negative. On the 10/11/2021, I went to the urgent care. I couldn't breathe, it hurt really bad. I tested positive for COVID-19. I had a really bad immune thorax on my left side of the body from my armpit to my waist. It looked like I was hit with a bus. I was admitted in the hospital. I had CT scan done. They found a pulmonary embolism in my body. My left lung clasped, and they inserted a chest tube, and they took 1.7 liters of blood out. They also inserted IVF in my right side to get blood clots out. I was in the hospital for 53 days and 21 days in acute rehab. I had no control over my body. I couldn't talk, walk, no balance. Basically, I couldn't do anything for myself anymore. I had no mobility. My life completely changed after I contracted COVID-19. I almost died 3 times.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Near death experience
Hospital-Tage
53,0
Labordaten
CTC Scan Blood Draw
Aktuelle Erkrankungen
None
Vorgeschichte
Cardiomyopathy
Andere Medikamente
Regular medications Alperonin Valsartan Metoprolol
Allergien
Nonocrim Oyster Extract
Vorherige Impfungen
-

VAERS 2268778

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
78,0
Geschlecht
M
Eingang
10.05.2022
Impfdatum
01.03.2021
Beginn
01.01.2022
Tage bis Beginn
306,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute myocardial infarction COVID-19 Cough Death Hypophagia Respiratory tract congestion SARS-CoV-2 test positive Urinary tract infection

Symptomtext

pt had a recent hospital admission (facility unknown) for poor oral intake, cough, congestion; dx with UTI, non-STEMI; family opted to pursue hospice care with comfort as the goal; admitted to Facility on 1/25/22; pt tested positive for COVID on 1/26/22; given O2 supplementation, dexamethasone and doxycycline; pt expired in the nursing home; med records and death certificate submitted per VAERS request

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
dementia, HTN, chronic systolic CHF, hyperlipidemia, GERD
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2249517

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
68,0
Geschlecht
M
Eingang
23.04.2022
Impfdatum
22.10.2021
Beginn
11.01.2022
Tage bis Beginn
81,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had breakthrough infection and passed away,

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
3,0
Labordaten
Positive COVID-19 test on 1/11/2022.
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Seizures COPD Sleep Apnea CAD HTN Dysrhythmia Pacemaker DM type 2 hyperlipidemia anxiety depression panic
Andere Medikamente
Atorvastatin Carvedilol Montelukast Nitroglycerin Sacubitril Finasteride Tamsulosin Fluticasone propionate Oxycodone Aspirin Insulin glargine Omeprazole Pramipexole Kombiglyze Insulin aspart Isosorbide mononitrate albuterol sulfate biotin d
Allergien
ACE inhibitors furosemide hydrocodone hydroxyzine latex tizanidine tape
Vorherige Impfungen
-

VAERS 2241168

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
IA
Alter
70,0
Geschlecht
F
Eingang
19.04.2022
Impfdatum
02.04.2021
Beginn
19.10.2021
Tage bis Beginn
200,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal pain Acute respiratory failure Aspartate aminotransferase increased Asthenia Asthma Blood calcium decreased Blood creatinine increased Blood glucose increased Body temperature increased COVID-19 Condition aggravated Culture negative Dyspnoea Fatigue Fibrin D dimer COVID-19 pneumonia Cardiac failure congestive Chronic obstructive pulmonary disease

Symptomtext

COVID Vaccine Breakthrough Case Pfizer Dose 1 3/11/21 (EN6205) Pfizer Dose 2 4/2/21 (EN6198) COVID Positive 10/20/21 10/24/21: Patient is a 71 year old female with a past medical history significant for BA, CHF, COPD, CKD stage 3, type 2 diabetes, OSA, hyperlipidemia, hypertension, morbid obesity, anxiety. The patient presents to the ED today with complaints of shortness of breath that began 5 days ago. The patient's accompanying symptoms include weakness, fatigue, nausea, abdominal pain. The patient denies any chest pain, fever, chills, diarrhea, rigors. The patient is vaccinated against COVID-19. Upon arrival to ED patient's temperature is 100.8?, heart rate 95, respirations 23, pulse ox 84% on room air, blood pressure 133/106. The patient was placed on 4 L oxygen via nasal cannula to maintain O2 saturations greater than 90%. CT abdomen reveals no acute intra-abdominal process, diffuse hepatic steatosis and hepatomegaly. CT chest reveals no PE, scattered bilateral areas of airspace disease involving all 5 lobes likely representing viral pneumonitis or multilobar pneumonia. Patient's laboratory findings are significant for glucose 316, creatinine 1.12, AST 44, calcium 8.2, lipase 12 hemoglobin 11.7, D-dimer 0.61, COVID-19 positive. Patient received DuoNeb x2, 500 mg IV azithromycin, 1 g IV Rocephin, 4 mg IV Zofran, 8 mg IV Decadron in ED. Patient was seen and examined at the bedside in the ED. The patient is in mild respiratory distress, expiratory wheezing noted from the door. Of note, the patient was admitted on 08/09/2021 and discharged on 08/13/2021 for acute COPD exacerbation, CHF exacerbation. The patient was discharged to skilled facility until 09/03/2021. 11/5/21: Acute hypoxic respiratory failure - on 4 L NC O2 COVID-19 Pneumonia --(+) 9/20 --vaccinated w/ Pfizer --Remdesivir started 10/24 for 2 doses and then d/c'd due to no IV access --Decadron started 10/25, which was gradually tapered --Actemra 10/28 - patient required supplemental oxygen, pulmonology was consulted on case and assisted. With interventions as above respiratory status improved, patient was weaned to room air prior to disposition and headed O2 walk which patient did not qualify for supplemental oxygen. She will be discharged with COVID safe for home and steroid taper as noted below. Asthma Exacerbation - on bronchodilators and steroids. Steroids and breathing treatments were spaced out, steroids taper down. As noted on room air prior to disposition will discharged on taper. Room air no wheezing prior to dispo. DM, type 2, with hypoglycemia - secondary to steroids. Had some up and down readings secondary to this. Steroids are being weaned down patient was maintained and manage with sliding scale and Lantus. Will continue q.i.d. blood glucose checks. All precautions provided. Will follow up with PCP within 7 days of discharge. Possible CAP -completed doxy, cultures remain negative. Essential hypertension - on amlodipine, losartan, hydralazine and Imdur Hx CVA, with residual left-sided weakness - on Plavix Morbid Obesity, BMI more than 40 kg/meter squared PT, OT eval- patient refuse placement All ED and RTC precautions were provided to patient she endorses understanding. All COVID and isolation precautions were provided to patient endorse understanding and agreement with plan as outlined. Follow-up with PCP within 7 days of discharge.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
13,0
Labordaten
-
Aktuelle Erkrankungen
BA CHF COPD CKD Stage 3 DM type 2 OSA HLD HTN obesity anxiety
Vorgeschichte
BA CHF COPD CKD Stage 3 DM type 2 OSA HLD HTN obesity anxiety
Andere Medikamente
APAP-hydrodocone 325-10 mg PO QID PRN albuterol nebs Q4h PRN allopurinol 300 mgPO QD alprazolam 0.5 mg PO BID amlodipine 5 mg PO QD bimatoprost 1 drop right eye HS brimonidine 1 drop both eyes Q8h brinzolamide 1 drop both eyes BID carbamaze
Allergien
tree nuts - anaphylaxis aspirin - mouth edema, hives coban - itching demerol - rash, swelling of throad fish - swelling jewelry - swellling meperidine - unknown morphine - rash nuts - swelling, breathing problem oxycontin - hives, suidical thoughts peanuts - breathing problems, swelling penicillins - rash, swelling of throad prednisone - unknown shellfish - unknown shrimp - swelling
Vorherige Impfungen
-

VAERS 2241124

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
84,0
Geschlecht
F
Eingang
19.04.2022
Impfdatum
07.03.2021
Beginn
01.09.2021
Tage bis Beginn
178,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
COVID-19 Death Dyspnoea Intensive care SARS-CoV-2 test positive Somnolence Unresponsive to stimuli

Symptomtext

pt to ED with SOB; placed on NRB with O2 sats in 90s; positive COVID test; treated with ABX, dexamethasone; transferred to ICU; later O2 sats between 40-60%, pt still comfortable just became progressively sleepy; became unresponsive and expired in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2218130

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
85,0
Geschlecht
F
Eingang
06.04.2022
Impfdatum
27.02.2021
Beginn
24.09.2021
Tage bis Beginn
209,0
Dosis
2
Route/Site
SYR / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death

Symptomtext

Information unavailable. Patient died at home. Covid 19 listed as a cause of death on death certificate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2216106

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
92,0
Geschlecht
M
Eingang
05.04.2022
Impfdatum
06.03.2021
Beginn
24.09.2021
Tage bis Beginn
202,0
Dosis
2
Route/Site
SYR / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death

Symptomtext

Information not available. Patient died at home. Covid 19 listed as cause of death on death certificate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2215949

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
87,0
Geschlecht
M
Eingang
05.04.2022
Impfdatum
27.02.2021
Beginn
28.09.2021
Tage bis Beginn
213,0
Dosis
2
Route/Site
SYR / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death

Symptomtext

Information not available. Patient died at home. Covid 19 listed as a cause of death on certificate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2215853

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
80,0
Geschlecht
F
Eingang
05.04.2022
Impfdatum
02.03.2021
Beginn
09.09.2021
Tage bis Beginn
191,0
Dosis
2
Route/Site
SYR / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Information unavailable. Medical records not received from LTC facility. Patient tested positive for Covid-19 on 09/09/2021 and died in facility on 10/11/2021 with Covid 19 listed as cause of death on certificate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2211537

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
37,0
Geschlecht
F
Eingang
01.04.2022
Impfdatum
04.03.2021
Beginn
01.08.2021
Tage bis Beginn
150,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Computerised tomogram Heavy menstrual bleeding Pulmonary embolism Thrombosis Ultrasound scan

Symptomtext

In August 2021, my period became very very heavy which is not normal for me. Then in March 2022 I developed a blot clot in my right lower leg that broke off and went up into both of my lungs causing bilateral pulmonary embolisms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
2,0
Labordaten
Ultrasound, CT scans (3/13/2022)
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2209515

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WI
Alter
93,0
Geschlecht
M
Eingang
31.03.2022
Impfdatum
18.11.2021
Beginn
30.03.2022
Tage bis Beginn
132,0
Dosis
UNK
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

Death related to COVID-19 infection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Other significant conditions: COPD, HTN, A-Fib, Dementia
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2196551

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
SD
Alter
80,0
Geschlecht
M
Eingang
24.03.2022
Impfdatum
22.03.2021
Beginn
29.12.2021
Tage bis Beginn
282,0
Dosis
1
Route/Site
SYR / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 03/01/2021 and 03/22/2021. They tested positive for COVID-19 on 12/29/2021. They were admitted to hospital on 01/02/2022. They remained hospitalized until their death on 01/11/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
9,0
Labordaten
Positive COVID-19 test on 12/29/2021 despite being vaccinated.
Aktuelle Erkrankungen
-
Vorgeschichte
Chronic Kidney Disease, Type 2 Diabetes, Hypertension, Heart Disease
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2194885

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WI
Alter
90,0
Geschlecht
M
Eingang
23.03.2022
Impfdatum
19.02.2021
Beginn
17.03.2022
Tage bis Beginn
391,0
Dosis
2
Route/Site
UN / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Aspiration pleural cavity Bacterial test negative Blood gases COVID-19 Chest X-ray abnormal Cytology normal Death Differential white blood cell count abnormal Dyspnoea Flow cytometry Full blood count abnormal Hypoxia Lung opacity Lymphocyte count increased Monocytosis Oxygen saturation decreased Pleural effusion Pneumonia bacterial

Symptomtext

Patient was vaccinated with Pfizer covid-19 vaccine on 1/29/21 and 2/19/21. On 3/17/2022 patient was scheduled for an outpatient CT-guided pleural biopsy. When the patient arrived for the procedure, he was found to have a low-grade temp of 100.5 ?F and hypoxic on room air desaturating into the mid to upper 80s. noted oxygen saturation improved with application of 2 L of oxygen. He was sent to the ED for further evaluation. In the ED he was again found to be hypoxic down to 85% on room air. Chest x-ray was obtained and notable for progressive multifocal bilateral airspace opacity and a small right pleural effusion. Patient was evaluated for suspected secondary bacterial pneumonia. Patient had been previously hospitalized on 3/6/2022 through 3/8/2022. Covid antibody was obtained on 3/7/2022 and came back positive. Patient had had COVID-19 for at least 10 to 14 days at that time. Per web report, based on that information patient is at least 20 days out from initial infection. He has not had leukocytosis. Patient had a right-sided thoracentesis for recurrent right-sided pleural effusion on 3/7/2022. Bacterial studies were negative. Cytology was negative for malignant cells. Flow cytometry was added on and pathologist contacted the hospitalist team on 3/8/2022. A peripheral smear was also reported to have increased smudge cells. The CBC differential indicated he continues to have lymphocyte predominance along with monocytosis. Report indicated patient became increasingly short of breath and patient was hardly maintaining a saturation of 90%. Patient?s breathing was then labored, RR low 30s, and patient complained of dyspnea. Patient was asked about intubation. patient stated he is not sure if he wanted that and would like to think about it. Stat CXR, ABGs. Patient was place on bipap. Per report it was noted: RN was notified that patient had a rhythm change. RN found patient already passed away. Time of death noted as 03:37.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
2,0
Labordaten
Labs: including bacterial studies and cytology Chest Xray Thoracentesis
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2194549

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
58,0
Geschlecht
M
Eingang
23.03.2022
Impfdatum
26.02.2021
Beginn
29.09.2021
Tage bis Beginn
215,0
Dosis
2
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 COVID-19 pneumonia Dyspnoea Hypoxia

Symptomtext

Presents for increasing SOB, dx with COVID x6 days PTA. Hypoxic on arrival. Admit for acute respiratory failure with hypoxia, COVID pneumonia. Tx: O2, abx, steroids, vitamins, remdesivir, baricitinib. DC home on O2.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
8,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1794987

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
65,0
Geschlecht
M
Eingang
21.03.2022
Impfdatum
27.03.2021
Beginn
20.09.2021
Tage bis Beginn
177,0
Dosis
1
Route/Site
IM / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
COVID-19 Cardiac arrest Cardiac disorder Death Dialysis SARS-CoV-2 test positive Dysarthria Endotracheal intubation Intensive care Laboratory test normal Mental status changes Muscular weakness Parenteral nutrition Renal failure Respiratory disorder

Symptomtext

tested positive for COVID 10 days ago in (Privacy); quarantined x 10 dys; flew home today; while at airport, began to have respiratory complaints; acute mental status changes, slurred speech and left arm weakness; was brought to ED; pt required intubation; tested positive for COVID; tests unremarkable for CVA; transferred to ICU; started on ABX; renal failure worsened; required TPN and dialysis; experienced cardiac changes during dialysis and went into cardiac arrest; pt did not survive; he died in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
8,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
CLL (immunosuppressed, on oral chemotherapy)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2184337

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
77,0
Geschlecht
M
Eingang
17.03.2022
Impfdatum
03.03.2021
Beginn
03.03.2022
Tage bis Beginn
365,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure Blood gases abnormal COVID-19 Cough Death Dyspnoea Endotracheal intubation Hypovolaemic shock Hypoxia Oxygen saturation decreased Rectal haemorrhage SARS-CoV-2 test positive

Symptomtext

Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received PfizerVaccine on 2/13/21 and 3/03/21. Presented to ED c/o SOB shortness and cough x/1 wk. Admitted for acute hypoxic respiratory failure due to COVID-19 and requiring high-flow O2. Course c/b rectal bleeding and hypovolemic shock; tx'd w/Phenylphrine. ABG showed severe hypoxia requiring intubation but patient requested DNR status. Tx'd with IV vancomycin, Rocephin and doxycycline. His oxygenation continued to decline, transitioned to comfort care. Pt expired 3/03/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
2,0
Labordaten
3/02/22-This sample was analyzed using the Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification(NAA)technology.
Aktuelle Erkrankungen
-
Vorgeschichte
BCC, PSA, HTN, hypothyroid, prostate cancer, OSA, CHF
Andere Medikamente
vitamin C, vitamin d3, clindamycin, clotrimazole/betamethasone, furosemide, levothyroxine,magnesium, melatonin, multivitamin, omerga 3, potassium chloride, sildenafil, tadalfil, ubidecarenone,
Allergien
gabapentin, codeine, nabumetone
Vorherige Impfungen
-

VAERS 2128449

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
78,0
Geschlecht
M
Eingang
15.03.2022
Impfdatum
13.02.2021
Beginn
06.03.2021
Tage bis Beginn
21,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death Intensive care SARS-CoV-2 test positive

Symptomtext

Patient passed away from COVID

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
6,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Afib, CHF, watchman device, HTN, CAD, T2DM,
Andere Medikamente
Cetirizine 10mg PO Qdaily Amiodarone 100mg PO Qdaily Atorvastatin 20mg PO QHS Carvedilol 3.125mg PO BID Lisinopril 2.5mg PO QDaily Omega-3 Fatty Acids/Fish Oil 1,000mg PO Qdaily Spironolactone 12.5mg PO Qdaily Aspirin 81mg PO BID KCl 10 mE
Allergien
codeine, oxycodone
Vorherige Impfungen
-

VAERS 2128449

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
78,0
Geschlecht
M
Eingang
15.03.2022
Impfdatum
13.02.2021
Beginn
06.03.2021
Tage bis Beginn
21,0
Dosis
2
Route/Site
IM / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death Intensive care SARS-CoV-2 test positive

Symptomtext

Patient passed away from COVID

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
6,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Afib, CHF, watchman device, HTN, CAD, T2DM,
Andere Medikamente
Cetirizine 10mg PO Qdaily Amiodarone 100mg PO Qdaily Atorvastatin 20mg PO QHS Carvedilol 3.125mg PO BID Lisinopril 2.5mg PO QDaily Omega-3 Fatty Acids/Fish Oil 1,000mg PO Qdaily Spironolactone 12.5mg PO Qdaily Aspirin 81mg PO BID KCl 10 mE
Allergien
codeine, oxycodone
Vorherige Impfungen
-

VAERS 2173768

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
85,0
Geschlecht
F
Eingang
11.03.2022
Impfdatum
05.03.2021
Beginn
06.12.2021
Tage bis Beginn
276,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death Diarrhoea General physical health deterioration Mental status changes SARS-CoV-2 test positive Vomiting

Symptomtext

pt comes to hospital with mental status change, D/V; positive for COVID; treated with steroids, ABX, baricitinib; O2 supplementation; pt's condition worsened and she was transitioned to comfort care; pt died in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
7,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
chronic kidney disease, CVA, dementia
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2173476

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
FL
Alter
83,0
Geschlecht
F
Eingang
11.03.2022
Impfdatum
26.03.2021
Beginn
28.01.2022
Tage bis Beginn
308,0
Dosis
1
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

ADMITTED TO HOSPITAL

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
6,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2168209

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
87,0
Geschlecht
M
Eingang
09.03.2022
Impfdatum
01.03.2021
Beginn
01.11.2021
Tage bis Beginn
245,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
COVID-19 COVID-19 pneumonia Chronic kidney disease Death Dementia Fall General physical health deterioration Hypertension Hypoxia SARS-CoV-2 test positive Scan normal

Symptomtext

pt had recent hospitalization (11/1 - 11/4/21_ for HTN, stage IIIB kidney disease, dementia, pt was a DNR; dc'd home; presents to ED after a fall; hypoxic; no evidence of fx and trauma scan negative; found to be positive for COVID; COVID pneumonia; started on remdesivir, decadron, ABX, O2 supplementation; hypoxia continued to worsen; pt's condition deteriorated; pt made comfort care by wife and he passed away in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
8,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2168145

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
72,0
Geschlecht
F
Eingang
09.03.2022
Impfdatum
02.03.2021
Beginn
20.12.2021
Tage bis Beginn
293,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute hepatic failure Acute kidney injury COVID-19 COVID-19 pneumonia Death Dyspnoea Endotracheal intubation Gastrointestinal haemorrhage Multiple organ dysfunction syndrome SARS-CoV-2 test positive Shock Withdrawal of life support

Symptomtext

Patient to hospital with c/o SOB x 4 days; took an at home COVID test and it was positive; admitted to hospital with COVID PNA; given remdesivir, steroids, vitamins C, D3, and zinc; patient required intubation; multi-organ failure; AKI; acute liver failure; GI bleeding; shock; family changed patient's status to DNR/DNI; withdrew life support and patient died in the hospital.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
13,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2165433

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
70,0
Geschlecht
M
Eingang
08.03.2022
Impfdatum
26.02.2021
Beginn
01.09.2021
Tage bis Beginn
187,0
Dosis
2
Route/Site
UN / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Death Intensive care Mechanical ventilation Respiratory disorder

Symptomtext

Was requiring high FiO2 and NIPPV support, with further worsening of the respiratory status. Was transferred to ICU. Upon d/W Dr. in ICU, family decided to proceed with only comfort care measures. NIPPV was DCed today and patient was kept comfortable. Patient was also followed by Dr., Palliative care. Patient was comfortable and passed away on 9/4/21

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2151473

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
81,0
Geschlecht
M
Eingang
01.03.2022
Impfdatum
12.03.2021
Beginn
14.01.2022
Tage bis Beginn
308,0
Dosis
2
Route/Site
UN / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure Angiogram pulmonary abnormal Atelectasis Body height decreased Bronchial wall thickening Bronchiolitis COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chills Death Dyspnoea Fatigue Gram stain negative Hyperkalaemia Lung infiltration Malaise Pleural effusion

Symptomtext

1/5/22 82-year-old male presents from nursing home by EMS with history of DNR, Parkinson's, CLL, A. fib presents emergency room with complaints of increased shortness of breath and fever/chills, malaise and fatigue. Presents by ambulance who gave him a neb treatment in route and placed on nasal cannula oxygen. He was recently admitted for approximately 1 week and discharged 2 days ago after admission for pneumonia with respiratory difficulty requiring supplemental oxygen and steroid treatment. No significant abdominal pain vomiting diarrhea or GI symptoms. No chest pressure palpitations or near syncope. 1/13/22 82-year-old male with past medical history of chronic lymphocytic leukemia, Parkinson's disease, MI, CVA, hypertension, A. fib on Eliquis and GERD who presented with worsening dyspnea after recently being discharged from Hospital with COVID PNA. He was treated for respiratory failure. Pulmonology was consulted and patient was given bronchodilators, cefepime/vanc, mucinex, solumedrol, ZnSO4. The patient repeatedly made comments to staff and the family indicating a desire to be allowed to die. Hospice was consulted. His family has met with hospice and wishes to honor his wishes. He was discharged to hospice scatter bed and expired at time and date listed above. Parkinson's disease, MI, CVA, hypertension, A. fib on Eliquis and GERD who presented with worsening dyspnea after recently being discharged from hospital with COVID PNA. He was treated for respiratory failure. Pulmonology was consulted and patient was given bronchodilators, cefepime/vanc, mucinex, solumedrol, ZnSO4. The patient repeatedly made comments to staff and the family indicating a desire to be allowed to die. Hospice was consulted. His family has met with hospice and wishes to honor his wishes. He was discharged to hospice scatter bed and expired at time and date listed above. Admission date: 1/13/2022 Date of death: 1/14/2022 Time of death: 6:55 AM Principal Problem: Hospice care (1/13/2022) POA: Not Applicable Acute respiratory failure with hypoxia (1/5/2022) POA: Yes Chronic lymphocytic leukemia (2/6/2012) POA: Yes Chronic kidney disease (6/30/2016) POA: Yes Benign prostatic hyperplasia (5/23/2019) POA: Yes Parkinson's disease (5/1/2005) POA: Yes History of cerebrovascular accident (1/1/2008) POA: Not Applicable Gastroesophageal reflux disease (10/24/2011) POA: Yes Atrial fibrillation (5/1/2019) POA: Yes Coronary artery disease involving native coronary artery (6/21/2018) POA: Yes Post-acute COVID-19 syndrome (12/29/2021) POA: Not Applicable HCAP (healthcare-associated pneumonia)/gram-negative pneumonia (1/8/2022) POA: Yes Hyperkalemia (1/11/2022) POA: No Admit date: 1/5/2022 Discharge date: 1/13/2022 Discharged Condition: Good Hospital Course: From initial H&P: "82-year-old male with past medical history of chronic lymphocytic leukemia, Parkinson's disease, MI, CVA, hypertension, A. fib on Eliquis and GERD who presented to ED with increasing shortness of breath and fever. Of note, patient was recently admitted to Hospital for Covid PNA and discharged on 1/3/2022. However patient reports increasing dyspnea with O2 sats in 80s on 4L NC and temp of 100.5. Patient is a DNR." He was treated for the following: Respiratory failure/COVID, treating for HCAP: pulmonology following. Giving scheduled and PRN bronchodilators, cefepime/vanc, mucinex, solumedrol, ZnSO4. - r required CLL: WBC >72K on 1/10 and suspect some elevation related to CLL. Parkinson's: continue sinemet A fib: anticoagulated on eliquis Hyperkalemia: BPH: flomax The patient repeatedly made comments to staff and the family indicating a desire to be allowed to die. Hospice was consulted. His family has met with hospice and wishes to honor his wishes. He will be discharged to hospice scatter bed. Discharge Diagnoses: Principal Problem: Acute respiratory failure with hypoxia Active Problems: Chronic lymphocytic leukemia Chronic kidney disease Benign prostatic hyperplasia (5/23/2019) Parkinson's disease (5/1/2005) History of cerebrovascular accident (1/1/2008) Gastroesophageal reflux disease (10/24/2011) Atrial fibrillation (5/1/2019) Coronary artery disease involving native coronary artery (6/21/2018) Post-acute COVID-19 syndrome (12/29/2021) HCAP (healthcare-associated pneumonia)/gram-negative pneumonia (1/8/2022) Hyperkalemia (1/11/2022) Additional information for Item 12: Balance problems R/T PARKINSON'S USES CANE W/AMBULATION o Blood dyscrasia o Carpal tunnel syndrome on right REPAIRED 5/1/18 o Cerebrovascular accident 6/30/2016 o CVA (cerebral vascular accident) 05/2008 "SLOW TO FIND WORDS" PER PT o Diffuse large B-cell lymphoma of lymph nodes of neck 1/26/2017 o Fatigue due to treatment o GERD (gastroesophageal reflux disease) DAILY OMEPRAZOLE o History of cancer chemotherapy 2017 R/T EAR SQUAMOUS CA & ORAL CHEMO R/T NON HODGKINS LYMPHEMA o History of shingles ABD-BACK , APPROX 2013 o HTN (hypertension) TOPROL BID-CARDIOLOGIST o Hx of therapeutic radiation 2016 & 2017 H/O R/T SQUAMOUS CELL CA/LEFT EAR o Infection of prosthetic joint 7/25/2016 o Intestinal malabsorption, unspecified 12/29/2021 o Low vitamin D level 12/28/2021 o Myocardial infarction "SILENT" o Non-Hodgkin's lymphoma 1998 ONCOLOGIST o Osteoarthritis S/P LTHR 2016 , HANDS o Osteoradionecrosis of temporal bone 3/28/2018 o Parkinson disease 05/2005 o SCC (squamous cell carcinoma) 2/27/2018 o Squamous cell cancer of skin of earlobe, left 2016 o Tremor RIGHT HAND & LEG R/T PARKINSON'S PER PT 1/8/22 XR Chest 1 Vw IMPRESSION: Progressive right perihilar and unchanged bibasilar infiltrates, suspicious for pneumonia 12/29/21 CT Angiogram Chest For PE IMPRESSION: 1.No evidence of pulmonary embolism 2.Smooth intralobular septal thickening with mild bronchial wall thickening at the lung bases may relate to mild interstitial pulmonary edema versus bronchiolitis 3.Trace effusions with bibasilar atelectasis 4.Further loss of height at the known L1 compression deformity in comparison to 2017. Please note that all CT scans at this facility use dose modulation, iterative reconstruction, and/or weight based dosing when appropriate to reduce radiation dose to as low as reasonably achievable Additional information for Item 9: amantadine (SYMMETREL) 100 MG capsule Take 100 mg by mouth 2 (two) times daily. apixaban (ELIQUIS) 5 MG tablet Take 1 tablet by mouth 2 (two) times daily. Aspirin (ASPIR-81 PO) Take 81 mg by mouth daily atorvastatin (LIPITOR) 40 MG tablet carbidopa-levodopa (SINEMET) 25-100 MG Take by mouth 4 (four) times daily Melatonin 1 MG/4ML LIQD 15 mg. metoprolol, TOPROL-XL, 50 MG 24 hr tablet Take 1 tablet by mouth daily. omeprazole (PRILOSEC) 20 MG capsule Take 20 mg by mouth daily. tamsulosin (FLOMAX) 0.4 MG CAPS TAKE 1 CAPSULE BY MOUTH ONCE DAILY

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
1,0
Labordaten
12/28/21 COVID-19 Result Detected Abnormal
Aktuelle Erkrankungen
-
Vorgeschichte
Balance problems R/T PARKINSON'S USES CANE W/AMBULATION o Blood dyscrasia o Carpal tunnel syndrome on right
Andere Medikamente
amantadine (SYMMETREL) 100 MG capsule Take 100 mg by mouth
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2139922

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
70,0
Geschlecht
M
Eingang
25.02.2022
Impfdatum
11.12.2021
Beginn
12.12.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Angiogram pulmonary abnormal Discomfort Dyspnoea Flank pain Pulmonary embolism SARS-CoV-2 test negative

Symptomtext

Patient presented to local ED with complaints of increasing dyspnea, flank pain, and discomfort for 48 hours. History of COPD, TIA, Stage 3a chronic kidney disease, hypertension, Vertigo, Atrial fibrillation, Coronary Artery Disease, AAA, and S/P aortic valve repair. COVID test was negative, however CTA showed acute PE. Previously vaccinated with Pfizer on 2/6/21, 2/27/21, and boosted on 12/11/21. Patient admitted 12/12/21 and discharged 12/20/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
9,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2136984

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
77,0
Geschlecht
M
Eingang
24.02.2022
Impfdatum
25.02.2021
Beginn
09.02.2022
Tage bis Beginn
349,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute myocardial infarction Acute respiratory failure Atrial fibrillation COVID-19 Death Distributive shock Dyspnoea Endotracheal intubation Pleural effusion Pyrexia

Symptomtext

Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 2/4/21 and 2/25/21. Presented to ED 2/6/22 with SOB and sxs worsened over 3 weeks. Previous Friday to admission began having fevers, prescribed azithromycin and inhalers. Tested negative for covid 2-3 times. Admitted for A-fib and acute hypoxic resp failure 2/2 Covid. Required HFNC during admission, intubated 2/8. STEMI 2/9 c/b distributive shock and bil. pleural effusions. Transitioned to comfort care. Tx'd with decadron, solumedrol, baricitinib,cefepime and vancomycin. Expired 02/09/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Afib, HLD, OA
Andere Medikamente
tylenol, chlorhexidine, docusate, ezetimibe, finasteride, gabapentin, HC/tylenol, hydromorphone,medrol dose pack, mupirocin, pantoprazole, xarelto, tapentadol, trazodone
Allergien
atorvastatin
Vorherige Impfungen
-

VAERS 2134660

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
86,0
Geschlecht
F
Eingang
23.02.2022
Impfdatum
17.03.2021
Beginn
12.09.2021
Tage bis Beginn
179,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute left ventricular failure Cardiac failure congestive Death SARS-CoV-2 test

Symptomtext

pt admitted to SNF with acute diastolic congestive heart failure and history of COVID pneumonia; (COVID test on 9/12/2021); was treated with antibiotics; in SNF for PT/OT, O2 supplementation; aggressive comfort measures; pt passed away in the SNF

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
GERD, HYPOTHYROIDISM, CHRONIC HYPOXIC RESPIRATORY FAILURE, A FIB, PULMONARY HTN, CKDIII
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2131093

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
80,0
Geschlecht
F
Eingang
22.02.2022
Impfdatum
25.02.2021
Beginn
25.01.2022
Tage bis Beginn
334,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Fully vaccinated with Pfizer vaccine x 2. Tested positive for COVID 19 on 01/25/2022. Patient was admitted to Hospital on 01/25/2022. Expired on 02/20/2022 while still hospitalized.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2123693

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
84,0
Geschlecht
F
Eingang
18.02.2022
Impfdatum
25.02.2021
Beginn
18.03.2021
Tage bis Beginn
21,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute respiratory failure

Symptomtext

Patient admitted for Acute hypoxemic respiratory failure. On 3/20 day of dc her O2 at rest was 92% so she will likely do all right w/o O2 at home. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2119305

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
78,0
Geschlecht
M
Eingang
17.02.2022
Impfdatum
02.03.2021
Beginn
24.05.2021
Tage bis Beginn
83,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Anticoagulant therapy Blood test Computerised tomogram Deep vein thrombosis Pulmonary embolism Ultrasound scan X-ray

Symptomtext

In May, I had an embolism in my lung and a DVT in my leg. I was hospitalized at a local HCF for over a day. They did CT scan, x-rays, ultrasound, and blood work. I was put on blood thinners.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
1,0
Labordaten
CT scan, X-ray, ultrasound, blood work.
Aktuelle Erkrankungen
N/A
Vorgeschichte
High blood pressure; high cholesterol
Andere Medikamente
Lepro; Atze
Allergien
N/A
Vorherige Impfungen
-

VAERS 2116437

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
77,0
Geschlecht
M
Eingang
16.02.2022
Impfdatum
24.02.2021
Beginn
05.02.2022
Tage bis Beginn
346,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Acute respiratory failure Atrioventricular block second degree COVID-19 COVID-19 pneumonia Cardiac pacemaker insertion Death Endotracheal intubation Hypercapnia Hyperkalaemia Hypervolaemia Hypoxia Polyuria Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 02/03/2021 and 02/24/2021. Covid-19 + 1/10/22. Presented to ED on 1/24/22 for hypoxia after recent discharge for COVID PNA and PPM placement for finding of Mobitz type 2. Placed on BiPAP and required HFNC. Aggressively diuresed for volume overload with no respiratory improvement (13L removed). On 2/4 noted to have AKI with hyperkalemia. On 2/5 noted to be less responsive to BiPAP. Labs showed acute hypoxic and hypercarbic respiratory failure and required intubation. Transitioned to DNAR. Treated with Levaquin, Cresemba, methylprednisolone. Expired 02/05/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
12,0
Labordaten
1/10/22 Covid +: This sample has been tested on the Quidel Sofia platform which detects Sars-COV2 antigen. Positive results do not require retesting.
Aktuelle Erkrankungen
COVID-19 PNA 1/12/22, PPM placement 1/20/22
Vorgeschichte
HX of colon cancer, pancreatic adenocarcinoma w/lung metastasis, s/p pancreatectomy, HFpEF, HTN, DM
Andere Medikamente
Tylenol, amlodipine, atorvastatin, furosemide, insulin glargine, insulin lispro, latanoprost, lifitegrast, lipase/protease/amylase, lisinopril
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2113417

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
81,0
Geschlecht
M
Eingang
15.02.2022
Impfdatum
04.03.2021
Beginn
01.01.2022
Tage bis Beginn
303,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure COVID-19 Cardio-respiratory arrest Condition aggravated Cough Death Gastrointestinal haemorrhage Respiratory failure Resuscitation SARS-CoV-2 test positive

Symptomtext

brought to hospital with suspected GI bleed; was found to be positive for COVID as well; acute on chronic hypoxemic respiratory failure (6L Hi-flow O2 supplementation); cough; experienced pulmonary code blue; CPR x 20mins without return of circulation; family contacted and decided to make pt DNR; pt died in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
6,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
COPD, CKDIIIA, DMT2, chronic hypoxemic respiratory failure (3L O2 via NC), lung CA, CAD, HTN, hyperlipidemia, obesity
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2095412

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
85,0
Geschlecht
M
Eingang
08.02.2022
Impfdatum
31.01.2021
Beginn
05.02.2022
Tage bis Beginn
370,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient fully vaccinated tested positive for COVID 1/28/2022 admitted to hospital 1/28/2022 patient expired 2/5/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2215753

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
82,0
Geschlecht
M
Eingang
03.02.2022
Impfdatum
28.02.2021
Beginn
17.09.2021
Tage bis Beginn
201,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure Anticoagulant therapy COVID-19 Cough Dizziness Fall Night sweats Pyrexia SARS-CoV-2 test positive

Symptomtext

Narrative: Patient completed Pfizer COVID-19 vaccination series in February 2021. Presented after fever, cough, nightsweats, and light-headedness with falls and hospitalized 9/17/21 and initially treated with supportive cares and Lovenox. Developed acute hypoxic respiratory failure and started remdesivir and dexamethasone (9/20-9/23). Discharged to rehab center 10/5/21. Stay prolonged due to COVID isolation protocols and rehab placement.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
9/17/21 Tested positive for COVID-19
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2085957

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
86,0
Geschlecht
F
Eingang
03.02.2022
Impfdatum
30.08.2021
Beginn
02.01.2022
Tage bis Beginn
125,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure Anxiety Aortic valve incompetence COVID-19 COVID-19 pneumonia Computerised tomogram thorax abnormal Constipation Cough Echocardiogram abnormal Hypertension Hypoxia Lumbar radiculopathy Lung opacity Mitral valve incompetence Muscle spasms Osteopenia Osteoporosis Pathological fracture

Symptomtext

86 year old female with pmh htn who was admitted for covid 19, acute respiratory failure. Please see h and p for details. The following issues were addressed: 1. Covid 19 virus infection/viral pneumonia - vaccinated - ct chest shows ground glass pulmonary infiltrates in a pattern highly suggestive of Covid 19 pneumonitis - status post remdesivir - received iv hydrocortisone, transitioned to iv decadron while in hospital - will discharge on oral decadron to complete course - continue zinc, vit c - needs repeat imaging as outpatient with pcp to ensure resolution 2. Viral sepsis (temp 95.7, respiratory rate 25), poa - afebrile > past 24 hours 3. Acute hypoxic respiratory failure - will discharge on 1L at rest, 3. Acute hypoxic respiratory failure - will discharge on 1L at rest, 4L with ambulation as determined by walking oximetry 4. Polymyalgia rheumatica - on prednisone at time of admission - resume 1/16/22 5. Hypertension, uncontrolled - continue hydralazine, metoprolol, lisinopril, hctz - continue prn clonidine as outlined below - patient to monitor blood pressure at home - record, bring to appointment with pcp/discuss with virtual hospital - may need further adjustment of medications as outpatient with pcp 6. Anxiety - started prn hydroxyzine as outlined below Dispo - PT recommends home health, will be arranged prior to discharge as well as virtual hospital START taking these medications Details benzonatate (TESSALON) 100 MG capsule Take 1 capsule by mouth 3 (three) times daily as needed for Cough. cloNIDine (CATAPRES) 0.1 MG tablet Take 1 tablet by mouth 3 (three) times daily as needed (sbp >170 or dbp >100). dexamethasone (DECADRON) 6 MG tablet Take 1 tablet by mouth daily with breakfast Take last dose on 1/15/22. dextromethorphan polistirex ER (DELSYM) 30 MG/5ML liquid Take 5 mLs by mouth every 12 (twelve) hours as needed for Cough. hydroCHLOROthiazide (HYDRODIURIL) 12.5 MG tablet Take 1 tablet by mouth daily. hydrOXYzine (ATARAX) 10 MG tablet Take 1 tablet by mouth 3 (three) times daily as needed for Anxiety. lisinopril (PRINIVIL) 40 MG tablet Take 1 tablet by mouth daily. sennosides (SENOKOT) 8.6 MG TABS Take 1 tablet by mouth daily as needed (constipation). vitamin C (VITAMIN C) 500 MG tablet Take 1 tablet by mouth daily. zinc sulfate (ZINCATE) 220 (50 Zn) MG capsule Take 1 capsule by mouth daily. CONTINUE these medications which have CHANGED Details hydrALAZINE (APRESOLINE) 100 MG tablet Take 1 tablet by mouth every 8 (eight) hours. metoprolol, TOPROL-XL, 25 MG 24 hr tablet Take 3 tablets by mouth daily. predniSONE (DELTASONE) 1 MG tablet Take 6 tablets by mouth daily Resume 1/16/22. CONTINUE these medications which have NOT CHANGED B Complex CAPS Take 1 tablet by mouth daily. Calcium Citrate-Vitamin D (CALCIUM CITRATE + D PO) Take 1 tablet by mouth daily Cholecalciferol (VITAMIN D3) 2000 UNITS capsule Take 2,000 Units by mouth daily. FIBER ADULT GUMMIES PO Take by mouth daily ibandronate (BONIVA) 150 MG tablet Take 1 tablet by mouth every 30 (thirty) days. Associated Diagnoses: Age-related osteoporosis with current pathological fracture, initial encounter MAGNESIUM PO Take 1 tablet by mouth. Multiple Vitamin (MULTIVITAMIN) tablet Take 1 tablet by mouth daily. Omega-3 Fatty Acids (FISH OIL) 1000 MG CAPS Take 2,000 mg by mouth daily Arthritis NECK Frequent PVCs 06/2018 Goiter colloid, toxic, nodular October 2015 Ultrasound and followed by biopsy. PATIENT DENIES THYROID ISSUES H/O cardiovascular stress test 7/2012 DR. History of chicken pox MEASLES, MUMPS AS A CHILD History of fracture RIGHT SMALL FINGER History of pleurisy 1/9/14 Hypertension Left bundle branch block (LBBB) 06/2018 Lumbar radiculopathy LVH (left ventricular hypertrophy) 06/2018 Echocardiogram mild mitral aortic regurgitation Mobitz type 1 second degree AV block 06/2018 Nocturnal leg cramps Obstructive sleep apnea Hypoxia uses CPAP Osteopenia PVC (premature ventricular contraction) 03/2017 Renal cell cancer (CMS/HCC) 2014 Varicose veins

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
8,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Arthritis NECK o Frequent PVCs 06/2018 o Goiter colloid, toxic, nodular October 2015 Ultrasound and followed by
Andere Medikamente
START taking these medications Detailsbenzonatate (TESSALON)
Allergien
Codeine, Cardura, Morphine, Sulfa, Penicillin, Norvasc
Vorherige Impfungen
-

VAERS 2082233

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MI
Alter
76,0
Geschlecht
F
Eingang
02.02.2022
Impfdatum
29.03.2021
Beginn
03.01.2022
Tage bis Beginn
280,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure Atelectasis Atrial fibrillation COVID-19 Chest X-ray abnormal Condition aggravated Lung infiltration SARS-CoV-2 test positive

Symptomtext

Patient was initially presented on 1/3/2022 with atrial fibrillation RVR as well as acute hypoxic respiratory failure due to COVID-19 infection. Patient was admitted for cardiac management. Patient was started on Dexamethasone as well as Remdesivir given her hypoxic respiratory failure.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
4,0
Labordaten
Xray: 1/3/22 Left lower lobe atelectasis/early infiltrate. COVID 19: Positive on 1/3/22
Aktuelle Erkrankungen
3/13/2021 Acute hypoxic respiratory failure COPD exacerbation. Left lower lobe pneumonia - likely community acquired pneumonia - bacterial etiology Atrial fibrillation
Vorgeschichte
Atrial fibrillation with RVR: currently rate controlled Chronic pain syndrome Polycythemia Hypothyroidism History of neuropathy History of migraine Fibromyalgia GIA CAD Essential hypertension Abdominal aortic aneurysm
Andere Medikamente
acetaminophen (TYLENOL) 325 MG tablet aspirin (HALFPRIN) 81 MG tablet atorvastatin (LIPITOR) 40 MG tablet bisacodyl (DULCOLAX) 10 MG suppository budesonide-formoterol (SYMBICORT) 160-4.5 MCG/ACT inhaler diltiazem (DILACOR-XR) 120 MG XR
Allergien
Codeine, Morphine.
Vorherige Impfungen
-

VAERS 2079169

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
79,0
Geschlecht
F
Eingang
01.02.2022
Impfdatum
06.03.2021
Beginn
19.07.2021
Tage bis Beginn
135,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
COVID-19 Death Dizziness Dyspnoea Endotracheal intubation General physical health deterioration Hyperglycaemia Intensive care Respiratory distress SARS-CoV-2 test positive

Symptomtext

pt brought by EMS to hospital with c/o increasing SOB and dizziness over past 1-2 wks; found to be hyperglycemic and positive for COVID; transferred to CCU for severe respiratory distress (O2 sats at 31%); placed on NRB with O2 sats now in the 80%; placed on FMV and later required intubation; DNR; pt's condition deteriorated and she died in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
18,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
GERD, DMT2, HTN
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1963236

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
80,0
Geschlecht
M
Eingang
01.02.2022
Impfdatum
09.03.2021
Beginn
29.11.2021
Tage bis Beginn
265,0
Dosis
UNK
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Asthenia Cough Death Dizziness Dyspnoea COVID-19 Intensive care Laboratory test normal SARS-CoV-2 test positive Fatigue General physical health deterioration Hypoxia Pneumonia

Symptomtext

pt c/o 4 days before he started having a cough, SOB, weakness, fatigue and dizziness; went to urgent care; diagnosed with pneumonia; given breathing treatments; found to be hypoxic on RA, given O2 and pt comes to ED with 3LO2 via NC (O2 sats 98%); pt's condition worsened requiring ICU; on 100% FiO2 on Vapotherm with addition of NRB mask; given remdesivir, dexamethasone; O2 requirements continued to increase; DNR/DNI; pt transitioned to comfort care with worsening condition, and he died in the hosp

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
19,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, ischemic cardiomyopathy, coronary disease status post PCI, HLD
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2068748

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
76,0
Geschlecht
M
Eingang
27.01.2022
Impfdatum
17.06.2021
Beginn
16.01.2022
Tage bis Beginn
213,0
Dosis
1
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 COVID-19 pneumonia Chest X-ray abnormal Death Hyporesponsive to stimuli Lung infiltration SARS-CoV-2 test positive Sepsis

Symptomtext

Janssen (J&J) COVID-19 and Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 4/20/2021 and Janssen (J&J) COVID-19 on 6/17/2021. Presented to the ED for decreased responsiveness. Reported COVID positive per nursing home. Admitted for sepsis and pneumonia due to COVID-19. Patient requiring increased oxygen requirements. Treated with: vitamin C, zinc, and antibiotics. DNR on arriaval. Expired 1/23/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
7,0
Labordaten
1/16/2022: COVID positive and Chest x-ray revealed early small left basilar infiltrate
Aktuelle Erkrankungen
-
Vorgeschichte
Alzheimer disease, anxiety, depression, dementia, GERD, hyperlipidemia, hypertension, insomnia, SAH
Andere Medikamente
acetaminophen, calcium carbonate-vitamin D, depakote, namenda, remeron, multivitamin, zyprexa, miralax
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2054094

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MN
Alter
86,0
Geschlecht
F
Eingang
21.01.2022
Impfdatum
25.02.2021
Beginn
17.01.2022
Tage bis Beginn
326,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

Dose 1 given 2/4/2021 lot # EM9809 Patient died form Covid 19 at Medical Center

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Lung cancer, hypertension, lymphoma, CHF
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2043661

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MI
Alter
69,0
Geschlecht
M
Eingang
18.01.2022
Impfdatum
04.10.2021
Beginn
10.01.2022
Tage bis Beginn
98,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 COVID-19 pneumonia Chest X-ray normal Chest discomfort Cough Dyspnoea exertional Electrocardiogram ST-T change Electrocardiogram abnormal Feeling abnormal Magnetic resonance imaging heart Myocardial injury Productive cough Prohormone brain natriuretic peptide increased SARS-CoV-2 test positive Supportive care

Symptomtext

Hospitalized 01/11/2022-still currently admitted; COVID-19 positive 01/10/2022; fully vaccinated plus booster 70-year-old man who was vaccinated induced that against COVID-19. He reports he has not been feeling himself for past 2 weeks. He reports that he has been having intermittent chest pressure, that comes and goes, it is not precipitated by activity. He reports that this has been ongoing for the past few weeks. He reports no chest pain currently. Patient also reports that he has been having some shortness of breath, cough that is nonproductive of sputum for approximately 2 weeks as well. ASSESSMENT / PLAN: Troponinemia 2/2 myocardial injury Recently elevated proBNP with DOE - Admit to GMF as inpatient, anticipate >2 midnight hospital stay. - Recently found to have elevated proBNP (11k), scheduled for outpatient TTE. - Trops 376 ? 345, EKG with non-specific ST-T wave changes. - CXR clear and maintaining appropriate SpO2 on baseline RA. - Cardiology contacted from ER ? no need for IV heparin, follow trops, will consult. - Obtain ECHO - Monitor volume status with daily weights and I/O?s. Monitor telemetry. COVID-19 infection - Symptom onset > 2 weeks. + PCR on 1/10. - Comfortable and saturating normally on baseline RA. - CXR clear without e/o opacities or infiltrates. - Not a candidate for remdesivir or dexamethasone. - Supportive care, encourage IS/pulm toilet. In regards to COVID-19, symptom onset does appear to be greater than 2 weeks. He is vaccinated and boosted. He is on room air. Chest x-ray without evidence of pneumonia. Agree he is not currently a candidate for remdesivir dexamethasone but would initiate dexamethasone if he were to develop hypoxemia. 01/14/2022 notes: Acute hypoxic respiratory failure; resolved COVID-19 pneumonia Continue Decadron 6 mg q.day Supplemental oxygen to maintain O2 sats greater than 90% Continue severe respiratory precautions 01/17/2022 notes: Acute hypoxic respiratory failure; resolved currently on room air COVID-19 pneumonia Continue Decadron 6 mg q.day Supplemental oxygen to maintain O2 sats greater than 90% Continue severe respiratory precautions Dispo: Transitioned to oral torsemide a nephrology; nephrology anticipating discharge from their perspective 1 2 days; cardiology recommending cardiac MRI tomorrow; still considering whether not to discharge patient on a Life Vest; likely patient will be hospitalized for at least 2-3 more days

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
7,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Syncope Syncope and collapse Type 2 diabetes mellitus without complication, without long-term current use of insulin Hypertension associated with diabetes Dyslipidemia associated with type 2 diabetes mellitus Shortness of breath Snoring Bilateral hearing loss, unspecified hearing loss type
Andere Medikamente
amLODIPine (NORVASC) 10 MG tablet aspirin 81 MG enteric coated tablet cholecalciferol (VITAMIN D3) 25 MCG (1000 UT) tablet cilostazol (PLETAL) 50 MG tablet citalopram (CELEXA) 40 MG tablet cyanocobalamin 1000 MCG tablet fenofibrate (TRIGLID
Allergien
NKA
Vorherige Impfungen
-

VAERS 2028229

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
OH
Alter
63,0
Geschlecht
F
Eingang
12.01.2022
Impfdatum
05.03.2021
Beginn
26.11.2021
Tage bis Beginn
266,0
Dosis
1
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 COVID-19 pneumonia Death SARS-CoV-2 test positive

Symptomtext

10. Covid monitoring documentation. PT admitted 11/26/21 documented to have positive covid. PT received Pfizer 3/5/21 Lot EN6198 for dose 1. Dose 2 was Pfizer given on 3/26/21 Lot EP6955. PT expired on 12/12/21 due to COVID19 pneumonia.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
17,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2021322

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
80,0
Geschlecht
F
Eingang
10.01.2022
Impfdatum
03.03.2021
Beginn
26.12.2021
Tage bis Beginn
298,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Blood pressure immeasurable COVID-19 COVID-19 pneumonia Death SARS-CoV-2 test positive

Symptomtext

Resident was admitted to Hospital on 12/26/2021 and returned to facility on 12/28/2021 with a diagnosis of Pneumonia due to COVID. On 01/08/2022 Physical Therapy asked nursing to assess her and they could not find a blood pressure. MD was notified and orders to send to the emergency room and resident expired before they sent her out. She was a DNR.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
2,0
Labordaten
SARS COVID positive
Aktuelle Erkrankungen
-
Vorgeschichte
Pneumonia due to CORONAVIRUS, HTN, Megaloblastic Anemia, Hypothyroidism, Type II Diabetes, Hyperlipidemia, Anxiety, GERD GOUT
Andere Medikamente
Allopurinol, Aspirin ,Atenolol, Atorvastatin, Celecoxib, Famotidine, Furosemide, Gabapentin, Isosorbide, Levothyroxine, Lisinopril, Metformin, Oxybutynin, Pantoprazole, Potassium, Ranolazine, Ropinirole, Tylenol
Allergien
Amoxicillin, Meperidine, Sulfacetamide, Tropicamide
Vorherige Impfungen
-

VAERS 2020650

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
73,0
Geschlecht
M
Eingang
10.01.2022
Impfdatum
04.02.2021
Beginn
09.01.2022
Tage bis Beginn
339,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient was admitted 1/2/2022 and tested positive for COVID. Patient was fully vaccinated and expired 1/9/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
7,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2551084

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
70,0
Geschlecht
M
Eingang
06.01.2022
Impfdatum
23.02.2021
Beginn
28.02.2021
Tage bis Beginn
5,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death Fall Head injury

Symptomtext

Narrative: patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing and adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient deceased after falling and hitting head. Patient had a h/o of ICM with an ICD and was already being seen by palliative care/hospice prior to COVID vaccinations.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2496163

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
78,0
Geschlecht
M
Eingang
05.01.2022
Impfdatum
-
Beginn
28.12.2021
Tage bis Beginn
-
Dosis
2
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure COVID-19 Chronic obstructive pulmonary disease Computerised tomogram thorax normal Condition aggravated Oxygen saturation decreased SARS-CoV-2 test positive

Symptomtext

Admissions diagnosis: Acute hypoxic Respiratory failure Admitted 12/28/21 - 12/29/21. 77-year-old male with a past medical history significant for non-small cell adenocarcinoma of the lung s/p chemotherapy/XRT now on immunotherapy, COPD, moderate aortic stenosis, HTN, HLD, BPH who presents with acute hypoxic respiratory failure secondary to COVID-19, receiving booster 9/29/2021. He has no known exposure to COVID-19, however to found to have AHRF with exertion in ED with desaturation to 88%. Also suspect concurrent COPD exacerbation with his hemoptysis and increased albuterol use. Immunotherapy pneumonitis possible but no evidence of pneumonitis on CT chest on admission. No PE or lung infiltrates noted on CT chest. Patient was treated with dexamethasone 6mh daily and remdesivir 200 IV x1 and then 100 IV daily, as well as azithromycin 500mg IV daily. On discharge, patient was satting well on Room Air, and walk test was within normal limits. Vaccination history: Date Immunization Series 09/29/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCH/0 3 02/27/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/0 3 02/06/2021 COVID-19 (PFIZER), MRNA, LNP-S, PF, 30 MCG/01

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
Date Test Name Result 12/28/2021@10:57 COVID-19 PCR (FLUVID CEPH) DETECTED Exam Date/Time 12/28/2021 11:01 Procedure Name CHEST-1 VIEW (AP/PA) Report: Findings: Single view of the chest with comparison CT scan on 11/23/2021 demonstrates no focal consolidation, pleural effusion, or pneumothorax. Right upper lobe lung neoplasm is better evaluated by CT scan. The cardiomediastinal silhouette is unremarkable. No acute osseous abnormality is identified.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2541683

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
98,0
Geschlecht
M
Eingang
04.01.2022
Impfdatum
04.03.2021
Beginn
30.04.2021
Tage bis Beginn
57,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMh significant for htn, af, aflutter, primary malignant neoplasm of penis. Pt was 96 years of age. No cause of death noted, or recent hospitalizations noted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2536299

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
81,0
Geschlecht
M
Eingang
04.01.2022
Impfdatum
02.03.2021
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death Pneumonia

Symptomtext

Narrative: Patient received two doses of covid vaccine. Patient died some time after at outside hospital. Admitted for PNA. PMHx significant for CAD hx of stent x 3 (2000 & 2012), Hyperlipidemia, HTN, end stage/severe COPD on continues home oxygen dependent, Hyperthyroidism, macular degeneration. No further details of death.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2533901

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
76,0
Geschlecht
M
Eingang
04.01.2022
Impfdatum
01.03.2021
Beginn
21.03.2021
Tage bis Beginn
20,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Cardiac failure Death Dyspnoea Oedema peripheral

Symptomtext

Narrative: Patient was previously COVID-19 positive in December 2020, but did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was admitted to the ED on 3/1/21 for a new onset heart failure diagnosis presenting with shortness of breath and bilateral lower leg edema. Patient was discharged on 3/3/21 with a request to received palliative care. He passed away on 3/21/21 with details surrounding his passing unclear and not documented in his chart. Comorbidities included COPD, smoker, chronic pain syndrome on chronic opioids with benzodiazepines, obesity, HTN

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2533020

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
79,0
Geschlecht
M
Eingang
04.01.2022
Impfdatum
04.03.2021
Beginn
25.03.2021
Tage bis Beginn
21,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Abdominal pain Computerised tomogram abdomen abnormal Computerised tomogram thorax abnormal Death

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. ON 3/19/21 Patient had a CT that showed a possible malignancy of lung cancer with possible liver metastases. He went to the ED on 3/25/21 with severe abdominal pain and later passed away that day. Care was outside of clinic, so unable to determine diagnosis or suspected cause of death. Comorbidities include CHF, afib, COPD, smoker, anemia, HTN, HLD, PTSD.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2532972

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
71,0
Geschlecht
M
Eingang
04.01.2022
Impfdatum
03.03.2021
Beginn
09.05.2021
Tage bis Beginn
67,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH Significant for T2DM, arteriosclerosis of coronary bypass graft, AF, cardiac arrhythmia, sleep apnea, diastolic dysfunction, cerebrovascular accident, hyperlipidemia, HTN. No recent hospitalizations or illness documented. Patient deceased 5/09 with no information regarding death noted. Pt was 69 years of age

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2529635

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
68,0
Geschlecht
M
Eingang
04.01.2022
Impfdatum
25.02.2021
Beginn
02.04.2021
Tage bis Beginn
36,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Condition aggravated Death Type 2 diabetes mellitus

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Comorbidities include diabetes, HLD, HTN, aortic stenosis, kidney stones, smoking. He was found deceased in his bed on 4/2/21 with unknown cause of death. Medical examiner listed possible causes of death as 1. Natural causes 2. possible due to hypertensive heart disease 3. Probable diabetes mellitus 2

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2529620

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
84,0
Geschlecht
M
Eingang
04.01.2022
Impfdatum
25.02.2021
Beginn
09.03.2021
Tage bis Beginn
12,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Abnormal behaviour Adverse drug reaction Cognitive disorder Death Malnutrition Vascular dementia

Symptomtext

Narrative: Patient was not previously Covid positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was 82 and the cause of death listed was vascular dementia. His cognitive status was declining up until his death along with his behavior. Caregiver had difficulty caring for patient and hospice was discussed prior to his passing. Patient was malnourished and had COPD.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2552119

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
59,0
Geschlecht
M
Eingang
03.01.2022
Impfdatum
04.03.2021
Beginn
03.04.2021
Tage bis Beginn
30,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Alcohol use Death Fall

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at this time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for liver steatosis, vitamin d3 deficiency, essential htn, alcohol abuse, cannabis use, hyperlipidemia, neoplasm of uncertain behavior of lung, tobacco use, hx of homeless. Per note 4/15, wife reported that patient found in his camper 4/3/2021. Patient had been drinking and climbed into bed and fell. No further no notation on cause of death.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2541644

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
88,0
Geschlecht
M
Eingang
03.01.2022
Impfdatum
24.02.2021
Beginn
05.05.2021
Tage bis Beginn
70,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death Mental status changes

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for malignant tumor urinary bladder, dementia, anemia, neoplasm of kidney, gout, hyperlipidemia, ckd stage 3, essential htn, poor diabetic control, hydronephrosis, copd. Presented to ED 3/6/21 for altered mental status. Placed on hospice care in April. Pt was 86 years of age at time of death.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2552122

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6198

kritisch
Staat
-
Alter
66,0
Geschlecht
M
Eingang
02.01.2022
Impfdatum
26.02.2021
Beginn
07.04.2021
Tage bis Beginn
40,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Abdominal pain upper Death

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. 64 y/o male with HTN, HLD, DMII, ETOH abuse, Tobacco use, chronic pancreatitis/b exocrine insufficiency on PERT, multiple pseudocysts and splenic vein thrombosis on anticoagulation. On March 06th patient was also admitted to ER for upper abdominal pain after eating. Also had an history of Pancreatitis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2500298

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6198

kritisch
Staat
-
Alter
74,0
Geschlecht
M
Eingang
02.01.2022
Impfdatum
10.03.2021
Beginn
13.05.2021
Tage bis Beginn
64,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Asthenia Death Decreased appetite Dysarthria Dyspnoea Dyspnoea exertional General physical health deterioration Speech disorder Unresponsive to stimuli

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. The patient was 72-year-old gentleman with a past medical history significant for non-small cell lung cancer with metastases to the brain and spine who is status post XRT, COPD (oxygen dependent)currently at 3 L nasal cannula, hypertension, insomnia, anxiety, CHF, chronic pain who was transferred from the Hospice to ED for evaluation and possible placement in a facility. The patient reports that he was no longer interested in treatment and was looking for comfort care. He states that he experiences dyspnea on minimal exertion and at times with no exertion at all. He also reports a diminished appetite with increasing weakness. The Patient Was Transferred to the facility on January 5, 2021. From there the patient's condition was noted to slowly decline. He became weaker and is speech became slurred and garbled. His appetite remained intact until just recently. The patient became unresponsive and passed quietly at 2044 on 5/12/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2500238

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
88,0
Geschlecht
M
Eingang
02.01.2022
Impfdatum
03.03.2021
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death

Symptomtext

Narrative: Patient received two doses of covid vaccine. Patient was end stage COPD on hospice. No other cause of death reported. Reporting per network instructions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2498946

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
90,0
Geschlecht
M
Eingang
02.01.2022
Impfdatum
27.02.2021
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death Traumatic shock

Symptomtext

Narrative: Patient received two covid vaccine doses. Patient was admitted to hospital shock trauma 3 weeks after second dose and passed. There is no documentation of exact cause of death. Reporting per facility instruction. PMH includes severe AS s/p TAVR at Hospital 5/28/2019, CAD s/p multiple prior PCI (3 PCI's to LAD most recent in 2008), CHF with mid-range EF of unclear etiology (EF 40-45% based on TTE 8/2019), symptomatic bradycardia s/p PPM (2011), HTN, HLD, Afib (CHADSVASC 6, on apixaban), prior CVA (2009), BPH, GERD, and RA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1992573

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
81,0
Geschlecht
M
Eingang
30.12.2021
Impfdatum
03.03.2021
Beginn
05.12.2021
Tage bis Beginn
277,0
Dosis
1
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient contracted COVID and passed away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
1,0
Labordaten
Positive COVID test on 12/04/2021
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 1988871

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
60,0
Geschlecht
F
Eingang
29.12.2021
Impfdatum
17.08.2021
Beginn
05.12.2021
Tage bis Beginn
110,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Acute respiratory failure COVID-19 Death Endotracheal intubation Pneumonia

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/5/2021, 2/26/2021, and 8/17/2021. PMHx ESRD s/p renal transplant on hemodialysis, dx'd w/Covid 13 days prior to admission on 12/5/2021. Admitted for acute respiratory failure w/hypoxia, PNA and acute on chronic renal failure. Tx'd w/steroids, bactrim, vancomycin and Cefepime. Was not a candidate for remdesivir, tocilizumab/baricitinib. Intubated 12/11/21. Expired12/16/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
11,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Renal transplant in 2019 due to IgA nephropathy, Anemia, Anxiety, ESRD, GERD, GOUT, Hypertension, hypercholesterolemia
Andere Medikamente
Cyanocobalamin 100 mcg QD, Dexlansoprazole 60 mg QD, Diazepam 5 mg Q8H prn Anxiety, Famotidine 10 mg QD, Norco 5/325 mg Q6H prn, Labetalol 150 mg BID PRN SBP >150, Mycophenolate 360 mg QID, Rosuvastatin 10 mg QD, Bactrim 400/80 mg QD, Tacro
Allergien
Pantoprazole (Headache)
Vorherige Impfungen
-

VAERS 1981995

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WI
Alter
68,0
Geschlecht
M
Eingang
27.12.2021
Impfdatum
24.08.2021
Beginn
23.12.2021
Tage bis Beginn
121,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

fully vaccinated-covid related death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
History of lymphoma; HTN; CKD stage 3
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1975017

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
76,0
Geschlecht
F
Eingang
23.12.2021
Impfdatum
03.03.2021
Beginn
30.08.2021
Tage bis Beginn
180,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had breakthrough infection and passed away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
15,0
Labordaten
Positive COVID test on 8/1/2021.
Aktuelle Erkrankungen
Peripheral neuropathy Vertigo HTN Hyperlipidemia Hypothyroidism Anemia (megaloblastic anemia) Anxiety Depression
Vorgeschichte
-
Andere Medikamente
Miralax Super B Complex-Vitamin C Vitamin D3 Escitalopram oxalate Levothyroxine Melatonin Metoprolol tartrate Pregabalin Simvastatin
Allergien
Allopurinol Doxycycline
Vorherige Impfungen
-

VAERS 1974805

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
67,0
Geschlecht
F
Eingang
23.12.2021
Impfdatum
03.03.2021
Beginn
26.09.2021
Tage bis Beginn
207,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had breakthrough infection and passed away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
17,0
Labordaten
Positive COVID-19 test on 8/28/2021.
Aktuelle Erkrankungen
Unknown
Vorgeschichte
None listed.
Andere Medikamente
Citalopram Premarin Hydrocodone-acetaminophen Rosuvastatin Losartan
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1959932

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WA
Alter
75,0
Geschlecht
M
Eingang
17.12.2021
Impfdatum
25.02.2021
Beginn
14.12.2021
Tage bis Beginn
292,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure Blood glucose abnormal COVID-19 COVID-19 pneumonia Condition aggravated Hypertension Inappropriate schedule of product administration SARS-CoV-2 test positive

Symptomtext

Patient received Pfizer COVID vaccine on 1/28/21 and 2/25/21. On 12/14/21, patient came to our ED and was admitted to our inpatient unit for acute hypoxemic respiratory failure and pneumonia due to COVID-19 and uncontrolled BG and HTN in the setting of DM type 2 . As of today (12/17/21), patient is still admitted in the med/surg unit.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
3,0
Labordaten
COVID status positive 12/14/21.
Aktuelle Erkrankungen
-
Vorgeschichte
non-insulin-dependent diabetes mellitus and hypertension
Andere Medikamente
baby aspirin, glipizide, hydroxyzine PRN, ibuprofen PRN, losartan, MVI/folic acid, pioglitazone, prednisone PRN, simvastatin
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1947895

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
68,0
Geschlecht
F
Eingang
14.12.2021
Impfdatum
17.03.2021
Beginn
23.11.2021
Tage bis Beginn
251,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure Anticoagulant therapy COVID-19 COVID-19 pneumonia Death Mechanical ventilation Oxygen saturation decreased SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/24/2021 and 3/17/2021 .68/F PMHx DMII, HTN, morbidly obese, hypo and hyperthyroidism, asthma and depression. Covid-19 + was going to get monoclonal antibody infusion but sats were in the low 80's subsequently told to report to the ED. Presented with acute hypoxic respiratory failure 2/2 Covid-19 PNA. Tx'd w/decadron, Tocilizumab, remdisivir, Lovenox and O2. Per pt. request care not escalated beyond non-invasive ventilation. Expired 12/09/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
16,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Depression, DM Type 2, GERD, Hypertension, Hyperlipidemia, Hypothyroidism, Asthma, Anxiety
Andere Medikamente
Albuterol MDI PRN, Amlodipine 5 mg QD, Benazepril 10 mg QD, Additional information for Item 9: Biotin QD, Calcipotriene cream BID, Cholecalciferol 125 mcg QD, Duloxetine 30 mg QD, Furosemide 40 mg QD, Icosapent ethyl 2 grams BID, Levothyro
Allergien
Celecoxib, Kiwi, Terconazole, Poria Mushroom, Sulfanilamide, Additional information for Item 10: Tetracyclines, Zucchini, Buproprion, Cefdinir, Sulfa antibiotics 68/F PMHx DMII, HTN,morbidly obese, hypo and hyperthyroidism, asthma and depression was going to get monoclonal antibody infusion but sats were in the low 80's. She was told to report to the ED. Presented with acute hypoxic respiratory failure 2/2 Covid-19 PNA. Tx'd w/decadron, Tocilizumab, remdisivir, Lovenox and O2. Per pt. request care not escalated beyond non-invasive ventilation. Expired 12/09/21.
Vorherige Impfungen
-

VAERS 1540970

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
61,0
Geschlecht
F
Eingang
08.12.2021
Impfdatum
19.03.2021
Beginn
08.08.2021
Tage bis Beginn
142,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Cardiac arrest Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Had breakthrough infection and expired.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Depression/mood disorder Diabetes mellitus Hyptertension
Andere Medikamente
None listed
Allergien
No Known Allergies
Vorherige Impfungen
-

VAERS 1928580

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
83,0
Geschlecht
M
Eingang
07.12.2021
Impfdatum
03.03.2021
Beginn
05.12.2021
Tage bis Beginn
277,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

After a long hospital stay and diagnosis of COVID19, patient died on 12/05/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Unknown
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 1921245

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
90,0
Geschlecht
M
Eingang
03.12.2021
Impfdatum
03.03.2021
Beginn
26.08.2021
Tage bis Beginn
176,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had breakthrough infection and passed away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
21,0
Labordaten
Positive COVID-19 test on 8/6/2021
Aktuelle Erkrankungen
Unknown
Vorgeschichte
CVA Aortic Stenosis HTN Valvular Insufficiency CKD
Andere Medikamente
Multivitamin Atorvastatin Metoprolol succinate Cefdnir Ferrous sulfate Furosemide Potassium Chloride Warfarin
Allergien
Penicillins
Vorherige Impfungen
-

VAERS 1915848

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
IL
Alter
52,0
Geschlecht
M
Eingang
02.12.2021
Impfdatum
17.02.2021
Beginn
28.05.2021
Tage bis Beginn
100,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: ja
Blood test Cardiac arrest Cardiac pacemaker insertion Electrocardiogram Loss of consciousness

Symptomtext

Heart stopped, passed out and heart restarted several times over the course of 5 days until a Medtronic pacemaker was implanted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
6,0
Labordaten
Was in the hospital from 5/28/2021 until 6/2/2021. Multiple EKGs, and blood tests were run prior to surgery to implant a pacemaker.
Aktuelle Erkrankungen
none
Vorgeschichte
ALL survivor 23 years in remission with no further ccurance.
Andere Medikamente
Lisinopril 20mg/daily, Atorvastatin 40mg/daily, Metoprolol Succinate ER 50mg/daily and One A Day multivitamin.
Allergien
none
Vorherige Impfungen
-

VAERS 1912668

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MI
Alter
74,0
Geschlecht
M
Eingang
01.12.2021
Impfdatum
04.03.2021
Beginn
20.11.2021
Tage bis Beginn
261,0
Dosis
1
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Agonal respiration COVID-19 COVID-19 pneumonia Cough Death Fatigue Hypoxia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Pt received Pfizer vaccines on 03/04/2021 and 03/25/2021. Pt presented to the ED with complaints of cough, congestion, and generalized fatigue. Pt was found to be COVID positive and diagnosed with COVID-19 pneumonitis. Pt was hypoxic requiring 5L of oxygen. Pt began experiencing agonal breathing and was a DNR/DNI status. Pt died on 11/24/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
SARS-COV-2 by NAA, POC positive for SARS
Aktuelle Erkrankungen
-
Vorgeschichte
Parotid cancer with chemotherapy, Friedreich's ataxia, HLD, paraplegia
Andere Medikamente
-
Allergien
none
Vorherige Impfungen
-

VAERS 1901883

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6198

kritisch
Staat
CA
Alter
66,0
Geschlecht
M
Eingang
26.11.2021
Impfdatum
26.02.2021
Beginn
26.11.2021
Tage bis Beginn
273,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Acute myocardial infarction Catheterisation cardiac Chest pain Coronary artery stenosis Dyspnoea Stent placement

Symptomtext

On June 7, 2021 at around 1700 hrs. experienced crushing chest pain and extreme SOB after climbing stairs in my home. I asked my son to take me to hospital - less than 1 mi. distant. I was diagnosed as having a NSTEMI, placed on heparin drip and transported to Medical Center. I was placed on a The following day Dr., Chief of Cardiology and Professor of Medicine, performed a coronary angiogram A 90% mid-LAD stenosis was observed and PCI performed. A drug eluding metal stent was placed with good result. I was discharged the following day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
Cardiac cath 90% mid-LAD occlusion.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1901862

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MI
Alter
72,0
Geschlecht
F
Eingang
26.11.2021
Impfdatum
09.02.2021
Beginn
24.11.2021
Tage bis Beginn
288,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure COVID-19 pneumonia Chills Chronic obstructive pulmonary disease Dyspnoea Hypoxia Pyrexia

Symptomtext

Pt complains of shortness of breath worse than baseline with fever and chills. Pt admitted for acute on chronic hypoxic respiratory failure secondary to COVID-19 pneumonia and acute COPD exacerbation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1897981

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
OH
Alter
63,0
Geschlecht
M
Eingang
24.11.2021
Impfdatum
26.03.2021
Beginn
28.03.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
SYR / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Myocardial infarction

Symptomtext

The patient had a heart attack and died two days after his second COVID-19 vaccine. He was taken to the hospital. Their phone number is (Privacy).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
The patient died of a heart attack on March 28, 2021
Aktuelle Erkrankungen
No illness.
Vorgeschichte
He was a type one diabetic.
Andere Medikamente
IC Metformin HCL 500 MG (one a day) Armour Thyroid 120 MG (30 mg tablet a day) IC Enalapril Maleate 5 MG (one a day) He also was a type one diabetic and would inject insulin into himself four times a day.
Allergien
No allergies.
Vorherige Impfungen
-

VAERS 1885854

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WA
Alter
75,0
Geschlecht
F
Eingang
19.11.2021
Impfdatum
24.02.2021
Beginn
30.03.2021
Tage bis Beginn
34,0
Dosis
1
Route/Site
SYR / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Condition aggravated Pulmonary embolism

Symptomtext

Patient reported that she received her first Pfizer Covid vaccine on 2/24/21 and on 3/30/21 she went to the hospital and was diagnosed with a Pulmonary Embolism. She stayed overnight.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
1,0
Labordaten
Unknown
Aktuelle Erkrankungen
Type 2 diabetes mellitus with diabetic polyneuropathy (*) Type II diabetes mellitus, uncontrolled (*) Hyperlipidemia Essential hypertension Vitamin B12 deficiency Type 2 diabetes mellitus with diabetic chronic kidney disease (*) Personal history of colonic polyps Iron deficiency anemia
Vorgeschichte
Type 2 diabetes mellitus with diabetic polyneuropathy (*) Type II diabetes mellitus, uncontrolled (*) Hyperlipidemia Essential hypertension Vitamin B12 deficiency Type 2 diabetes mellitus with diabetic chronic kidney disease (*) Personal history of colonic polyps Iron deficiency anemia DVT GERD Basal Cell Carcinoma Chronic Kidney Disease Pulmonary Embolus
Andere Medikamente
Current medication list: Rivaroxaban (XARELTO) 20 MG tablet D-MANNOSE PO Cephalexin 250 MG tablet Calcium 500 MG tablet MULTIPLE VITAMINS-MINERALS PO Wheat Dextrin (BENEFIBER DRINK MIX PO) triamterene-hydrochlorothiazide 37.5-25 MG
Allergien
Amlodipine Robitussin Pk Cold Day-nght Dm [dm-gg & Pe-diphenhyd-apap]
Vorherige Impfungen
-

VAERS 1885417

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WA
Alter
67,0
Geschlecht
M
Eingang
19.11.2021
Impfdatum
22.02.2021
Beginn
01.04.2021
Tage bis Beginn
38,0
Dosis
1
Route/Site
SYR / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Amnesia Blood test Computerised tomogram Creutzfeldt-Jakob disease Death Irritability Lumbar puncture Magnetic resonance imaging Motor dysfunction

Symptomtext

what began as memory loss and irritability was followed by loss of motor skills, later diagnosed as Cruetzfeldt-Jakobs disease. Death occurred early morning 10/29/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
CT scan 9/10/2021 MRI 9/24/21 multiple blood tests and Lumbar Puncture late September 2021
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Lisinopril 10mg
Allergien
none
Vorherige Impfungen
-

VAERS 1876609

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
74,0
Geschlecht
M
Eingang
17.11.2021
Impfdatum
26.02.2021
Beginn
18.09.2021
Tage bis Beginn
204,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cerebral haemorrhage Condition aggravated Death

Symptomtext

Brain bleed resulting in death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebral haemorrhage
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
"Brain Bleed"
Vorgeschichte
Cardiovascular and Mediastinum HTN (hypertension) Atrial fibrillation CAD in native artery Respiratory OSA on CPAP Digestive Gastric polyp Other History of right thalamic and right occipital stroke Pure hypercholesterolemia Routine general medical examination at a health care facility
Andere Medikamente
amLODIPine (NORVASC) 2.5 MG tablet aspirin 81 MG chewable tablet Cholecalciferol (VITAMIN D) 1000 units tablet lisinopril (PRINIVIL) 40 MG tablet Omega-3 Fatty Acids (FISH OIL) 1000 MG capsule simvastatin (ZOCOR) 40 MG tablet spironol
Allergien
NKA
Vorherige Impfungen
-

VAERS 1873571

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
52,0
Geschlecht
F
Eingang
16.11.2021
Impfdatum
06.03.2021
Beginn
08.08.2021
Tage bis Beginn
155,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute kidney injury Acute respiratory failure COVID-19 COVID-19 pneumonia Death Dyspnoea Endotracheal intubation General physical health deterioration Hyperkalaemia Mechanical ventilation Myalgia Respiratory tract congestion Shock

Symptomtext

pt states was diagnosed 5 dys ago with COVID @ urgent care clinic; presents to ED with increasing SOB, myalgias, congestion; started on O2 supplementation 4-5 L, remdesivir, dexamethasone; COVID pneumonia and ARF; pt's condition worsened and she required intubation with ventilation; developed shock, AKI and hyperkalemia; was made a DNR by family; pt deteriorated and expired in the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
19,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1873233

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
89,0
Geschlecht
M
Eingang
16.11.2021
Impfdatum
20.02.2021
Beginn
09.08.2021
Tage bis Beginn
170,0
Dosis
2
Route/Site
IM / OT
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 pneumonia Death Dyspnoea Mental status changes Renal failure

Symptomtext

Presented with SOB, AMS; dx with Covid PNA; treated with steroids, 2 doses of remdesivir, Vit C, Zinc, supplemental O2; developing renal failure; family decided on comfort measures; pt died on 8/17

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
9,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1869755

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
80,0
Geschlecht
F
Eingang
15.11.2021
Impfdatum
16.03.2021
Beginn
10.07.2021
Tage bis Beginn
116,0
Dosis
1
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Asthenia Bradycardia COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Dyspnoea Endotracheal intubation Fatigue Goitre Hypoxia Inappropriate schedule of product administration Positive airway pressure therapy Pulseless electrical activity Respiratory distress SARS-CoV-2 test positive Sepsis

Symptomtext

Admitted 7/26 from ED with COVID, PNA, sepsis. Patient removed BiPAP and dev. hypoxia & bradycardia. Went into PEA when intubating. Symptoms: weakness, CXR noted for PNA, exhausted with minor activity, hypoxic, respiratory distress Non-LTCF. (+) PCR 7/10/2021. Dx: PNA due to COVID, ARF with hypoxia, sepsis without acute organ dysfunction, enlarged thyroid. S/S: cough, wheezing, weakness, develop PNA, SOA, tachycardia. C/M: A. fib with RVR, HTN, HLD. Pfizer: 2/27/2021 & 3/16/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Former smoker, essential HTN, HLD; A-fib with RVR
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1869644

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
76,0
Geschlecht
M
Eingang
15.11.2021
Impfdatum
28.03.2021
Beginn
10.05.2021
Tage bis Beginn
43,0
Dosis
1
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asymptomatic COVID-19 Death Dehydration Hypernatraemia Hyperosmolar state Malnutrition Oesophageal carcinoma SARS-CoV-2 test positive

Symptomtext

Not LTCF. PCR(+) 05/10/2021. Noted to be asymptomatic for Covid in May 2021. Died at home. Last hospital encounter 5/1/21 notes: dx of malignant neoplasm of esophagus, dehydration, malnutrition, hyperosmolality and hypernatremia. C/M: HTN, current smoker, immunosuppressive condition. Fully Vaccinated (Pfizer): 02/27/2021 & 03/28/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
esophagus cancer; current smoker; HTN; COPD; alcohol abuse; protein-calorie malnutrition
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1865326

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MI
Alter
88,0
Geschlecht
M
Eingang
12.11.2021
Impfdatum
13.04.2021
Beginn
05.11.2021
Tage bis Beginn
206,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Computerised tomogram abdomen Computerised tomogram thorax Hypoxia SARS-CoV-2 test

Symptomtext

Acute respiratory failure Pt has mild hypoxia. Plan: lovenox per IM oxygen saturation was 94% on RA - does not qualify for monoclonal ab d/t hypoxia - hold off decadron and remdesvir now - if hypoxia worsens will start decadron, remdesvir - covid isolation

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
1. ct chest/abd . 2. COVID test
Aktuelle Erkrankungen
generalized weakness, difficulty ambulating.
Vorgeschichte
AKI (acute kidney injury) ? Cognitive impairment, mild, so stated ? Adjustment disorder with depressed mood ? Leukocytosis ? Closed fracture of proximal end of left humerus ? SDH (subdural hematoma) ? Atrial flutter ? DM (diabetes mellitus), type 2 ? Hyperlipidemia ? Essential hypertension
Andere Medikamente
amLODIPine (NORVASC) 2.5 MG PO Tab atorvastatin (LIPITOR) 10 MG PO Tab glimepiride (AMARYL) 1 MG PO Tab lisinopril (PRINIVIL, ZESTRIL) 10 MG PO Tab metFORMIN (GLUCOPHAGE) 500 MG PO Tab methylPREDNISolone (MEDROL DOSEPAK) 4 MG PO Tablet
Allergien
None
Vorherige Impfungen
-

VAERS 1864278

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
71,0
Geschlecht
F
Eingang
12.11.2021
Impfdatum
01.03.2021
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Anxiety Cardiac discomfort Chest pain Hypoaesthesia Myocardial infarction Pharyngeal hypoaesthesia

Symptomtext

like having a heart attack; my throat was numb.; It was extreme like after the reflex like pain in my chest; I was having Heart pressure and my heart and my jaw and my throat was numb.; anxiety; I was having Heart pressure and my heart and my jaw and my throat was numb.; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6198), via an unspecified route of administration, administered in left arm (left upper arm) on 01Mar2021 (age at vaccination was 71 years) as DOSE 2, SINGLE for covid-19 immunization. Medical history included cancer (have cancer two years ago) and high blood pressure; both from an unknown date and unknown if ongoing. Concomitant medications included letrozole taken for cancer (A chemo pill, To prevent the cancer from coming back), start and stop date were not reported; lisinopril taken for high blood pressure, start and stop date were not reported. The patient previously received bnt162b2 (Batch/Lot Number: EN5318), via an unspecified route of administration, administered in left upper arm on 08Feb2021 (age at vaccination was 70 years) as DOSE 1, SINGLE for covid-19 immunization. On an unknown date, the patient experienced like having a heart attack, my throat was numb, It was extreme like after the reflex like pain in my chest, I was having Heart pressure and my heart and my jaw and my throat was numb, my jaw was numb, anxiety. The patient was having heart pressure and her heart and jaw and throat was numb. She stated that it was extreme like after the reflex like pain in her chest and numbing in her throat and in her jaw like having a heart attack. When asked about the corrective therapy, the patient reported that she just gave three medication that she was on, because of her cancer. She take Cannabis Mint and anti anxiety at night, a pill, So when she had those adverse effect because at that she was having Heart pressure and her heart and her jaw and her throat was numb so she took a CBD to relax her body to the anxiety after almost a hour it come down. She took Xanax and CBD Mint 2.5 milligram. Petra Kiera Concession Cannabis infused Mint and she have one more pill the anti anxiety pill was Xanax and its 0.5 milligram and alprazolam. Therapeutic measures were taken as a result of the events. Investigation assessment was reported. The outcome of the events like having a heart attack, and It was extreme like after the reflex like pain in my chest was unknown. The outcome of the events my throat was numb, I was having Heart pressure and my heart and my jaw and my throat was numb, my jaw was numb, anxiety were recovering. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Blood pressure high; Cancer (have cancer two years ago)
Andere Medikamente
LETROZOLE; LISINOPRIL
Allergien
-
Vorherige Impfungen
-

VAERS 1861105

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MI
Alter
86,0
Geschlecht
M
Eingang
11.11.2021
Impfdatum
19.03.2021
Beginn
12.10.2021
Tage bis Beginn
207,0
Dosis
2
Route/Site
SYR / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death Dizziness Dyspnoea Fall General physical health deterioration Implantable cardiac monitor insertion SARS-CoV-2 test positive

Symptomtext

Patient presented to emergency department on 10/12/2021 with shortness of breath and lightheadedness. He was found to be COVID-19 positive. He was previously admitted to observation unit from 10/2/21 to 10/5/21 following a fall and was given a loop recorder. He was treated with dexamethasone, baricitinib, remdesivir, and supplemental oxygen. His condition did improved during stay, but eventually decompensated. He was placed on comfort care measures only on 10/20/21. Patient expired on 10/23/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
11,0
Labordaten
COVID-19 test positive on 10/12/2021.
Aktuelle Erkrankungen
None known
Vorgeschichte
Syndrome of inappropriate ADH production, coronary artery disease, allergic rhinitis, essential hypertension, benign prostatic hypertrophy, hypercholesterolemia, arthritis, congestive heart failure, gastroesophageal reflux disease, myocardial infarction, peripheral vascular disease, tremor
Andere Medikamente
amLODIPine (NORVASC) 5 MG tablet atorvastatin (LIPITOR) 40 MG tablet clopidogrel (PLAVIX) 75 MG tablet ferrous sulfate (FEOSOL, 65 FE,) 325 (65 FE) MG tablet isosorbide mononitrate (IMDUR) 30 MG SR tablets levETIRAcetam (KEPPRA) 500 MG tabl
Allergien
Propoxyphene-apap (hallucinations)
Vorherige Impfungen
-

VAERS 1857612

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
75,0
Geschlecht
M
Eingang
10.11.2021
Impfdatum
24.02.2021
Beginn
06.11.2021
Tage bis Beginn
255,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

DX WITH COVID ON 10/15/2021; FULLY VACCINATED; PATIENT EXPIRED ON 11/06/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
COPD A- FIB NON USED LEFT ARM FISTULA GOUT, HTN PNEUMOCONIOSIS CHRONIC RESPIRATORY FAILURE
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1854591

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
69,0
Geschlecht
F
Eingang
09.11.2021
Impfdatum
24.02.2021
Beginn
03.11.2021
Tage bis Beginn
252,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

HX OF COVID AFTER VACCINATION; PATIENT EXPIRED ON 11/03/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
HX OF COVID ERSD WITH HD DM II HYPOTHYROIDISM HTN METASTATIC BREAST CA WITH CHEMO
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1840639

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
OR
Alter
69,0
Geschlecht
F
Eingang
03.11.2021
Impfdatum
24.03.2021
Beginn
11.07.2021
Tage bis Beginn
109,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Arrhythmia Arthralgia Atrial fibrillation Cardiac arrest Cardioversion Chest X-ray normal Chest pain Dyspnoea Echocardiogram Electrocardiogram normal Feeling hot Infection Oropharyngeal pain Pain Painful respiration Pericardial rub Pericarditis Pyrexia

Symptomtext

7-11-2021: Mid chest pain, 7/10 PN scale with1. increase with deep breathing or lying down or increased activity and right and left shoulder pain into trapezial ridge.. Phone consult with ER Dr. at hospital resulted in Urgent Care visit at Urgent care. ECG and CXR essentially negative. Rx nitroglycerin, F/U with PCP. One week later (7-16-21), first arrhythmic episode, (subsequently Dxd as Afib), lasting 40 minutes, resolving spontaneously. During F/U for chest pain on 7-20-21, another episode of arrhythmia occurred and PCP sent me to ER. There they did cardioversion, observed overnight due to 8 second flatline post cardioversion procedure. Echo done, hospitalist HPI continued: Saw hospitalist MD, on 7-21-21 and he remarked he thought infection without elaboration. I agreed. I had had some preceding symptoms of sore throat and a temperature of 99.5 which felt feverish as I consistently run 97.3-6 F and I had taken my temperature when I felt quite unusually hot. Dr. Rx 1 tab metoprolol 25 mg PO prn Afib,. Saw cardiologist at first available on 9-8-21. MD, cardiologist thought pericarditis though she said no objective findings were evident, but my symptoms fit and began protocol of Colchicine .6 mg BID for 3 months with Ibuprofen 800 mg TID in a tapering protocol of 1-2 weeks. I both felt and heard , with stethoscope, the cardiac rub off and on for a few days. However, PCP in F/U did not get to hear as it resolved a week after pericarditis protocol of Colchicine and Ibuprofen were started. Now, two months into treatment for pericarditis it is much less bothersome. Many days have no symptoms. A 3rd booster dose of Pfizer Covid-19 vaccine was received on 10/06/2021 at recommendation of Cardiologist. Another incident of the pericarditis pain began on 10-15-2021 with chest pain, ( 5/10 with deep breath) and SOB. Symptoms have tapered off with a few days of increased pain by bedtime necessitating sleeping upright. I am reporting because, as a completely healthy adult, these symptoms seemed to come out of the blue and I had been reading about pericarditis and myocarditis as conditions that matched my symptoms and had mentioned on several visits to medical providers previous to Dr.'s diagnosis. Subsequently, I read of reports emerging that myocarditis and pericarditis have been seen as adverse reactions to the Covid-19 vaccine and decided to report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
DJD right knee, asymptomatic otherwise none
Andere Medikamente
Multiple vitamin, proteolytic enzymes including: protease AM, proteolytic enzymes including cont'd: Bromelain, Protease 6.0 Alkaline Protease, Papain. also including: Botselia, ginger root extract, yucca root, turmeric rhizome, alpha-lip
Allergien
No known food or drug allergies
Vorherige Impfungen
-

VAERS 2602710

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
87,0
Geschlecht
M
Eingang
01.11.2021
Impfdatum
20.02.2021
Beginn
13.08.2021
Tage bis Beginn
174,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure Anticoagulant therapy Atrial fibrillation Atrial flutter Blood creatinine Blood glucose increased COVID-19 COVID-19 pneumonia Cardiac disorder Chest pain Chronic obstructive pulmonary disease Condition aggravated Constipation Decreased appetite Deep vein thrombosis Diabetes mellitus inadequate control Dyslipidaemia Dyspnoea

Symptomtext

Narrative: ADMISSION DATE: 8/13/21 DISCHARGE DATE: 8/23/21 DISCHARGE TYPE: Regular PRINCIPAL DIAGNOSIS (Reason for admission after study): Acute hypoxic respiratory failure due to Covid ADDITIONAL DIAGNOSES: A-fib, Hypertension, DM Type 2, Chronic DVT on apixaban, prostate cancer HISTORY OF PRESENT ILLNESS: 86yo M admitted from the ER to hospital for further care management for chest pain with heart jumping , COVID-19 PNA,and Myoclonic Jerks. Patient reports he has been feeling ill with bodyaches for past 5 days but the heart jumping and myoclonic jerks of the face and hands started 2 days ago. Jerking sensations were worse last night while chair. Significant PMHX: AFib, HTN, DMT2, Chronic DVT on Apixiban and Prostate Cancer. ROS: + Decrease in appetite x 5d, denies any history of seizure, syncope, CVA or muscle twitching to this severity, no numbness, +nervous feeling, + Chest pain fleeting, + HOH and degree of difficulty hearing, no visual defects, Per ER chart - in 2014 he had a report of involuntary twitching. , no n/v/d/f/c +SOB with +DOE sometimes , no dysphagia, decrease appetite over past week, moving bowels and urinating wnl, no dysuria, no headache/vertigo or dizziness, no coughing, +shakes with cold intolerence and no skin rash/lesions/swelling or pruritus. HOSPITAL COURSE: 1. Acute COVID 19 pneumonia - S/P Decadron and Remdesivir x 5 days. 2.Acute hypoxic respiratory failure -this was all due to Covid and unfortunately we were unable to wean the patient completely off so will be discharged on home oxygen 3. Bradycardia -due to Amiodarone -last Amiodarone dose on 08/16/2021 morning. 4. Atrial flutter -normal sinus rhythm this morning -continue Eliquis -Amiodarone discontinued due to bradycardia 5. Muscle twitches -resolved 6. Primary hypertension -continued Hydrochlorothiazide, Losartan and Norvasc 7. Diabetes mellitus type 2 -blood sugar uncontrolled (216-222), A1c = 8.0% -okay to resume home insulin 8. CKD, stage IIIA -creatinine remained right around patient's baseline on the inpatient setting. 9. Chronic obstructive pulmonary disease -no acute exacerbation - continued inhaled steroids, bronchodilators and oxygen suuplement 10. Dyslipidemia -continued Lipitor 11. GERD -continued Omeprazole 12. Constipation -resolved

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1833644

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
PA
Alter
83,0
Geschlecht
M
Eingang
01.11.2021
Impfdatum
25.02.2021
Beginn
13.10.2021
Tage bis Beginn
230,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure Angiogram pulmonary abnormal COVID-19 COVID-19 pneumonia Cardiac telemetry Cardiomegaly Chest X-ray abnormal Chronic kidney disease Cognitive disorder Computerised tomogram Condition aggravated Cough Decreased appetite Dyspnoea Exposure to SARS-CoV-2 Fatigue Fibrin D dimer increased Hyperglycaemia

Symptomtext

10/19/2021 COUGH,SOB ED to Hosp-Admission Discharged 10/22/2021 - 10/30/2021 (8 days) MD Last attending ? Treatment team Acute respiratory failure with hypoxia (CMS/HCC) Principal problem Chief Complaint Patient presents with ? Shortness of Breath 1. COVID 19 2. Hypoxemia 3. Type 2 diabetes mellitus with hyperglycemia with insulin use 4. CKD Stage 3 5. Mild cognitive impairment Plan: Patient is fully vaccinated but still ill. Will require admission under telemetry and pulse oximetry. Start decadron 6mg IV daily x 10 days -> obviously will make sugars worse but can work on that as we go forward. Remdesivir full 5 day IV course. Procalcitonin level to determine need for antibiotics. Insulin sliding scale high algorithm for now - monitor sugars closely. Start insulin stat dose now. Spoke to ED physician personally. Patient is an 83 y.o. male. "Patient is a 83 y.o. yo male presenting to the ED with complaints of increasing shortness of breath over the past few weeks. Patient states recently tested positive for Covid however is fully vaccine against Covid as well. Patient states increasing shortness of breath as well as fatigue and loss of appetite however not claiming significant fevers, chills, body aches, nausea, vomiting, abdominal pain, dominant changes urination changes. Patient is also known diabetic and takes insulin. Patient also has history of hypertension, hyperlipidemia however no previous history of pulmonary disease or any cardiac disease. Patient not complain of any lower extremity swelling.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
8,0
Labordaten
10/19/2021 1114 COVID-19 (SARS CoV-2,RNA Molecular Amplification) Collected: 10/19/21 1114 | Final result | Specimen: Swab from Nares COVID-19 SARS-CoV-2 Overall Result Detected Critical 10/19/2021 Narrative & Impression XR CHEST 2 VW IMPRESSION: Patchy bibasilar infiltrates suspicious for multifocal pneumonia. END OF IMPRESSION: INDICATION: Contact with and (suspected) exposure to covid-19 Cough, unspecified. TECHNIQUE: PA and lateral projections of the chest are acquired. COMPARISON: 1/31/2018 FINDINGS: There are patchy bibasilar infiltrates. Heart is mildly enlarged. No pneumothorax or pleural effusion. Degenerative changes are noted in the spine and shoulders. X-ray chest 2 views Result Date: 10/19/2021 XR CHEST 2 VW IMPRESSION: Patchy bibasilar infiltrates suspicious for multifocal pneumonia. END OF IMPRESSION: INDICATION: Contact with and (suspected) exposure to covid-19 Cough, unspecified. TECHNIQUE: PA and lateral projections of the chest are acquired. COMPARISON: 1/31/2018 FINDINGS: There are patchy bibasilar infiltrates. Heart is mildly enlarged. No pneumothorax or pleural effusion. Degenerative changes are noted in the spine and shoulders. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view, Portable Result Date: 10/27/2021 XR CHEST 1 VW PORT IMPRESSION: Interval increase of bilateral patchy airspace opacities within the periphery of the lungs. END OF IMPRESSION: INDICATION: Worsening hypoxia with activity. TECHNIQUE: AP portable projection of the chest is acquired. COMPARISON: Portable chest dated 10/22/2021. FINDINGS: There has been a slight interval increase of the bilateral patchy airspace opacities within the periphery of the lungs when compared with 10/22/2021. No pleural effusions or pneumothorax are identified. The cardiomediastinal silhouette is stable. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view Result Date: 10/23/2021 XR CHEST 1 VW IMPRESSION: 1. Some patchy lung infiltrates suspicious of infectious process and COVID-19 pneumonia changes. 2. Stable some cardiomegaly. END OF IMPRESSION: INDICATION: Shortness of breath. TECHNIQUE: Single AP projection of the chest is acquired. COMPARISON: Chest radiograph dated October 19, 2021. FINDINGS: Some cardiomegaly changes are stable. Some interstitial vascular lung marking prominence is stable. Some patchy lung infiltrates are reidentified. No pneumothorax or effusion changes are noted. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Ultrasound lower extremity venous bilateral Result Date: 10/25/2021 US LOWER EXTREMITY VENOUS BILATERAL IMPRESSION: 1. Suboptimal visualization of the left peroneal vein. 2. Otherwise no evidence of DVT of the bilateral lower extremities. END OF IMPRESSION: INDICATION: Elevated D-Dimer, rule out DVT. TECHNIQUE: Multiple longitudinal and transverse 2D real-time ultrasound images were performed from the groin to knee, and at the calf and ankle. Color flow and spectral duplex Doppler imaging was also performed. Permanently-recorded images were obtained and stored. COMPARISON: Venous Doppler evaluation of the bilateral lower extremities dated January 30, 2018. FINDINGS: No evidence of deep venous thrombosis. On each side, there is normal flow, compressibility, and augmentation in the common femoral, greater saphenous, superficial and deep femoral veins, and popliteal veins. There is also normal flow, compressibility, and augmentation in the posterior tibial veins, right peroneal, and small saphenous veins in the calves. There is suboptimal visualization of the left peroneal vein. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT angiogram chest pulmonary embolism with and without contrast Result Date: 10/24/2021 CTA CHEST PULMONARY EMBOLISM W WO CONTRAST IMPRESSION: Suboptimal opacification of the main pulmonary artery. No large central embolus identified. Evaluation is suboptimal for smaller segmental and subsegmental emboli. Multifocal patchy asymmetric groundglass air-space disease bilaterally, consistent with changes of multifocal COVID-19 pneumonia. END OF IMPRESSION: INDICATION: COVID-19 pneumonia with elevated D-dimer. Assess for pulmonary artery embolism. TECHNIQUE: Enhanced helical CTA scan of the chest was performed from the lung apices to below the diaphragm, including the pulmonary artery. 2 mm axial reconstructions with MPR coronal, oblique and sagittal images were created. 3D post processing imaging was obtained and stored. CONTRAST: 100 mL of IODIXANOL 320 MG IODINE/ML INTRAVENOUS SOLUTION administered INTRAVENOUS. Quality of contrast opacification was suboptimal. COMPARISON: Chest radiograph October 22, 2021. FINDINGS: There is poor opacification of the main pulmonary artery. No large central embolus identified. Evaluation is suboptimal for smaller segmental and subsegmental emboli. No evidence of thoracic aortic aneurysm or dissection. No adenopathy noted. No pleural or pericardial effusions are seen. Regional soft tissues are grossly intact. Limited evaluation of the upper abdomen is unremarkable. On lung windows, there are multifocal patchy asymmetric groundglass infiltrates noted, consistent with changes of multifocal COVID-19 pneumonia. Central airways are patent, without evidence for endobronchial lesions. Osseous structures are grossly intact with scattered degenerative changes. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient
Aktuelle Erkrankungen
-
Vorgeschichte
Nervous Polyneuropathy, diabetic (CMS/HCC) Lower back pain Early stage nonexudative age-related macular degeneration of both eyes Pseudophakia of both eyes Benign neoplasm of skin of right lower eyelid Respiratory Acute respiratory failure with hypoxia (CMS/HCC) Cough Bronchitis Circulatory Hypertension Digestive Rectal polyp Vitamin D deficiency Obesity, morbid (more than 100 lbs over ideal weight or BMI > 40) (CMS/HCC) Obesity (BMI 30-39.9) Obesity (BMI 30-39.9) Genitourinary Benign enlargement of prostate Stage III chronic kidney disease (CMS/HCC) Musculoskeletal Actinic keratosis Furuncle Skin lesion of back Skin lesion of left upper extremity Cellulitis of both lower extremities Skin lesion of right leg Intertriginous candidiasis Endocrine/Metabolic Dyslipidemia Hyperkalemia Hypoglycemia Type 2 diabetes mellitus (CMS/HCC) Hematologic Anemia Leukopenia Infectious/Inflammatory COVID-19 Immune Allergic drug reaction Other Elevated prostate specific antigen (PSA) Gynecomastia, male Mild cognitive impairment Overweight(278.02) Dietary noncompliance Localized edema Memory loss H/O colonoscopy
Andere Medikamente
ACCU-CHEK AVIVA strip amLODIPine (NORVASC) 10 mg tablet aspirin 81 mg tablet carvediloL (COREG) 6.25 mg tablet cholecalciferol, vitamin D3, 25 mcg (1,000 unit) capsule codeine-guaiFENesin (ROBITUSSIN-AC) 10-100 mg/5 mL liquid dutaster
Allergien
DoxycyclineHives / Urticaria AtorvastatinOther (document details in comments) CephalexinRash EzetimibeOther (document details in comments)
Vorherige Impfungen
-

VAERS 1831956

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
IN
Alter
61,0
Geschlecht
F
Eingang
31.10.2021
Impfdatum
21.10.2021
Beginn
26.10.2021
Tage bis Beginn
5,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Anticoagulant therapy Back pain Chest X-ray Chills Computerised tomogram thorax abnormal Echocardiogram Headache Hypopnoea Laboratory test abnormal Pain Pain in extremity Painful respiration Pulmonary embolism Pyrexia Ultrasound scan

Symptomtext

Mild symptoms of left arm soreness, body aches and headache began Friday, October 22nd , 2021 in the morning. These symptoms continued until Tuesday, October 26th , 2021 at 7pm when a fever, chills, headache (not migrainous), PE symptoms including shallow, painful breathing and stabbing pain in right chest radiating to back, began. This was followed by a trip to the Emergency Department on Wednesday, October 27th, 2021 at 8:30am which led to hospitalization, Heparin injections, and Xarelto treatments following release from hospital on Friday, October 29th, 2021 at noon.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
2,0
Labordaten
Chest X-Ray, lab work, CT Scan, Ultrasound, Echocardiogram all took place on Wednesday, October 27th, 2021 while in the Emergency Department. Continued lab work was done throughout the hospital stay. All results are not in at the time of this report. Results available through medical record. Labs and CT Scan ultimately revealed PE.
Aktuelle Erkrankungen
SEL Flare
Vorgeschichte
SEL, Diabetes, High Blood Pressure, Migraine Headaches
Andere Medikamente
Aimovig Autoinjector, Centrum Silver Women, Vitamin D3, Metformin, Losartin-Hydrochlorothiazide, Potassium Chloride, Methenamine, Omeprazole, Prednisone, Promethazine, Synthroid, valACYclovir, Vitamin C, Xanax, Zyrtec
Allergien
Gluten and Flax, IVP Dye, Tape on Skin
Vorherige Impfungen
-

VAERS 1828986

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
82,0
Geschlecht
F
Eingang
29.10.2021
Impfdatum
02.03.2021
Beginn
21.10.2021
Tage bis Beginn
233,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had a breakthrough infection and deceased.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
6,0
Labordaten
Positive COVID-19 PCR test on 10/15/2021.
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Atorvastatin, lisinopril, omeprazole, oxybutynin
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1828678

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
89,0
Geschlecht
F
Eingang
29.10.2021
Impfdatum
23.02.2021
Beginn
28.10.2021
Tage bis Beginn
247,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute kidney injury Acute myocardial infarction Atrial fibrillation Blood lactic acid Brain natriuretic peptide increased COVID-19 Chest X-ray abnormal Dyspnoea Glomerular filtration rate decreased Malaise Pleural effusion Sepsis Unresponsive to stimuli

Symptomtext

Patient was a 89 y.o female with medical hx including afib, htn, hypothyroidism who presented to OHRH ED with worsening SOB after being diagnosed with COVID19 on 10/20/2021. Symptoms started a few days prior. She was COVID 19 vaccinated. She was requiring some O2 via nc, but not more than a few L. However, she was in afib RVR and minimal pleural effusions seen in CXR. Pt's GFR was only 35 no remdesivir not given. bnp 2800, lactic acid 5.4. ER concerned about suggestive of infectious process. No wbc, procal pending. No purulent sputum production. Cardiology consulted. Patient was resumed on oral medication and weaned from Cardizem drip. Cardiology also felt that her NSTEMI was demand ischemia from her underlying sepsis. Staff were able to control her heart rate. Unfortunately, she did have some issues with AKI, but they could not give any fluids due to shortness of breath and 3rd spacing. Pt was being treated empirically for severe sepsis. She received vancomycin and cefepime. According the the Dr. she was complaining of not feeling well when he visited her. The Doctor stated her morning labs had not yet resulted as they were not collected until 0847 hr. About 15 min after he saw her. MRT was called. He urgently went to the room, unfortunately, Pt. was already unresponsive.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1741639

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
78,0
Geschlecht
M
Eingang
27.10.2021
Impfdatum
02.03.2021
Beginn
07.09.2021
Tage bis Beginn
189,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute respiratory failure COVID-19 Condition aggravated Death Endotracheal intubation SARS-CoV-2 test positive

Symptomtext

pt diagnosed with COVID on 9/7; hx of DMT2, CKD,ARF, critical lower limb ischemia; admitted to hospital (9/21) from previous facility already intubated (9/19); transferred to hospital for possible dialysis and vascular surgery consult; pt made a DNAR; condition worsened; comfort case measures instituted and pt was extubated; he passed away in the hospital; AHRF due to COVID

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1741639

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
78,0
Geschlecht
M
Eingang
27.10.2021
Impfdatum
02.03.2021
Beginn
07.09.2021
Tage bis Beginn
189,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute respiratory failure COVID-19 Condition aggravated Death Endotracheal intubation SARS-CoV-2 test positive

Symptomtext

pt diagnosed with COVID on 9/7; hx of DMT2, CKD,ARF, critical lower limb ischemia; admitted to hospital (9/21) from previous facility already intubated (9/19); transferred to hospital for possible dialysis and vascular surgery consult; pt made a DNAR; condition worsened; comfort case measures instituted and pt was extubated; he passed away in the hospital; AHRF due to COVID

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1815135

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WI
Alter
99,0
Geschlecht
F
Eingang
25.10.2021
Impfdatum
19.02.2021
Beginn
16.10.2021
Tage bis Beginn
239,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

COVID-19 death of a fully vaccinated individual.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
atrial fibrillation, CKD, HTN, hypothyroidism
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1718710

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6198

kritisch
Staat
KY
Alter
76,0
Geschlecht
F
Eingang
22.10.2021
Impfdatum
23.02.2021
Beginn
14.10.2021
Tage bis Beginn
233,0
Dosis
1
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 pneumonia

Symptomtext

pt developed covid 19 pneumonia

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
renal failure, gerd, pvd osa, hypothroidism, htn, hyperlipedemia, morbid obesity, single kidney
Andere Medikamente
-
Allergien
unknown
Vorherige Impfungen
-

VAERS 1718710

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
76,0
Geschlecht
F
Eingang
22.10.2021
Impfdatum
23.02.2021
Beginn
14.10.2021
Tage bis Beginn
233,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 pneumonia

Symptomtext

pt developed covid 19 pneumonia

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
renal failure, gerd, pvd osa, hypothroidism, htn, hyperlipedemia, morbid obesity, single kidney
Andere Medikamente
-
Allergien
unknown
Vorherige Impfungen
-

VAERS 1804254

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
53,0
Geschlecht
F
Eingang
21.10.2021
Impfdatum
24.02.2021
Beginn
06.10.2021
Tage bis Beginn
224,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Abdominal pain COVID-19 Chills Death Dyspnoea Endotracheal intubation Nausea Pain Respiratory disorder SARS-CoV-2 test positive Vomiting

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/29/2021 and 2/24/2021. Presented to ED on 10/6/2021 complaining of shortness of breath x3 days, diffuse body aches, chills, nausea, vomiting, and abdominal pain. On presentation satting 94% on room air. Patient started on dexamethasone. Patient's respiratory sats decompensated on 10/9/21, requiring intubation. Patient continued to decline and expired on 10/16/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
10,0
Labordaten
Positive COVID test on 10/6/21 using the Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification(NAA)technology.
Aktuelle Erkrankungen
-
Vorgeschichte
Anemia of chronic disease, Chronic diastolic CHF, Kidney transplant, hypertension, Ellis0van Creveld syndrome, GERD, ESRD on peritoneal dialysis, Lumbar spondylosis, obesity, H/O DVT, H/O seizure, venous insufficiency.
Andere Medikamente
Acetaminophen PRN, Peridex 15 ml Daily, Cholecalciferol 1000 u QD, Cyanocobalamin 1000 mcg QD, TheraFlu PRN, Envarsus 6 mg QD, Famotidine 20 mg QD, Norco PRN, Myfortic 360 mg QD, Prednisone 5 mg QD, Tizanidine 2 mg Q12h PRN.
Allergien
Hydromorphone (tremor), Lisinopril (angioedema)
Vorherige Impfungen
-

VAERS 1801664

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
67,0
Geschlecht
F
Eingang
20.10.2021
Impfdatum
25.03.2021
Beginn
10.10.2021
Tage bis Beginn
199,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Death Vaccine breakthrough infection

Symptomtext

Patient had breakthrough infection and expired.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
History of heart disease, has a pacemaker
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 1801521

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
75,0
Geschlecht
M
Eingang
20.10.2021
Impfdatum
23.02.2021
Beginn
12.09.2021
Tage bis Beginn
201,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Angiogram pulmonary abnormal COVID-19 Death Dialysis Dyspnoea Endotracheal intubation General physical health deterioration Intensive care Liver function test increased Lung infiltration Lung opacity Malaise Multiple organ dysfunction syndrome Pyrexia SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/28/2021 and 2/23/2021. He began to feel unwell on 9/12 and tested COVID+ on 9/14. He began to have progressive dyspnea and fevers at home up to 103 F so he presented on 9/19 to ED. SpO2 was in 70s on RA, failed NRB, and was placed on HFNC. CTA chest negative for PE but notable for extensive GGO and alveolar infiltrates. He was also found to have an AKI and elevated LFTs. He was admitted to HCF due to HCF requirements. He was started on Decadron. Dr was consulted who recommended Remdesivir and okay with continuation of his cellcept. He was determined not to be a candidate for Toci or Baricit a. He was started on empiric abx. Unfortunately, he decompensated requiring intubation. Despite supportive measures, he slowly clinically declined with multisystem organ failure including ARF requiring dialysis. He was compassionately extubated and passed at 1225 10/1/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Myasethenia gravis - AChR antibody positive, BPH,
Andere Medikamente
Mycophenolate 500 mg BID, Aspirin 81 mg QD
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1794887

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
74,0
Geschlecht
M
Eingang
18.10.2021
Impfdatum
18.02.2021
Beginn
06.10.2021
Tage bis Beginn
230,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

PATIENT EXPIRED ON 10/06/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
DM HTN CAD CHRONIC RENAL FAILURE
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1793658

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6198

kritisch
Staat
CA
Alter
65,0
Geschlecht
F
Eingang
16.10.2021
Impfdatum
02.03.2021
Beginn
20.07.2021
Tage bis Beginn
140,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dyspepsia Electrocardiogram Electrocardiogram Q wave abnormal Myocardial infarction Stress echocardiogram

Symptomtext

Developed constant heartburn in mid to late May. Prior to having an endoscopy, I needed an ECG. ECG indicated a q wave abnormality indicative of a previous heart attack. Referred to cardiologist. Echocardiogram and stress echocardiogram conducted, no indication of a previous heart attack. I have had ECGs in the past and there was never any mention of a q wave issue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocardial infarction
Hospital-Tage
-
Labordaten
ECGs, echocardiogram and stress echocardiogram.
Aktuelle Erkrankungen
None
Vorgeschichte
Low thyroid
Andere Medikamente
Synthroid 100mcg daily
Allergien
None
Vorherige Impfungen
-

VAERS 1355360

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
AR
Alter
65,0
Geschlecht
M
Eingang
16.10.2021
Impfdatum
27.02.2021
Beginn
28.02.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Atrioventricular block Blood test Catheterisation cardiac Chest pain Myocardial infarction Coronary artery bypass Immediate post-injection reaction Pain in extremity

Symptomtext

4 blockages; heart attack; chest pain; left arm was hurting; This is a spontaneous report from a contactable consumer (patient). This consumer reported events after two doses of the vaccine. This is the first of two reports. This report is for the first dose. This 65-year-old male patient received first dose of BNT162B2 (COMIRNATY, Batch/lot number: EN6198), via unspecified route of administration in left shoulder (arm) on 27Feb2021 14:00-15:00 at patient age of 65-year-old as single dose for COVID-19 immunisation. Medical history included blood pressure (abnormal), diabetes diagnosed 12 years ago, and on Cpap breathing machine for 7-8 years. Family history included father died of diabetes 20 years ago. Concomitant medications included blood pressure and diabetes medication, prostate medication. None prior vaccinations within 4 weeks. None event following prior vaccinations. On 28Feb2021, he began having chest pain when woke up and left arm was hurting something awful. He went to the ER in Feb2021 at 1:00 AM, after 5.5 hours he saw a doctor, got checked and got a blood test. They said he was not having a heart attack and it was probably indigestion. Three weeks later in Mar2021, he turned around and his chest was bothering him. He went to hospital and was there from 10:00 AM-7 PM. They drew blood and said he was not having a heart attack. He left and by 9:00 PM, his heart was beating out of his chest and he went back to ER. He passed out and he was in the ER and about 30 minutes he was coming to. They did not have equipment or personnel to treat him in ER. They said he was having a heart attack. The patient was transported to hospital. They did a catheter and found he had 4 blockages and spent 10 days (22Mar2021-01Apr2021) in the hospital with a quadruple bypass. The patient stated that prior to getting the vaccine, he had no chest pain or any heart issues. The patient stated that the vaccine might be triggering heart attack from blockages. The outcome of the event chest pain was not resolved. The outcome of the event heart blockages was recovered/resolved with sequel. The outcome of the other events was unknown. ; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101318800 same patient, same drug (different dose), different event

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocardial infarction
Hospital-Tage
10,0
Labordaten
Test Name: blood test; Result Unstructured Data: Test Result:normal; Test Name: catheter; Result Unstructured Data: Test Result:4 blockages
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Blood pressure abnormal (He was on blood pressure and diabetes medication.); Diabetes (He was on blood pressure and diabetes medication.); Diabetes (Father died of Diabetes 20 years ago)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1788078

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MD
Alter
75,0
Geschlecht
F
Eingang
15.10.2021
Impfdatum
01.03.2021
Beginn
22.03.2021
Tage bis Beginn
21,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Cerebrovascular accident Fatigue Headache Limb discomfort Magnetic resonance imaging head abnormal Migraine

Symptomtext

When she rcvd the vaccine she stated it felt like she could feel the medicine going through her arms. Extremely tired. About 2 1/2 to 3 weeks later she started having pounding headaches. She was taken to urgent care on April 12th because the pounding throbbing headaches got real bad. The doctor told her she was having migraine headaches which she never had before. Called her pcp and referred her to get a MRI on the brain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
MRI showed some silent strokes.
Aktuelle Erkrankungen
No
Vorgeschichte
High blood pressure, high cholesterol
Andere Medikamente
AMLODIPINE; PRAVASTATAN SODIUM
Allergien
No
Vorherige Impfungen
-

VAERS 1785312

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
87,0
Geschlecht
M
Eingang
14.10.2021
Impfdatum
07.04.2021
Beginn
31.08.2021
Tage bis Beginn
146,0
Dosis
1
Route/Site
- / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 pneumonia Death SARS-CoV-2 test positive

Symptomtext

DEVELOPED SYMPTOMS, ACUTE HYPOXIC RESPIRATORY FAILURE, COVID19 PNEUMONIA AND DIED.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
POSITIVE COVID19 TEST 8/31/2021
Aktuelle Erkrankungen
-
Vorgeschichte
RENAL INSUFFICIENCY, DYSPHAGIA, ENCEPHALOPATHY, HUMAN IMMUNODEFICIENCY VIRUS
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1784971

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
NY
Alter
67,0
Geschlecht
M
Eingang
14.10.2021
Impfdatum
24.02.2021
Beginn
27.03.2021
Tage bis Beginn
31,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Cerebrovascular accident

Symptomtext

stroke time unknown, in June 2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
Admit to Hospital on June 29, 2021. Discharged on 7/11/21
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
1. blood clot medication, 2. high blood med, 3. cholesterol
Allergien
none
Vorherige Impfungen
-

VAERS 1782822

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
AR
Alter
83,0
Geschlecht
M
Eingang
13.10.2021
Impfdatum
12.02.2021
Beginn
01.10.2021
Tage bis Beginn
231,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Abnormal loss of weight Acute kidney injury Acute respiratory failure Ageusia Anion gap Blood calcium normal Blood chloride decreased Blood creatinine normal Blood culture negative Blood glucose increased Blood potassium normal Blood sodium normal Blood urea increased Blood urea nitrogen/creatinine ratio increased COVID-19 Coronary artery disease Decreased appetite Diastolic dysfunction

Symptomtext

co illness onset 9/24, fever, chills, nausea, loss of appetite & taste, HA, cough. dx w covid 9/26. 9/29 had monoclonal antibodies, then to ED in BV, and was discharged on O2. today PCP. last ibuprofen at 0800 History of Present Illness Symptom onset 9/24 or 25, home test dx 9/26, then to ED - dxed, 9/29 monoclonal antibodies, sent home on O2. Went to PCP Dr. or least contacted him ?virtual visit? told to come to ED as pulse ox reading 80s despite being on oxygen Fever, HA, cough, somewhat productive but swallows sputum so hasn;t seen it. Fully vaccinated w Pfizer vaccine second shot in March. States had plans to get booster right before starting having these symptoms. Assessment/Plan 1. Pneumonia due to COVID-19 virus 2. Acute respiratory failure with hypoxemia symptom onset 9/25, s/p monoclonal antibodies, fully vaccinated second shot (Pfizer) in March, not received booster will start Dex, RDSV, Baricitinib as has many risk factors for worsening and already increased O2 needs, on 15L CXR looks more like left sided infiltrate and not severe at this point at least, repeat in am 3. Lactic acidosis he appears dry, mild AKI, urine concentrated, start fluids w LR 4. CAD (coronary artery disease) cont DAPT, statin 5. Hyperglycemia due to type 2 diabetes mellitus start basal-prandial insulin as CBGs expected to go up more with Dex 6. Transaminitis mild, not to where need to hold RDSV, baricitinib or statin but need followed 7. Thrombocytopenia no old labs to compare, ?due to COVID, will cont DAPT with CAD but hold off on adding chemical vte prophylaxis - recheck CBC in am Problem List/Past Medical History CAD HTN Dyslipidemia BPH Procedure/Surgical History CABG - Coronary artery bypass graft Hernia Stent Medications Inpatient acetaminophen, 650 mg= 2 tab(s), PO, q4hr, PRN albuterl inhaler, 2 puff(s), Inh, q4hrWA aspirin, 81 mg= 1 tab(s), PO, Daily atorvastatin, 40 mg= 1 tab(s), PO, at bedtime baricitinib, 4 mg= 2 tab(s), PO, Daily clopidogrel, 75 mg= 1 tab(s), PO, Daily dexamethasone, 6 mg= 1.5 mL, IV Push, Daily Dextrose 50%, 25 Gm= 50 mL, IV Push, as needed, PRN Insulin Corrective Scale Low Dose, Corrective Dose Scale 0-8 Units, Subcut, acTID insulin glargine, 10 unit(s), Subcut, wBKF insulin lispro, 3 unit(s)= 0.03 mL, Subcut, wMeals LR 1,000 mL, 1000 mL, IV melatonin, 5 mg= 1 tab(s), PO, at bedtime ondansetron, 4 mg= 1 tab(s), PO, q8hr, PRN ondansetr Pharmacy Consult COVID ICU Fluid Restriction - PIV, 1 EA, Misc, as directed Once Remdesivir additive + Normal Saline 250mL 250 mL Remdesivir additive + Normal Saline 250mL 250 mL Remdesivir additive + Normal Saline 250mL 250 mL Saline FLUSH Peripheral, 2.5 mL, IV Flush, BID tamsulosin, 0.4 mg= 1 cap(s), PO, at bedtime Currently hospitalized on 10/12:Length of stay: 12 Total Critical Care Days: 11 Subjective Chart reviewed. Patient is alert. He denies dyspnea. He does describe a productive cough. Taking p.o.. Patient does complain of anorexia. . Continued hospitalization due to: Current condition requires inpatient care. Objective VS/Measurements Vital Signs( 10/11/21 14:05:12 to current ) VITAL SIGN LAST CHARTED MINIMUM MAXIMUM Blood Pressure 104/67 (10/12 12:00) 97/45 (10/12 06:15) 151/78 (10/11 17:00) Heart Rate 85 (10/12 12:00) 57 (10/12 03:00) 97 (10/12 08:30) Respirations 28 (10/12 12:00) 17 (10/12 02:00) 42 (10/12 01:00) Temperature 96.5 (10/12 12:00) 96.5 (10/12 12:00) 97.4 (10/11 20:00) SpO2 100 (10/12 12:00) 84 (10/12 08:30) 100 (10/12 12:00) Oxygen Flow Rate 70 (10/12 12:00) 40 (10/11 15:46) 70 (10/12 12:00) Weight 79.6 (10/12 04:00) 79.6 (10/12 04:00) 79.6 (10/12 04:00) , Weight Measurements Current Weight Last Weight Weight Difference 79.6 kg 10/12/21 04:00 80.2 kg 10/11/21 05:52 -0.600 Current Weight Admission Weight Weight Difference 79.6 kg 10/12/21 04:00 86 kg 10/01/21 13:59 -6.400 Intake and Output I & O Summary - 24 Hour 0700-0659 Input: 10.50 ml Output: 1150.00 ml Balance: -1139.50 ml Stool Count: 0 I & O Summary - Full Visit Input: 8023.42 ml Output: 18480.00 ml Balance: -10456.58 ml Stool Count: 2 , I & O Detailed Summary - 24 Hour 0700-0659 INTAKE IV Volume Infused 10.50 ml Total 10.00 ml OUTPUT Urine Voided 1150.00 ml Total 1150.00 ml BALANCE: -1139.50 ml , I & O Summary - Full Visit Input: 8023.42 ml Output: 18480.00 ml Balance: -10456.58 ml Stool Count: 2 Physical Examination General: No acute distress. Eye: Normal conjunctiva. Sclera: Not icteric. HENT: Normocephalic. Neck: Supple. Trachea: Midline. Respiratory: Respirations are non-labored, Breath sounds are equal, Symmetrical chest wall expansion. Breath sounds: No rhonchi present, No wheezes present. Breath sounds: No crackles present. Cardiovascular: Normal rate, Regular rhythm, No murmur, No gallop, No edema, No Pericardial friction rub. Gastrointestinal: Soft, Non-tender, Non-distended, Normal bowel sounds. Integumentary: Warm, Dry. Neurologic: Alert, Oriented. Psychiatric: Cooperative, Appropriate mood & affect. Review / Management General Review: Rhythm Strip. Rhythm Strip Interpretation: I personally reviewed the study, Sinus rhythm. Ventilatory Support Basic Oxygen Information 10/12/2021 12:00 SpO2 100 % Oxygen Flow Rate 70 L/min Oxygen Therapy Nasal cannula, Humidification FIO2 100 % 10/11/2021 23:15 SpO2 96 % Oxygen Flow Rate 60 L/min Oxygen Therapy Nasal cannula, Humidification FIO2 100 % Laboratory Results: Basic Chemistry Result Sodium Level 136 mmol/L (10/12/21) Potassium Level 3.7 mmol/L (10/12/21) Chloride 92 mmol/L (10/12/21) - Low CO2 32 mmol/L (10/12/21) AGAP 12 mmol/L (10/12/21) BUN 43.9 mg/dL (10/12/21) - High Creatinine 1.1 mg/dL (10/12/21) BUN/Creat Ratio 40 (10/12/21) - High eGFR 61 mL/min/1.73m? (10/12/21) Glucose Level 75 mg/dL (10/12/21) Calcium 9.1 mg/dL (10/12/21) , , Basic Hematology Result WBC 16.53 K/mcL (10/12/21) - High Hgb 15.2 Gm/dL (10/12/21) Hct 44.9 % (10/12/21) Platelet 225 K/mcL (10/12/21) . Microbiology: Blood Cultures 10/1/2021 15:54 NEG Blood Culture 10/1/2021 15:50 NEG Blood Culture . Point of care testing: Diabetic View (FS) 10/12/2021 11:13 POC Glucose 154 mg/dL HI 10/12/2021 7:47 POC Glucose 87 mg/dL 10/12/2021 4:37 Glucose Level 75 mg/dL 10/11/2021 16:20 POC Glucose 343 mg/dL HI . Radiology results X-ray: Diagnostic Radiology (FS) : Diagnostic Radiology 10/12/2021 6:25 CDT XR Chest 1 View Radiology Report , I personally reviewed the study, Bilateral infiltrates either unchanged or slightly worse. Medication Review: Current Meds Reviewed, Home Meds Reviewed. DVTProphylaxis: Patient currently receiving: Lovenox. GI Prophylaxis: Patient currently receiving: Lansoprazole. Education and Follow-up: Counseled: Patient. Early Progressive Mobility Protocol (EPMP): EPMP Level: Level 3. Nutrition PO Nutrition ADLs 10/12/2021 12:00 Diet Type dental soft 10/12/2021 8:00 Breakfast Percent 15 % Nutrition Recommendations Malnutrition Diagnosis Malnutrition Severity: severe (10/11/21) Context: acute illness/ injury (10/11/21) Related to: poor appetite, respiratory status, early satiety (10/11/21) As evidenced by: unintended wt loss (10.9% x ~17), average intakes intakes provided <50% x1 wk prior to admit, skeletal muscle depletion (mild- 1 areas, moderate- 3 areas), subcutaneous fat loss (mild- 1 area), (10/1-10/1) avg provided 22% energy and 16% est protein needs (10/11/21) Progress: worsened (10/11/21) Dietitian Recommendations Oral 1: dental soft chopped, NCS, NAS (10/11/21) Supplement 1: Smoothie @ breakfast and dinner (10/11/21) Supplement 2: old fashioned shake @ lunch (10/11/21) Enteral 1: EN indicated as of 10/6, will be at refeeding risk. (10/11/21) Enteral 2: RD available PRN for recs if indicated MNT desired. (10/11/21) Enteral 3: . (10/11/21) Parenteral 1: TPN indicated if unable to obtain EN access as of 10/6 (10/11/21) Parenteral 2: . (10/11/21) Parenteral 3: . (10/11/21) Impression and Plan Diagnosis: Pneumonia due to COVID-19 virus. Course: Baricitinib day 9 of 14. Remdesivir day 5 of 5. Dexamethasone day 10 of 10. Plan: Continue to support. . Diagnosis: Acute respiratory failure with hypoxemia. Plan: Titrate O2 as we are able. Encourage self proning. . Diagnosis: Hyperglycemia due to type 2 diabetes mellitus. Plan: Sliding scale insulin . Diagnosis: Transaminitis. Plan: Most likely viral (COVID) induced . Diagnosis: CAD (coronary artery disease). Plan: ASA, Plavix, EF 70%. Probable diastolic dysfunction . Diagnosis: COPD. Plan: Scheduled bronchodilators . Diagnosis: Severe protein calorie malnutrition. Plan: Encourage p.o. intake . Diagnosis: Over weight BMI -26. Course: Unchanged, . Orders: Addendum: I discussed resuscitation status with the patient. He wishes to discuss this with his wife. We will speak again tomorrow..

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
10/1/2021 COVID-19 positive.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1782406

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
IN
Alter
52,0
Geschlecht
F
Eingang
13.10.2021
Impfdatum
10.03.2021
Beginn
26.09.2021
Tage bis Beginn
200,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chest pain Dyspnoea Pulmonary embolism

Symptomtext

began having shortness of breath and chest pain in September 2021. Went to ER and had both lungs with Pulmonary Emboli. Client had covid virus October 2020.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
Hospital has all records.
Aktuelle Erkrankungen
-
Vorgeschichte
high blood pressure. Had another blood clot in 2012 in her leg.
Andere Medikamente
multivitamins, vitamin B 3, fish oil, probiotics, vitamin c, Allegra, Flonase, Pepcid, Eliquis, lisinopril
Allergien
Erythromycin
Vorherige Impfungen
-

VAERS 1772110

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
96,0
Geschlecht
F
Eingang
08.10.2021
Impfdatum
26.02.2021
Beginn
16.09.2021
Tage bis Beginn
202,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Case fully vaccinated with Pfizer. Last dose on 2/26/2021. Tested positive for COVID on 9/16/2021. Admitted to Hospital on 9/11/2021. Expired while still hospitalized on 9/27/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1769008

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
74,0
Geschlecht
M
Eingang
07.10.2021
Impfdatum
27.03.2021
Beginn
01.09.2021
Tage bis Beginn
158,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 Cough Cyanosis Death Decreased appetite Diarrhoea Dyspnoea Fatigue Hypopnoea Hypoxia Mechanical ventilation Nausea Pain Pyrexia SARS-CoV-2 test positive Vomiting

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/27/2021 and 3/27/2021. Presented to ED on 9/11/2021 after patients son found him shallow breathing this morning and appears cyanotic and pushed on his chest which prompt patient to take a deep breath subsequently his color returned. EMS upon arrival noted he was hypoxic, placed him on 15 L of non-rebreather. Patient states that he has symptom onset about 10 days ago. He felt very fatigued, no appetite, generalized body ache, fever, cough and shortness of breath. He also have nausea vomiting couple days ago this has improved. He has some diarrhea a few days ago this is resolved. He continued to require high-flow oxygen and subsequently requiring mechanical ventilation on 9/20/21. He completed the 5 day course of remdesivir. Patient also treated with IV antibiotic therapy. Patient required vasopressor support. Determination made to initiate comfort care. The patient expired on 9/30/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
19,0
Labordaten
Positive COVID test on 9/11/2021 SARS assay platform using PCR or equivalent Nucleic Acid Amplification(NAA)technology.
Aktuelle Erkrankungen
-
Vorgeschichte
A-fib, Arthritis, Asthma, CAD, CHF, COPD, Depression, Diabetes mellitus, Foot Ulcer, Hyperlipidemia, Hypertension, Sleep apnea, Squamous cell carcinoma, H/O stroke, H/O TIA
Andere Medikamente
Albuterol MDI PRN, Aspirin 81 mg QD, Atorvastatin 80 mg QD, Clopidogrel 75 mg QD, Lotrisone Cream BID, Empagliflozin 10 mg QD, Ferrous Sulfate 325 mg TID, Furosemide 40 mg QD, Hydrocodone+APAP PRN, Insulin glargine 20 units QAM 30 units QPM
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1769000

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
86,0
Geschlecht
M
Eingang
07.10.2021
Impfdatum
26.02.2021
Beginn
17.09.2021
Tage bis Beginn
203,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Agitation COVID-19 COVID-19 pneumonia Cough Death Dyspnoea Encephalopathy Fall Femoral neck fracture Hallucination Hypervolaemia Imaging procedure abnormal Inappropriate schedule of product administration Mental status changes Oxygen saturation decreased Pyrexia Respiratory distress SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/27/2021 and 2/26/2021. He tested positive for COVID on 9/20/21 after cough, fever, sob developed on 9/17. He was brought to the ED by spouse on 9/22 for a mechanical fall and worsening altered mentation with hallucinations. In the ED imaging shows worsening fluid overload, COVID PNA and left femoral neck fracture. COVID treatment was initiated (Remdesivir and Dexamethasone) and it was the plan for him to go to the OR. However, he continued to decompensate and O2 demand continued to increase - he was transitioned to high flow nasal cannula. He remained encephalopathic, agitated, and in respiratory distress. Family requested comfort care in the hospital. He was admitted for EOL cares on GIP service and ultimately expired on 10/3/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
11,0
Labordaten
9/22/2021 Positive COVID-19 test using the Roche LIAT SARS assay platform using PCR or equivalent technology.
Aktuelle Erkrankungen
-
Vorgeschichte
Ataxia, BPH, Dementia, Hyperlipidemia, H/O poliomyelitis, hypocalcemia, hypothyroidism.
Andere Medikamente
Acetaminophen 500 mg Q6H PRN, Atorvastatin 10 mg QD, Calcium carbonate 500 mg QD, Caclium-Vitamin D 250 mg/2.5 mcg BID, Cyanocobalamin 100 mcg QD, Levothyroxine 112 mcg QD, Melatonin 3 mg QHS, Pantoprazole 40 mg QD.
Allergien
Alfuzosin
Vorherige Impfungen
-

VAERS 1768512

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
75,0
Geschlecht
F
Eingang
07.10.2021
Impfdatum
01.03.2021
Beginn
27.09.2021
Tage bis Beginn
210,0
Dosis
UNK
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 Death Pneumonia Pulmonary embolism

Symptomtext

death J18.9 - Pneumonia I26.99 - Pulmonary embolism U07.1 - COVID-19

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1719530

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
ME
Alter
66,0
Geschlecht
M
Eingang
07.10.2021
Impfdatum
25.03.2021
Beginn
26.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Abdominal discomfort Anxiety Arthralgia Atrial fibrillation Blood test Chest pain Disease recurrence Dyspnoea Blood thyroid stimulating hormone Computerised tomogram Death of relative Dizziness Dysphagia Dysuria Fall Heart rate increased Hyperthyroidism Insomnia

Symptomtext

thyroiditis/ acute inflammation; AFIB; Platelet count high; Alpha 1 and Alpha 2 Globulin High; Alpha 1 and Alpha 2 Globulin High; Sciatica; Hip pain after severe; neuropathy like symptoms with both leg involvement; lung nodules; Prostatitis; short of breath; chest pains; Lung infection and inflammation/ feels this is infectious/inflammatory process; Lung infection and inflammation/ feels this is infectious/inflammatory process; Lung infection and inflammation/ feels this is infectious/inflammatory process; This is a spontaneous report from a contactable consumer (patient). A 66-year-old male patient received BNT162B2, via an unspecified route of administration on 25Mar2021 15:00 (Batch/Lot Number: ER8727) at the age of 66 years old as dose 2, single for COVID-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD) and enlarged prostate; on 17Feb2021, acute pancreatitis, meningomyelocele (MMC) hospitalization followed by Dr; lung infection and inflammation, has had numerous scans for several years to keep watch on these "nodules" which come and go. No known allergies. Concomitant medication(s) included fluticasone furoate, umeclidinium bromide, vilanterol trifenatate (TRELEGY ELLIPTA) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of BNT162B2 (Batch/Lot Number: EN6198) on 04Mar2021 14:00. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 26Mar2021 (day after), the patient experienced short of breath and chest pains. Within 3 days increased shortness of breath. On 10Aug2021, difficulty urinating - prostatitis. Improved. BACTRIM twice daily X 6 weeks. On 11Aug2021, consult with Dr for lung nodules. Lung infection and inflammation Has had numerous scans for several years to keep watch on these nodules which come and go. He feels this is infectious/inflammatory process (in 2021). Started on Amoxicillin 500 mg-potassium clavulanate 125 mg tablet Twice daily X 10 days. On 19Aug2021, sciatica/neuropathy like symptoms with both leg involvement, hip pain after severe. On 31Aug2021, bloodwork done for autoimmune disorders (unknown results). Gabapentin now BID. Platelet count high. Alpha 1 and Alpha 2 Globulin High. On 01Sep2021, atrial fibrillation (AFIB). On 16Sep2021 thyroiditis, bloodwork showing acute inflammation. Events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Treatment was received for events including antibiotic, prednisone, many testing and physical. No hospitalization prolonged. The outcome of the events was recovering. The case was not assessed as not serious by the reporter. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death of relative
Hospital-Tage
-
Labordaten
Test Date: 20210831; Test Name: Alpha 1 and Alpha 2 Globulin; Result Unstructured Data: Test Result:High; Test Date: 20210831; Test Name: Alpha 1 and Alpha 2 Globulin; Result Unstructured Data: Test Result:High; Test Date: 20210831; Test Name: bloodwork; Result Unstructured Data: Test Result:unknown results; Comments: for autoimmune disorders; Test Date: 20210916; Test Name: bloodwork; Result Unstructured Data: Test Result:acute inflammation; Test Date: 20210831; Test Name: Platelet count; Result Unstructured Data: Test Result:High
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Acute pancreatitis; COPD; Enlarged prostate; Hospitalization; Lung infection (Has had numerous scans for several years to keep watch on these nodules which come and go); Lung inflammation (Has had numerous scans for several years to keep watch on these nodules which come and go); Myelomeningocele
Andere Medikamente
TRELEGY ELLIPTA
Allergien
-
Vorherige Impfungen
-

VAERS 1745271

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
77,0
Geschlecht
M
Eingang
29.09.2021
Impfdatum
04.03.2021
Beginn
05.08.2021
Tage bis Beginn
154,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute respiratory failure COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Death Dyspnoea Fatigue Hypoxia Lung infiltration Positive airway pressure therapy Pyrexia SARS-CoV-2 test positive

Symptomtext

hx of prostate and pancreatic cancer; 3 days ago had chemotherapy treatment; within 24 hrs after chemo, pt began to experience fever, fatigue, cough and SOB; presented to ED with SOB; chest x-ray showed severe diffuse bilateral asymmetric infiltrates; positive for COVID-19; pt was a DNR/DNI; placed on BIPAP; condition worsened and pt died in the hospital; Acute Respiratory Failure with Hypoxemia; pneumonia due to COVID-19

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1736876

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MO
Alter
79,0
Geschlecht
M
Eingang
27.09.2021
Impfdatum
29.01.2021
Beginn
13.09.2021
Tage bis Beginn
227,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 Cough Death Dyspnoea Fatigue Intensive care Myalgia Nausea Parosmia Pyrexia Rhinorrhoea SARS-CoV-2 test positive Taste disorder

Symptomtext

ONSET 09/13/2021 WITH SOB, MYALGIA, RHINORRHEA, OLFACTORY/TASTE DISORDER, FATIGUE, COUGH, FEVER 102.6, NAUSEA RESULTING IN ICU HOSPITALIZATION AND DEATH

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
3,0
Labordaten
POSITIVE COVID-19 PCR TEST ON 09/20/2021
Aktuelle Erkrankungen
-
Vorgeschichte
HYPERTENSION, GOUT, T2NIDDM
Andere Medikamente
AMLODIPINE, ATENOLOL, AZITHROMYCIN, ESCITALOPRAM, HCTZ, LISINOPRIL, PIOGLITAZONE, TAMSULOSIN, ZOPIDEM
Allergien
-
Vorherige Impfungen
-

VAERS 1736745

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
75,0
Geschlecht
M
Eingang
27.09.2021
Impfdatum
27.02.2021
Beginn
31.08.2021
Tage bis Beginn
185,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure Asthenia Bacterial test Blood creatinine increased Blood lactic acid normal Brain natriuretic peptide increased COVID-19 Cardiac failure congestive Chest tube insertion Death Dysstasia Gait disturbance Mobility decreased Pneumothorax spontaneous Procalcitonin Renal failure SARS-CoV-2 test positive Troponin

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/6/2021 and 2/27/2021. Patient presented to ED with generalized weakness for several days prior to admission. Patient noticed difficulty walking and progressed to being unable to stand/get out of chair. In the ED, temp 99.9, vitals stable. Labs with normal WBC, procalcitonin 0.51, lactate wnl, Cr 2.06, BNP 604 and trop 0.1. UA with rare bact, 3+LE, 20-50 WBCs. Patient was admitted for acute hypoxic respiratory failure, due to covid 19. He was treated with steroids for 10 days and cefepime. He had acute CHF, renal failure. He eventually developed spontaneous PTX and had chest tube placed by pulmonary. Goals of care addressed with family who eventually elected comfort measures and hospice. Patient expired at 1600 on 9/17/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
17,0
Labordaten
COVID19 Positive 8/31/21
Aktuelle Erkrankungen
-
Vorgeschichte
CAD s/p CABG, HTN, HLD, TIA(2017), Obesity, GERD, Arthritis, Nephrolithiasis
Andere Medikamente
Tylenol 500mg 2 tab daily, aspirin 81mg daily, atenolol 25mg daily, vitamin b-12 500mcg Qweekly, hydrochlorothiazide 12.5mg daily, lisinopril 20mg daily, multivitamin daily, pantoprazole 20mg daily, rosuvastatin 20mg daily, sildenafil 100m
Allergien
Penicillin, Sulfamethoxazole-trimethoprim
Vorherige Impfungen
-

VAERS 1736741

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
78,0
Geschlecht
F
Eingang
27.09.2021
Impfdatum
05.03.2021
Beginn
26.08.2021
Tage bis Beginn
174,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Back pain Blood culture positive Bronchiectasis COVID-19 Computerised tomogram thorax abnormal Condition aggravated Death Diarrhoea Dyspnoea Escherichia infection Fungal test positive Influenza A virus test negative Influenza B virus test Lung infiltration Myalgia Nausea Positive airway pressure therapy Pulmonary fibrosis

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/1/2021 and 3/5/2021. Patient presented to ED on 8/26/2021 with shortness of breath, after a diagnosis of COVID-19 the day prior. Patient also has had nausea, diarhhea, diffuse muscle aches and fever as high as 101. UTI noted and patient was discharged from ED with Bactrim. Patient returned to ED on 8/31/2021 with complaints of fever, back pain, and O2 sats of 88% subsequently admitted with diagnosis of COVID-19, E. coli UTI, Severe sepsis with organ dysfunction. Patient started on ceftriaxone, remdesivir, and steroids. Blood cultures positive for staph epi 2/2 sets and started on vancomycin. Cultures cleared with patient placed on Vancomycin. Patient ultimately required high O2 requirement on HFNC. She showed some improvements but declined and 9/10 repeat CT chest showed: persistent infiltrates, worsened fibrotic changes and traction bronchiectasis compared to 1.5 weeks ago. She also was noted to have a positive fungitell. She eventually progressed to BiPAP. Pallitiave care was consulted and patient's MPOA, transitioned to DNR/AND on 9/15. Comfort care initiated with the assistance of palliative care physician.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
COVID-19 Positive 8/31/2021 using Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification technology. Influenza A and B negative
Aktuelle Erkrankungen
UTI one month prior
Vorgeschichte
Myasthenia, Sarcoma, Dementia
Andere Medikamente
Bactrim DS BID, Ibuprofen 600 mg Q6H PRN, Lidoderm patch PRN, Methocarbamol 500 mg QID, Macrobid BID, Prednisolone 15 mg QOD.
Allergien
Penicillin, Codeine, Oxycodone
Vorherige Impfungen
-

VAERS 1731338

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
85,0
Geschlecht
F
Eingang
24.09.2021
Impfdatum
02.03.2021
Beginn
15.08.2021
Tage bis Beginn
166,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death Delirium General physical health deterioration Lethargy Mental status changes SARS-CoV-2 test positive

Symptomtext

PT PRESENTED WITH ALTERED MENTAL STATUS, DELERIUM WHICH RESULTED IN LETHARGY; POSITIVE FOR COVID-19, HX OF CLL AND A FIB; PT'S CONDITION WORSENED WHERE SHE DIED IN THE HOSPITAL

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1723579

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
72,0
Geschlecht
F
Eingang
22.09.2021
Impfdatum
31.03.2021
Beginn
12.09.2021
Tage bis Beginn
165,0
Dosis
UNK
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Blood osmolarity decreased COVID-19 COVID-19 pneumonia Death Hyponatraemia Thrombocytopenia

Symptomtext

death J12.82 - Pneumonia due to coronavirus disease 2019 U07.1 - COVID-19 N17.9 - Acute kidney failure, unspecified E87.1 - Hypo-osmolality and hyponatremia D69.6 - Thrombocytopenia, unspecified

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1715588

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
78,0
Geschlecht
F
Eingang
20.09.2021
Impfdatum
19.03.2021
Beginn
19.09.2021
Tage bis Beginn
184,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 Cardiac arrest Death Dyspnoea Intensive care Mechanical ventilation Oxygen saturation decreased Pulseless electrical activity SARS-CoV-2 test positive

Symptomtext

Patient is a 78 y.o. female with a history of HTN, DMII, anxiety and depression presenting with worsening shortness of breath over the past 1 week. Pt went to PCP on 9/13 and was ordered curb-side rapid COVID test, and was notified the following day that it was positive. Pt underwent Regeneron infusion on 9/15. When symptoms worsened pt came to ED for further evaluation and treatment. Patient was admitted to the COVID-19 cool floor. Patient was placed on AV APS for acute hypoxic respiratory failure. It appears her mask was dislodged, oxygen saturations to dropped patient went into PEA cardiac arrest. ROSC obtained patient was transferred to the ICU where she was coded again. Once again, ROSC regained. Patient was placed on an epinephrine followed by norepinephrine and vasopressin. hydrocortisone followed by hydrocortisone every 8 hr. Family was at bedside they were notified of patient's poor prognosis. They asked patient remains a full code. Once again patient coded, asystole. ACLS protocols were started, family was updated in a asked patient"s status to DNR patient expired soon after. time of death240hr

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1709427

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
73,0
Geschlecht
M
Eingang
17.09.2021
Impfdatum
25.02.2021
Beginn
23.04.2021
Tage bis Beginn
57,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cardiac stress test Chest pain Electrocardiogram Magnetic resonance imaging abnormal Pulmonary embolism Ultrasound scan normal

Symptomtext

Pain in left chest on Thursday night but eased. Pain in left chest on Friday night and went to ER Blood thinner zarelto in hospital and for 6 months

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
MRI of chest/lungs - 2 PE in upper left lobe, possibly 1 PE in lower left lobe Drug induced heart and blood vessel stress test with EKG - Good Ultrasound of veins in both legs - Clear
Aktuelle Erkrankungen
-
Vorgeschichte
High Blood Pressure - controlled High Cholesterol - controlled
Andere Medikamente
Ezetimibe 10 mg Irbesartan 300 mg Claritin 1 tab/day Vitamin D3 5000 iu Multi-Vitamin CoQ10 100 mg Aspirin 81 mg - 4/week
Allergien
-
Vorherige Impfungen
-

VAERS 1454552

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
70,0
Geschlecht
M
Eingang
16.09.2021
Impfdatum
26.02.2021
Beginn
15.06.2021
Tage bis Beginn
109,0
Dosis
1
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Condition aggravated Death Erythema General physical health deterioration Hypoxia Pyrexia SARS-CoV-2 test positive Skin necrosis Skin ulcer Wound infection staphylococcal

Symptomtext

evaluated for fever and redness of right heel necrotic ulcer - wound growing MRSA; hypoxia, tested positive for COVID, pt's condition declined

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
16,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1700248

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
82,0
Geschlecht
F
Eingang
15.09.2021
Impfdatum
25.02.2021
Beginn
14.09.2021
Tage bis Beginn
201,0
Dosis
2
Route/Site
SYR / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death

Symptomtext

COVID RELATED DEATH; FULLY VACCINATED PT.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1689512

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
FL
Alter
55,0
Geschlecht
M
Eingang
10.09.2021
Impfdatum
18.03.2021
Beginn
24.08.2021
Tage bis Beginn
159,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure COVID-19 COVID-19 pneumonia Cough Dyspnoea Intensive care Positive airway pressure therapy Pyrexia SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID-19 breakthrough case. 8/22/21: Patient arrived at the ER due to worsening dyspnea and non-productive cough, he noted a fever of 101 at home. As his dyspnea worsened, he states he used his home CPAP and started feeling better. Reports testing positive for COVID on 8/21/21. admitted to ICU on 8/22. Note: Patient previously received Pfizer COVID-19 vaccine, first dose on 2/25/2021 Lot # EL9263 and 2nd dose on 3/18/2021 Lot # EN6198. Diagnosed with acute hypoxic respiratory failure, COVID-19 pneumonia. 8/30/21: Patient discharged home

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
7,0
Labordaten
8/24: SARS CoV 2 PCR COVID-19 Positive
Aktuelle Erkrankungen
unknown
Vorgeschichte
childhood NHL s/p chemotherapy (age 11-13 including cardiac arrest), IDDM, NICM s/p HM3 2017 in Tampa, CHF, HTN, Sleep Apnea
Andere Medikamente
carvedilol, dofetilide, febuxistat, gabapentin, losartan, nifedipine, potassium chloride, simvastatin, warfarin, escitalopram, pantoprazole
Allergien
Phenobarbital, Tape, aspartame
Vorherige Impfungen
-

VAERS 1683492

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
77,0
Geschlecht
M
Eingang
08.09.2021
Impfdatum
23.02.2021
Beginn
17.08.2021
Tage bis Beginn
175,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute sinusitis COVID-19 Cough Death Dyspnoea General physical health deterioration Hypoxia Oxygen saturation decreased Plasmapheresis Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/28/2021 and 2/23/2021. Presented to physician office on 8/9/2021 for evaluation of dry non-productive cough, clear runny nose x3 days. Was prescribed levofloxacin for acute sinusitis, benzonatate, albuterol nebs, and prednisone taper. Patient called provider back on 8/11/2021 stating symptoms are still persistent and a COVID test was ordered w positive result. on 8/12 the prednisone taper was discontinued and patient was prescribed dexamethasone 4 mg QD. on 8/17/2021 patient presented to ED with shortness of breath and hypoxia. Pulse ox on presentation was 70% on room air. Patient was treated with dexamethasone, Remdesivir, ascorbic acid, zinc sulfate, and convalescent plasma. Patient status deteriorated and was switched to comfort care on 9/4/2021, expired at 1335.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
18,0
Labordaten
COVID-19 Positive on 8/11/2021 using PCR or equivalent
Aktuelle Erkrankungen
-
Vorgeschichte
Anemia, Chronic Lymphocytic Leukemia, Diabetes, Hyperlipidemia, Hypertension, Myasthenia gravis, skin cancer
Andere Medikamente
Albuterol nebs PRN, Apixaban 5 mg QD, atorvastatin 20 mg QD,azathioprine 100 mg BID, benzonatate 200 mg TID prn, Pulmicort flexhaler BID, carvedilol 6.25 mg BID, Dexamethasone 4 mg QD, ferrous sulfate 325 mg QD, finasteride 5 mg QD, Ibrut
Allergien
Sulfa Antibiotics
Vorherige Impfungen
-

VAERS 1656556

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
84,0
Geschlecht
M
Eingang
30.08.2021
Impfdatum
26.02.2021
Beginn
07.03.2021
Tage bis Beginn
9,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Abdominal X-ray Arteriogram carotid Barium swallow Blood lactic acid Chest X-ray abnormal Computerised tomogram abdomen Computerised tomogram head Death Ear pain Echocardiogram Electrocardiogram Full blood count Headache Hepatitis Laboratory test Lumbar puncture Magnetic resonance imaging head Meningitis

Symptomtext

*** SEVERE NEUROLOGICAL IMPACT*** *** MASSIVE BRAIN INFLAMMATION*** *** DEATH *** 3/07/2021: Intractable stabbing pain in head at ears every 3-4 seconds. Pain level 10. 3/10/2021: Intractable stabbing pain in head at ears every 3-4 seconds. Pain level 10. ER visit Urgent Care ER Treatment: morphine IV ER Tests: CT brain w/o IV contrast; CTA carotid; Basic Metabolic Panel; CBC w platelet count Diagnosis: Neck muscle spasm Rx: tramadol (not helpful after morphine wore off) 3/12/2021: Intractable stabbing pain in head at ears every 3-4 seconds continues. Pain level 10. ER visit Urgent Care: ER Treatment: morphine pills - twice; Tylenol; Colace; Lidocaine ER Tests: XR 2 views; Basic Metabolic Panel; CBC w platelet count; Lactic acid, venous Diagnosis: Left ear pain; pneumonia due to infectious organism, unspecified laterality, unspecified part of lung Rx: amoxicillin-clavulanate; neomycin-polymyxin-hydrocortisone (did not fill these prescriptions) 3/14/2021: Intractable stabbing pain in head at ears every 3-4 seconds continues. Pain level 10. ER visit Hospital: admitted to hospital; treatment for 14 days; Discharge diagnosis: ACUTE METABOLIC ENCEPHALOPATHY and HEPATITIS 3/28/2021: Transferred to Hospice. 3/31/2021: Transferred to Home Hospice. 4/10/2021: Death occurred Death Certificate: PRESUMED MENINGITIS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
14,0
Labordaten
Laboratory tests; Metabolic Panel; CT Head; MRI Brain; Us carotid duplex; Transthoracic Echocardiogram Complete; ECG; XR chest; XR abdomen; CT Abdomen; CT Head; IR Lumbar Puncture; Modified Barium Swallow; XR hip.
Aktuelle Erkrankungen
-
Vorgeschichte
MCI/Dementia; essential tremor; Parkinsonism; depression-controlled with treatment; glaucoma; high cholesterol; arthritis; rhinorrhea; TIA (3 during past 5 years); BPH-corrected by surgery and medication
Andere Medikamente
Seroquel; Viibryd; Gabapentin; Aricept; Namenda; Trazadone; Cardura; Proscar; Lipitor; Plavix: Latanoprost; Fluticasone Propionate; Ipratopium Bromide
Allergien
Sulfa MSG
Vorherige Impfungen
-

VAERS 1656124

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
80,0
Geschlecht
M
Eingang
30.08.2021
Impfdatum
04.03.2021
Beginn
09.08.2021
Tage bis Beginn
158,0
Dosis
2
Route/Site
SYR / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Death Hypoxia Infection

Symptomtext

Breakthrough infection 8/10/2021; patient died 8/15/2021 - hypoxia

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
6,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1655833

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
FL
Alter
60,0
Geschlecht
M
Eingang
30.08.2021
Impfdatum
21.04.2021
Beginn
15.08.2021
Tage bis Beginn
116,0
Dosis
1
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute cardiac event Apnoeic attack Blood creatine increased Brain herniation Brain oedema COVID-19 Cardiac arrest Death Endotracheal intubation Hunt and Hess scale Mechanical ventilation SARS-CoV-2 test positive Subarachnoid haemorrhage Syncope Unresponsive to stimuli Ventricular cisternostomy

Symptomtext

8/15/21: Patient arrived at the ER due to sudden collapse. EMS was called at 1349 and on arrival the patient was in asystole and apneic. Patient underwent emergent right frontal ventriculostomy. COVID-19 PCR came back positive on 8/15/21. Serum creatinine on admission was 1.39 which has gotten worse at 2.67. Patient intubated/mechanically ventilated, sedated; on 3 vasopressors. Stage 5 [Hunt and Hess] SAH associated with diffuse brain edema/herniation. 8/17/21: patient expired. Note: Spouse did not report symptoms of COVID-19 prior to cardiac event. Unknown if COVID-19 was symptomatic or asymptomatic due to patients unresponsive at admission. Please note: Spouse reports 2 doses of Pfizer vaccine in March 2021. Patient received first dose Pfizer vaccine on 3/31/2021 Lot # EN6198 and the second dose on 4/21/2021 Lot # ER8732

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
3,0
Labordaten
COVID19 PCR detected 8/15/21
Aktuelle Erkrankungen
-
Vorgeschichte
Coronary artery disease, Coronary stents, hypertension
Andere Medikamente
amlodipine, aspirin, atorvastatin, clonidine, clopidogrel, hydralazine, lisinopril, metoprolol
Allergien
Unable to obtain
Vorherige Impfungen
-

VAERS 1637391

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WA
Alter
97,0
Geschlecht
M
Eingang
26.08.2021
Impfdatum
27.02.2021
Beginn
01.07.2021
Tage bis Beginn
124,0
Dosis
1
Route/Site
UN / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient died of COVID-19 illness on 07/01/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
6,0
Labordaten
Tested positive for COVID-19 on 6/22/2021
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Chronic heart disease Chronic kidney disease Stage 3 kidney disease, heart attack at some point
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 1628631

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
80,0
Geschlecht
M
Eingang
24.08.2021
Impfdatum
03.03.2021
Beginn
13.08.2021
Tage bis Beginn
163,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Pt was hospitalized on 8/13/2021 and passed away on 8/21/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
8,0
Labordaten
Pt tested positive for COVID-19 by RNA on 08/13/2021.
Aktuelle Erkrankungen
-
Vorgeschichte
COPD, Diabetes mellitus, AKI
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 1628068

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
65,0
Geschlecht
M
Eingang
24.08.2021
Impfdatum
23.02.2021
Beginn
10.07.2021
Tage bis Beginn
137,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute respiratory failure COVID-19 COVID-19 pneumonia Cough Death

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA Patient received Pfizer Vaccines on 1/29/2021 and 2/23/2021. Patient presented to ED on 7/16/2021 with symptom onset 7/10/2021 of cough, diagnosed with COVID-19 and acute hypoxic respiratory failure secondary to COVID-19 pneumonia. While in the hospital, patient was treated with remdesivir, steroids, antibiotics and tocilizumab. Patient expired on 8/5/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
19,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Abnormal glucose level, Arteriosclerotic vascular disease, Colonic polyp, Coronary artery disease, GERD, Hyperlipemia, Hypertension, Obesity, Type 2 diabetes mellitus, Vitamin D deficiency
Andere Medikamente
doxycycline (100 mg), albuterol (90 mcg), aspirin (81 mg); atorvastatin calcium (40 mg), azithromycin (250 mg), benzonatate (200 mg), bromphenarimine, (10 mLs), carvedilol (25 mg), cholecalciferol (2,000 IU), clotrimazole, doxycycline hycl
Allergien
-
Vorherige Impfungen
-

VAERS 1627995

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
77,0
Geschlecht
M
Eingang
24.08.2021
Impfdatum
25.02.2021
Beginn
07.08.2021
Tage bis Beginn
163,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Abdominal pain COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chills Cough Death Decreased appetite Fatigue Headache Lung opacity Pneumonia Pyrexia Respiratory distress Respiratory failure SARS-CoV-2 test positive Thirst decreased

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA Patient received Pfizer-BioNTech COVID Vaccines on 2/4/2021 and 2/25/2021. Patient diagnosed with COVID-19 on 8/6/21 presented to ED complaining of worsening repsiratory status over a couple of days. 1 day prior to ED visit pt was given Decadron and discharged from unknown location per provider note. Associated symptoms include headache, cough, fever (T-max 104?), chills, decreased appetite/thirst, abdominal cramping with cough, and fatigue. X-ray shows moderate bilateral airspace opacities left greater than right, most consistent with multilevel low-grade pneumonia in this clinical setting. Pt treated with ceftriaxone, azithromycin x 3days 8/10, solumedrol #4 cont.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hx of malignant skin melanoma, COPD, paroxysmal AFIB, CAD, DM II cont.
Andere Medikamente
asprin 81mg chewable daily, carvedilol 12.5mg BID cont.
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1587007

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN-6198

kritisch
Staat
CA
Alter
70,0
Geschlecht
F
Eingang
19.08.2021
Impfdatum
28.02.2021
Beginn
21.03.2021
Tage bis Beginn
21,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Angiogram pulmonary abnormal Anticoagulant therapy Pulmonary embolism

Symptomtext

multiple pulmonary embolus diagnosed after pt came into the emergency room 4/5/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
CT ANGIO ,still on pradaxa
Aktuelle Erkrankungen
-
Vorgeschichte
htn depression
Andere Medikamente
hctz, alvesco, albuterol
Allergien
no
Vorherige Impfungen
-

VAERS 1574576

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WA
Alter
71,0
Geschlecht
F
Eingang
16.08.2021
Impfdatum
03.03.2021
Beginn
20.05.2021
Tage bis Beginn
78,0
Dosis
UNK
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 pneumonia Death Dyspnoea SARS-CoV-2 test positive

Symptomtext

5/20/2021 experiencing symptoms: dyspnea 5/24/2021 Admitted to hosp. and treated for COVID-19/ pneumonia 5/30/2021: died

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
6,0
Labordaten
5/23/2021 COVID-19 PCR positive
Aktuelle Erkrankungen
UNK
Vorgeschichte
Chronic heart disease, Diabetes Mellitus, Severe obesity
Andere Medikamente
UNK
Allergien
UNK
Vorherige Impfungen
-

VAERS 1530068

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
IL
Alter
67,0
Geschlecht
F
Eingang
06.08.2021
Impfdatum
19.02.2021
Beginn
24.03.2021
Tage bis Beginn
33,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Cerebrovascular accident Death Thrombosis

Symptomtext

Stroke on March 24, 2021. Widespread blood clots discovered on April 3rd, 2021. Death on April 5th, 2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
13,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1529193

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
FL
Alter
77,0
Geschlecht
F
Eingang
05.08.2021
Impfdatum
08.03.2021
Beginn
28.07.2021
Tage bis Beginn
142,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute kidney injury Acute respiratory failure Ageusia Anosmia Asthenia COVID-19 Decreased appetite Hypernatraemia Influenza Influenza virus test positive Malaise Pancytopenia Productive cough

Symptomtext

Patient hospitalized due to breakthrough covid-19 infection from 7/28/21 to 8/4/21. Patient completed the Pfizer vaccine series in March. Below information is copied from patient progress note (8/3/21): Patient is a 77 y.o. female with a history of CKD, diabetes mellitus, CVA without residual deficits and hypertension the presented to the emergency department with complaints generalized weakness, productive cough, malaise, decreased appetite, loss of taste and smell. COVID-19 positive. Acute hypoxemic respiratory failure due to COVID-19 -Stable tolerating NC -COVID 19 order set initiated -Cardiac and SpO2 monitoring -Dexamethasone 6 milligram p.o. daily times 10 days -Trend markers -ProBNP 524 -TTE WNL -Awaiting home o2, possible DC if O2 deliver Hypernatremia -Start D5W -Oral intake AKI over CKD -Improving -Continue to monitor -Avoid nephrotoxic agents -Hold spironolactone -Strict I/O -Nephrology consulted Insulin-dependent diabetes mellitus -Improving, steroid induce -Follow accucheks -Endoconsulted -Continue insulni per endo recs -Hold glipizide for now Pancytopenia -likely secondary to acute infection with COVID-19 -Monitor Hypertension - home antihypertensives: Amlodipine 10 mg PO daily, Metoprolol 25 mg PO BID, Spironolcatone 50 mg BID -Continue amlodipine and metoprolol -Hold spironolactone with possible acute on chronic kidney injury

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
8,0
Labordaten
7/28/2021 by FLU/SARS-COV-2 (Rapid ED-Only) (Collected 07/28/21) - confirmed positive
Aktuelle Erkrankungen
-
Vorgeschichte
CVA without residual deficits, 2019 Hypertension Insulin-dependent diabetes mellitus CKD
Andere Medikamente
Home medications unknown, states she was on aspirin and Plavix.
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1528852

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
74,0
Geschlecht
F
Eingang
05.08.2021
Impfdatum
03.03.2021
Beginn
29.07.2021
Tage bis Beginn
148,0
Dosis
2
Route/Site
SYR / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Death Vaccine breakthrough infection

Symptomtext

COVID -19 BREAKTHROUGH CASE THAT EXPIRED FOUR MONTHS AFTER COMPLETING COVID VACCINATION SERIES.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1515293

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
65,0
Geschlecht
M
Eingang
30.07.2021
Impfdatum
02.03.2021
Beginn
06.04.2021
Tage bis Beginn
35,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Chest X-ray abnormal Dyspnoea Pulmonary embolism

Symptomtext

Patient received Pfizer 1st dose afterwards develop L arm pain and L trunk numbness resolved on own started day after vaccine and resolved after three weeks. After 2nd dose developed shortness of breath and bilateral pulmonary emboli, started four weeks after second dose and is still being resolved now with anticoagulation therapy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
Chest x-ray in July.
Aktuelle Erkrankungen
None
Vorgeschichte
Hyperlipidemia and hypertension
Andere Medikamente
Multivitamin
Allergien
None
Vorherige Impfungen
-

VAERS 1512860

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
88,0
Geschlecht
F
Eingang
29.07.2021
Impfdatum
27.02.2021
Beginn
17.07.2021
Tage bis Beginn
140,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute kidney injury Cerebrovascular accident

Symptomtext

I63.9 - Cryptogenic stroke (CMS/HCC) I63.9 - Cerebrovascular accident (CVA), unspecified mechanism (CMS/HCC) N17.9 - Acute kidney failure, unspecified

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1512612

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
91,0
Geschlecht
F
Eingang
29.07.2021
Impfdatum
19.03.2021
Beginn
24.05.2021
Tage bis Beginn
66,0
Dosis
1
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute kidney injury COVID-19 Cardiac failure Chest wall haematoma Computerised tomogram thorax abnormal Condition aggravated Death Delirium Encephalopathy Fall Haematoma Hypoxia Lung opacity Pneumonia Pulmonary hypertension SARS-CoV-2 test positive

Symptomtext

92 year female admitted to hospital for fall on 5/24/2021. Unknown exposures in 14 days prior. Pfizer vaccine 2/25/2021 & 3/19/2021. PCR positive 5/24/2021. Transferred to hospice on 29th. Passed on 5/30/2021. Diagnosis at time of death: ARF on chronic with hypoxia, hematoma anterior chest wall left hip and upper thigh, suspected mild heart failure preserved ejection fraction, mechanical fall, delirium, bilateral PNA, pulmonary HTN, acute encephalopathy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
CT shows Ground glass appearance supporting of COVID
Aktuelle Erkrankungen
-
Vorgeschichte
CAD sp CABG, A-fib, mitral valve regurgitation, heart failure preserved ejection fraction, OSA on CPAP, DM2, osteoporosis, obesity, insomnia, depression, OA, chronic back pain
Andere Medikamente
Xeralto, Tylenol
Allergien
-
Vorherige Impfungen
-

VAERS 1487416

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
90,0
Geschlecht
F
Eingang
20.07.2021
Impfdatum
04.02.2021
Beginn
15.07.2021
Tage bis Beginn
161,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

The patient expired 7/15/2021 under Hospice care.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Patient COVID-19 positive by PCR on 07/04/2021.
Aktuelle Erkrankungen
n/a
Vorgeschichte
No
Andere Medikamente
n/a
Allergien
Azo Urinary Tract Defense, Clindamycin, Codeine, Doxycycline, Peniccillians, Sulfas.
Vorherige Impfungen
-

VAERS 1226463

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
HI
Alter
56,0
Geschlecht
M
Eingang
18.07.2021
Impfdatum
30.03.2021
Beginn
02.04.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Arterial occlusive disease Asthenia Chest pain Cold sweat Dyspepsia Arterial thrombosis Cardiac operation Decreased appetite Dyspnoea Carotid artery stent insertion Catheterisation cardiac abnormal Coronary artery disease Myocardial infarction Electrocardiogram Fatigue Gastrooesophageal reflux disease Pain in extremity Thrombosis

Symptomtext

hard time breathing; heart attack; minor chest pain which he thought was indigestion and heart burn; had clot arteries based in blood clots; 1 artery was 99% blocked; cold sweats; afraid to eat because he was so bloated/acid reflux; could not hold food down; out of energy; fatigued, totally out of energy; minor chest pain which he thought was indigestion and heart burn; This is a spontaneous report form a contactable consumer (patient). A 56-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE ) on 30Mar2021 for covid-19 immunisation at the age of 56-year-old. Lot number was EP7533. Medical history included diabetes in 2018. Concomitant medications were unknown. Patient received first dose of BNT162B2 on 09Mar2021 for covid-19 immunisation (Lot Number: EN6198 Anatomical Location: Left Arm). On unknown date, electrocardiogram showed shows heart attack. The patient experienced heart attack on 06Apr2021 (treated with surgery, and received 2 stents in his heart), hard time breathing on 11Apr2021, minor chest pain on 02Apr2021 which he thought was indigestion and heart burn on 06Apr2021, had clot arteries based in blood clots, 1 artery was 99% blocked, cold sweats, fatigued and totally out of energy on 06Apr2021, afraid to eat because he was so bloated/acid reflux, vomit on 06Apr2021. The patient was hospitalized for myocardial infarction, dyspnea and chest pain. The outcome of the events was unknown. Follow up attempts are needed. Further information has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocardial infarction
Hospital-Tage
-
Labordaten
Test Name: EKG; Result Unstructured Data: Test Result:Unknown; Comments: shows that you have been having a heart attack
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Diabetes
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1466971

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
81,0
Geschlecht
M
Eingang
13.07.2021
Impfdatum
25.02.2021
Beginn
16.06.2021
Tage bis Beginn
111,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Death Dyspnoea Endotracheal intubation Mechanical ventilation

Symptomtext

shortness of breath, endotracheal intubation, ventilator, death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
13,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
type 2 diabetes hypertension Hyperlipidemia anemia Kidney disease Hypothyroidism Peripheral artery disease
Andere Medikamente
amlodipine 5 mg tablet once a day with benazepril; omeprazole 20 mg tablet once a day in the morning; Synthroid 75 ?g tab, 1 every day; atorvastatin 40 mg tablet, 1 every evening; doxazosin 2 mg tablets 1 every day; clopidogrel 75 mg tablet
Allergien
none
Vorherige Impfungen
-

VAERS 1464271

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
77,0
Geschlecht
M
Eingang
12.07.2021
Impfdatum
10.03.2021
Beginn
22.06.2021
Tage bis Beginn
104,0
Dosis
UNK
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Death

Symptomtext

death N17.9 - Acute kidney failure, unspecified

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1457387

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
71,0
Geschlecht
F
Eingang
08.07.2021
Impfdatum
05.04.2021
Beginn
20.06.2021
Tage bis Beginn
76,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Cerebrovascular accident

Symptomtext

I63.9 - CVA (cerebral vascular accident) (CMS/HCC) I63.9 - Cerebrovascular accident (CVA), unspecified mechanism (CMS/HCC)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1450126

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
85,0
Geschlecht
F
Eingang
06.07.2021
Impfdatum
01.03.2021
Beginn
24.03.2021
Tage bis Beginn
23,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute myocardial infarction

Symptomtext

I21.4 - Non-ST elevation (NSTEMI) myocardial infarction

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1450056

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
94,0
Geschlecht
M
Eingang
06.07.2021
Impfdatum
20.03.2021
Beginn
02.05.2021
Tage bis Beginn
43,0
Dosis
UNK
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Death Pneumonia

Symptomtext

death J18.9 - Pneumonia, unspecified organism

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1440889

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
PA
Alter
78,0
Geschlecht
M
Eingang
01.07.2021
Impfdatum
24.02.2021
Beginn
22.06.2021
Tage bis Beginn
118,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure COVID-19 Endotracheal intubation Intra-aortic balloon placement

Symptomtext

Patient was Positive for Covid-19 in September 2020, repeat testing in October showed negative result. Patient was vaccinated on 2/24/21 and 3/17/21 with Pfizer-BioNTech COVID-19 vaccine. Patient developed COVID 19 on 6/20/21, and was hospitalized for acute respiratory failure. Patient was intubated and required pressor support with norepinephrine and an IABP.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Potassium, Telmisartan/HCTZ
Allergien
Contrast dye, latex, PCN
Vorherige Impfungen
-

VAERS 1437439

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
IN
Alter
78,0
Geschlecht
F
Eingang
30.06.2021
Impfdatum
02.03.2021
Beginn
18.05.2021
Tage bis Beginn
77,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Acute kidney injury Acute respiratory failure COVID-19 COVID-19 pneumonia Cardiac failure congestive Condition aggravated Death Hyperkalaemia Metabolic acidosis Pneumonia SARS-CoV-2 test

Symptomtext

Death 5/25/2021 Causes of death listed on death certififcate: 1. Acute Hypoxic Respiratory Failure due to Bilateral COVID-19 pneumonia 2. Bilateral Covid-19 Pneumonia 3. Covid-19 disease 4. Acute Renal failure, Metabolic Acidosis, Hyperkalemia, Acute Congestive cardiac failure

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
RT-PCR or other NAAT test
Aktuelle Erkrankungen
Bilateral Covid-19 Pneumonia Covid-19 disease Acute Renal failure, Metabolic Acidosis,
Vorgeschichte
Hyperkalemia
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1433235

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
68,0
Geschlecht
M
Eingang
29.06.2021
Impfdatum
09.03.2021
Beginn
20.05.2021
Tage bis Beginn
72,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute myocardial infarction

Symptomtext

I21.4 - NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1432919

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
66,0
Geschlecht
F
Eingang
29.06.2021
Impfdatum
19.03.2021
Beginn
21.05.2021
Tage bis Beginn
63,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute myocardial infarction

Symptomtext

I21.4 - NSTEMI (non-ST elevated myocardial infarction)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1431193

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
71,0
Geschlecht
F
Eingang
28.06.2021
Impfdatum
27.02.2021
Beginn
08.06.2021
Tage bis Beginn
101,0
Dosis
UNK
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Death Pneumonia

Symptomtext

Death J18.9 - Pneumonia, unspecified organism

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1431178

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
84,0
Geschlecht
F
Eingang
28.06.2021
Impfdatum
09.03.2021
Beginn
12.06.2021
Tage bis Beginn
95,0
Dosis
UNK
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Death Hyponatraemia Hypoosmolar state Seizure like phenomena Subarachnoid haemorrhage Thrombocytopenia

Symptomtext

Death SAH (subarachnoid hemorrhage) Observed seizure-like activity Hypo-osmolality and hyponatremia Acute kidney failure, unspecified Thrombocytopenia, unspecified

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1427848

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
NM
Alter
78,0
Geschlecht
M
Eingang
25.06.2021
Impfdatum
19.02.2021
Beginn
12.04.2021
Tage bis Beginn
52,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death Hepatic cirrhosis Hepatic encephalopathy SARS-CoV-2 test positive Sepsis

Symptomtext

Symptom onset 4/12, hospital admission date 4/19, died 4/25. Primary cause of death COVID-19, underlying causes sepsis secondary to COVID-19, hepatic encephalopathy, liver cirrhosis

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
6,0
Labordaten
COVID-19 PCR positive tests collected on both 4/19/2021 and 4/20/2021
Aktuelle Erkrankungen
Liver disease
Vorgeschichte
Liver disease
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1427430

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
ID
Alter
65,0
Geschlecht
F
Eingang
25.06.2021
Impfdatum
19.03.2021
Beginn
13.06.2021
Tage bis Beginn
86,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Cerebral calcification Cerebrovascular accident Computerised tomogram head abnormal Dysarthria Echocardiogram Magnetic resonance imaging head abnormal Neurological examination abnormal Ultrasound Doppler

Symptomtext

Slurring of speech. Went to hospital. Suspected Stroke, hospital administered tPA shot. Neurologist diagnosed a stroke caused by calcification.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
2,0
Labordaten
CT Scan, Echocardiogram, Ultrasound of carotid arteries, MRI (6/14/21)
Aktuelle Erkrankungen
None
Vorgeschichte
Breast cancer (in remission), hypertension (treated), Osteoporosis (in treatment)
Andere Medikamente
Losartan 100mg, Metoprolol 100mg/day, Tamoxifen Citrate 20mg, Senior Multivitamin, Calcium,
Allergien
Penicillin, Codiene
Vorherige Impfungen
-

VAERS 1425897

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
IN
Alter
88,0
Geschlecht
M
Eingang
25.06.2021
Impfdatum
26.02.2021
Beginn
14.04.2021
Tage bis Beginn
47,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 pneumonia Coronary artery disease Death

Symptomtext

Death 4/26/2021 Causes of death listed on death certificate: 1) Pneumonia 2) Coronary Artery Disease Other: Covid 19

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Antigen
Aktuelle Erkrankungen
Pneumonia Covide-19
Vorgeschichte
Coronary Artery Disease
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1421796

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
ND
Alter
89,0
Geschlecht
F
Eingang
23.06.2021
Impfdatum
06.02.2021
Beginn
16.05.2021
Tage bis Beginn
99,0
Dosis
2
Route/Site
UN / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Case was hospitalized and passed away. 2nd vaccine given 2/27/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
11,0
Labordaten
unknown
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
none known
Vorherige Impfungen
-

VAERS 1414492

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
PA
Alter
73,0
Geschlecht
F
Eingang
21.06.2021
Impfdatum
05.02.2021
Beginn
30.05.2021
Tage bis Beginn
114,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute respiratory failure Adenovirus test Angiogram cerebral normal Arteriogram carotid normal Bordetella test negative COVID-19 Chest X-ray abnormal Computerised tomogram head normal Computerised tomogram thorax abnormal Cough Decreased appetite Dyspnoea Echocardiogram Echocardiogram abnormal Ejection fraction decreased Endotracheal intubation Enterovirus test negative Exposure to SARS-CoV-2

Symptomtext

Nursing Home Visit 6/2/2021 Geriatric Medicine COVID-19 virus infection +4 more Dx Progress Notes SUBJECTIVE: Patient with history of multiple myeloma, osteonecrosis of jaw on IV antibiotic, CAD with history of stent, seizure disorder and hypertension was seen today. She has been complaining of sinus congestion for past 3 to 4 days. Apparently there has been other resident who tested positive for COVID-19 so rapid antigen test was performed on her. Unfortunately she also tested positive for COVID-19. She has received full dose of COVID-19 vaccine earlier in February. She denies any fever or chills. She denies any shortness of breath. She does complain of cough and sinus congestion going on for a week or so. Chief complaint: Acute hypoxic respiratory failure due to COVID-19 SUBJECTIVE: Patient with history of multiple myeloma, osteonecrosis of jaw on IV antibiotic, hypertension, CAD and seizure disorder was tested positive for COVID-19 yesterday. She has been complaining of sinus congestion for the past for 5 days. However this has been at her baseline. She has multiple allergies and taking antihistamine chronically. There has been Covid outbreak in the facility and multiple other residents are positive for COVID-19. She also tested positive for COVID-19 yesterday. Unfortunately this morning she declined and needed oxygen support. Her oxygen saturation dropped to mid 70s to upper 80s on 5 L O2. She was not using any accessory muscle. She did complain of mild cough but denied any chest pain. Her appetite is poor. She does not look toxic. Date: 6/3/2021 Admission Date: 6/3/2021 Assessments Patient is a 74 y.o. female on hospital day number 0 Medical Problems Hospital Problems POA * (Principal) Pneumonia due to COVID-19 virus Yes Plan Chief Complaint Patient presents with ? Shortness of Breath #. COVID-19 pneumonia with hypoxia. -Patient was offered plasma and she wants to get plasma therapy. Patient has signed a consent form for blood product transfusion. -Patient states she cannot take steroids due to her medical history. She is refusing steroid therapy. -IV remdesivir ordered for the patient. -Patient is consulted with the ID due to her complicated history. -Patient is on oxygen support via nasal cannula. #. Mandible osteomyelitis diagnosed recently. -Patient has been seen by infectious disease during the prior admission and has PICC line for long-term IV antibiotic. -Patient is reordered IV antibiotic in the form of imipenem and oral doxycycline as well as azithromycin. #. Essential hypertension -Patient continues on various antihypertensive medication. #. Diabetes mellitus type 2 -Patient is on insulin therapy while in the hospital. Patient is on polypharmacy and was advised to discuss with her family doctor to cut down on her unnecessary or unimportant medications if possible. History of Present Illness Patient is an 74 y.o. female. Patient is 74-year-old female, who presented from a facility chief complaint of acute hypoxic respiratory failure due to COVID-19 pneumonia. Patient has been at this facility since 5/12/2021 after being diagnosed with bisphosphonate related out for necrosis of the jaw with cellulitis and possible osteomyelitis. Patient had been transferred from a Hospital on 5/12/2021. Patient had been getting IV antibiotics for the osteomyelitis of the mandible and was apparently doing well until today when she was noted to be hypoxic. Patient has been complaining of sinus congestion over the past 5 to 7 days. According to the medical director, there has been Covid outbreak in the facility and multiple other residents are noted to be positive for COVID-19. Patient had a Covid test done yesterday and she was COVID-19 positive. Patient respiratory status declined. Patient required oxygen support. Her oxygen saturation had dropped into the mid 70s to upper 80s and patient was on 5 L/min of oxygen via nasal cannula. Patient had not been using accessory muscles. Patient also reports occasional cough and has yellowish phlegm production. Patient was referred to Hospital emergency department for further evaluation and treatment. ED to Hosp-Admission Discharged 6/3/2021 - 6/14/2021 (11 days) Last attending ? Treatment team Sepsis due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Principal problem DETAILS OF HOSPITAL STAY Presenting Problem/History of Present Illness/Reason for Admission Hypoxia COVID-19 virus infection Pneumonia due to COVID-19 virus Acute respiratory failure Hospital Course Patient is a 74 y.o. female with a history of multiple myeloma on fifth line treatment. Patient with recent diagnosis of osteomyelitis and on antibiotics per ID. She was admitted to the hospital 6/3 with acute shortness of breath and following 2 days on the general medical floor she required increasing oxygen supplementation and was transferred to the ICU. In the ICU patient had a seizure and required acute intubation for protection of her airway. Patient had further decline of her respiratory status. She did pass SBT's and was extubated. Shortly after she experienced likely an episode of aspiration. She continued to have increased work of breathing following this event. Patient transitioned to comfort care per family request. She received morphine and Ativan as needed and experienced asystole at 0834 this morning.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
11,0
Labordaten
Pneumonia due to COVID-19 virus 6/3/2021 - Present Sepsis due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (CMS/HCC) 6/12/2021 - Present New Results - Lab Updated Procedure 06/03/21 1606 Respiratory virus detection panel Collected: 06/03/21 1317 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result DetectedCritical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Synctial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected Resident Critical Care Procedures Signed Date of Service: 6/6/2021 8:47 PM Procedure Orders Central Line Insertion [3286736624] ordered by MD Arterial Line Insertion [3286736626] ordered by MD Post-procedure Diagnoses Acute respiratory failure with hypoxia Results Procedure Component Value Ref Range Date/Time X-ray chest 1 view Resulted: 06/12/21 0706 Order Status: Completed Updated: 06/12/21 0706 Narrative: XR CHEST 1 VW PORT IMPRESSION: 1. Unchanged diffuse bilateral airspace disease. 2. Indwelling tubes as detailed in the body of the report. END OF IMPRESSION: INDICATION: Dyspnea. TECHNIQUE: AP portable semierect projection of the chest is acquired. COMPARISON: Chest radiograph performed on June 11, 2021. FINDINGS: Redemonstrated are diffuse bilateral airspace opacities, similar compared to the prior study. No pleural effusion or pneumothorax identified. Endotracheal tube terminates approximately 5.9 cm superior to carina. An enteric tube terminates out of the field of view inferior to the diaphragm. A right-sided PICC line terminates in the SVC. Multilevel thoracic spondylosis and postoperative changes of prior thoracic vertebral plasty are redemonstrated. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view Resulted: 06/11/21 0644 Order Status: Completed Updated: 06/11/21 0644 Narrative: XR CHEST 1 VW PORT IMPRESSION: Stable lines and tubes. Diffuse opacities throughout the lungs persist, mildly increased at the right lung base. END OF IMPRESSION: INDICATION: cxr. TECHNIQUE: AP portable chest. COMPARISON: 6/9/2021 FINDINGS: Stable lines and tubes. Diffuse opacities throughout the lungs bilaterally, mildly increased at the right lung base. No pneumothorax or pleural effusion. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view Resulted: 06/09/21 0926 Order Status: Completed Updated: 06/09/21 0926 Narrative: XR CHEST 1 VW PORT IMPRESSION: Bilateral diffuse airspace opacities unchanged. Endotracheal and enteric tubes remain in satisfactory position. END OF IMPRESSION: INDICATION: cxr. TECHNIQUE: AP portable projection of the chest is acquired. COMPARISON: Portable chest on 6/7/2021. FINDINGS: Endotracheal and enteric tubes remain in satisfactory position. Bilateral diffuse airspace opacities remain unchanged. There is no pleural fluid or pneumothorax. The cardiomediastinal silhouette is stable. Kyphoplasty is noted in the lower thoracic spine. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Transthoracic echo (TTE) limited Resulted: 06/07/21 1307 Order Status: Completed Updated: 06/07/21 1310 LVIDd 4.40 3.70 - 5.60 cm LVIDs 2.80 2.00 - 3.80 cm IVSd 1.10 0.6 - 1.1 cm LVPWd 1.00 0.6 - 1.1 cm LADs 2.20 1.9 - 4 cm LVOT diameter 2.20 cm Aortic Root (2.0-3.7) 3.60 cm TR max PG 30.70 mmHg TR max vel 276.90 cm/sec Narrative: FINALIZED REPORT TWO-DIMENSIONAL ECHOCARDIOGRAPHIC FINDINGS LEFT VENTRICLE: Normal LV size with normal wall thickness. No regional wall motion abnormalities. RIGHT VENTRICLE: Normal size with mildly reduced function AORTIC VALVE: Trileaflet MITRAL VALVE: Normal TRICUSPID VALVE: Normal PULMONIC VALVE: Normal LEFT ATRIUM: Normal RIGHT ATRIUM: Normal INTERATRIAL SEPTUM: Intact AORTIC ROOT: Normal size PERICARDIUM: No effusion IVC: Normal size with normal collapse AORTIC ARCH: Not well seen COLOR AND SPECTRAL DOPPLER: PA systolic pressure in the range of 35 mmHg. Doppler evidence decreased LV compliance FINAL IMPRESSIONS: Normal LV size with normal wall thickness. No regional wall motion abnormalities. EF 55 to 60% Normal RV size with mildly reduced function No valvular abnormalities PA systolic pressure range 35 mmHg Doppler evidence decreased LV compliance X-ray chest 1 view Resulted: 06/07/21 0810 Order Status: Completed Updated: 06/07/21 0810 Narrative: XR CHEST 1 VW PORT IMPRESSION: 1. Unchanged bilateral airspace disease. 2. Indwelling lines and tubes as detailed in the body of the report. END OF IMPRESSION: INDICATION: Intubated. TECHNIQUE: AP upright portable projection of the chest is acquired. COMPARISON: Chest radiograph performed on June 6, 2021. FINDINGS: Redemonstrated is bilateral airspace disease, similar compared to prior study. No pleural effusion or pneumothorax identified. Endotracheal tube terminates approximately 4.6 cm superior to carina. An enteric tube terminates in the stomach. A right-sided PICC line is noted, with tip terminating in the distal SVC. Multilevel thoracic spondylosis and changes of prior thoracic vertebral plasty are noted. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT angiogram head with and without contrast Resulted: 06/06/21 1247 Order Status: Completed Updated: 06/06/21 1247 Narrative: CT ANGIOGRAM HEAD W WO CONTRAST, CT ANGIOGRAM NECK W WO CONTRAST, CT BRAIN PERFUSION W WO CONTRAST IMPRESSION: No CT perfusion evident infarct. No CT perfusion evident ischemia. No hemodynamically significant ICA stenosis by NASCET criteria. No cutoff occlusion, dissection, or measurable aneurysm. No measurable mass or abnormal enhancement. Known COVID-19 pneumonia and ARDS. END OF IMPRESSION: CONTRAST: 140mL of IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION administered INTRAVENOUS. CLINICAL HISTORY: Stroke alert , initial encounter. TECHNIQUE: CT angiography head and neck: Helical CT scanning of the head and neck was performed in arterial phase after the uneventful IV administration of 140 cc Omnipaque 350. Multiplanar reformations and 3D volume renderings are created on a separate image postprocessing workstation under my concurrent supervision and permanently recorded. Dose limiting techniques utilized when possible. CT perfusion: CT perfusion was performed utilizing intravenous contrast at an injection rate of 4 ml/sec. RAPID software utilized for determination of cerebral blood flow/CBF, blood volume/CBV, Time to peak/Tma and mean transit time/MTT. COMPARISON: 10/4/2020 FINDINGS: NECK: Diffuse COVID-19 pneumonia and ARDS. ETT above carina; enteric tube in esophagus. No cut-off occlusion, dissection or measurable aneurysm. Minimal/mild left and mild right soft and calcific atherosclerosis of the bilateral carotid bifurcation/ICA origins - without hemodynamically significant stenosis by NASCET criteria. Patent left and normal-caliber right vertebral arteries - no dissection or hemodynamically significant stenosis. No suspicious mass or adenopathy. HEAD: Minimal calcific atherosclerosis of the bilateral cavernous, clinoidal, and ophthalmic segment intracranial ICAs - without hemodynamically significant stenosis, dissection or cut off occlusion. Patent bilateral M1 and M2 segment middle cerebral arteries; patent bilateral A1 and A2 segment anterior cerebral arteries; patent anterior communicating artery. Patent basilar artery; patent bilateral P1 and P2 segment posterior cerebral arteries; robust right posterior to indicating artery; hypoplastic versus absent left posterior communicating artery. No dural venous sinuses are major central cerebral veins thrombotic filling defects. No measurable mass, abnormal enhancement or acute process. No measurable aneurysm. PERFUSION: TOTAL HYPOPERFUSION: Using a threshold of Tmax > 6 seconds, there is no diffuse or focal hypoperfusion. CORE INFARCT: Using the threshold of CBF < 30%, there is no evidence for irreversible ischemia. PENUMBRA: N/A. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT angiogram neck with and without contrast Resulted: 06/06/21 1247 Order Status: Completed Updated: 06/06/21 1247 Narrative: CT ANGIOGRAM HEAD W WO CONTRAST, CT ANGIOGRAM NECK W WO CONTRAST, CT BRAIN PERFUSION W WO CONTRAST IMPRESSION: No CT perfusion evident infarct. No CT perfusion evident ischemia. No hemodynamically significant ICA stenosis by NASCET criteria. No cutoff occlusion, dissection, or measurable aneurysm. No measurable mass or abnormal enhancement. Known COVID-19 pneumonia and ARDS. END OF IMPRESSION: CONTRAST: 140mL of IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION administered INTRAVENOUS. CLINICAL HISTORY: Stroke alert , initial encounter. TECHNIQUE: CT angiography head and neck: Helical CT scanning of the head and neck was performed in arterial phase after the uneventful IV administration of 140 cc Omnipaque 350. Multiplanar reformations and 3D volume renderings are created on a separate image postprocessing workstation under my concurrent supervision and permanently recorded. Dose limiting techniques utilized when possible. CT perfusion: CT perfusion was performed utilizing intravenous contrast at an injection rate of 4 ml/sec. RAPID software utilized for determination of cerebral blood flow/CBF, blood volume/CBV, Time to peak/Tma and mean transit time/MTT. COMPARISON: 10/4/2020 FINDINGS: NECK: Diffuse COVID-19 pneumonia and ARDS. ETT above carina; enteric tube in esophagus. No cut-off occlusion, dissection or measurable aneurysm. Minimal/mild left and mild right soft and calcific atherosclerosis of the bilateral carotid bifurcation/ICA origins - without hemodynamically significant stenosis by NASCET criteria. Patent left and normal-caliber right vertebral arteries - no dissection or hemodynamically significant stenosis. No suspicious mass or adenopathy. HEAD: Minimal calcific atherosclerosis of the bilateral cavernous, clinoidal, and ophthalmic segment intracranial ICAs - without hemodynamically significant stenosis, dissection or cut off occlusion. Patent bilateral M1 and M2 segment middle cerebral arteries; patent bilateral A1 and A2 segment anterior cerebral arteries; patent anterior communicating artery. Patent basilar artery; patent bilateral P1 and P2 segment posterior cerebral arteries; robust right posterior to indicating artery; hypoplastic versus absent left posterior communicating artery. No dural venous sinuses are major central cerebral veins thrombotic filling defects. No measurable mass, abnormal enhancement or acute process. No measurable aneurysm. PERFUSION: TOTAL HYPOPERFUSION: Using a threshold of Tmax > 6 seconds, there is no diffuse or focal hypoperfusion. CORE INFARCT: Using the threshold of CBF < 30%, there is no evidence for irreversible ischemia. PENUMBRA: N/A. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT brain perfusion with and without contrast Resulted: 06/06/21 1247 Order Status: Completed Updated: 06/06/21 1247 Narrative: CT ANGIOGRAM HEAD W WO CONTRAST, CT ANGIOGRAM NECK W WO CONTRAST, CT BRAIN PERFUSION W WO CONTRAST IMPRESSION: No CT perfusion evident infarct. No CT perfusion evident ischemia. No hemodynamically significant ICA stenosis by NASCET criteria. No cutoff occlusion, dissection, or measurable aneurysm. No measurable mass or abnormal enhancement. Known COVID-19 pneumonia and ARDS. END OF IMPRESSION: CONTRAST: 140mL of IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION administered INTRAVENOUS. CLINICAL HISTORY: Stroke alert , initial encounter. TECHNIQUE: CT angiography head and neck: Helical CT scanning of the head and neck was performed in arterial phase after the uneventful IV administration of 140 cc Omnipaque 350. Multiplanar reformations and 3D volume renderings are created on a separate image postprocessing workstation under my concurrent supervision and permanently recorded. Dose limiting techniques utilized when possible. CT perfusion: CT perfusion was performed utilizing intravenous contrast at an injection rate of 4 ml/sec. RAPID software utilized for determination of cerebral blood flow/CBF, blood volume/CBV, Time to peak/Tma and mean transit time/MTT. COMPARISON: 10/4/2020 FINDINGS: NECK: Diffuse COVID-19 pneumonia and ARDS. ETT above carina; enteric tube in esophagus. No cut-off occlusion, dissection or measurable aneurysm. Minimal/mild left and mild right soft and calcific atherosclerosis of the bilateral carotid bifurcation/ICA origins - without hemodynamically significant stenosis by NASCET criteria. Patent left and normal-caliber right vertebral arteries - no dissection or hemodynamically significant stenosis. No suspicious mass or adenopathy. HEAD: Minimal calcific atherosclerosis of the bilateral cavernous, clinoidal, and ophthalmic segment intracranial ICAs - without hemodynamically significant stenosis, dissection or cut off occlusion. Patent bilateral M1 and M2 segment middle cerebral arteries; patent bilateral A1 and A2 segment anterior cerebral arteries; patent anterior communicating artery. Patent basilar artery; patent bilateral P1 and P2 segment posterior cerebral arteries; robust right posterior to indicating artery; hypoplastic versus absent left posterior communicating artery. No dural venous sinuses are major central cerebral veins thrombotic filling defects. No measurable mass, abnormal enhancement or acute process. No measurable aneurysm. PERFUSION: TOTAL HYPOPERFUSION: Using a threshold of Tmax > 6 seconds, there is no diffuse or focal hypoperfusion. CORE INFARCT: Using the threshold of CBF < 30%, there is no evidence for irreversible ischemia. PENUMBRA: N/A. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT head stroke without contrast Resulted: 06/06/21 1234 Order Status: Completed Updated: 06/06/21 1234 Narrative: CT HEAD STROKE WO CONTRAST IMPRESSION: No acute intracranial abnormality. END OF IMPRESSION: INDICATION: Stroke alert, COVID-19 positive, initial encounter. TECHNIQUE: Helical CT scanning of the head is performed without IV contrast. Multiplanar reformations created and submitted for review. Dose limiting techniques utilized when possible. COMPARISON: MRI brain 5/8/2021, CT stroke series including perfusion angiography 10/3/2020 FINDINGS: No acute intracranial hemorrhage. No measurable mass or mass effect. Normal gray-white distinction and CSF spaces. No acute or aggressive osseous abnormality; no acute fluid. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view Resulted: 06/06/21 1108 Order Status: Completed Updated: 06/06/21 1108 Narrative: XR CHEST 1 VW PORT IMPRESSION: Endotracheal tube tip projects over the trachea 3.8 cm with the chin in neutral/slightly down position. Upper enteric tube courses below the diaphragm and inferior image edge. Patchy confluent COVID-19 pneumonia +/- ARDS are grossly stable. No pneumothorax or significant effusion; stable enlarged heart. Stable mediastinum and bones. END OF IMPRESSION: INDICATION: post ET and OG placement. TECHNIQUE: AP portable supine chest COMPARISON: 6/5/2021 back through 6/3/2021, reference chest CT 6/5/2021 This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Ultrasound lower extremity venous bilateral Resulted: 06/05/21 1414 Order Status: Completed Updated: 06/05/21 1414 Narrative: US LOWER EXTREMITY VENOUS BILATERAL IMPRESSION: Negative bilateral lower extremity venous ultrasound. END OF IMPRESSION: INDICATION: sob , rule out clot. Lower extremity swelling. TECHNIQUE: Multiple longitudinal and transverse 2D real-time ultrasound images were performed from groin to knee, and at the calf and ankle. Color and grayscale and duplex Doppler imaging was also performed. Permanently recorded images were obtained and stored. COMPARISON: None available. FINDINGS: No evidence of deep venous thrombosis. On each side, there is normal flow, compressibility and augmentation in the common femoral, greater saphenous, superficial and deep femoral veins and popliteal veins. There is also normal flow, compressibility and augmentation in the posterior tibial veins, peroneal veins and small saphenous veins in the calves. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT angiogram chest pulmonary embolism with and without contrast Resulted: 06/05/21 1155 Order Status: Completed Updated: 06/05/21 1155 Narrative: CTA CHEST PULMONARY EMBOLISM W WO CONTRAST IMPRESSION: No evidence of pulmonary embolism or aortic dissection. Progressive diffuse patchy bilateral groundglass airspace disease related to changes of progressive multifocal COVID-19 pneumonia. END OF IMPRESSION: INDICATION: ?PE. Assess for pulmonary artery embolism. TECHNIQUE: Enhanced helical CTA scan of the chest was performed from the lung apices to below the diaphragm, including the pulmonary artery. Two mm axial reconstruction with MPR coronal, oblique, and sagittal images were created. Three-D post processing imaging were obtained and stored. CONTRAST: 80 mL of IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION administered INTRAVENOUSLY. Quality of contrast opacification was adequate. COMPARISON: June 3, 2021. FINDINGS: There are no acute intravascular filling defects identified to suggest acute pulmonary embolism. No evidence of thoracic aortic aneurysm or dissection. No pleural or pericardial effusion is noted. No pathologic adenopathy. Prominent calcified nodes related to old granulomatous disease. There is a small hiatal hernia. Limited evaluation of the upper abdomen is unremarkable. On lung windows, progressive diffuse bilateral groundglass airspace disease related to multifocal COVID-19 pneumonia. Osseous structures are grossly intact with chronic compressive deformity of the T9 vertebral body status post vertebral augmentation. Healing sternal fracture is noted. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view Resulted: 06/05/21 0702 Order Status: Completed Updated: 06/05/21 0702 Narrative: XR CHEST 1 VW PORT IMPRESSION: 1. Some improved interstitial alveolar lung infiltrates, in keeping with COVID-19 infection. 2. See below report. END OF IMPRESSION: INDICATION: Shortness of breath, COVID-19, hypoxia, rule out CHF. TECHNIQUE: Single AP projection of the chest is acquired. COMPARISON: Chest radiograph dated June 3, 2021. FINDINGS: Right-sided PICC line is unchanged with the tip in the mid SVC. Mild cardiomegaly changes are stable. Diffuse interstitial lung marking prominence or infiltrates probably in keeping with COVID-19 infection may be mildly improved. No pneumothorax or effusion or consolidation is noted. Multilevel degenerative changes to the thoracic spine are reidentified. Lower thoracic spine vertebral augmentation/cement deposition is stable. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT angiogram chest pulmonary embolism with and without contrast Resulted: 06/03/21 1810 Order Status: Completed Updated: 06/03/21 1810 Narrative: CTA CHEST PULMONARY EMBOLISM W WO CONTRAST IMPRESSION: No acute pulmonary embolism. Diffuse bilateral ground glass airspace disease, consistent with given history of COVID related lung disease. Trace bilateral pleural effusions. END OF IMPRESSION: INDICATION: COVID pneumonia with hypoxia, evaluate for pulmonary embolism TECHNIQUE: CT angiography of the chest was obtained from the thoracic inlet to the upper abdomen after the administration of intravenous contrast using a pulmonary embolism protocol. 3-D shaded surface display, Maximum Curved Intensity Projection (MIP) and multiplanar reconstructions were performed on an independent workstation and permanently recorded. This CTA exam was performed using one or more of the following dose reduction techniques: automated exposure control, adjustment of the mA and/or kV according to patient size, or use of iterative reconstruction technique. CONTRAST: 80mL of IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION administered INTRAVENOUS. COMPARISON: 5/8/2021. FINDINGS: Supportive devices: Right arm PICC terminates at the cavoatrial junction. Pulmonary arteries: Good bolus of contrast in pulmonary arterial system. Opacification through the distal subsegmental level. Respiratory motion artifact. No filling defects. Main pulmonary artery normal in size. No evidence of right heart strain. Remaining vasculature: Aorta and visualized branches normal in caliber without significant atherosclerotic disease. Mediastinum: Thyroid and thoracic inlet normal. No enlarged mediastinal, hilar, or axillary lymph nodes by radiographic criteria. Heart size enlarged. Coronary atherosclerotic calcifications. No pericardial effusion. Esophagus normal. Small hiatal hernia. Lungs/pleura: Central airways patent. Diffuse bilateral groundglass airspace disease. Trace bilateral pleural effusions. Abdomen: Visualized upper abdomen normal. Bones/soft tissues: No suspicious osseous or soft tissue lesions. Prior vertebral augmentation of the T9 vertebral body. Healing sternal fracture. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view Resulted: 06/03/21 1300 Order Status: Completed Updated: 06/03/21 1301 Narrative: XR CHEST 1 VW IMPRESSION: Worsening patchy bilateral airspace opacities, particularly in the right upper and left lower lobes. END OF IMPRESSION: INDICATION: Shortness of Breath. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: 5/8/2021 FINDINGS: Interval worsening of patchy bilateral airspace opacities, particularly in the right upper and left lower lobes. No pneumothorax or pleural effusion. Stable heart size and cardiomediastinal silhouette. Right-sided PICC line terminates in the superior vena cava. Kyphoplasty changes are noted in the midthoracic spine.
Aktuelle Erkrankungen
-
Vorgeschichte
Nervous Chronic pain syndrome Fibromyalgia Myofascial pain syndrome Recurrent seizures (HCC) Trochanteric bursitis of left hip Coronary artery disease of native artery of native heart with stable angina pectoris (HCC) Respiratory Moderate persistent asthma Chronic frontoethmoidal sinusitis Multiple pulmonary nodules determined by computed tomography of lung Pneumonia due to COVID-19 virus Acute respiratory failure with hypoxia (HCC) Circulatory Essential hypertension Hemorrhoids CAD (coronary artery disease), native coronary artery Pulmonary hypertension, unspecified (HCC) Digestive Chronic constipation Irritable bowel syndrome Gastroesophageal reflux disease Vitamin D deficiency Folate deficiency Genitourinary Kidney stone Urethral prolapse Hematuria due to acute cystitis Prolapsed urethral mucosa Stage 3a chronic kidney disease Musculoskeletal Disc degeneration, lumbar Generalized osteoarthritis Osteopenia Osteoarthritis of left hip Osteomyelitis (HCC) Osteonecrosis due to drugs, jaw (HCC) Osteomyelitis of mandible Endocrine/Metabolic Hyperlipidemia Hypoglycemia Hematologic Chemotherapy-induced neutropenia (HCC) Multiple myeloma without remission (HCC) Secondary thrombocytopenia Thrombocytopenia due to drugs Iron deficiency anemia due to chronic blood loss Infectious/Inflammatory Port or reservoir infection, initial encounter Immune Sepsis due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (HCC) Sepsis due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (HCC) Other Depressive disorder Occult blood in stools Patient has living will Generalized anxiety disorder Failure of outpatient treatment Knee joint replaced by other means Presence of drug coated stent in anterior descending branch of left coronary artery Dizziness Immunocompromised (HCC) Asymptomatic bacteriuria History of CVA (cerebrovascular accident)
Andere Medikamente
acetaminophen (TYLENOL) 325 mg tablet acetaminophen (TYLENOL) 500 mg tablet acyclovir (ZOVIRAX) 400 mg tablet albuterol 2.5 mg /3 mL (0.083 %) nebulizer solution albuterol HFA (PROVENTIL;VENTOLIN) 90 mcg/actuation inhaler alum-mag hydroxide
Allergien
Levaquin [Levofloxacin]Hives / Urticaria PenicillinsSwelling , Rash Sulfa (Sulfonamide Antibiotics)Swelling , Rash, Hives / Urticaria SulfasalazineHives / Urticaria Cat DanderItching, Other (document details in comments) Dog DanderItching PhenytoinRash RanitidineRash
Vorherige Impfungen
-

VAERS 1414305

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
40,0
Geschlecht
M
Eingang
21.06.2021
Impfdatum
23.02.2021
Beginn
24.02.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Blood test Chills Coma Computerised tomogram Diarrhoea Dyspnoea Endotracheal intubation Fatigue Feeling abnormal Gastrostomy Headache Limb injury Lung disorder Magnetic resonance imaging Mechanical ventilation Muscle atrophy Neck injury Nerve injury

Symptomtext

Following the vaccination on 2/23/21, Pt had fever, chills, fatigue the first two days. On the third and fourth days, he added diarrhea and headache to those symptoms. He felt awful over the weekend and spoke to his doctor on Monday, 3/1. The doctor began him on steroids and ivermectin. Over the next 24 hours his breathing began to worsen. He entered the hospital on Tuesday, 3/2, for supplemental oxygen. Things continued to get worse. He was intubated and put on a ventilator on 3/6/21 and ultimately spent 13 days in a coma. He was extubated on 3/19/21 but then had seizures on 3/20/21 and had to be reintubated to secure his airway. Pt was taken back off the ventilator on 3/24/21. He suffered vocal cord paralysis and ultimately wound up with both a PEG tube and tracheotomy. He was discharged from the hospital after 43 days and then spent 10 days in an inpatient rehab center. He continues to deal with vocal cord issues, tracheal stenosis, nerve damage in his neck and shoulder, muscle atrophy, and damaged lungs.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Coma
Hospital-Tage
43,0
Labordaten
Pt hospital record is over 500 pages. He had numerous amounts of blood work, CTs, MRIs, scans, etc during his time in the hospital as well as after discharged.
Aktuelle Erkrankungen
seasonal allergies
Vorgeschichte
none
Andere Medikamente
men's multivitamin; fish oil; garlic supplement
Allergien
none at the time; now norepinephrine and phenyeprhine HCL
Vorherige Impfungen
-

VAERS 1412820

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
FL
Alter
82,0
Geschlecht
F
Eingang
19.06.2021
Impfdatum
18.03.2021
Beginn
19.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
SYR / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Brain scan normal Chest pain Confusional state Death Dizziness Dyspnoea Fatigue Vitamin B12 deficiency Weight decreased

Symptomtext

within 24 hours after second dose of vaccine my mother complained of chest pains and shortness of breath. She saw her Primary Care Dr on 5/10/2021 after experiencing dizziness, fatigue, confusion. She had lost a considerable amount of weight during this time and I was concerned and accompanied her to the doctor visit. Dr prescribed cyanocobalamin B-12 as she had been defficient in her latest blood analysis on 3/15/2021. She also added Donepezil 5mg tablet daily and trazodone 50 mg nightly to help with sleep. She gave referral to get Neuroligical evaluation. My mother had a driving episode on 4/30/2021 where she was taken to Medical Center and some Scans were taken of her brain that were apparently normal they contacted me to pick her up around 2:30 AM 5/01/2021. The number on her release folder to obtain medical Records. My mother was residing with me my home until her appointment for evaluation . She passed away on 6/02/2021 in my home.. Dr was contacted to sign off on her Death Certificate . I have not received Death Certificate as of today but I believe the cause she was putting was Natural Causes due to age.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
There was a Cat Scan done on her Brain on 4/30/2021 at Medical Center. I do not have the results of that test.
Aktuelle Erkrankungen
none
Vorgeschichte
Lung Cancer surgery 1990, Breast Cancer double masectomy 2015, Pace maker 2013 Model#PM2110 serial#7389583 Implant date 9/05/2013.
Andere Medikamente
amlodipine 5mg tablet daily, atorvastatin 40mg tablet daily, Bayer Aspirin 325mg tablet daily, hydrochlorothiazide 25 mg daily, lorazepam 1mg as needed, metoprolol succinate ER 100 mg daily.
Allergien
None
Vorherige Impfungen
-

VAERS 1407048

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
73,0
Geschlecht
M
Eingang
17.06.2021
Impfdatum
26.02.2021
Beginn
16.06.2021
Tage bis Beginn
110,0
Dosis
1
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Condition aggravated Death

Symptomtext

Pt. did not die from COVID vaccine. He was diagnosed with COVID19 on 06/04/2021. He had an extensive past medical history with several preexisting conditions which COVID exacerbated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
None Known
Vorgeschichte
Diabetes CHF Hx of stroke obesity hypertension kidney disease Parkinson's Disease
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1397725

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
83,0
Geschlecht
M
Eingang
14.06.2021
Impfdatum
23.02.2021
Beginn
24.02.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Cerebrovascular accident Imaging procedure abnormal Neurological symptom

Symptomtext

stroke the day following 2nd dose of Pfizer COVID vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
14,0
Labordaten
4/23/21 presented for care. for stroke symptoms. imaging revealed subacute stroke with onset suspected in time range of 2/24/21. pt and family reported stroke like symptoms 2/24/21 (the day following 2nd COVID vaccine) that resolved spontaneously and so he did not seek care. recurrence of stroke like sx on 4/23/21 prompted care at hospital
Aktuelle Erkrankungen
see below
Vorgeschichte
atrial fibrillation, mesenteric ischemia due to acute embolism 12/2020, s/p open thrombectomy 12/2020, recurrent hematochezia during 2019/2020 - presumed angioectasias or diverticular henorrhage, possible small bowel stricture s/p acute ischemic event r/t thromboembolism in 12/2020 - managed with low residue diet
Andere Medikamente
atorvastatin, carvedilol, apixiban, escitalopram, lisinopril, pantoprazole
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1397257

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
45,0
Geschlecht
F
Eingang
14.06.2021
Impfdatum
02.03.2021
Beginn
09.03.2021
Tage bis Beginn
7,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Anticoagulant therapy Blood test Computerised tomogram thorax abnormal Deep vein thrombosis Pulmonary embolism Ultrasound Doppler abnormal

Symptomtext

Deep Vein Thrombosis, pulmonary embolism blood thinners no final outcome as I am still in treatment

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
Dvt diagnosed by an ultrasound Pulmonary embolism diagnosed through ct scan Blood work done
Aktuelle Erkrankungen
Na
Vorgeschichte
Na
Andere Medikamente
Na
Allergien
Benadryl
Vorherige Impfungen
-

VAERS 1151399

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
-
Geschlecht
M
Eingang
11.06.2021
Impfdatum
03.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Blood pressure increased Blood pressure measurement Dizziness Electrocardiogram Feeling abnormal Hyperhidrosis Memory impairment Myocardial infarction Nausea Ocular discomfort Hypertension Scan brain Vertigo

Symptomtext

blood pressure was high 190/114; horrible dizzy spells/ lightheadedness; when he puts his head between his shoulders he almost falls over; nauseous; sweating; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on 03Mar2021 (Lot number was not reported) as single dose for covid-19 immunisation. Medical history and concomitant medications were not reported. On unknown date in Mar2021 patient experienced horrible dizzy spells, lightheadedness, when he puts his head between his shoulders he almost falls over, blood pressure was high 190/114, nauseous, sweating. Patient stated that he received the first dose of the Pfizer COVID vaccine on 03Mar2021. He did not have any problems directly after the vaccine. Patient started having problems the middle of the week of the report with horrible dizzy spells and lightheadedness. Patient stated that when he puts his head between his shoulders he almost falls over. He was taken to the emergency room by ambulance and had an Electrocardiogram (EKG) done in Mar2021 that was normal. Patient stated that his blood pressure was high 190/114 and he was given medication for it. Patient had been nauseous and sweating. Patient had read on the internet that other people have had this same experience. He stated that his symptoms are really debilitating. Patient wanted to know how long his side effects will last, wanted to know if his side effects are normal and if he should receive the second dose of the vaccine. Events resulted in emergency room visit. Outcome of the events was unknown. No follow-up attempts are possible; Information about lot/batch number cannot be obtained.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocardial infarction
Hospital-Tage
-
Labordaten
Test Date: 202103; Test Name: blood pressure; Result Unstructured Data: Test Result:190/114; Comments: blood pressure was high 190/114; Test Date: 202103; Test Name: EKG; Result Unstructured Data: Test Result:Normal
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1374741

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
80,0
Geschlecht
M
Eingang
04.06.2021
Impfdatum
27.02.2021
Beginn
12.05.2021
Tage bis Beginn
74,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Cerebrovascular accident Facial paralysis Pneumonia

Symptomtext

R29.810 - Facial droop I63.9 - Cerebrovascular accident (CVA), unspecified mechanism (CMS/HCC) J18.9 - Pneumonia, unspecified organism

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1374131

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
69,0
Geschlecht
M
Eingang
04.06.2021
Impfdatum
27.02.2021
Beginn
01.06.2021
Tage bis Beginn
94,0
Dosis
UNK
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Cardiac arrest Death Pneumonia

Symptomtext

death I46.9 Cardiac Arrest J18.9 - Multifocal pneumonia

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1372096

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
VA
Alter
39,0
Geschlecht
M
Eingang
03.06.2021
Impfdatum
29.04.2021
Beginn
29.04.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pathology test Sudden death

Symptomtext

Patient died abruptly 2-3 hours after receiving shot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Sudden death
Hospital-Tage
-
Labordaten
In progress - have not received final pathology notes/results
Aktuelle Erkrankungen
none known
Vorgeschichte
Epilepsy and Neurofibroma
Andere Medikamente
melatonin, clobazam (10mg), gabapentin (800mg), omeprazole (40mg), levetiracetam (1000mg), divalproex (500mg), hydroxyzine (25mg) , fluticasone nasal spray (60mg), emtricitabine (200-300mg), lidocaine 5%
Allergien
none known
Vorherige Impfungen
-

VAERS 1371618

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
70,0
Geschlecht
M
Eingang
03.06.2021
Impfdatum
29.01.2021
Beginn
17.05.2021
Tage bis Beginn
108,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Body temperature increased Chest X-ray abnormal Computerised tomogram thorax abnormal Deep vein thrombosis Dyspnoea Full blood count Glomerular filtration rate Influenza A virus test Influenza B virus test Metabolic function test Myalgia Pulmonary embolism SARS-CoV-2 test Ultrasound Doppler abnormal Urine analysis

Symptomtext

May 17, 2021: sever shortness of breath, low grade temperature, muscle aches for 2 weeks. Worsening. ER Hospital on May 30, 2021. Diagnosis: DVT (left leg); multiple PE's bilateral lungs

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
2,0
Labordaten
Chest x-rays, laboratory (CBC, metabolic panel, GFSR, Covid, Influenza A&B tests, urinalysis, CT of chest, Bilateral Ultrasound of legs.
Aktuelle Erkrankungen
-
Vorgeschichte
Lymphocytic Colitis; Exocrine Pancreatic Insufficiency (EPI); Hypertension; PTSD (depression & anxiety), Neuropathy (feet).
Andere Medikamente
Paxil, Remeron, Budesonide, Gabapentin, Valsartan, Buspirone, Nifedipine, Potassium, Imodium, B-12, D3
Allergien
Indigo Carmine, FD&C blue #2
Vorherige Impfungen
-

VAERS 1369067

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
FL
Alter
68,0
Geschlecht
M
Eingang
02.06.2021
Impfdatum
16.03.2021
Beginn
30.05.2021
Tage bis Beginn
75,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Angiogram pulmonary abnormal Pulmonary embolism

Symptomtext

30 May 2021 I was diagnosed as an otherwise healthy male with pulmonary embolism in the lower right lung. No predispositions to blood clots.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
3,0
Labordaten
CT Angiogram of the chest. Final report available at Hospital
Aktuelle Erkrankungen
None
Vorgeschichte
Mild hypertension (8 years)
Andere Medikamente
Amlodipine 10mg
Allergien
None
Vorherige Impfungen
-

VAERS 1355095

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
PA
Alter
72,0
Geschlecht
F
Eingang
27.05.2021
Impfdatum
17.03.2021
Beginn
22.03.2021
Tage bis Beginn
5,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Breath sounds abnormal Chest X-ray abnormal Computerised tomogram thorax abnormal Cough Death Dysphonia General physical health deterioration Intensive care Malaise Oxygen saturation decreased Pneumonia Pneumonitis Pulmonary fibrosis Respiratory tract congestion SARS-CoV-2 test negative

Symptomtext

Daughter reporting after her mother's death . She got her vaccine and called her daughter in the afternoon around 2:00 and told her that she got it. At 6:00 she received a VM where she said that she was having joint pain and wanted to know if she could call her doctor to get her joint pain medicine. Later that evening her daughter told her that was why she was put on the Hydroxychloroquine and they wanted her to see the rheumatologist. She complained of pain a lot, but she specifically asked for joint pain medicine. On the 22nd on another VM her daughter noticed that she sounded raspy hoarse sounding and congested and had a cough. Then subsequent messages after that the hoarseness was there that didn't go away. Her daughter took her to the dentist on 4/15/21 and she remembered that the caregiver told her that she did not want to go to the dentist as she did not feel good. She did not like to get out of the apartment. Then on 4/19/21 she was admitted to the hospital and that she had pneumonia. They were going to discharge her home and she was going to pick her up on 4/22/21, and then they called her back and told her that she sounded junky and they were going to keep her another day. She made arrangements to pick her up on Friday and then her oxygens dropped and would discharge her on Monday. She normally gets oxygen 1 liter of oxygen only at night, and when she was admitted her oxygen levels were low and they put her on 6 liters when she was admitted. Then she was weaned off oxygen completely, and her daughter informed them that she slept with oxygen and that's when they were talking about going home. On Friday she dropped her oxygen level into the 60's On Saturday 4/24/21 she was on 9 liters of oxygen and the doctor came in and said that she was on 14. By Saturday night she was on the Critical care Unit, but her on Vancomycin and was on Vapotherm on high-flow oxygen and she had maxed out at 40 liters at 100% oxygen. They talked to the daughter about putting her on ventilation and thought it was toxicity to Vancomycin and other things and couldn't figure it out and said that it was some sort of inflammation of her lungs. They put her on high levels of steroids and was then taken off of high-flow oxygen and then was still on 20% liters. They recommended hospice and palliative care. They decided to bring her home on Hospice with 15 liters of oxygen. It was up and down levels. She was given steroids when she came home on Hospice and was given steroids. She then started to decline and hospice nurse came and she was admitted to Hershey and they repeated her chest x-ray and COVID testing, and that her lungs were so scarred there was nothing that they could do for her. They tested her for COVID multiple times, the CAT Scans came back that it was worsening and consistent with COVID but tested negative twice while was there. She was then sent to Hospital and tested again and was negative, and she passed on 5/10/2021. HOSPITAL ADMISSIONS: She was admitted to on 4/19/21 discharged home on hospice on 5/6/21. She was admitted to Medical Center on 5/6/21 and she died on 5/10/21 at 5:48 PM.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
21,0
Labordaten
See above.
Aktuelle Erkrankungen
None.
Vorgeschichte
Hemorrhagic stroke 11 years ago, paralyzed on right side (wheelchair bound), seizure disorder, COPD, working her up as one of her blood tests suggested an autoimmune disorder. She had full time caregivers.
Andere Medikamente
Hydroxychloroquine, Lasix, Morphine, Celexa, Seroquel, Flexeril, Glucosamine, Synthroid, Plavix, long-acting potassium, Flonase prn, Keppra, Xanax, Oxycodone, aspirin 81 mg. enteric coated.
Allergien
None.
Vorherige Impfungen
-

VAERS 1350978

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MI
Alter
78,0
Geschlecht
M
Eingang
26.05.2021
Impfdatum
02.03.2021
Beginn
24.03.2021
Tage bis Beginn
22,0
Dosis
2
Route/Site
SYR / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 COVID-19 pneumonia Chest X-ray abnormal Death Electrocardiogram normal Oxygen saturation decreased Pleural effusion Respiratory failure SARS-CoV-2 test positive Troponin increased

Symptomtext

78y.o. male with a past medical history of COPD, DM II, and HTN who presented to the hospital's emergency department from an extended care facility. Patient was recently hospitalized and treated with IV antibiotics for HCAP. Patient tested positive for COVID on 3/24/2021. EKG was negative for ischemic signs but patient had an elevated troponin. CXR showed right pleural effusion. Patient was admitted with COVID-19 pneumonia and severe respiratory failure. Patient's oxygenation continued to deteriorate despite Remdesivir, decadron and lovenox. Patient went into respiratory failure and expired from progressive respiratory failure.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
13,0
Labordaten
SARS-CoV-2 (COVID-19), Point of Care: Positive (3/24/2021)
Aktuelle Erkrankungen
-
Vorgeschichte
COPD, diabetes, high cholesterol, hypertension, pancreatitis, CHF
Andere Medikamente
Albuterol-ipratropium, Novolog, Mylanta, Maalox, Dulcolax, Pepto Bismol, Colace, Proscar, Lasix, Lantus, Milk of Magnesia, Glucophage, Lopressor, Nitrostat, Oscal, Protonix, Flomax, Vitamin D
Allergien
-
Vorherige Impfungen
-

VAERS 1350670

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WY
Alter
47,0
Geschlecht
F
Eingang
26.05.2021
Impfdatum
25.02.2021
Beginn
25.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Death Decreased appetite Hypersomnia Loss of personal independence in daily activities Mental status changes Posture abnormal Wheelchair user

Symptomtext

After first dose her mental status become slightly altered and she leaned to the left a bit when standing up and walking.. From the day of second dose my sisters appetite decreased. She started sleeping more, got weaker to the point I had to bathe her, she had to start using a wheelchair. Mental status much more altered. She was to weak to go to dialysis on Monday March 22 2021 hospice was called in Tuesday March 23 2021 and she passed away at approximately 4:00 P.M. March 24th 2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Kidney disease
Andere Medikamente
Ametriptolin, eliquis, seizure medicine
Allergien
Penicillin, msg
Vorherige Impfungen
-

VAERS 1347634

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
76,0
Geschlecht
M
Eingang
25.05.2021
Impfdatum
02.03.2021
Beginn
05.03.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute kidney injury Acute respiratory failure Asthenia Blood creatinine increased Breath sounds absent Cardiogenic shock Death Dysstasia Fall Heart sounds abnormal Hypotension Nodal arrhythmia Pulse absent Pupil fixed Respiratory arrest Unresponsive to stimuli

Symptomtext

3/5, admitted 3 days after covid vaccine and died. Patient presented to ED feeling very weak and had fallen and could not get up. He was brought to the emergency room, and a trauma evaluation was negative. He was found to have a severe junctional bradycardia with a heart rate in the 20s and systolic blood pressures in the 60s. In addition, he was found to have a creatinine now of greater than 5 when his previously had been in the low 1s. Patient admitted with junctional bradycardia, acute renal failure, hypotension, cardiogenic shock, and acute hypoxemic respiratory failure with high O2 needs. PMH significant for CAD, pulmonary HTN, aortic stenosis, obstructive lung disease, and chronic hypoxia. This patient has been made DNR/DNI over the weekend which is quite appropriate. Patient was found to be unresponsive with fixed/dilated pupils, absent heart and breath sounds, no respiratory effort, absent pulses, and no response to painful stimuli. Patient was pronounced deceased on 03/10/2021 at 0405.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1347546

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
73,0
Geschlecht
F
Eingang
25.05.2021
Impfdatum
27.02.2021
Beginn
02.03.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Anticoagulant therapy Dyspnoea Musculoskeletal chest pain Pulmonary embolism

Symptomtext

3/2, admitted 3 days after 2nd covid vaccine with PE. Patient ecently diagnosed GBM who is s/p chemo radiation and who presented to the ER with chest wall pain and SOB. Patient was found to have a large, saddle PE and treated with a heparin gtt. She did fairly well and was cleared for discharge to home by PT and OT. It was recommended discharge on lovenox until her f/u on 3/12 and which time she will likely change to pradaxa. She will continue to follow with oncology, her PCP as needed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1346723

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CO
Alter
102,0
Geschlecht
M
Eingang
25.05.2021
Impfdatum
25.05.2021
Beginn
25.05.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Death Laboratory test SARS-CoV-2 antibody test negative Vaccine breakthrough infection

Symptomtext

Patient contracted covid 2 months after receiving the full vaccine series. He was admitted the hospital and subsequently passed away. Variant testing was conducted (results are pending) and antibody testing was done. Antibody testing showed no antibodies were produced in response to the vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
See above.
Aktuelle Erkrankungen
None. Other than being 100 years old, patient was in relatively good health. Did have a diagnosis of atrial fibrillation and essential hypertension.
Vorgeschichte
Atrial fibrillation and essential hypertention.
Andere Medikamente
Amiodarone, potassium chloride, furosemide, metoprolol succinate, dabigatran
Allergien
nuts
Vorherige Impfungen
-

VAERS 1343036

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
VA
Alter
65,0
Geschlecht
M
Eingang
24.05.2021
Impfdatum
01.03.2021
Beginn
10.03.2021
Tage bis Beginn
9,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Cerebrovascular accident

Symptomtext

Patient suffered CVA on 3/10/2021 affecting the left side of his body, and subsequently spent three days at Hospital as the result of this incident.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Essential Hypertension- well controlled
Andere Medikamente
Voltaren 75, Lisinopril HCT, Omeprazole, Klorcon,
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1338610

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
82,0
Geschlecht
M
Eingang
21.05.2021
Impfdatum
27.02.2021
Beginn
20.04.2021
Tage bis Beginn
52,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Death Pneumonia

Symptomtext

Death J18.9 - Pneumonia, unspecified organism

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1333292

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
PA
Alter
65,0
Geschlecht
F
Eingang
20.05.2021
Impfdatum
10.03.2021
Beginn
26.03.2021
Tage bis Beginn
16,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Acute respiratory failure Adenovirus test Anticoagulant therapy Barium swallow abnormal Bladder catheterisation Blood calcium increased Blood chloride normal Blood creatinine normal Blood culture positive Blood folate normal Blood potassium normal Blood sodium normal Blood urea increased Bordetella test negative Computerised tomogram abdomen Computerised tomogram abnormal Computerised tomogram head

Symptomtext

Sore throat, Fever, unspecified fever cause, Exposure to COVID-19 virus ED to Hosp-Admission Discharged 4/1/2021 - 5/14/2021 (43 days) Hospital MD Last attending o Treatment team COVID-19 Principal problem Discharge Summary MD (Physician) o o Internal Medicine HOSPITAL DISCHARGE SUMMARY HOSPITALIST GROUP . Patient: Date: 5/14/2021 DOB: Admission Date: 4/1/2021 MRN: Length of stay: 43 Days PCP:MD Discharging provider: MD Admission diagnosis: Primary Admission Diagnosis Medical Problems Hospital Problems Hospital Course HPI: Past medical history significant for type 1 diabetes mellitus, essential hypertension, obstructive sleep apnea, peripheral vascular disease status post femoropopliteal bypass 2016, status post multiple toe amputations on left foot, history of right foot osteomyelitis, left foot osteomyelitis in November 2020 who presented to ER on 4/1/2021 with shortness of breath. She was diagnosed with acute hypoxic respiratory insufficiency in the setting of Covid pneumonia with AKI, hyponatremia, troponin elevation, LFT elevation admitted to regular floor on high flow nasal cannula oxygen. Patient was intubated on 4/2/2021 for increased work of breathing and worsening hypoxemia and hypercapnia. Later patient was found to have persistent Candida fungemia. Hospital Course: Persistant Candida fungemia, now improving Blood cultures positive for Candida albicans from 4/12, 4/14 and 4/17/2021. Cardiology was consulted for TEE, done on 04/30 which was negative for vegetations. Ophthalmology was consulted and there was no evidence of fungal endophthalmitis. Blood cultures from 4/23/2021 so far no growth. PICC line has been placed. ID recommendations appreciated. -Currently patient on 6 weeks of IV micafungin, to be continued through 6/7/2021 as per ID recommendations. ID has therapy plan in system Moderate to severe pharyngeal dysphagia Post extubation SLP and modified barium swallow demonstrated aspiration with thin and thickened liquids. S/p PEG tube on 5/7/2021. CT head did not reveal any infarct. Repeat modified barium swallow done today , patient now advanced to level 3 soft diet with thin liquids. -Continue with tube feeds and alter tube feeds based on patient's diet advancement Type I Diabetes mellitus: Labile blood sugars in the setting of changes done to tube feeding. Patient currently on tube feeding and diet has been advanced today. Regimen at the time of discharge Lantus twice daily: With sliding scale insulin and standing dose of short-acting insulin with tube feeds bolus. -Patient will need close monitoring of her blood sugars given changes being done to tube feed and diet advancement, will need titration of insulin based on blood sugars. Lower extremity edema, improved Likely dependent lower extremity edema. Echo April 2021 reviewed: Normal EF, no diastolic dysfunction. -Elevate legs while patient is seated -Ace wraps -Restarted home dose of hydrochlorothiazide Acute on chronic anemia Received 1 unit of blood transfusion during this hospitalization Monitor hemoglobin Vitamin B12 and folate level normal. Hb on last check was 8.0 COVID-19 pneumonia Acute hypoxic and hypercapnic respiratory failure -resolved Status post extubation 04/06/2021 Treated with Remdesivir,convalescent plasma, Decadron as well as Tocilizumab. Treated with IV vancomycin, Levaquin and cefepime in the setting of possible secondary bacterial pneumonia. CT chest ruled out PE but showed extensive infiltrates on admission. Patient is off Covid precautions Currently saturating well on room air and stable from respiratory standpoint. Elevated d dimer, POA : Patient had elevated D-dimer on presentation. Lower extremity ultrasound 4/3/2021 was negative for DVT. CT chest ruled out PE. She was initially placed on intermediate dose of anticoagulation. D-dimer eventually trended down. Currently patient is on subcu heparin for prophylaxis. AKI POA now resolved Creatinine stable. -Continue to monitor renal function, electrolytes and urine output. Hypernatremia : resolved Acute Urinary retention, now resolved. Foley catheter was placed on 4/24 after patient had multiple straight cath done. DC'd Foley catheter on 5/3/2021. Patient is currently voiding without any issues. Chronic medical issues : o Essential Hypertension: On amlodipine, Coreg and hydrochlorothiazide. o Peripheral vascular disease status post femoropopliteal bypass: Restarted home aspirin, statin. _ Admission Current 5/14/2021 - present (6 days) Hospital MD Last attending o Treatment team COVID-19 with multiple comorbidities Principal problem Physical Medicine and Rehabilitation History and Physical Date: 5/14/2021 Admission Date: (Not on file) PCP: MD DOB: Hospitalist: MD Assessments Patient is a 65 y.o. female on hospital day number 0 Active Problems: No Active Hospital Problems: There are no active hospital problems currently on the Problem List. Please update the Hospital Problem List and refresh. IMPRESSION / PLAN: 1. Covid pneumonia/sepsis with hypoxic respiratory failure Received remdesivir, dexamethasone, convalescent plasma Received IL-6 inhibitor Intubation 4/1/2021?extubated, O2 weaned and now tolerating room air CTA chest 4/22/2021?extensive consolidation in both lungs C/W Covid pneumonia, no PE 2. Diabetes mellitus type 1 Lantus scheduled dose twice daily Humalog every 6 hours scheduled and sliding scale Insulin to be adjusted as PEG feedings decrease 3. Diabetic peripheral neuropathy arterial insufficiency Status post femoropopliteal bypass 2016? Status post right common femoral and mid popliteal bypass 9/28/2020 Dr. ?no use of synthetic graft Status post remote history of multiple toe amputations left foot osteomyelitis Acute necrotic areas of feet being treated locally 4. Candida albicans fungemia On 6-week course of IV micafungin Weekly CBC, LFT, sed rate, CRP and BMP 5. Essential hypertension On amlodipine, carvedilol, HCTZ, 6. Dysphagia PEG tube placed 5/7/2021?Dr. Cleared for dysphagia level 3 soft diet thin liquids 5/14/2021 Aspiration precautions Speech and Language Pathology 7. Decreased ambulation and functional mobility and functional ability for activities of daily living Physical therapy, Occupational Therapy Plan Patient is admitted for comprehensive inpatient rehabilitation program consisting of physical therapy, Occupational Therapy, speech and language pathology, rehabilitative nursing, psychology, and case management support. Goals will be aligned with patient family goals and directed to improving functional mobility, functional interaction, and activities of daily living to allow the patient to return home safely and continue his rehabilitation as an outpatient or at a home health basis. Estimated length of stay is 16 days. Patient has a good prognosis History of Present Illness Patient is an 65 y.o. female with history of diabetes mellitus type 1 hypertension and sleep apnea who became febrile with shortness of breath over several days. Her PCP, Dr, ordered Covid test which was positive. She presented to Hospital on 4/1/2021 for further work-up. On admission she was found to be in hypoxic respiratory failure requiring high flow oxygen which progressed to requiring a nonrebreather and eventually intubation with ICU care. She received remdesivir, dexamethasone, and convalescent plasma. Patient also received IL-6 inhibitor Tocilizumab recommendation of pulmonary critical care. Procalcitonin level was 35.32. Because of concern of superimposed bacterial pneumonia she was also treated with broad-spectrum antibiotics. Patient had a prolonged complicated acute care hospital course. On 4/12/2021 ENT evaluation showed poor phonatory effort but mobile true vocal cord without lesions. Patient was found to have a fungemia from cultures of 4/12/2021 of C albicans with positive blood cultures with C. albicans on 4/17/2021. Patient was placed on IV micafungin for a total of 6-week course. TEE showed no evidence of acute valve pathology. Ophthalmology was consulted and there was no evidence of fungal endophthalmitis. Repeat blood cultures from 4/23/2021 showed no growth. Patient had PEG tube placed by Dr of GI on 5/7/2021. Repeat modified barium swallow on 5/14/2021 showed improvement of swallowing and the patient was upgraded to a dysphagia level 3 soft diet with double swallows and thin liquids via cup or straw with aspiration precautions. Patient was evaluated by therapies while at Hospital acute care. She requires supervision to rise from sit to stand using a rolling walker and contact-guard ambulate 45 feet using a rolling walker with wheelchair follow and verbal cues for walker management. She continues to have some knee buckling. She needs minimal assistance for bathing and min mod assistance for lower body dressing. She is able to perform toileting with contact-guard. Acute inpatient rehabilitation was recommended. Patient is being transferred to the Hospital for comprehensive inpatient rehabilitation program. Additional information for Item 19: Updated Procedure 04/01/21 1217 Respiratory virus detection panel Collected: 04/01/21 0917 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result DetectedCritical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Synctial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected 03/27/21 1807 COVID-19 (SARS CoV-2,RNA Molecular Amplification) Collected: 03/27/21 0859 | Final result | Specimen: Swab COVID-19 SARS-CoV-2 Overall Result DetectedCritical Labs/Imaging LABORATORY: CBC: Results from last 7 days Lab Units 05/13/21 0557 05/10/21 0614 05/09/21 0724 WBC AUTO K/mcL 5.4 5.0 4.7 HEMOGLOBIN g/dL 8.0* 8.0* 8.5* HEMATOCRIT % 24.7* 25.3* 26.4* PLATELETS K/mcL 201 197 196 NEUTROS PCT AUTO % 67 -- -- LYMPHS PCT AUTO % 21 -- -- MONOS PCT AUTO % 8 -- -- EOS PCT AUTO % 4 -- -- CHEMISTRY: Results from last 7 days Lab Units 05/14/21 0609 05/13/21 0557 05/10/21 0614 SODIUM mmol/L 137 134* 136 POTASSIUM mmol/L 4.2 4.2 3.9 CHLORIDE mmol/L 103 101 104 CO2 mmol/L 28 25 26 BUN mg/dL 23 21 16 CREATININE mg/dL 0.86 0.78 0.82 CALCIUM mg/dL 9.0 8.8 8.6 Results from last 7 days Lab Units 05/14/21 0609 05/13/21 0557 05/10/21 0614 MAGNESIUM mg/dL 2.0 1.9 1.7 COAGULATION: OTHER TESTS: 0 Lab Value Date/Time TROPONINI 0.10 (H) 04/06/2021 0412 TROPONINI 0.17 (H) 04/03/2021 0436 TROPONINI 0.29 (H) 04/02/2021 1655 TROPONINI 0.28 (H) 04/02/2021 1323 TROPONINI 0.29 (H) 04/02/2021 1107 TROPONINI 0.28 (H) 04/02/2021 0546 TROPONINI 0.38 (H) 04/01/2021 1248 TROPONINI 0.15 (H) 04/01/2021 0857 TROPONINI 0.01 11/27/2012 0522 TROPONINI 0.08 (H) 11/26/2012 1104 TROPONINI 0.04 11/26/2012 0626 TROPONINI 0.04 11/25/2012 2304 IMAGING: Gastrostomy tube, place Result Date: 5/7/2021 Gastrostomy tube, place Procedure Note Surgical Pre-Operative Patient Identification Yes, after the patient was placed on the operating room/procedure table, I confirmed the patient's identity. Impression Overall Impression: Normal EGD up to second part of duodenum. 20 PEG placed without any immediate complications. Recommendation There is no recommended follow-up for this procedure. Okay to use back for medications and water flushes. Start feeding via PEG tomorrow after GI evaluation. Indication Pre-procedure diagnosis: Pharyngeal dysphagia Post-procedure diagnosis: See impression Preprocedure A history and physical has been performed, and patient medication allergies have been reviewed. The patient's tolerance of previous anesthesia has been reviewed. The risks and benefits of the procedure and the sedation options and risks were discussed with the patient. All questions were answered and informed consent obtained. Details of the Procedure The patient underwent monitored anesthesia care, which was administered by an anesthesia professional. The patient's blood pressure, heart rate, level of consciousness, oxygen, respirations, ETCO2 and ECG were monitored throughout the procedure. The scope was introduced through the mouth and advanced to the second part of the duodenum. Retroflexion was performed in the cardia, fundus and incisura. The patient experienced no blood loss. The procedure was not difficult. The patient tolerated the procedure well. There were no apparent complications. See anesthesia record for more information regarding anesthesia administered. Specimens * No specimens in log * Implants No implants documented in log. I attest the accuracy of any implant/graft nursing documentation. Findings The cricopharynx, upper third of the esophagus, middle third of the esophagus, lower third of the esophagus, GE junction, Z-line, cardia, fundus of the stomach, body of the stomach, greater curve of the stomach, lesser curve of the stomach, incisura, antrum, prepyloric region, pylorus, duodenal bulb, 1st part of the duodenum and 2nd part of the duodenum appeared normal. PEG-G tube successfully placed in the body of the stomach using a deformable internal bolster via the pull technique after the site was identified via transillumination, visualized indentation and needle passed through abdominal wall; distance from external bolster to external end of tube: 3 cm; scope reinserted to confirm placement Staff/Assistant(s) Staff Role RN Other CRNA Other Other MD Other Disposition: PACU - hemodynamically stable. Condition: stable Attending Attestation: I performed the entire procedure. CT abdomen pelvis without contrast Result Date: 4/15/2021 PROCEDURE INFORMATION: Exam: CT Abdomen And Pelvis Without Contrast Exam date and time: 4/15/2021 12:00 AM Age: 65 years old Clinical indication: Other: Na; Additional info: Distention, fungemia workup. TECHNIQUE: Imaging protocol: Computed tomography of the abdomen and pelvis without contrast. Radiation optimization: All CT scans at this facility use at least one of these dose optimization techniques: automated exposure control; mA and/or kV adjustment per patient size (includes targeted exams where dose is matched to clinical indication); or iterative reconstruction. COMPARISON: No relevant prior studies available. FINDINGS: Tubes, catheters and devices: Small bowel feeding tube noted. Lungs: Bibasilar patchy nodular airspace disease with ground-glass opacity. Liver: Normal. No mass. Gallbladder and bile ducts: Multiple gallstones. Pancreas: Normal. No ductal dilation. Spleen: Normal. No splenomegaly. Adrenal glands: Normal. No mass. Kidneys and ureters: Bilateral renal vascular calcifications. Stomach and bowel: Visualized bowels demonstrated a generalized constipation. Appendix: Not well seen. Intraperitoneal space: Unremarkable. No free air. No significant fluid collection. Vasculature: Moderate atherosclerotic changes. Lymph nodes: Unremarkable. No enlarged lymph nodes. Urinary bladder: Unremarkable as visualized. Reproductive: Unremarkable as visualized. Bones/joints: Degenerative changes within the lumbar spine. Soft tissues: Unremarkable. IMPRESSION: Bibasilar nodular airspace disease with ground-glass opacity. No other acute inflammatory process or obstructive uropathy within the abdomen and pelvis. THIS DOCUMENT HAS BEEN ELECTRONICALLY SIGNED BY MD X-ray abdomen 1 view Result Date: 5/4/2021 XR ABDOMEN 1 VW PORT IMPRESSION: Weighted enteric tube with the tip in the gastric antrum. Residual oral contrast throughout a nondilated colon. END OF IMPRESSION: INDICATION: ng tube placement ng tube placement. TECHNIQUE: AP supine portable projection of the abdomen was acquired. COMPARISON: AP abdomen on 4/15/2021. FINDINGS: The gas pattern is unremarkable. There is residual oral contrast equally distributed throughout a nondilated colon. There is a new weighted enteric tube with the tip in the gastric antrum. Small right lung base pleural effusion is present. No abnormal mass effect is noted. No significant radiopaque calculus is identified. There are no significant bony findings. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray abdomen 1 view Result Date: 4/15/2021 XR ABDOMEN 1 VW PORT IMPRESSION: Orogastric tube is in the stomach. Nonspecific bowel gas pattern. END OF IMPRESSION: INDICATION: Feeding tube placement. TECHNIQUE: Single view of the abdomen. COMPARISON: Prior examination of April 15, 2020. FINDINGS: Orogastric tube is in the stomach. Nonspecific bowel gas pattern is noted. Osseous skeleton is grossly intact. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT head without contrast Result Date: 4/21/2021 CT HEAD WO CONTRAST IMPRESSION: No acute intracranial pathology. Mucoperiosteal thickening in the ethmoid sinuses as well as some opacification of the bilateral mastoid air cells consistent with chronic sinus disease and mastoiditis. END OF IMPRESSION: INDICATION: DYSPHAGIA DYSPHAGIA. TECHNIQUE: Spiral CT scan through the head from the skull base through the vertex was performed with 5 mm axial reconstructions. Images obtained without contrast. CONTRAST: No contrast was administered. COMPARISON: April 13, 2021 FINDINGS: No acute hemorrhage, mass, or mass effect. No abnormal extra-axial fluid collections are identified. There is preservation the gray-white differentiation. No evidence to suggest large vascular distribution infarct. The ventricles, cisterns, and other CSF containing spaces demonstrate normal size, shape, and configuration. The basal cisterns are patent and symmetric. Stable focal area of gliosis in the right frontal white matter. The calvarium is intact. The visualized portions the aerated paranasal sinuses mastoid air cells demonstrate bilateral ethmoid sinus mucoperiosteal thickening. Additionally there is scattered opacification of some mastoid air cells bilaterally. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Fluoroscopy video swallow with speech therapy Result Date: 4/19/2021 FL VIDEO SWALLOW WITH SPEECH THERAPY MBSS IMPRESSION: Aspiration of thin and nectar thick liquid. Please refer to speech therapy report. END OF IMPRESSION: INDICATION: Dysphagia. Concern for aspiration. Covid 19. SUPERVISION: Procedure was performed by RRA under direct supervision by MD TECHNIQUE: Fluoroscopy assistance was provided to the speech pathology department. Multiple consistencies of barium and food products were administered to the patient. Fluoroscopy of the oral and pharyngeal region was performed. FLUOROSCOPY TIME: 1.1 minutes COMPARISON: Modified barium swallow of 4/12/2021. FINDINGS: Aspiration of thin and nectar thick fluid. Hypopharyngeal residue with all trials provided. Significant dry secretions in the oral cavity and pharynx. Please see speech pathologist's report for further details and recommendations. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Fluoro NG long tube placement Result Date: 4/30/2021 FL NG LONG TUBE PLACEMENT IMPRESSION: Successful fluoroscopically guided Dobbhoff placement. END OF IMPRESSION: INDICATION: Dobbhoff placement. SUPERVISION: Procedure was performed by staff member under personal supervision by Dr.. TECHNIQUE: Fluoroscopic guidance for nasogastric tube placement. FLUOROSCOPY TIME: 2.2 minutes COMPARISON: None available. FINDINGS: Using fluoroscopic guidance, a nasogastric tube was placed from the left nares into the stomach. Upon placement of the nasogastric tube, 10 cc of Omnipaque contrast material was injected to confirm placement. Opacification within the stomach was visualized confirming appropriate NG tube placement. There were no intraprocedural complications and the procedure was well tolerated by the patient. The patient was discharged from the imaging department in satisfactory condition. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view Result Date: 4/26/2021 XR CHEST 1 VW PORT IMPRESSION: NG tube in the fundus of stomach left upper abdomen. END OF IMPRESSION: INDICATION: SOB evaluate NGT placement following advancement.. TECHNIQUE: AP projection of the chest is acquired. COMPARISON: 4/26/2021 FINDINGS: NG tube in the fundus of stomach left upper abdomen. Stable diffuse patchy infiltrates both lungs in the upper, mid to lower zones and left effusion. No pneumothorax. The heart size is normal. Rib cage is unremarkable. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view - portable Result Date: 4/26/2021 XR CHEST 1 VW PORT IMPRESSION: 1. Interval increase in diffuse airspace opacity and effusions from prior. 2. NG tube tip in the region of the GE junction. Consider further advancement. END OF IMPRESSION: INDICATION: Hypoxia, acute shortness of breath. TECHNIQUE: Portable AP view of the chest is acquired. COMPARISON: 4/22/2021. FINDINGS: Diffuse airspace opacity and effusions appear mildly increased from prior. The NG tube tip is in the region of GE junction. Recommend further advancement. No pneumothorax is identified. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view Result Date: 4/22/2021 XR CHEST 1 VW PORT IMPRESSION: Persistent diffuse patchy infiltrates bilaterally, consistent with Covid infection. END OF IMPRESSION: INDICATION: hypoxia. Covid 19. TECHNIQUE: AP upright projection of the chest is acquired. COMPARISON: Radiographs of 4/18/2021. FINDINGS: The cardiomediastinal silhouette is unchanged. Persistent diffuse patchy infiltrates bilaterally, consistent with Covid infection. No evidence of pleural effusion or pneumothorax. No significant change compared to prior radiographs. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view, Portable Result Date: 4/18/2021 XR CHEST 1 VW PORT IMPRESSION: Enteric tube extends into the stomach. Tip collimated from view. Multifocal airspace disease, increased slightly since 4/13/2021. END OF IMPRESSION: INDICATION: Verify placement of NG tube. TECHNIQUE: AP upright portable projection of the chest is acquired. COMPARISON: 4/13/2021 FINDINGS: An enteric tube extends into the stomach; the tip is collimated from view. The lungs are symmetrically aerated. Multifocal airspace opacities are slightly increased since 4/13/2021. No pneumothorax or pleural effusion. Cardiomediastinal silhouette is stable. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Transthoracic echo (TTE) limited Result Date: 4/21/2021 FINALIZED REPORT TWO-DIMENSIONAL ECHOCARDIOGRAPHIC FINDINGS LEFT VENTRICLE: Normal size and function RIGHT VENTRICLE: Normal size and function AORTIC VALVE: Trileaflet sclerotic MITRAL VALVE: Mitral annular calcification TRICUSPID VALVE: Normal PULMONIC VALVE: Not well seen LEFT ATRIUM: Normal size RIGHT ATRIUM: Normal size INTERATRIAL SEPTUM: Intact AORTIC ROOT: Normal size PERICARDIUM: No effusion IVC: Normal size and normal collapse AORTIC ARCH: Not well seen COLOR AND SPECTRAL DOPPLER: PA systolic pressure in the range of 30 mmHg FINAL IMPRESSIONS: This is a technically limited study with poor acoustic windows and poor endocardial border definition. Normal LV size with normal wall thickness. No clear-cut regional wall motion abnormalities. EF 55 to 60% Normal RV size and function Aortic sclerosis Mitral annular calcification No vegetations or a source of fungemia noted Transesophageal echo (TEE) Result Date: 4/30/2021 FINALIZED REPORT TWO-DIMENSIONAL ECHOCARDIOGRAPHIC FINDINGS: INTUBATION: Anesthesia airway management provided by the anesthesiologist. I intubated esophagus myself without difficulty LEFT VENTRICLE: LV cavity size mild LVH normal function EF 55-60 RIGHT VENTRICLE: Normal RV size function AORTIC VALVE: Leaflet no vegetation MITRAL VALVE: Appears normal no vegetation TRICUSPID VALVE: Appears normal no vegetation PULMONIC VALVE: Appears normal no vegetation LEFT ATRIUM: Appears normal RIGHT ATRIUM: Appears normal INTERATRIAL SEPTUM: Intact SVC: Appears normal IVC: Appears normal PERICARDIU no effusion LEFT ATRIAL APPENDAGE: Appears normal PULMONARY VEINS: Not well seen AORTIC ROOT: Appears normal ASCENDING THORACIC AORTA: Appears normal AORTIC ARCH: Appears normal DESCENDING AORTA: Appears normal COLOR AND SPECTRAL DOPPLER: No stenotic regurgitant lesions noted FINAL IMPRESSIONS: No vegetations noted Normal LV cavity size wall thickness function EF 55-60 Normal RV size function No valve abnormalities Ultrasound upper extremity venous right Result Date: 4/24/2021 US UPPER EXTREMITY VENOUS RIGHT IMPRESSION: No DVT identified. Superficial thrombosis identified in the cephalic vein. END OF IMPRESSION: INDICATION: Concern for DVT. TECHNIQUE: Real-time two-dimensional ultrasound of the right upper extremity was performed with grayscale, color and duplex Doppler imaging. Compression and augmentation were performed where possible. Permanently recorded images were obtained and stored. FINDINGS: The internal jugular vein, subclavian vein, axillary vein, brachial veins, basilic vein are normal. They demonstrate normal flow and compressibility. There is a thrombus identified in the right cephalic vein at the mid arm through distal forearm. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT angiogram chest pulmonary embolism with and without contrast Result Date: 4/22/2021 CTA CHEST PULMONARY EMBOLISM W WO CONTRAST IMPRESSION: No evidence of pulmonary embolus or right heart strain. Extensive parenchymal consolidation in both lungs, left greater than right consistent with severe pneumonia such as Covid 19 pneumonia. Moderate left-sided small to moderate right sided pleural effusions are seen with associated compressive atelectasis. Enlarged main pulmonary artery which can be seen in the setting of chronic pulmonary hypertension. Interval development of large mediastinal adenopathy particularly in the right paratracheal region and subcarinal region. These may be reactive in nature in the setting of as diffuse pneumonia. Enterogastric tube with the tip extending to just within the stomach. END OF IMPRESSION: INDICATION: pneumonia. Assess for pulmonary artery embolism. TECHNIQUE: Enhanced helical CT scan of the chest was performed from the lung apices to below the diaphragm. 2mm axial reconstruction with MPR coronal, oblique and sagittal images were created. 3D shaded surface images also created on a separate workstation and permanently stored. CONTRAST: 100mL of IOHEXOL 350 MG IODINE/ML INTRAVENOUS SOLUTION administered INTRAVENOUS. Quality of contrast opacification was adequate. COMPARISON: July 22, 2013 FINDINGS: Lung windows demonstrate extensive consolidation involving the lungs, left greater than right. There is a moderate left-sided effusion and a small to moderate right sided effusion with associated compressive atelectasis. The trachea and bronchi are grossly unremarkable. No endobronchial lesions are seen. Soft tissue windows demonstrate a grossly unremarkable thoracic inlet. The thyroid is unremarkable. Moderate bilateral axillary lymph nodes are seen with extensive bulky adenopathy in the mediastinum to include the right paratracheal region as well as the subcarinal region and to a lesser extent the hila. The largest lymph nodes are seen in the paratracheal chain demonstrating short axis of approximately 15 mm. Smaller lymph nodes are seen in the aortopulmonary window. These may be reactive in nature. The heart demonstrates a normal configuration. No right heart enlargement is seen. No pericardial effusion is seen. The thoracic aorta and great vessels demonstrate normal branching pattern. Normal course and caliber is seen. The pulmonary arteries demonstrate normal course. There is moderate dilation of the main pulmonary artery up to 3.2 cm. This can be seen in the setting of chronic pulmonary arterial hypertension. No filling defects are seen. Enterogastric tube is seen with the distal tip extending to just within the proximal stomach. The visualized portions of the upper abdomen are grossly unremarkable. The surrounding osseous structures demonstrate mild degenerative changes of the thoracic spine. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
43,0
Labordaten
Updated Procedure 04/01/21 1217 Respiratory virus detection panel Collected: 04/01/21 0917 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma p
Aktuelle Erkrankungen
-
Vorgeschichte
Hospital COVID-19 with multiple comorbidities Non-Hospital Acute osteomyelitis of right calcaneus Atherosc
Andere Medikamente
Outpatient Medications acetaminophen (TYLENOL) 325 mg tablet a
Allergien
NKA
Vorherige Impfungen
-

VAERS 1316829

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
85,0
Geschlecht
F
Eingang
14.05.2021
Impfdatum
09.03.2021
Beginn
15.03.2021
Tage bis Beginn
6,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute myocardial infarction Chest pain

Symptomtext

Non-ST elevation (NSTEMI) myocardial infarction chest pain

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1316724

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
69,0
Geschlecht
M
Eingang
14.05.2021
Impfdatum
29.03.2021
Beginn
16.04.2021
Tage bis Beginn
18,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute kidney injury Pneumonia Pulmonary embolism

Symptomtext

Other pulmonary embolism without acute cor pulmonale Pneumonia, unspecified organism Acute kidney failure, unspecified Pulmonary embolism Acute renal failure (ARF)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1311456

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
64,0
Geschlecht
F
Eingang
12.05.2021
Impfdatum
03.03.2021
Beginn
25.03.2021
Tage bis Beginn
22,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute myocardial infarction

Symptomtext

I21.4 - NSTEMI (non-ST elevated myocardial infarction)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1311448

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
83,0
Geschlecht
F
Eingang
12.05.2021
Impfdatum
29.03.2021
Beginn
09.04.2021
Tage bis Beginn
11,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Pulmonary embolism

Symptomtext

I26.99 - Acute pulmonary embolism, unspecified pulmonary embolism type, unspecified whether acute cor pulmonale present

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1311404

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
71,0
Geschlecht
F
Eingang
12.05.2021
Impfdatum
17.02.2021
Beginn
23.03.2021
Tage bis Beginn
34,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Pulmonary embolism

Symptomtext

Other pulmonary embolism without acute cor pulmonale

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1307867

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
64,0
Geschlecht
F
Eingang
11.05.2021
Impfdatum
29.03.2021
Beginn
16.04.2021
Tage bis Beginn
18,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Acute myocardial infarction Myocardial infarction

Symptomtext

I21.4 - Non-ST elevation (NSTEMI) myocardial infarction

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1307373

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
81,0
Geschlecht
F
Eingang
11.05.2021
Impfdatum
27.02.2021
Beginn
04.03.2021
Tage bis Beginn
5,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute myocardial infarction Hyponatraemia Hypoosmolar state Thrombocytopenia

Symptomtext

I21.4 - Non-ST elevation (NSTEMI) myocardial infarction E87.1 - Hypo-osmolality and hyponatremia D69.6 - Thrombocytopenia, unspecified

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1307193

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
78,0
Geschlecht
F
Eingang
11.05.2021
Impfdatum
04.03.2021
Beginn
17.04.2021
Tage bis Beginn
44,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute myocardial infarction Cerebrovascular accident Chest pain Facial paresis

Symptomtext

Non-ST elevation (NSTEMI) myocardial infarction Facial weakness NSTEMI (non-ST elevated myocardial infarction) CHEST PAIN CEREBROVASCULAR ACCIDENT

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1307068

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
85,0
Geschlecht
F
Eingang
11.05.2021
Impfdatum
15.03.2021
Beginn
28.03.2021
Tage bis Beginn
13,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute myocardial infarction

Symptomtext

NSTEMI (non-ST elevated myocardial infarction)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1306565

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
66,0
Geschlecht
M
Eingang
11.05.2021
Impfdatum
06.02.2021
Beginn
08.02.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute kidney injury Cerebral haemorrhage Cerebrovascular accident Facial paresis Lacunar stroke

Symptomtext

I61.9 - ICH (intracerebral hemorrhage) (CMS/HCC) I63.9 - CVA (cerebrovascular accident) (CMS/HCC) I63.81 - Right-sided lacunar stroke (CMS/HCC N17.9 - Acute kidney failure, unspecified R29.810 - Facial weakness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebral haemorrhage
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1304105

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
75,0
Geschlecht
F
Eingang
10.05.2021
Impfdatum
10.03.2021
Beginn
18.04.2021
Tage bis Beginn
39,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Cerebrovascular accident Facial paresis

Symptomtext

CEREBROVASCULAR ACCIDENT R29.810 - Facial weakness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1303239

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
76,0
Geschlecht
F
Eingang
10.05.2021
Impfdatum
27.02.2021
Beginn
17.03.2021
Tage bis Beginn
18,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute myocardial infarction Epistaxis Systemic inflammatory response syndrome

Symptomtext

This 76 year old black female received the Covid shot on 2/27/21 and went to the ED and was admitted on 3/17/21 and again to the ED and admitted on 4/7/21 with the diagnoses listed below. Systemic inflammatory response syndrome (sirs) of non-infectious origin without acute organ dysfunction Non-ST elevation (NSTEMI) myocardial infarction Epistaxis

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1300378

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
76,0
Geschlecht
F
Eingang
08.05.2021
Impfdatum
27.02.2021
Beginn
03.04.2021
Tage bis Beginn
35,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Cerebral infarction Cerebrovascular accident

Symptomtext

This 76 year old female received the Pfizer Covid shot on 2/27 /21 and went to the ED on 4/3/21 and was admitted on 4/3/21 with the following diagnoses listed below. I63.9 - CVA (cerebral vascular accident) I63.9 - Cerebral infarction, unspecified

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1300362

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
71,0
Geschlecht
F
Eingang
08.05.2021
Impfdatum
26.02.2021
Beginn
15.03.2021
Tage bis Beginn
17,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Blood osmolarity decreased Cerebral infarction Cerebrovascular accident Hyponatraemia

Symptomtext

This 71 year old female received the Pfizer Covid shot on 2/26/21 and went to the ED on 3/15/21 and was admitted on 3/15/21 with the following diagnoses listed below. I63.9 - CVA (cerebral vascular accident) I63.9 - Cerebral infarction, unspecified E87.1 - Hypo-osmolality and hyponatremia

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1285762

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
73,0
Geschlecht
F
Eingang
04.05.2021
Impfdatum
13.03.2021
Beginn
30.04.2021
Tage bis Beginn
48,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Pulmonary embolism

Symptomtext

Pulmonary embolism, bilateral

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1281798

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
83,0
Geschlecht
M
Eingang
03.05.2021
Impfdatum
22.03.2021
Beginn
05.04.2021
Tage bis Beginn
14,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Cardiac failure congestive Chronic kidney disease Death Oedema peripheral

Symptomtext

This 83 year old black male received the Covid shot on 03/22/2021 and went to the ED on 4/5/21 and was admitted on 4/8/21 with CHF, bilateral lower extremity edema, chronic kidney disease and died on 5/1/21 . Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1281778

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
73,0
Geschlecht
F
Eingang
03.05.2021
Impfdatum
27.02.2021
Beginn
29.04.2021
Tage bis Beginn
61,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Cardiac arrest Death Respiratory distress

Symptomtext

This 73 year old female received the Covid shot on 2/27/21 and went to the ED on 4/29/21 and was admitted on 4/29/21 with respiratory distress, cardiac arrest and other symptoms and died on 5/1/21 . Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1280775

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
66,0
Geschlecht
M
Eingang
02.05.2021
Impfdatum
26.02.2021
Beginn
11.03.2021
Tage bis Beginn
13,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute kidney injury Bradycardia Diarrhoea Hyperkalaemia Hypotension Hypothermia Pancytopenia Pneumonia Sepsis Septic shock Transaminases increased

Symptomtext

Pt was hospitalized with severe sepsis and septic shock with hypotension, hypothermia, bradycardia, AKI, pancytopenia requiring pressors on 3/11/21. This was 14d after the initial vaccine. He received his second vaccine on 4/2 and was hospitalized with severe sepsis again on 4/27/21 with similar symptoms. First episode c/o diarrhea but no pathogen identified. Second episode with bilateral multifocal pneumonia but no pathogen identified.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Septic shock
Hospital-Tage
19,0
Labordaten
Severe pancytopenia in both hospital stays, recovered in between AKI in both stays with hyperkalemia but did not require RRT and recovered to baseline Transaminitis in both hospital stays, still currently hospitalized and not recovered
Aktuelle Erkrankungen
-
Vorgeschichte
Diabetes, neuropathy, CKD
Andere Medikamente
Tylenol Multivitamin
Allergien
None
Vorherige Impfungen
-

VAERS 1280682

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
94,0
Geschlecht
F
Eingang
02.05.2021
Impfdatum
25.02.2021
Beginn
25.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Anticoagulant therapy Anxiety Atrial fibrillation Blood culture COVID-19 pneumonia Coronavirus infection Death Decreased appetite Dyspnoea Food refusal General physical health deterioration Hyporesponsive to stimuli Laboratory test Oxygen saturation decreased Somnolence

Symptomtext

Patient admitted on 03/25/2021 through the emergency department for complaint of shortness of breath she was a resident of a Nursing Facility. Her oxygen saturations were into 80%. Patient was poor historian her daughter at the bedside provided most history. Patient with recent admissions for coronavirus on 03/03/2021 and then again on 03/05/2021 for post coronavirus pneumonia. Throughout hospitalization patient with poor appetite, on 03/28/2021 noted to be somnolent, additional blood cultures and labs checked. Patient continue to decline, refused medications. Minimal responsiveness on 04/01/2021. Had episode of PAF on 4/1/21, renal dosed Eliquis per Cardiology. Service discussed with family multiple times about code status, he continued to be on decided home willing to change code status. Patient remained on high-flow oxygen and not eating. Patient very anxious increase work of breathing. Patient died on 04/03/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
9,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1275922

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WA
Alter
73,0
Geschlecht
M
Eingang
01.05.2021
Impfdatum
24.02.2021
Beginn
27.02.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 COVID-19 pneumonia Chills Cough Death Dyspnoea Pyrexia SARS-CoV-2 test positive

Symptomtext

On 3/8/21, patient presented to the ED with cough, fever > 103, chills, SOB, all starting 9 days ago (2/27/21) about 3 days after 2nd dose of Pfizer vaccine. Patient was admitted to the hospital with main diagnosis COVID-19 pneumonia and patient expired on 4/8/21.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
COVID-19 positive 3/8/21
Aktuelle Erkrankungen
-
Vorgeschichte
CLL on expectant management and CAD
Andere Medikamente
Aspirin, atorvastatin, azithromycin
Allergien
None
Vorherige Impfungen
-

VAERS 1271190

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TN
Alter
77,0
Geschlecht
F
Eingang
29.04.2021
Impfdatum
07.03.2021
Beginn
04.04.2021
Tage bis Beginn
28,0
Dosis
2
Route/Site
IM / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Contracted COVID-19 on 4/4/2021, Pt. demise 4/15/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
9,0
Labordaten
SAR-CoV-2 on 4/6/2021 - positive result
Aktuelle Erkrankungen
-
Vorgeschichte
DM2, DKD Stage III, CAD, HTN, OSA, PAF, dementia, Liver cirrhosis secondary NASH, HLD
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 1269564

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
ND
Alter
63,0
Geschlecht
F
Eingang
29.04.2021
Impfdatum
24.02.2021
Beginn
01.02.2021
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Blood cholesterol Blood glucose Brain stem infarction Cardiac monitoring Cardiovascular function test Cerebrovascular accident Computerised tomogram Dysarthria Dysgraphia Gait inability Glycosylated haemoglobin increased Magnetic resonance imaging head Muscular weakness Pain in extremity Peripheral coldness Ultrasound Doppler Ultrasound chest

Symptomtext

Stroke; MRI showed Pontine Stroke; left arm was weak; her writing looked like a baby's scribble/she cannot write or type; arm was sore; she sounded different; they said her speech sounded slurred; was prediabetic before her hospitalization with her number (A1c) usually being 6.5-6.8. She added that when she was in the hospital it was 7.4; was not able to walk at first; her arm was cold; This is a spontaneous report from a contactable consumer (patient) reported that a 63-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6198), via an unspecified route of administration on 24Feb2021 08:00 (at the age of 63-years-old) as a single dose for covid-19 immunisation. The vaccine was administered at the hospital. The patient medical history included high blood pressure that was diagnosed 2-3 years ago, diabetes; she was prediabetic, heart;cholesterol has been high for about 30 years; since she was in her 30s; all from an unknown date and ongoing. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247) on 02Feb2021 (at the age of 63-years-old) for covid-19 immunization. The patient had no prior vaccination in four weeks. Concomitant medications included rosuvastatin taken for blood cholesterol and takes 20mg once a day prior to stroke and in the hospital they increased it to 40mg once a day and ongoing; ramipril taken for blood pressure and she was prescribed with this medication for a while prior to her stroke. It was discontinued in the hospital. Stated that she did not take it everyday because she was allergic to it; and sitagliptin (JANUVIA [SITAGLIPTIN]) taken for diabetes from an unspecified start date and ongoing and stated that she has been taking for quite a while. On 24Feb2021 she had her second shot. She said that everything was fine that morning; that afternoon her arm was sore. Stated she thought nothing of it. That evening she entertained guest. They were saying she sounded different; they said her speech sounded slurred. She had gotten her vaccine at around 08:00. Again, she didn't think anything about her speech. On 25Feb2021, she got up and did some laundry going up and down the steps. Stated that it was difficult because her arm was still sore. She cleaned the house. At around 15:30 she was doing bills and noticed that her writing looked like a baby's scribble. On 26Feb2021, she noticed that her left arm was weak and was told by her doctor to go to the Emergency Room where they told her she had a stroke. She added that it seemed like her arm was cold for a number of weeks. Stated she was the type to wear t-shirts in the winter because she was always hot. During those weeks she was wearing heavy clothes and was under blankets. She was just now starting to feel more like herself and not so cold all the time. The patient was unable to recall time frame when this symptom began. The events did require a visit to emergency room and physician office. The patient was hospitalized for 4 days due to the events from 26Feb2021 to 01Mar2021. During hospitalization, the patient saw a cardiologist, neurologist, her primary care provider, and the hospitalists who all said it was very suspicious that her stroke happened right after her vaccine. Before she got her second vaccine, she was doing embroidery and everything she normally does; nothing was wrong. They did a CAT Scan that showed nothing. Then the MRI of the brain showed a Pontine Stroke on 26Feb2021. Cardiologist put a heart monitor on her and could not find anything. They were looking for A-Fib or something like that when she was on the heart monitor in the hospital; but it never showed anything irregular. She had a loop recorder implanted to monitor her heart and they haven't found anything wrong on it. She had heart tests, carotid artery tests, ultrasound of her heart and nothing was found on those tests. They pretty much told her in the hospital that they couldn't find a reason for her stroke. She kept asking about the vaccine. They did not rule it out as a cause, but they also did not say it was the cause. All the doctors said they could not pin her stroke on the vaccine. They stated it was suspicious and that they had seen 2-3 other patients with a similar situation. One of the doctor's told her he would not rule it out. They did an ultrasound of her carotids and heart and did not find anything on those tests that would have caused her stroke. She was having lasting effects related to her stroke. Her arm was still sore at times, stated it was a different kind of sore and could be related to all the therapy she does now. The lingering effects after stroke was reported as she was not able to walk at first. She's been doing therapy focused on her left side. Stated that her left side was the dominant side and she cannot write or type. She couldn't do the report online due to the difficulty with typing. She wanted to make sure this was reported. The patient has been doing therapy for 7 weeks, twice a day; and stated she likely still has months more of therapy to try and get her left side back to normal. She said that simple daily duties are difficult. The patient also stated that she was prediabetic before her hospitalization with her number (A1c) usually being 6.5-6.8. She added that when she was in the hospital it was 7.4. She doesn't know what made it go up. Then states she doesn't know if the vaccine made it go up or not. She has a follow up with the neurologist soon. The patient also reported medications she has been taking since her stroke and hospitalization; but not prior to her vaccine which included Amlodipine-Benazepril: 5-20mg once a day and Aspirin: 325mg once a day. The patient stated that stroke and heart problems do not run in her family. The outcome of the events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
4,0
Labordaten
Test Name: cholesterol; Result Unstructured Data: Test Result:has been high; Comments: for about 30 years; since she was in her 30s; Test Name: A1c; Result Unstructured Data: Test Result:6.5-6.8; Test Date: 202102; Test Name: A1c; Result Unstructured Data: Test Result:7.4; Test Date: 202102; Test Name: heart monitor; Result Unstructured Data: Test Result:could not find anything; Comments: looking for A-Fib or something like that when she was on the heart monitor in the hospital; but it never showed anything irregular; Test Date: 202102; Test Name: heart tests; Result Unstructured Data: Test Result:nothing was found; Test Date: 202102; Test Name: CAT Scan; Result Unstructured Data: Test Result:showed nothing; Test Date: 20210226; Test Name: MRI Brain; Result Unstructured Data: Test Result:Showed Pontine Stroke; Test Date: 202102; Test Name: ultrasound of her heart; Result Unstructured Data: Test Result:nothing was found; Test Date: 202102; Test Name: carotid artery tests; Result Unstructured Data: Test Result:nothing was found
Aktuelle Erkrankungen
Blood pressure high (diagnosed 2-3 years ago); Cholesterol (heart; cholesterol has been high for about 30 years; since she was in her 30s); Diabetes (she was prediabetic); Prediabetes
Vorgeschichte
-
Andere Medikamente
ROSUVASTATIN; RAMIPRIL; JANUVIA [SITAGLIPTIN]
Allergien
-
Vorherige Impfungen
-

VAERS 1268064

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
76,0
Geschlecht
F
Eingang
28.04.2021
Impfdatum
19.03.2021
Beginn
25.04.2021
Tage bis Beginn
37,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Death

Symptomtext

This 76 year old female received the 2nd Covid shot on 3/19/21 and died on 4/25/21. Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1266615

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
81,0
Geschlecht
M
Eingang
28.04.2021
Impfdatum
18.03.2021
Beginn
24.04.2021
Tage bis Beginn
37,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Death

Symptomtext

Death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1261821

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WV
Alter
70,0
Geschlecht
U
Eingang
27.04.2021
Impfdatum
26.02.2021
Beginn
10.03.2021
Tage bis Beginn
12,0
Dosis
2
Route/Site
- / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Cardiac arrest Dizziness Endoscopy Gastrointestinal haemorrhage Haemorrhage Nausea Small intestinal haemorrhage

Symptomtext

unknown bleeding; nausea; lightheaded; GI bleed; cardiac arrest; bleed in small intestine; This is a spontaneous report from a contactable consumer (patient's daughter). A 70-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Deltoid Right on 26Feb2021 (Batch/Lot Number: EN6198) as SINGLE DOSE for covid-19 immunisation. Vaccine Administered at Military Facility was no. Patient received the first dose of vaccine on 05Feb2021 at age of 70 years old for covid-19 immunization and experienced rash on face, loss of blood found to be from small intestine, hemoglobin low, cardiac arrest, going into shock. The patient medical history and concomitant medications were not reported. The patient experienced unknown bleeding (death, hospitalization, medically significant) on 10Mar2021, nausea (hospitalization) in 2021 with outcome of unknown, lightheaded (hospitalization) in 2021 with outcome of unknown, gastrointestinal (GI) bleed (medically significant) in 2021 with outcome of unknown, cardiac arrest (medically significant) in 2021 with outcome of unknown, bleed in small intestine (medically significant) in 2021 with outcome of unknown. Patient went to the hospital on 10Mar2021 with nausea and lightheaded. Endoscopy found GI bleed in 2021. Received blood went into cardiac arrest. Sent to another hospital found bleed in small intestine. Patient experienced unknown bleeding on 10Mar2021, which required visit to Emergency room/ intensive care unit on 18Mar2021 and received treatment, it resulted in death. The patient died on 18Mar2021. An autopsy was not performed.; Reported Cause(s) of Death: unknown bleeding

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
-
Labordaten
Test Date: 2021; Test Name: Endoscopy; Result Unstructured Data: Test Result:GI bleed
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1259253

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
76,0
Geschlecht
F
Eingang
26.04.2021
Impfdatum
27.02.2021
Beginn
13.04.2021
Tage bis Beginn
45,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute respiratory failure Death Dehydration Dyspnoea Heart rate increased Laboratory test abnormal Troponin increased Vomiting

Symptomtext

This 76 year old female received the Covid shot on 2/27/2021 and went to the ED on 4/13/2021 and was admitted on 4/13/2021 with hortness of breath, abnormal lab, and returned to ED on 4/16/2021 and admitted on 4/17/2021 with vomiting, elevated troponin, dehydration and returned on 4/23/2021 and admitted on 4/24/2021 with rapid heart rate and acute respiratory failure and died on 4/24/2021. Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1258867

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
72,0
Geschlecht
F
Eingang
26.04.2021
Impfdatum
15.03.2021
Beginn
03.04.2021
Tage bis Beginn
19,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Abdominal pain Acute myocardial infarction Chest pain Death Nausea

Symptomtext

This 72 year old female received the Covid shot on 03/15/2021 and went to the ED on 4/3/2021 and was admitted on 4/3/2021 with abdominal pain, nausea, chest pain, NSTEMI and died on 04/24/2021 . Please refer to the other details submitted within this report and contact the person who submitted this report via email for additional follow up details and investigation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1167965

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
IN
Alter
75,0
Geschlecht
F
Eingang
26.04.2021
Impfdatum
04.03.2021
Beginn
05.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Agonal respiration Asthenia Autoimmune thyroiditis Autopsy Death Base excess negative Blood bicarbonate decreased Blood gases Blood glucose increased Blood pH decreased Blood potassium normal Blood sodium normal Body temperature decreased Calcium ionised decreased Carbon dioxide decreased Cardiac arrest Cardio-respiratory arrest Cardiopulmonary bypass

Symptomtext

Information received from patient's daughter, As well and EMR Chart and Autopsy Report. Patient's daughter reports that in the morning on March 4 patient received her second dose of Pfizer COVID-19 vaccine. She felt quite well through the day on Thursday but through the night Thursday night into Friday started developing postvaccine symptoms of low-grade fever, nausea, vomiting, diarrhea, and lightheadedness. The symptoms persisted into Saturday. The patient's daughter reports that the patient, herself, and patient?s son had discussions through the course of Friday and Saturday indicating that these were likely expected side effects of the second dose of vaccine and counseled her regarding supportive care management. On Sunday, March 7 patient contacted me regarding persistent issues with the above symptoms. Indicated that her blood pressure was running low. I had her hold a dose of her blood pressure medication. Subsequently on Monday morning she indicated to her son that her blood pressure was climbing. She contacted 911 as she felt she was not doing well. EMTs arrived at her home and initiated transport to the hospital. During the transport to the hospital, she went into cardiac arrest. EMS initiated CPR protocols. Upon arrival to emergency department at 0942 she was noted to be in PEA. She was given several doses of epinephrine and bicarbonate. Full Code ensued for nearly one hour. Ultimately, after several cycles of CPR, epinephrine, atropine, efforts were terminated, and she was pronounced dead at 1040 on March 8, 2021. Coroner was contacted and autopsy requested. Autopsy Report indicated the following anatomic findings: Bilateral Pulmonary Emboli, Left Ventricular Hypertrophy, Gastric Polyposis, Patchy Bronchopneumonia (mild), and Chronic Lymphocytic Thyroiditis (moderate to severe). Cause of Death?Pulmonary Embolism. Manner of Death?Natural.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Group Detail Date Value w/Units Flags Normal Range Normal Reference Text Comment Ind Blood Gases Sample BG 3/8/2021 10:39:24 Ven NA Y Blood Gases Allen'S Test BG 3/8/2021 10:39:24 NA NA Y Blood Gases Site BG 3/8/2021 10:39:24 R Radial NA Y Blood Gases Sodium BG 3/8/2021 10:39:24 141 mmol/L NA 136.0-145.0 Y Blood Gases Potassium BG 3/8/2021 10:39:24 4.6 mmol/L NA 3.50-5.00 Y Blood Gases Ionized Ca BG 3/8/2021 10:39:24 0.92 mmol/L LOW 1.150-1.350 Y Blood Gases Glucose BG 3/8/2021 10:39:24 284 mg/dL HI 70.0-105.0 Y Blood Gases pH BG 3/8/2021 10:39:24 7.074 CRIT 7.350-7.450 Y Blood Gases pH (Temp Corrected) BG 3/8/2021 10:39:24 7.086 CRIT 7.350-7.450 Y Blood Gases pCO2 (Temp Corrected) BG 3/8/2021 10:39:24 44.8 mmHg NA 35.00-45.00 Y Blood Gases pO2 (Temp Corrected) BG 3/8/2021 10:39:24 33 mmHg CRIT 75.0-100.0 Y Blood Gases pCO2 BG 3/8/2021 10:39:24 46.8 mmHg HI 35.00-45.00 Y Blood Gases CO2 Total BG 3/8/2021 10:39:24 15 mmol/L LOW 23.0-27.0 Y Blood Gases pO2 BG 3/8/2021 10:39:24 35 mmHg CRIT 75.0-100.0 Y Blood Gases SBE BG 3/8/2021 10:39:24 -16 mmol/L LOW -2-2 Y Blood Gases HCO3 BG 3/8/2021 10:39:24 13.7 mmol/L LOW 20.0-26.0 Y Blood Gases O2 SAT BG 3/8/2021 10:39:24 46 % LOW 95-98 Y Blood Gases Hgb BG 3/8/2021 10:39:24 8.8 GM/dL LOW 12.00-18.00 Y Blood Gases HCT % BG 3/8/2021 10:39:24 26 LOW 34.0-51.0 Y Blood Gases FIO2 3/8/2021 10:39:24 100 NA Y Blood Gases Patient Temperature 3/8/2021 10:39:24 36.0 C NA Y Blood Gases CPB BG 3/8/2021 10:39:24 No NA Y Blood Gases Oxygen Delivery BG 3/8/2021 10:39:24 Code/BVM NA Y Blood Gases Critical Values BG 3/8/2021 10:39:24 pH NA Y Blood Gases Time Called BG 3/8/2021 10:39:24 1038 NA Y
Aktuelle Erkrankungen
No other known acute Illnesses.
Vorgeschichte
CAD, Diverticulitis, Chronic Diarrhea, Chronic GERD, Hypercholesterolemia, Hypertension, Irritable Bowel Syndrome, Lumbar Pain, Persistent Vertigo, Morbid Obesity (BMI 37), Mitral Valve Regurgitation
Andere Medikamente
Amlodipine 5 mg PO QD, Carvedilol 25 mg PO BID, Questran Light1/2 scoop AM & 1/4 scoop PM, Lansoprazole 30 mg PO QAM , Losartan 100 mg PO QAM , Meclizine 25 mg PO TID PRN, ASA 81 mg PO QAM.
Allergien
Cortisone, Decadron, Flagyl, Hydrochlorothiazide, Sulfa, Vicodin
Vorherige Impfungen
-

VAERS 1167965

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
IN
Alter
75,0
Geschlecht
F
Eingang
26.04.2021
Impfdatum
04.03.2021
Beginn
05.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Agonal respiration Asthenia Autoimmune thyroiditis Autopsy Death Base excess negative Blood bicarbonate decreased Blood gases Blood glucose increased Blood pH decreased Blood potassium normal Blood sodium normal Body temperature decreased Calcium ionised decreased Carbon dioxide decreased Cardiac arrest Cardio-respiratory arrest Cardiopulmonary bypass

Symptomtext

Information received from patient's daughter, As well and EMR Chart and Autopsy Report. Patient's daughter reports that in the morning on March 4 patient received her second dose of Pfizer COVID-19 vaccine. She felt quite well through the day on Thursday but through the night Thursday night into Friday started developing postvaccine symptoms of low-grade fever, nausea, vomiting, diarrhea, and lightheadedness. The symptoms persisted into Saturday. The patient's daughter reports that the patient, herself, and patient?s son had discussions through the course of Friday and Saturday indicating that these were likely expected side effects of the second dose of vaccine and counseled her regarding supportive care management. On Sunday, March 7 patient contacted me regarding persistent issues with the above symptoms. Indicated that her blood pressure was running low. I had her hold a dose of her blood pressure medication. Subsequently on Monday morning she indicated to her son that her blood pressure was climbing. She contacted 911 as she felt she was not doing well. EMTs arrived at her home and initiated transport to the hospital. During the transport to the hospital, she went into cardiac arrest. EMS initiated CPR protocols. Upon arrival to emergency department at 0942 she was noted to be in PEA. She was given several doses of epinephrine and bicarbonate. Full Code ensued for nearly one hour. Ultimately, after several cycles of CPR, epinephrine, atropine, efforts were terminated, and she was pronounced dead at 1040 on March 8, 2021. Coroner was contacted and autopsy requested. Autopsy Report indicated the following anatomic findings: Bilateral Pulmonary Emboli, Left Ventricular Hypertrophy, Gastric Polyposis, Patchy Bronchopneumonia (mild), and Chronic Lymphocytic Thyroiditis (moderate to severe). Cause of Death?Pulmonary Embolism. Manner of Death?Natural.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
Group Detail Date Value w/Units Flags Normal Range Normal Reference Text Comment Ind Blood Gases Sample BG 3/8/2021 10:39:24 Ven NA Y Blood Gases Allen'S Test BG 3/8/2021 10:39:24 NA NA Y Blood Gases Site BG 3/8/2021 10:39:24 R Radial NA Y Blood Gases Sodium BG 3/8/2021 10:39:24 141 mmol/L NA 136.0-145.0 Y Blood Gases Potassium BG 3/8/2021 10:39:24 4.6 mmol/L NA 3.50-5.00 Y Blood Gases Ionized Ca BG 3/8/2021 10:39:24 0.92 mmol/L LOW 1.150-1.350 Y Blood Gases Glucose BG 3/8/2021 10:39:24 284 mg/dL HI 70.0-105.0 Y Blood Gases pH BG 3/8/2021 10:39:24 7.074 CRIT 7.350-7.450 Y Blood Gases pH (Temp Corrected) BG 3/8/2021 10:39:24 7.086 CRIT 7.350-7.450 Y Blood Gases pCO2 (Temp Corrected) BG 3/8/2021 10:39:24 44.8 mmHg NA 35.00-45.00 Y Blood Gases pO2 (Temp Corrected) BG 3/8/2021 10:39:24 33 mmHg CRIT 75.0-100.0 Y Blood Gases pCO2 BG 3/8/2021 10:39:24 46.8 mmHg HI 35.00-45.00 Y Blood Gases CO2 Total BG 3/8/2021 10:39:24 15 mmol/L LOW 23.0-27.0 Y Blood Gases pO2 BG 3/8/2021 10:39:24 35 mmHg CRIT 75.0-100.0 Y Blood Gases SBE BG 3/8/2021 10:39:24 -16 mmol/L LOW -2-2 Y Blood Gases HCO3 BG 3/8/2021 10:39:24 13.7 mmol/L LOW 20.0-26.0 Y Blood Gases O2 SAT BG 3/8/2021 10:39:24 46 % LOW 95-98 Y Blood Gases Hgb BG 3/8/2021 10:39:24 8.8 GM/dL LOW 12.00-18.00 Y Blood Gases HCT % BG 3/8/2021 10:39:24 26 LOW 34.0-51.0 Y Blood Gases FIO2 3/8/2021 10:39:24 100 NA Y Blood Gases Patient Temperature 3/8/2021 10:39:24 36.0 C NA Y Blood Gases CPB BG 3/8/2021 10:39:24 No NA Y Blood Gases Oxygen Delivery BG 3/8/2021 10:39:24 Code/BVM NA Y Blood Gases Critical Values BG 3/8/2021 10:39:24 pH NA Y Blood Gases Time Called BG 3/8/2021 10:39:24 1038 NA Y
Aktuelle Erkrankungen
No other known acute Illnesses.
Vorgeschichte
CAD, Diverticulitis, Chronic Diarrhea, Chronic GERD, Hypercholesterolemia, Hypertension, Irritable Bowel Syndrome, Lumbar Pain, Persistent Vertigo, Morbid Obesity (BMI 37), Mitral Valve Regurgitation
Andere Medikamente
Amlodipine 5 mg PO QD, Carvedilol 25 mg PO BID, Questran Light1/2 scoop AM & 1/4 scoop PM, Lansoprazole 30 mg PO QAM , Losartan 100 mg PO QAM , Meclizine 25 mg PO TID PRN, ASA 81 mg PO QAM.
Allergien
Cortisone, Decadron, Flagyl, Hydrochlorothiazide, Sulfa, Vicodin
Vorherige Impfungen
-

VAERS 1255148

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
FL
Alter
61,0
Geschlecht
F
Eingang
25.04.2021
Impfdatum
19.03.2021
Beginn
01.04.2021
Tage bis Beginn
13,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Cerebral palsy Cerebrovascular accident Hypoaesthesia Muscle spasms Muscular weakness Pain in extremity Radial nerve palsy

Symptomtext

she could have partially had a stroke; She woke up and her left hand and arm were numb; left arm hurts a couple of days ago; Her hand is now cramped up, and she cannot bend it, almost like someone who has cerebral palsy.; she could not use her left hand; Her hand is now cramped up, and she can not bend it, almost like someone who has cerebral palsy./all her fingers are cramped and she cant open them and her hand is in a brace; radial nerve palsy; This is a spontaneous report from a contactable consumer or other non hcp. A 61-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot Number: EN6198) via an unspecified route of administration, administration in left arm on 19Mar2021 as SINGLE DOSE for covid-19 immunization. Medical history was not reported. There were no concomitant medications. On 01Apr2021, she woke up and her left hand and arm were numb. She went to the hospital, and they told her she could have partially and had a stroke. Three days after receiving the first dose of the Covid vaccine, she could not use her left hand. Her hand was now cramped up, and she could not bend it, almost like someone who had cerebral palsy. She stated that after the first dose her left hand went numb, and she went to the hospital and was diagnosed with radial nerve palsy. She stated that all her fingers are cramped, and she can't open them, and her hand was in a brace. She stated that she would have to do physical therapy. It was her left hand, the same arm that she got the first dose of the Covid vaccine in. She could not move her left hand. She was really annoyed about it, and she was scared. The patient stated that she had a grandson and a daughter. This vaccine was the best possible way to prevent Covid. She had always got vaccines. Upon follow-up received on 09Apr2021, she was calling about the Pfizer Covid vaccine. She does not have a ride to get her second dose of the Covid vaccine on Saturday morning. She does not know the name of the facility where she was supposed to go. She was asking for help with an (cab service). She thought she was calling her county. She would call her county and ask for help with a ride. She had a reaction after her first dose of the Covid vaccine. She received the first dose on 19Mar2021. She does not know if it was because of the Covid vaccine. She was asking if she should get the second dose of the Covid vaccine in the same arm as last time. She wanted to get the second dose of the Covid vaccine in the same arm as last time, so that she does not mess up the other side of her body. She was asking what was going on with her arm. She was asking if thaws had anything to do with the Covid vaccine. Upon follow-up received on 09Apr2021, she scheduled second dose due on 10Apr. Her left arm hurts a couple of days ago, it ended her going to the hospital. She called to ask if it had something to do with the Covid vaccine. The event hypoaesthesia, cerebral palsy, muscular weakness, muscle spasms outcome was reported as not recovered. The event cerebrovascular accident, pain in extremity, radial nerve palsy outcome was reported as Unknown. The action taken in response to the events for bnt162b2 was not applicable. Therapeutic measures were taken as a result of her hand was now cramped up, and she cannot bend it, almost like someone who had cerebral palsy. (cerebral palsy). Follow-up (09Apr2021): This follow-up spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that: New significant information.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1211330

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
OK
Alter
44,0
Geschlecht
M
Eingang
24.04.2021
Impfdatum
09.03.2021
Beginn
27.03.2021
Tage bis Beginn
18,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Anticoagulant therapy Brain oedema Cerebral haematoma Cerebral haemorrhage Fall Blood test Cerebrovascular accident Disturbance in attention Magnetic resonance imaging Movement disorder Head injury Intensive care Magnetic resonance imaging abnormal Scan with contrast abnormal Seizure Speech disorder Superior sagittal sinus thrombosis Thrombosis

Symptomtext

Blood clot in the brain, stroke, and seizure on 27th of March. Heparin drip, Keppra as a seizure medication, blood thinner medication. No movement right arm and hand, speech difficulties, impairment of concentration.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebral haemorrhage
Hospital-Tage
-
Labordaten
MRI on 27th of March, blood work 27th of March Superior sagittal sinus thrombosis
Aktuelle Erkrankungen
None.
Vorgeschichte
None.
Andere Medikamente
Magnesium 400mg.
Allergien
Penicillin.
Vorherige Impfungen
-

VAERS 1211330

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
OK
Alter
44,0
Geschlecht
M
Eingang
24.04.2021
Impfdatum
09.03.2021
Beginn
27.03.2021
Tage bis Beginn
18,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Anticoagulant therapy Brain oedema Cerebral haematoma Cerebral haemorrhage Fall Blood test Cerebrovascular accident Disturbance in attention Magnetic resonance imaging Movement disorder Head injury Intensive care Magnetic resonance imaging abnormal Scan with contrast abnormal Seizure Speech disorder Superior sagittal sinus thrombosis Thrombosis

Symptomtext

Blood clot in the brain, stroke, and seizure on 27th of March. Heparin drip, Keppra as a seizure medication, blood thinner medication. No movement right arm and hand, speech difficulties, impairment of concentration.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebral haemorrhage
Hospital-Tage
-
Labordaten
MRI on 27th of March, blood work 27th of March Superior sagittal sinus thrombosis
Aktuelle Erkrankungen
None.
Vorgeschichte
None.
Andere Medikamente
Magnesium 400mg.
Allergien
Penicillin.
Vorherige Impfungen
-

VAERS 1229005

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
70,0
Geschlecht
F
Eingang
19.04.2021
Impfdatum
27.02.2021
Beginn
01.04.2021
Tage bis Beginn
33,0
Dosis
2
Route/Site
SYR / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Death

Symptomtext

Death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1225437

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
NY
Alter
48,0
Geschlecht
M
Eingang
18.04.2021
Impfdatum
08.04.2021
Beginn
11.04.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Angiogram Anticoagulant therapy Chest pain Computerised tomogram abnormal Computerised tomogram thorax Deep vein thrombosis Dyspnoea Fatigue Pulmonary embolism Thrombectomy Ultrasound Doppler Ultrasound scan abnormal

Symptomtext

4/11/21 generalized fatigue 4/14/21 shortness of breath and chest pain 4/15/21 right lower extremity Deep vein thrombosis and bilateral Pulmonary emboli 4/16/21 mechanical thrombectomy of pulmonary emboli 4/15/21 - 4/18/21 treatment with heparin infusion which was transitioned to eliquis

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
3,0
Labordaten
CTA Chest 4/15/21 - Bilateral Pulmonary Emboli US Duplex LE bilateral 4/15/21 - RLE DVT Coronary/Pulmonary Artery Angiogram 4/16/21 - mechanical thrombectomy of pulmonary emboli
Aktuelle Erkrankungen
none
Vorgeschichte
Newly diagnosed Diabetes Mellitus Type II
Andere Medikamente
Aspirin 81mg daily
Allergien
None
Vorherige Impfungen
-

VAERS 1224585

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
FL
Alter
89,0
Geschlecht
M
Eingang
18.04.2021
Impfdatum
04.03.2021
Beginn
08.03.2021
Tage bis Beginn
4,0
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Body temperature increased Cerebrovascular accident Confusional state Decreased appetite Dysstasia Fatigue Gait disturbance General physical health deterioration Inappropriate schedule of product administration Malaise Somnolence Speech disorder

Symptomtext

States that his symptoms are like he had a stroke; his health declined after the shot; not eating; he is not able to walk by himself; Can't stand up on his own; Mind is not working correctly/The patient was not himself/his mind goes in and out; Speech is Difficult/he was not responding to her and his speech was bad; not feeling very well/not feeling good; Tired and Sleepy; Tired and Sleepy; Noticed patient was warm but didn't take temperature; The patient didn't receive the second shot because he has been in the hospital.; This is a spontaneous report from a contactable consumer (patient's wife). An 89-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 04Mar2021 14:15 (Lot Number: EN6198) at the age of 89 years, as single dose for covid-19 immunisation. Medical history included pituitary gland tumour from 2018 and ongoing (it is not growing according to tests), ongoing asthma which he had for years, and ongoing low blood pressure. His blood pressure goes up and down. He has had it for a long time but started this medication 2 years ago because it was too low. Clarified that it was not taken within 2 weeks of receiving the vaccine because his blood pressure had been too high. There were no concomitant medications. The patient previously took fludrocortisone 0.1 mg once a day. The consumer (patient's wife) stated that she called on behalf of her husband. The patient was still in the hospital. The patient received the vaccine on 04Mar2021 and by 11Mar2021, the patient was in the hospital. They have not been able to find out what was wrong with him. The patient's symptoms were like he had a stroke. The patient was 89 years old, so she took him to get the shot and his health declined after the shot and he is still under the care of the (Hospital name) in (City) (State). The reporter clarified that his symptoms were that he was feeling tired and sleepy on 08Mar2021. The patient said he was not feeling good on 08Mar2021. On 11Mar2021, he was not responding to her and his speech was bad, and now he is not able to walk by himself and can't stand up on his own. This started after he received the shot. The patient didn't receive the second shot because he has been in the hospital. He was doing fine before and now he has these issues. The patient's wife (reporter) noticed the patient was a little warm but didn't take his temperature on 08Mar2021. The reporter stated that last Thursday (11Mar2021) they called the doctor and the doctor suggested taking him to the ER at the hospital. On 11Mar2021, the patient was not himself and not eating and she doesn't know what is going on with him, but he is under care at the hospital. Reporter stated the patient is doing therapy in the hospital and they are helping him to walk but he is having difficulty. She stated they keep asking if she knows what is going on, but she has no results or medical records. Reporter stated the patient's mind is not working correctly and speech was difficult for him. She clarified that he wasn't making sense sometimes and she was not able to understand him. States the patient speaks two languages but he started speaking a third language to her. She stated that his mind goes in and out. Treatment: rest and at the hospital they are doing therapy for his legs. States she will get on update on his progress on Friday. States she can't see him because of Covid restrictions. The patient did not receive any vaccines 4 weeks prior to COVID vaccine. Outcome of the events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Asthma (States he has had for years.); Low blood pressure; Pituitary tumour (it is not growing according to tests)
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1224177

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
GA
Alter
29,0
Geschlecht
F
Eingang
18.04.2021
Impfdatum
24.02.2021
Beginn
12.03.2021
Tage bis Beginn
16,0
Dosis
2
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Cerebrovascular disorder Death Life support Mobility decreased Thrombosis

Symptomtext

Blood clot blocking blood flow to brain - 1st episode: ( 3/12/21) stabilized, minor limited movement left side - 2nd episode: (3/24/21) no blood flow to brain, death (maintained on life support for organ donation)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1093448

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
TX
Alter
66,0
Geschlecht
M
Eingang
18.04.2021
Impfdatum
22.02.2021
Beginn
03.03.2021
Tage bis Beginn
9,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Brain injury Cerebrovascular accident Computerised tomogram Discomfort Electrocardiogram Magnetic resonance imaging abnormal Hypoaesthesia Magnetic resonance imaging head abnormal Musculoskeletal stiffness

Symptomtext

Is he mic Stroke. Damage to brain as detected by MRI.. Hospitalised for 3 days. Only symptom was numbness of the right side of the body. Numbness (no tingling, just stiffness and heavy feeling) is persisting though improving as of date.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
3,0
Labordaten
MRI CATSCAN EKG
Aktuelle Erkrankungen
Macular degeneration Had taken injection avostin in February 2021 in both eyes. Cancelled the schedule of monthly injections following the stroke
Vorgeschichte
Diabete Age related macular degeneration
Andere Medikamente
Ozempic Novolog Tojuo Lisinopril Atorvostatin
Allergien
None
Vorherige Impfungen
-

VAERS 1218811

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
VA
Alter
37,0
Geschlecht
F
Eingang
16.04.2021
Impfdatum
10.02.2021
Beginn
05.03.2021
Tage bis Beginn
23,0
Dosis
2
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Amniocentesis normal Foetal death Foetal gastrointestinal tract imaging abnormal Foetal hypokinesia Inappropriate schedule of product administration Single umbilical artery Stillbirth Ultrasound antenatal screen abnormal Viral test negative

Symptomtext

is 38 yo healthy G5P 2012 at time of event. -LMP 10/14/2020, EDC 7/21/2021 -Prenatal Ultrasound on 1/15/2021, size consistent with GA, 13 2/7 days, 3 vessel cord, rest WNL -received first Pfizer Covid-19 vaccine 2/10/2021 at 16 0/7 GA -received second Pfizer Covid-19 vaccine 3/1/2021 (19 days from first, NOT recommended 21 DAYS) -3/12/2021 had MFM level II ultrasound for advanced maternal age. -3/12/21 US revealed early IUGR est. fetal weight 296gm, GA consistent with 19/37 GA, now SINGLE uterine artery and echogenic bowel -Amnio, NITP, TORCH all normal/neg -4/3//21 mother noted no movements, fetal demise confirmed, delivered stillborn 4/4/21

Weitere VAERSDATA-Felder
Praegender Schweregrund
Foetal death
Hospital-Tage
1,0
Labordaten
can be provided Utrasounds, labwork
Aktuelle Erkrankungen
None.
Vorgeschichte
ADHD. All meds discontinued before pregnancy.
Andere Medikamente
Prenatal vitamins
Allergien
Nkda, no food allergies or other allergies.
Vorherige Impfungen
-

VAERS 1218731

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
70,0
Geschlecht
F
Eingang
16.04.2021
Impfdatum
24.02.2021
Beginn
19.03.2021
Tage bis Beginn
23,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Blood test Cerebrovascular accident Computerised tomogram Echocardiogram Magnetic resonance imaging X-ray

Symptomtext

I had a stroke.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
I had a CT-scan, a x-ray, a mri , and a echo cardiogram. Also many blood tests. From 3/20/2021 until 3/23/2021
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension (but under control )
Andere Medikamente
Levothyroxine Montelukast Atenolol
Allergien
penicillin
Vorherige Impfungen
-

VAERS 1207106

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
69,0
Geschlecht
M
Eingang
14.04.2021
Impfdatum
11.03.2021
Beginn
31.03.2021
Tage bis Beginn
20,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Cardiac arrest Death

Symptomtext

CARDIAC ARREST DEATH

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1132491

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WV
Alter
69,0
Geschlecht
M
Eingang
14.04.2021
Impfdatum
05.02.2021
Beginn
12.02.2021
Tage bis Beginn
7,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Blood culture Cardiac disorder Computerised tomogram Death Electrocardiogram Cardiac arrest Haemoglobin Haemoglobin decreased Lower gastrointestinal haemorrhage Rash Endoscopy Faeces discoloured Full blood count Gastrointestinal haemorrhage Laboratory test Melaena Metabolic function test Presyncope

Symptomtext

Facial and neck red rash and skin irritation starting on 2/12. Near syncopal episode and black tarry stools starting on 3/10. Seen in ER and admitted for GI Bleeding on 3/10. Vagal episode on 3/11, cardiac event. Transferred to higher care facility on 3/11. Deceased on 3/18.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
9,0
Labordaten
3/10 - CBC, BMP, EKG, CT Scan, urinalysis, Hemoccult. Hgb 9.0 3/11 - Endoscopy , routine labs. Hgb 7.3 3/15 - Emergency endoscopy 3/16 - Interventional Radiology
Aktuelle Erkrankungen
None
Vorgeschichte
High blood pressure, High cholesterol
Andere Medikamente
Atorvastatin, Potassium, Baby Aspirin, Neurontin, Amlodipine, Losartan
Allergien
Codeine
Vorherige Impfungen
-

VAERS 1201247

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
73,0
Geschlecht
F
Eingang
13.04.2021
Impfdatum
27.02.2021
Beginn
09.03.2021
Tage bis Beginn
10,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Death Paralysis

Symptomtext

Paralysis (CMS/HCC) death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1200619

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
74,0
Geschlecht
F
Eingang
13.04.2021
Impfdatum
29.03.2021
Beginn
02.04.2021
Tage bis Beginn
4,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Abdominal pain Death Sepsis

Symptomtext

Death Sepsis abdominal pain

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1200591

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
91,0
Geschlecht
F
Eingang
13.04.2021
Impfdatum
10.03.2021
Beginn
13.03.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Asthenia Atrial fibrillation Death Dyspnoea Hyponatraemia Inappropriate antidiuretic hormone secretion Pleural effusion Sinus node dysfunction

Symptomtext

Death SHORTNESS OF BREATH Hyponatremia Atrial fibrillation (CMS/HCC) Generalized weakness SIADH (syndrome of inappropriate ADH production) (CMS/HCC) Pleural effusion on right Syndrome of inappropriate secretion of antidiuretic hormone Sick sinus syndrome

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1200569

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
73,0
Geschlecht
F
Eingang
13.04.2021
Impfdatum
04.03.2021
Beginn
09.03.2021
Tage bis Beginn
5,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Abdominal pain Biliary tract disorder Colon cancer Computerised tomogram abnormal Death Hyperbilirubinaemia Jaundice cholestatic Obstruction gastric

Symptomtext

Death Abdominal pain Abnormal CT scan Partial gastric outlet obstruction Disorder of common bile duct Hyperbilirubinemia Colon cancer (CMS/HCC) Obstructive jaundice

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1188271

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WA
Alter
66,0
Geschlecht
M
Eingang
09.04.2021
Impfdatum
26.02.2021
Beginn
08.03.2021
Tage bis Beginn
10,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blindness Cerebral ischaemia Cerebrovascular accident Headache Magnetic resonance imaging abnormal Mental status changes Ophthalmological examination normal Thalamic infarction Vertigo

Symptomtext

Symtoms: headache, loss of vision in left eye, vertigo. Stroke took time to diagnos, I thought it was a vision problem. Long time delays occurred while scheduling further testing (CT and MRI). Summary from MRI: "Study Result Impression: There is diffusion restriction along the left thalamus consistent with subacute ischemia, greater than 6 hours in etiology but less than 2 weeks." Outcome: Vision is slowly improving, headache is mostly gone, vertigo & mental status slowly improving.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
vision testing: 03/23/2021 - no problems found that was cause reduced vision in left eye. CT - 3/24/2021; MRI - 03/26/2021; thalamic subacute ischemia (stroke);
Aktuelle Erkrankungen
None
Vorgeschichte
hypertension
Andere Medikamente
Irbesartan / Hydrochloorothiazide 150-12.5 mg (blood pressure)
Allergien
None known
Vorherige Impfungen
-

VAERS 1169181

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
VT
Alter
79,0
Geschlecht
M
Eingang
05.04.2021
Impfdatum
13.03.2021
Beginn
16.03.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Back pain Cyanosis Death Discomfort Hyperhidrosis Myocardial infarction Pain in extremity Unresponsive to stimuli

Symptomtext

Wife reported that no side effects from vaccine noted until 3/16/2021 when patient had arm and back pain and wanted to go back to bed and she noted he was extremely sweaty at that time. He was lifted back to bed and was reportioned several times because he could not get comfortable. She went to get him a drink from the kitchen and heard a guttural sound and rushed back to find him unresponsive and blue in color. She called "911" and patient was dead upon arrival (and a DNR) so the Medical examiner arrived and pronounced him dead. She states sx started at about 4pm and he was pronounced dead at about 5pm. Medical examiner determined a heart attack cause of death. The family not sure that the vaccination had anything to do with death but wanted it to be reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Quadraparesis due to neuromuscular juctional disorder Neurogenic bladder Hemrrhoids Basal Cell Carcinoma shoulder
Vorgeschichte
Quadraparesis
Andere Medikamente
Vitamin D3 Sominex Probiotic Ferrous Sulfate 324mg Multivitamin Flomax 0.4mg Ketaconazole Cream PRN Triamcinolone Cream PRN
Allergien
Sulfa Drug - rash
Vorherige Impfungen
-

VAERS 1163548

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
42,0
Geschlecht
F
Eingang
03.04.2021
Impfdatum
01.03.2021
Beginn
24.03.2021
Tage bis Beginn
23,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Blood test Computerised tomogram thorax abnormal Heart rate increased Pulmonary embolism Thrombosis Ultrasound Doppler abnormal

Symptomtext

10 days after my first shot my feet were swollen and I didn't feel well by 18 days after it was not getting better. I got my 2nd shot on day 21 and the day after I got an alert on my Watch regarding resting heart rate exceeding 125bpm and have been inactive for 10mins, so my husband call the doctor's office to make an appointment. They said we could go to the appointment or hospital, so we went to the hospital.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
2,0
Labordaten
blood testing, CAT scan and ultrasounds found 2 blood clots in my lungs and 1 in my left leg
Aktuelle Erkrankungen
none
Vorgeschichte
factor v leiden
Andere Medikamente
none
Allergien
heparin and alieve
Vorherige Impfungen
Tingly legs and fainted, tetanus shot, age 30

VAERS 1159775

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
68,0
Geschlecht
F
Eingang
02.04.2021
Impfdatum
03.03.2021
Beginn
06.03.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Angiogram pulmonary abnormal Anticoagulant therapy Chest pain Dyspnoea Gastrointestinal haemorrhage Pleuritic pain Pulmonary embolism Vena cava filter insertion

Symptomtext

3/6/21-About two in a half days following the 2nd dose, patient had sudden onset of right sided chest pain, pleuritic, lasted several days- did not seek attention. 3/17/21- Sudden onset of severe left sided pleuritic chest pain and dyspnea. Presented to ER, found to have extensive Bilateral Pulmonary Emboli. 3/17/21- Patient admitted to Hospital. Initially put on anticoagulation, but due to GI bleeding had placement of Inferior Vena Cava Filter. 3/23/21- Discharged from Hospital.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
6,0
Labordaten
3/18/21- CTA of chest, Bilateral Pulmonary Emboli.
Aktuelle Erkrankungen
NONE
Vorgeschichte
Hypertension, Probable COPD
Andere Medikamente
Celebrex, HCTZ, Ibuprofen, Zyrtec, Vitamin D
Allergien
Azithromycin, Moxifloxacin
Vorherige Impfungen
-

VAERS 1152421

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
VT
Alter
63,0
Geschlecht
F
Eingang
31.03.2021
Impfdatum
12.03.2021
Beginn
25.03.2021
Tage bis Beginn
13,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

hospice patietn passed away

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Hospice patient - Malignant neoplasm upper lobe r bronchus or lung and Secondary neoplasm of brain
Vorgeschichte
Hospice patient - Malignant neoplasm upper lobe r bronchus or lung and Secondary neoplasm of brain
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1148785

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
68,0
Geschlecht
M
Eingang
31.03.2021
Impfdatum
03.03.2021
Beginn
15.03.2021
Tage bis Beginn
12,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Chills Haemorrhoids Hypothermia Pulmonary embolism

Symptomtext

Chills; seems to have some kind of hypothermia/kept reading 94.7; hemorrhoids; pulmonary embolism in his right lower lobe; This is a spontaneous report from a contactable pharmacist (patient). A 68-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on 03Mar2021 (Batch/Lot Number: EN6198; Expiration Date: 30Jun2021), at the age of 68-years at vaccination, as SINGLE DOSE for COVID-19 immunisation. Medical history included paraplegic, he has been paralyzed for 45 years. The patient received first dose of the vaccine on 10Feb2021 with lot number: EN5318, expiration 31May2021. There were no concomitant medications. The patient went on Monday to the ER for an unrelated condition and they did a CT scan and found a blood clot, a pulmonary embolism in his right lower lobe. He confirms the pulmonary embolism was diagnosed on Monday, 15Mar2021. He got home that night and read the headline in the (Withheld) times that said several countries are pulling the Astra Zeneca vaccine over concerns about blood clots even though there has not been any causal relationship found. He thought that with the drug companies, they should be able to have data regarding potential adverse effects for Pfizer so he was calling report that. He discusses it with the ER doctor and he couldn't really figure out why he had a blood clot, it was incidental to what he was being scanned for, it surprised him. They put him on Eliquis so he is on an anticoagulant, which will cost him a fortune. Today will be the third day he has been on the Eliquis. He is at home and he would say his only concern is that he does have hemorrhoids so when he has bowel movement tomorrow, because he doesn't go every day, but when he goes he is concerned if he starts to bleed that the anti-coagulant might cause the bleeding to be more significant than it usually is. No further information provided. His only other concern is he seems to have some kind of hypothermia, he is not entirely sure because of his thermometer is not very good. That is the reason he went into the Emergency Department because it kept reading 94.7 and he googled it and it said if it is below 95 it is a medical emergency and go to the ER so he got to the Emergency Department and it was 97.6 and now he checked his temperature again with the thermometer and it was 96.8 so either he has a faulty thermometer or something but he is experiencing some kind of chills. The outcome of the events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
Test Name: temperature; Result Unstructured Data: Test Result:94.7; Test Name: temperature; Result Unstructured Data: Test Result:97.6; Test Name: temperature; Result Unstructured Data: Test Result:96.8; Test Name: CT scan; Result Unstructured Data: Test Result:found a blood clot
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1148542

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WV
Alter
56,0
Geschlecht
M
Eingang
30.03.2021
Impfdatum
24.02.2021
Beginn
12.03.2021
Tage bis Beginn
16,0
Dosis
1
Route/Site
SYR / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Catheterisation cardiac Chest pain Coronary angioplasty Coronary arterial stent insertion Electrocardiogram abnormal Myocardial infarction

Symptomtext

My father woke up 16 days after Pfizer medication was injected. According to his story, he briefly exercised, developed extreme chest pain. His significant other was present and took him to the ER and Medical Center. After obtaining EKG, the ER determined he was having an MI. Appropriate medication were initiated, he was stabalized, and transferred by ambulance to hospital. He received 2 stents in the LAD and an angioplasty for a blockage "further down".

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocardial infarction
Hospital-Tage
3,0
Labordaten
I do not have access to any medical tests or laboratory results relating to my father's MI. However, they would be found in his medical records from 3/12-3/15 from medical center and other hospital.
Aktuelle Erkrankungen
none
Vorgeschichte
ulcers. heartburn
Andere Medikamente
benadryl q noc for sleep, ativan (prn) q 1 week, started chantex approximately 3/2/21
Allergien
Aspirin
Vorherige Impfungen
-

VAERS 1095069

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
72,0
Geschlecht
F
Eingang
30.03.2021
Impfdatum
03.03.2021
Beginn
03.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cerebrovascular accident Hypoaesthesia Muscular weakness Nerve compression Peripheral coldness Tremor SARS-CoV-2 test Seizure

Symptomtext

mini stroke or seizure; mini stroke or seizure; pinched nerve; left arm was weak, numb, cold; left arm was weak, numb, cold; left arm was weak, numb, cold; a fine tremor on extension of my arm; This is a spontaneous report from a contactable other hcp (nurse and patient). A 72-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 03Mar2021 14:45 (Batch/Lot Number: EN6198) as SINGLE DOSE (at the age of 72 years) for covid-19 immunisation. Medical history included partial seizures, autoimmune thyroiditis, eczema, osteoarthritis, asthma, irritable bowel syndrome, carpal tunnel syndrome from an unknown date and unknown if ongoing 10 years ago. The patient is not pregnant, and the patient did not have Covid prior vaccination. Concomitant medication included phenytoin (DILANTIN) taken for seizure, start and stop date were not reported; levothyroxine sodium (SYNTHROID); ergocalciferol (VIT D) and unspecified vitamin. The patient previously took amoxicillin and experienced drug hypersensitivity, erythromycin and experienced drug hypersensitivity, azithromycin and experienced drug hypersensitivity. The patient experienced mini stroke or seizure on an unspecified date with outcome of unknown, left arm was weak, numb, cold and a fine tremor on extension of arm on 03Mar2021 14:45 with outcome of recovered. On 06Mar2021, patient woke up and left arm was weak, numb, cold and she had a fine tremor on extension of arm. Symptoms resolved after 45 minutes but returned within 30 minutes and lasted another 45 minutes. No treatment was received for left arm was weak, numb, cold and she had a fine tremor on extension of arm. Patient called doctor, spoke to the advice nurse and was advised to go to the ER (emergency room) now. Patient did deep breathing and relaxation, symptoms resolved, and did not go to the ER. Instead spoke with a doctor and agreed to go to the ER if symptoms returned. Patient also had a video visit with primary doctor, and she was advised to take baby ASA. The Doctor said it could be a pinched nerve on unspecified date with outcome of unknown. Symptoms have not returned. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 08Mar2021. The case was reported as non-serious.; Sender's Comments: Based on the information provided by the reporter, it appears unlikely that subject vaccine contributed to the CVA and other events. The reported events likely represent intercurrent medical conditions. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics including Head CT/MRI, EEG, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
Test Date: 20210308; Test Name: Nasal Swab; Test Result: Negative
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Asthma; Carpal tunnel syndrome (10 years ago); Eczema; Hashimoto's thyroiditis; Irritable bowel syndrome; Osteoarthritis; Partial epilepsy; Raynaud's syndrome; Seizure (last seizure was 30 years ago and it was a partial complex seizure localized to the left hand)
Andere Medikamente
DILANTIN [PHENYTOIN]; SYNTHROID; VIT D
Allergien
-
Vorherige Impfungen
-

VAERS 1095069

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
72,0
Geschlecht
F
Eingang
30.03.2021
Impfdatum
03.03.2021
Beginn
03.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cerebrovascular accident Hypoaesthesia Muscular weakness Nerve compression Peripheral coldness Tremor SARS-CoV-2 test Seizure

Symptomtext

mini stroke or seizure; mini stroke or seizure; pinched nerve; left arm was weak, numb, cold; left arm was weak, numb, cold; left arm was weak, numb, cold; a fine tremor on extension of my arm; This is a spontaneous report from a contactable other hcp (nurse and patient). A 72-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 03Mar2021 14:45 (Batch/Lot Number: EN6198) as SINGLE DOSE (at the age of 72 years) for covid-19 immunisation. Medical history included partial seizures, autoimmune thyroiditis, eczema, osteoarthritis, asthma, irritable bowel syndrome, carpal tunnel syndrome from an unknown date and unknown if ongoing 10 years ago. The patient is not pregnant, and the patient did not have Covid prior vaccination. Concomitant medication included phenytoin (DILANTIN) taken for seizure, start and stop date were not reported; levothyroxine sodium (SYNTHROID); ergocalciferol (VIT D) and unspecified vitamin. The patient previously took amoxicillin and experienced drug hypersensitivity, erythromycin and experienced drug hypersensitivity, azithromycin and experienced drug hypersensitivity. The patient experienced mini stroke or seizure on an unspecified date with outcome of unknown, left arm was weak, numb, cold and a fine tremor on extension of arm on 03Mar2021 14:45 with outcome of recovered. On 06Mar2021, patient woke up and left arm was weak, numb, cold and she had a fine tremor on extension of arm. Symptoms resolved after 45 minutes but returned within 30 minutes and lasted another 45 minutes. No treatment was received for left arm was weak, numb, cold and she had a fine tremor on extension of arm. Patient called doctor, spoke to the advice nurse and was advised to go to the ER (emergency room) now. Patient did deep breathing and relaxation, symptoms resolved, and did not go to the ER. Instead spoke with a doctor and agreed to go to the ER if symptoms returned. Patient also had a video visit with primary doctor, and she was advised to take baby ASA. The Doctor said it could be a pinched nerve on unspecified date with outcome of unknown. Symptoms have not returned. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 08Mar2021. The case was reported as non-serious.; Sender's Comments: Based on the information provided by the reporter, it appears unlikely that subject vaccine contributed to the CVA and other events. The reported events likely represent intercurrent medical conditions. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics including Head CT/MRI, EEG, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
Test Date: 20210308; Test Name: Nasal Swab; Test Result: Negative
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Asthma; Carpal tunnel syndrome (10 years ago); Eczema; Hashimoto's thyroiditis; Irritable bowel syndrome; Osteoarthritis; Partial epilepsy; Raynaud's syndrome; Seizure (last seizure was 30 years ago and it was a partial complex seizure localized to the left hand)
Andere Medikamente
DILANTIN [PHENYTOIN]; SYNTHROID; VIT D
Allergien
-
Vorherige Impfungen
-

VAERS 1143055

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
74,0
Geschlecht
M
Eingang
29.03.2021
Impfdatum
09.03.2021
Beginn
26.03.2021
Tage bis Beginn
17,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Cardiac arrest Death

Symptomtext

CARDIAC ARREST DEATH

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1086178

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
65,0
Geschlecht
F
Eingang
29.03.2021
Impfdatum
04.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Balance disorder Chills Defaecation urgency Dizziness Circulatory collapse Diarrhoea Epigastric discomfort Fall Feeling abnormal Hyperhidrosis Dysstasia Fatigue Limb injury Nausea Pain in extremity Loss of consciousness Tinnitus

Symptomtext

then everything went black &collapse but not unconscious; felt slightly dizzy; sudden strange feeling in head like wave washing over; Then intense feeling of sudden diarrhea; nausea; profuse sweating soaks clothes; weak all over; shaking with chills; shaking with chills; can't get up or will black out again; ringing in ears; Exhausted/fatigued; arm hurt; This is a spontaneous report from a contactable consumer (patient). A 65-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: EN6198, expiry date not reported), via an unspecified route of administration, administered in right arm on 04Mar2021 13:15 at a single dose for COVID-19 immunization. Medical history included migraine with aura, vertigo vestibular nueronitis, osteoporosis, TIA (transient ischaemic attack), B12 deficiency, IBS (irritable bowel syndrome), all from an unknown date and unknown if ongoing. The patient was not pregnant at the time of the report and vaccination. The patient had no covid prior vaccination. Concomitant medications included acetylsalicylic acid (ASPIRIN 81, 81 mg tablet) at 81 mg, once a day; cyanocobalamin (B12-VITAMIN), and colecalciferol (D3), all taken for an unspecified indication, start and stop date were not reported. The patient previously took antihistamines, cephalexin (CEFALEXIN), amoxicillin but experienced allergies. The patient had no other vaccine in four weeks. Few minutes after shot, 04Mar2021 at 07:15 PM, patient felt slightly dizzy for few seconds then felt fine until 6 hrs after injection while sitting watching tv, wherein sudden strange feeling in head like wave washing over, then intense feeling of sudden diarrhea. Patient went to toilet, nothing happened, then everything went black and collapse but not unconscious. Patient went back on toilet, normal BM, no diarrhea, with nausea, profuse sweating soaks clothes, weak all over, shaking with chills, couldn't get up or will black out again, ringing in ears. These lasted total 20-30 minutes. Patient was also exhausted, fatigued, went to bed, and woke up 4 a.m. Her arm hurt but felt ok (Mar2021). Patient was weak, fatigued all day. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive treatments for the events reported. The patient was not tested for COVID post vaccination. The outcome of the events was reported as recovered in Mar2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circulatory collapse
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: B12 deficiency anemia; Irritable bowel syndrome; Migraine with aura; Neuritis; Osteoporosis; TIA; Vestibular vertigo
Andere Medikamente
ASPIRIN 81; B12-VITAMIN; D3
Allergien
-
Vorherige Impfungen
-

VAERS 1086178

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
65,0
Geschlecht
F
Eingang
29.03.2021
Impfdatum
04.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Balance disorder Chills Defaecation urgency Dizziness Circulatory collapse Diarrhoea Epigastric discomfort Fall Feeling abnormal Hyperhidrosis Dysstasia Fatigue Limb injury Nausea Pain in extremity Loss of consciousness Tinnitus

Symptomtext

then everything went black &collapse but not unconscious; felt slightly dizzy; sudden strange feeling in head like wave washing over; Then intense feeling of sudden diarrhea; nausea; profuse sweating soaks clothes; weak all over; shaking with chills; shaking with chills; can't get up or will black out again; ringing in ears; Exhausted/fatigued; arm hurt; This is a spontaneous report from a contactable consumer (patient). A 65-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: EN6198, expiry date not reported), via an unspecified route of administration, administered in right arm on 04Mar2021 13:15 at a single dose for COVID-19 immunization. Medical history included migraine with aura, vertigo vestibular nueronitis, osteoporosis, TIA (transient ischaemic attack), B12 deficiency, IBS (irritable bowel syndrome), all from an unknown date and unknown if ongoing. The patient was not pregnant at the time of the report and vaccination. The patient had no covid prior vaccination. Concomitant medications included acetylsalicylic acid (ASPIRIN 81, 81 mg tablet) at 81 mg, once a day; cyanocobalamin (B12-VITAMIN), and colecalciferol (D3), all taken for an unspecified indication, start and stop date were not reported. The patient previously took antihistamines, cephalexin (CEFALEXIN), amoxicillin but experienced allergies. The patient had no other vaccine in four weeks. Few minutes after shot, 04Mar2021 at 07:15 PM, patient felt slightly dizzy for few seconds then felt fine until 6 hrs after injection while sitting watching tv, wherein sudden strange feeling in head like wave washing over, then intense feeling of sudden diarrhea. Patient went to toilet, nothing happened, then everything went black and collapse but not unconscious. Patient went back on toilet, normal BM, no diarrhea, with nausea, profuse sweating soaks clothes, weak all over, shaking with chills, couldn't get up or will black out again, ringing in ears. These lasted total 20-30 minutes. Patient was also exhausted, fatigued, went to bed, and woke up 4 a.m. Her arm hurt but felt ok (Mar2021). Patient was weak, fatigued all day. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive treatments for the events reported. The patient was not tested for COVID post vaccination. The outcome of the events was reported as recovered in Mar2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circulatory collapse
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: B12 deficiency anemia; Irritable bowel syndrome; Migraine with aura; Neuritis; Osteoporosis; TIA; Vestibular vertigo
Andere Medikamente
ASPIRIN 81; B12-VITAMIN; D3
Allergien
-
Vorherige Impfungen
-

VAERS 1086178

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
65,0
Geschlecht
F
Eingang
29.03.2021
Impfdatum
04.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Balance disorder Chills Defaecation urgency Dizziness Circulatory collapse Diarrhoea Epigastric discomfort Fall Feeling abnormal Hyperhidrosis Dysstasia Fatigue Limb injury Nausea Pain in extremity Loss of consciousness Tinnitus

Symptomtext

then everything went black &collapse but not unconscious; felt slightly dizzy; sudden strange feeling in head like wave washing over; Then intense feeling of sudden diarrhea; nausea; profuse sweating soaks clothes; weak all over; shaking with chills; shaking with chills; can't get up or will black out again; ringing in ears; Exhausted/fatigued; arm hurt; This is a spontaneous report from a contactable consumer (patient). A 65-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot Number: EN6198, expiry date not reported), via an unspecified route of administration, administered in right arm on 04Mar2021 13:15 at a single dose for COVID-19 immunization. Medical history included migraine with aura, vertigo vestibular nueronitis, osteoporosis, TIA (transient ischaemic attack), B12 deficiency, IBS (irritable bowel syndrome), all from an unknown date and unknown if ongoing. The patient was not pregnant at the time of the report and vaccination. The patient had no covid prior vaccination. Concomitant medications included acetylsalicylic acid (ASPIRIN 81, 81 mg tablet) at 81 mg, once a day; cyanocobalamin (B12-VITAMIN), and colecalciferol (D3), all taken for an unspecified indication, start and stop date were not reported. The patient previously took antihistamines, cephalexin (CEFALEXIN), amoxicillin but experienced allergies. The patient had no other vaccine in four weeks. Few minutes after shot, 04Mar2021 at 07:15 PM, patient felt slightly dizzy for few seconds then felt fine until 6 hrs after injection while sitting watching tv, wherein sudden strange feeling in head like wave washing over, then intense feeling of sudden diarrhea. Patient went to toilet, nothing happened, then everything went black and collapse but not unconscious. Patient went back on toilet, normal BM, no diarrhea, with nausea, profuse sweating soaks clothes, weak all over, shaking with chills, couldn't get up or will black out again, ringing in ears. These lasted total 20-30 minutes. Patient was also exhausted, fatigued, went to bed, and woke up 4 a.m. Her arm hurt but felt ok (Mar2021). Patient was weak, fatigued all day. Adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive treatments for the events reported. The patient was not tested for COVID post vaccination. The outcome of the events was reported as recovered in Mar2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circulatory collapse
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: B12 deficiency anemia; Irritable bowel syndrome; Migraine with aura; Neuritis; Osteoporosis; TIA; Vestibular vertigo
Andere Medikamente
ASPIRIN 81; B12-VITAMIN; D3
Allergien
-
Vorherige Impfungen
-

VAERS 1142047

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
IN
Alter
87,0
Geschlecht
F
Eingang
28.03.2021
Impfdatum
02.03.2021
Beginn
11.03.2021
Tage bis Beginn
9,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Cerebrovascular accident Death Gait disturbance General physical health deterioration Pain Urinary tract infection

Symptomtext

Patient received the injection on May 2nd. Following the injection, we noticed an increased weakness and general achiness. On the 8th she was so weak that we purchased a gait belt to assist her. We were not super concerned as we were expecting the second shot to cause body aches or flu like symptoms based on what we had heard from others who had received both vaccine shots. She continued to be unsteady and we found that she has a mild UTI which we had begun treating with prescribed antibiotics. Late afternoon on the 11th, mother suffered a major stroke. we did not take her to the hospital because we had already been told that they would not be able to do anything at her age should she suffer a stroke. On the 12th I called the doctors office and asked for them to send Hospice to the house as we could tell that she was dying. Mother died on the 13th. Just a week prior to her death I had spoken with Dr. and we had discussed how that she was declining in health but that she was not even close to needing Hospice, yet she is dead a week later. Less than 2 weeks after getting her second Covid Shot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
There were no tests done as we allowed her to pass at home.
Aktuelle Erkrankungen
UTI
Vorgeschichte
A-Fib, high blood pressure, hypothyroidism, Diastolic congestive heart failure due to hypertensive cardiomyopathy
Andere Medikamente
Losartan/HCT, Diclofenac, Levothyroxin, Amlodipine, Myrbetriq, Atorvastatin, Eliquis, Potassium, Mirtazapine
Allergien
None
Vorherige Impfungen
-

VAERS 1136163

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6198

kritisch
Staat
OH
Alter
88,0
Geschlecht
M
Eingang
25.03.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
SYR / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Seizures Heart Dementia Stroke 12 yrs ago
Andere Medikamente
Keppra Potassium Triamterene Quetiapine
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 1132480

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
FL
Alter
70,0
Geschlecht
M
Eingang
25.03.2021
Impfdatum
01.03.2021
Beginn
02.03.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Chest pain Dizziness Fatigue Lethargy Myocardial infarction Pain Paraesthesia SARS-CoV-2 test Vision blurred Visual impairment

Symptomtext

symptoms of heart attack; chest pain; hands and fingers tingly; dizzy; blurred vision; Vision decreased; extreme tiredness; lethargic; hurting all over; This is a spontaneous report from a contactable consumer (patient). A 70-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EN6198) intramuscularly in left arm on 01Mar2021 05:45PM (at the age of 70-year-old) at single dose for COVID-19 immunisation. Relevant medical history included 5 back surgeries, Barrett's esophagus and H. pylori. Known allergies included Eliquis. Concomitant medications included dexlansoprazole (DEXILANT), hydrocodone, atorvastatin (LIPITOR), famotidine and chondroitin sulfate sodium, glucosamine hydrochloride (TAZAN). For 4-5 days after vaccine the patient had extreme tiredness, was lethargic and hurting all over. On day 5 chest pain started, hands and fingers tingly, dizzy, blurred vision both eyes off and in, vision decreased by 50% right eye. He experienced all symptoms of heart attack. Onset date for extreme tiredness, lethargic and hurting all over was 02Mar2021, while all the other events occurred on 06Mar2021. The patient was hospitalized for 1 day. No treatment was received. The patient underwent COVID test post vaccination, nasal swab on 07Mar2021 and it was negative. The events resolved in Mar2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocardial infarction
Hospital-Tage
1,0
Labordaten
Test Date: 20210307; Test Name: Nasal Swab; Test Result: Negative
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Back surgery (5); Barrett's esophagus; Helicobacter pylori gastritis
Andere Medikamente
DEXILANT; HYDROCODONE; LIPITOR [ATORVASTATIN]; FAMOTIDINE; TAZAN
Allergien
-
Vorherige Impfungen
-

VAERS 1131585

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
80,0
Geschlecht
F
Eingang
24.03.2021
Impfdatum
10.03.2021
Beginn
22.03.2021
Tage bis Beginn
12,0
Dosis
1
Route/Site
UN / UN
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Death

Symptomtext

death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1127873

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CO
Alter
42,0
Geschlecht
F
Eingang
23.03.2021
Impfdatum
03.03.2021
Beginn
06.03.2021
Tage bis Beginn
3,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Computerised tomogram thorax Dyspnoea Laboratory test Pulmonary embolism

Symptomtext

Pulmonary Emboli, shortness of breath

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
-
Labordaten
labs, CT chest
Aktuelle Erkrankungen
none
Vorgeschichte
depression, lipid storage disorder, history of hypercoag state, obesity
Andere Medikamente
Levothyroxine, MVI
Allergien
PCN
Vorherige Impfungen
-

VAERS 1125144

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WA
Alter
65,0
Geschlecht
F
Eingang
23.03.2021
Impfdatum
27.02.2021
Beginn
14.03.2021
Tage bis Beginn
15,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death Stress cardiomyopathy

Symptomtext

Death unknown. Patient caregiver reported that it may be related to broken heart syndrome due her family member's passing.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Chronic Pain, Scoliosis, Dysthymic Disorder
Andere Medikamente
-
Allergien
Morphine, Oxycodone, Tapentadol, Tramadol
Vorherige Impfungen
-

VAERS 1124679

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WA
Alter
69,0
Geschlecht
F
Eingang
22.03.2021
Impfdatum
23.02.2021
Beginn
16.03.2021
Tage bis Beginn
21,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Aphasia Blood test Cerebrovascular accident Computerised tomogram Intensive care Magnetic resonance imaging Memory impairment

Symptomtext

Stroke - globus pallidus area Lost ability to speak and recognize objects. Immediately taken to ER and evaluated and TPA given. Results good following drug administration sent home after two days. Some mental affects still.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
3,0
Labordaten
2 CAT scans, 1 MRI, numerous blood tests and 24 hour monitoring in ICU 3/16/2021 to 3/18/2021
Aktuelle Erkrankungen
none
Vorgeschichte
some list not available
Andere Medikamente
several, list not available
Allergien
several list not available
Vorherige Impfungen
-

VAERS 1121860

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
VA
Alter
-
Geschlecht
F
Eingang
22.03.2021
Impfdatum
03.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Body temperature Chills Cough Ear pain Erythema Eye swelling Fatigue Feeling cold Glassy eyes Headache Hypersensitivity Lymph node pain Lymphadenopathy Nasal congestion Near death experience Oropharyngeal pain Periorbital swelling

Symptomtext

she was mostly clawing at her neck, it was an internal reaction, allergies; she was figuratively knocked on the ground; felt like she had been beat to death; eyes puffy and swollen; eyes puffy and swollen; Headache; Tiredness; cold/ she was freezing to death; lymph node swelling; congestion; Fever; Rash; Chills; Cough; ears and throat hurting; detect red across her chest or stuff; her ear canals and lymph nodes in her throat hurt and she was aching/ her ears and throat were hurting; her ear canals and lymph nodes in her throat hurt and she was aching; her eyes are tired right now and glassy; her knees are aching; scratching/ itching; This is a spontaneous report from a contactable consumer. A 58-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, administered in right arm on 03Mar2021 as single dose for COVID-19 immunisation. Medical history included asthmatic, stage 2, multiple allergies, allergies to shellfish and egg. Concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 on 03Feb2021 (lot number: EL9269) for Covid-19 immunization. In Mar2021, the patient stated that her eyes were puffy and swollen like she was extremely sick, and she had a slight headache and was real tired, however when she went to bed she tossed and turned. She says she woke up at 04:00AM scratching her neck and chest and under her breasts, but she was mostly clawing at her neck, it was an internal reaction, allergies, so she looked in the mirror to see if she had hives or a rash and only could detect red across her chest or stuff. She says it was unknown if this was because she was scratching stuff, she took her temperature and it was a half degree above normal, and she laid back down. She says after she got up with the itching that night, 2.5 hours later she had no welts or anything, it was internal itching like what she had experienced when she had eaten something with a form of iodine content in it, where it causes a red streaky itching underneath. She says on Thursday she got up and felt like she had been beat to death, and she went to work and it got worse as the day went on, she was more tired. She says by 11:00AM she was freezing to death so she checked her temperature and it was still just a half degree different, so she used a space heater. She says that at 03:15PM she had a nurse check her temperature and it was still 97.5 degrees Fahrenheit, and she was so cold when she came home she took her temperature by mouth and then it was 100 degrees Fahrenheit she was figuratively knocked on the ground. She says if there was a difference, she doesn't know. She says she went to bed freezing to death so she put flannels on. She says 2 hours later she had taken Tylenol since her temperature was up almost to 101 degrees Fahrenheit. She says yesterday evening her ear canals and lymph nodes in her throat hurt and she was aching. She says that she didn't experience a cough until today, she is congested a little, which is not abnormal for her because of her allergies. She says her temperature was better today. She says for the Tylenol she took 625mg yesterday morning at 08:30AM, she never took more because she was never running a fever and she is not one to pop pills. She says she didn't take another until 05:30PM-06:00PM because she had heard that she was going to have chills but not a fever so she thought that was what she was experiencing and it wasn't until she got home and used her mouth thermometer and her ears and throat were hurting that she thought she had better check it and it was 2.5 degrees above normal so she took more. She says that she gets allergy shots, and she was supposed to go today but she doesn't know if she should because she feels tired, her eyes are tired right now and glassy, and her knees are aching, and her right ear is stopped up. She says she doesn't think that she needs to deal with allergy shots while she feels this way now. She says she usually gets her allergy shot twice a week, and her allergist said to have a day separation so she got her dose on Monday of the allergy shot, then got her COVID shot on Wednesday and she doesn't want to do her second shot this week, she couldn't go in today, it clearly knocked her on the ground, she didn't know it was 04:00AM when she got up. The outcome of the events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Near death experience
Hospital-Tage
-
Labordaten
Test Name: Temperature elevation; Result Unstructured Data: Test Result:97.5 degrees Fahrenheit; Test Name: Temperature elevation; Result Unstructured Data: Test Result:a half degree above normal; Test Name: Temperature elevation; Result Unstructured Data: Test Result:100 degrees Fahrenheit; Comments: so cold when she came home she took her temperature by mouth and then it was 100 degrees Fahrenheit.; Test Date: 20210304; Test Name: Temperature elevation; Result Unstructured Data: Test Result:101 farenheit; Comments: Temperature elevation
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergy multiple (Verbatim: Allergy multiple); Asthmatic (Verbatim: Asthmatic, stage 2); Egg allergy; Shellfish allergy
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1107885

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
IA
Alter
82,0
Geschlecht
M
Eingang
17.03.2021
Impfdatum
24.02.2021
Beginn
02.03.2021
Tage bis Beginn
6,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain lower Acute kidney injury Blood culture Brain natriuretic peptide Computerised tomogram abdomen Computerised tomogram pelvis Death Full blood count Metabolic function test Pollakiuria Procalcitonin Small intestinal obstruction Urine analysis

Symptomtext

Patient presented to the ER on 3/2 for urinary frequency and lower abdominal pain. He was hospitalized at Medical Center- on 3/2/2021 for small bowel obstruction and acute kidney injury. Patient passed on 3/2/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
CT of abdomen and pelvis, CBC, BMP, BNP, procalcitonin, urine, blood culture- all on 3/2/2021.
Aktuelle Erkrankungen
Patient had chronic medical conditions as listed below. No acute illnesses at the time of vaccination or within the prior month.
Vorgeschichte
bladder cancer, type 2 diabetes, hyperlipidemia, HTN, anemia, carotid atherosclerosis, osteoarthritis, inguinal hernia
Andere Medikamente
triamterene-HCTZ, atorvastatin, potassium chloride, benazepril, diltiazem, glipizide, ferrous sulfate, aspirin, omega-3 fatty acids
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1106446

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
KY
Alter
22,0
Geschlecht
F
Eingang
16.03.2021
Impfdatum
27.02.2021
Beginn
04.03.2021
Tage bis Beginn
5,0
Dosis
UNK
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy Foetal death Full blood count normal Laboratory test normal Live birth Pathology test Postpartum haemorrhage Premature labour

Symptomtext

20 weeks and 3 days pregnant with a girl at time of COVID vaccine, due date July 14th 2021. Anatomy scan on 2/26/21 and everything was normal. Two prior pregnancies both healthy and carried full term in 2017 and 2019. Spontaneous preterm labor on March 6th, 2021. Resulted in baby being born and dying about an hour and a half later due to how early she was. Labs came back normal, no signs of infection, placenta pathology came back normal. Baby was healthy as of 2/26/21 and was born alive.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Foetal death
Hospital-Tage
1,0
Labordaten
CBC- normal within range for labor and delivery, normal also for postpartum hemorrhage and blood loss 3/6/21 and 3/7/21
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Smarty Pants Prenatal Vitamin
Allergien
None
Vorherige Impfungen
-

VAERS 1104698

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
66,0
Geschlecht
F
Eingang
16.03.2021
Impfdatum
03.02.2021
Beginn
03.03.2021
Tage bis Beginn
28,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Death Respiratory distress

Symptomtext

RESPIRATORY DISTRESS Death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1103847

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
84,0
Geschlecht
M
Eingang
16.03.2021
Impfdatum
06.02.2021
Beginn
11.02.2021
Tage bis Beginn
5,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Asthenia Death Pyrexia

Symptomtext

weakness fever death

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1096461

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
PA
Alter
86,0
Geschlecht
F
Eingang
13.03.2021
Impfdatum
12.03.2021
Beginn
12.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cardiac arrest Death Malaise

Symptomtext

Patient received vaccine at 10:35am, was observed for 15 minutes then returned home with family. Patient began to not feel well, experienced cardiac arrest as witnessed by son, was taken to hospital Emergency Department where she expired at 12:50pm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1095588

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
IA
Alter
69,0
Geschlecht
F
Eingang
12.03.2021
Impfdatum
26.02.2021
Beginn
27.02.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute myocardial infarction Acute respiratory failure Alanine aminotransferase increased Aortic aneurysm Aphasia Aspartate aminotransferase increased Aspiration pleural cavity Blood alkaline phosphatase increased Blood alkaline phosphatase normal Blood bilirubin increased Blood creatinine normal Blood culture negative Blood culture positive Blood lactic acid increased Blood potassium decreased Blood sodium decreased Body temperature increased Chest X-ray abnormal

Symptomtext

Pfizer COVID-19 Vaccine EUA 3/2: Pt received Pfizer vaccine 2/26/2021 and started feeling progressively worse - endorsed fever, diarrhea, body aches, trouble breathing, lack of appetite. On 3/2/2021 pt and husband presented to ED. Pt's husband stated that pt had become more and more confused since she received the vaccine and that on 3/2 she could not complete her sentences. Temp 101.6 on arrival, tachycardic in 130s, tachypneic in 120s, but not hypoxic. Patient was given acetaminophen on arrival. IV was inserted and patient was given 1 L intravenous fluid replacement as well as 2 g ceftriaxone for broad-spectrum coverage within 3 hours of arrival. Blood work was drawn that shows no leukocytosis but lactic acidosis to 3.3. There are multiple electrolyte abnormalities, hyponatremia 127, hypokalemia 2.8, creatinine 1.01, ALT 59 AST 53, ALP 136, total bili 1.3, lactic acidosis 3.3, troponin 0.02. Patient was given 40 mEq of oral potassium. Additional L of normal saline was given for total of 2 L normal saline bolus. Chest x-ray shows right basilar pneumonia. Also shows pulmonary nodule of which husband was made aware. LFTs are noted be elevated, so biliary ultrasound was obtained that was negative with limit to body habitus. Husband was updated. Azithromycin was added on. Rapid COVID antigen was negative. 3/3/21: Febrile, SOB overnight. Pt more lethargic, trailing off in the middle of sentences and having difficulties following conversation. Continue sepsis protocol, add vancomycin IV to ceftriaxone and azithromycin. Frequent neuro checks. MRCP. Chest pain-free, serial cardiac enzymes from yesterday to demonstrate nonischemic pattern likely type 2 NSTEMI. 2/2 blood cultures from 3/2 positive for Streptococcus pyogenes (Group A). Vancomycin and azithromycin dc'd. 3/11: Discharged from hospital. Patient admitted for acute hypoxic respiratory failure secondary to right basilar community-acquired pneumonia. Blood culture grew Streptococcus pyogenes, patient was initially treated with ceftriaxone and switched to Ancef . repeat blood culture on 03/04/2021 showed no growth. Patient will complete a total 14 day course of antibiotics with amoxicillin from culture negative date. Patient had right-sided pleural effusion, pulmonary consulted and she underwent thoracentesis x2 culture showed no growth, considered parapneumonic effusion. Patient required 2 L continuous oxygen and deemed stable for discharge. She will follow up with Pulmonary in 3 weeks, outpatient chest CT in 4-6 weeks to be ordered by Pulmonary to assess lung nodule and known thoracic aortic aneurysm. PTOT recommended home discharge with VNA. On discharge patient was a febrile and hemodynamically stable. Remained COVID negative throughout.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
10,0
Labordaten
Please see description of adverse event.
Aktuelle Erkrankungen
-
Vorgeschichte
Retroperitoneal fibrosis Hypercholesterolemia Obesity Benign essential hypertension Depressive disorder Decreased vitamin D Osteoarthritis of left knee Thoracic aortic aneurysm, without rupture Osteoporosis
Andere Medikamente
Amlodipine 10 mg QD Aspirin 325 mg PO QD Atenolol 50 mg PO QD Atorvastatin 20 mg PO QD Cholecalciferol 5000 IU PO QD Diclofenac 1% gel 4 gm topical PRN Doxazosin 1 mg PO QHS Hydrochlorothiazide-irbesartan 25-300 mg PO QD Venlafaxine 37.5 mg
Allergien
Ethambutol - skin reaction Latex - rash, itching Lisinopril - cough Metals - rash, itching
Vorherige Impfungen
-

VAERS 1094322

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
66,0
Geschlecht
M
Eingang
12.03.2021
Impfdatum
03.02.2021
Beginn
02.03.2021
Tage bis Beginn
27,0
Dosis
2
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Death

Symptomtext

2nd dose given on 2/24/2021, deceased on 3/2/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1094265

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6198

kritisch
Staat
ME
Alter
51,0
Geschlecht
M
Eingang
12.03.2021
Impfdatum
23.02.2021
Beginn
27.02.2021
Tage bis Beginn
4,0
Dosis
2
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Acute myocardial infarction Coronary artery dissection Laboratory test

Symptomtext

ACUTE ST ELEVATION MYOCARDIAL INFARCTION SPONTANEOUS DISSECTION OF CORONARY ARTERY

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
2,0
Labordaten
SEVERAL WHILE IN THE HOSPITAL FOR 2 DAYS
Aktuelle Erkrankungen
N/A
Vorgeschichte
TYPE II DIABETES
Andere Medikamente
ALLOPURINOL 300MG TRULICITY 1.5 MG LEVOTHYROXINE 50 MCG LISINOPRIL 10MG metFORMIN 1000MG DAILY VITAMIN VITAMIN D PROBIOTIC
Allergien
PRAVASTATIN SODIUM
Vorherige Impfungen
-

VAERS 1086429

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
73,0
Geschlecht
F
Eingang
09.03.2021
Impfdatum
05.03.2021
Beginn
08.03.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Angiogram pulmonary abnormal Blood pH normal Brain natriuretic peptide normal Chest X-ray Dyspnoea Fibrin D dimer increased Full blood count normal Hypoxia Influenza virus test negative Laboratory test normal Pleuritic pain Pulmonary embolism Pulmonary infarction Respiratory syncytial virus test negative SARS-CoV-2 test negative Tachycardia Troponin normal

Symptomtext

Patient developed left sided pleuritic chest pain and dyspnea on 3/8 in the evening. She presented to the ED 3/9 and was found to have a segmental left lower lobe pulmonary embolism (left lateral basilar segment) with associated LLL pulmonary infarction. She had tachycardia to low 110s, mild hypoxia to 89% on room air with no evidence of pneumonia or typical COVID infiltrates. She had no known COVID exposure. She had one prior pulmonary embolism in 1999 treated for 6 months with coumadin, and was subsequently found in 2000 to be heterozygous for Factor V Leiden. She is being admitted to the hospital for treatment of pulmonary embolism.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
2,0
Labordaten
COVID-19/influenza/RSV multiplex PCR 3/9/2021: negative Screening labs (CBC, chem 7) unremarkable, BNP and troponin normal, D-dimer 2.53 (normal <= 0.49), ABG 7.43/35/62 on room air CT angio chest (see result above) CXR
Aktuelle Erkrankungen
No acute illnesses
Vorgeschichte
Factor V Leiden heterozygosity with history of Pulmonary embolism in 1999 HTN CKD stage 2, baseline cr 0.9-1.0 Dyslipidemia Osteoporosis
Andere Medikamente
Atenolol 50mg once daily Pravachol 40mg once daily
Allergien
codeine norco tetracycline
Vorherige Impfungen
-

VAERS 1085783

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
CA
Alter
37,0
Geschlecht
M
Eingang
09.03.2021
Impfdatum
24.02.2021
Beginn
05.03.2021
Tage bis Beginn
9,0
Dosis
2
Route/Site
SYR / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Sudden death

Symptomtext

Sudden Unexpected Death - No signs or symptoms

Weitere VAERSDATA-Felder
Praegender Schweregrund
Sudden death
Hospital-Tage
-
Labordaten
Currently with Coroner.
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
Lactose Intolerant
Vorherige Impfungen
-

VAERS 1085254

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
NJ
Alter
90,0
Geschlecht
M
Eingang
09.03.2021
Impfdatum
01.03.2021
Beginn
01.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain Aspiration Cardiac arrest Death Feeding disorder Gastric aspiration procedure Gastric lavage Gastrointestinal necrosis Insomnia Mechanical ventilation Pulmonary necrosis Thrombosis

Symptomtext

Severe abdominal pain unable to eat or sleep for 36 hours. He went by ambulance to the Hospital emergency room. They tried to pump his stomach but he aspirated and and went into cardiac arrest. He was revived but never regained consciousness. (The ICU Dr said that he had blood clots in his abdomen from a recent stroke. We were unaware of him having a stroke other than in 2026. The same Dr. said that he had necrosis in his lungs from aspirating. The necrosis was from his bowel dying) He was put on a ventilator and given drugs to increase his heart rate. On 3-5-21 the heart drugs were reduced and he died. I was with him when he recieved the vaccination and he was healthy, just old. I think that the shot killed him.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
stroke in 2016
Andere Medikamente
furosemide metaprolol eliquis lisprinopril pravastatin doxazosin glimeperide omperozole diltiazem potadsium
Allergien
-
Vorherige Impfungen
-

VAERS 1081308

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
MI
Alter
71,0
Geschlecht
M
Eingang
08.03.2021
Impfdatum
02.03.2021
Beginn
02.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Cardiac arrest Death Laboratory test normal

Symptomtext

Death 3 days afterards, undetermined cause at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cardiac arrest
Hospital-Tage
-
Labordaten
Multiple Cardiac tests were done at ER, all were returned normal. Went into Cardiac arrest and was unable to resuscitate.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 1080435

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
-
Alter
62,0
Geschlecht
M
Eingang
07.03.2021
Impfdatum
27.02.2021
Beginn
01.03.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Death

Symptomtext

DEATH Narrative: 61 y.o. male with pmh afib, substance dependance, renal failure, recent admissions in the community for acute hypotension and acute kidney injury (11/2020 & 2/2021). Was found deceased in his apartment on the afternoon of 03/01/2021. Request sent to ME office for report if one exists. Patient was listed as having no known allergies.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
ALL LABS WITHIN 30 DAYS PRIOR TO DEATH----CHEMISTRY -GENERAL----SERUM Feb 26 Feb 09 Feb 09 Reference 2021 2021 2021 08:45 11:20 11:29 Units Ranges NA 142 136 mmol/L 135 - 145 K 4.1 5.1 H mmol/L 3.5 - 5 CL 106 94 L mmol/L 100 - 110 CO2 26 30 mmol/L 20 -30 BUN 21 39 H mg/dL 7 - 25 CREAT 1.7 H 3.7 H mg/dL .5 - 1.5 cGFR 50 L 20L* mL/min Ref: >=60 GLUCOSE 106H 116 H mg/dL 65 - 100 CA,TOT 8.6 9.0 mg/dL 8.5-10.5 PROTEIN 7.3 7.5 g/dL 6 - 8.5 ALBUMIN 3.7 3.6 g/dL 3.5 - 5 PO4 3.7 3.1 mg/dL 2.5 - 5 URIC AC 10.9 H mg/dL 3.3 - 8.7 T. BIL 0.30 0.40 mg/dL .2 - 1.2 D. BILI 0.1 0.2 mg/dL 0 - .5 LD TOT U/L 125 - 243 TRYGLYC 168 mg/dL 0 - 199 CHOL 192 mg/dL 0 - 199 HDL 59 mg/dL Ref: >=40 VLDL mg/dL 0 - 30 LDL 99 mg/dL 0 - 129 D.LDL mg/dL 0 - 129 AST 15 16 U/L 5 - 40 ALT 11 17 U/L 7 - 52 ALK PHO 63 59 U/L 40 - 150 CK TOT U/L 30 - 200 AMYLASE 129 H U/L 25 - 125 LIPASE 89 H U/L 8 - 70 MAG 1.9 1.7 mg/dL 1.6 - 2.6 GGT U/L 10 - 65 TOT AcP U/L 3.1 - 7 ProsAcP ng/mL 0 - 2.7 COPPER 5'NUC U/L 0 - 10 CERULOP mg/dL 20 - 60 OSMOL mOsm/kg 275 - 300 ANION G 10 12 mEq/L 6 - 16 COMMENTS: a d h a. Evaluation for GLU: Results must be interpreted on a case-by case basis. Values >200 may require further follow-up to rule out diabetic mellitus. ***For test CO2 Units: mEq/L *** Evaluation for MG: Minor changes to reference range were implemented on 6/13/12 in order to standardize ranges across the database. *** For test cGFR Normals: low: >=60 *** Evaluation for cGFR: As of April 16, 2010 a new formula was implemented for cGFR which is based on a creatinine that is now matched to the national standard (IDMS). New values should be considered more accurate. Ordering Provider: MD Report Released..: Feb 26, 2021@10:40 Reporting Lab.....Effective 10/16/13 - Vitamin D, Total (Screen) test should not be used when single dose 50,000 IU D2 is administered. *** For test CO2 Units: mEqL *** Evaluation for UA: Patients receiving Elitck(Rasburicase) therapy may have falsely decreased uric acid values if drawn in a room temperature gold top tube(scrum). If concerned about Rasburicase interference, please recollect blood sample in a pre-chilled green top tube containing heparin, immediately place on ice and deliver ASAP for analysis. Evaluation for CHO: <200 mg/dL is desirable; 200-239 is borderline/high; >=240 is high Evaluation for TRI: 150-199 mg/dL is Borderline-high 200-499 is High 500 mg/dL or above is Very High*** For test HDL Normals: low: >=40 *** *** For test cGFR Normals: low: >=60 *** Ordering Provider: MD Report Released..: Feb 09, 2021@13:13 Reporting Lab....: Performing Lab...: *CHEM 7 Not Performed: Feb 09, 2021@11:33 *NP Reason: duplicate *LIPASE Not Performed: Feb 09, 2021@11:33 *NP Reason: duplicate Ordering Provider: MD Report Released..: Feb 09, 2021@12:32 Reporting Lab....: Performing Lab...: ENDOCRINE TESTS,SERUM ----SERUM TSH T-4 T%UPTK FTI T4 FRE T3 FRE E E Ref range low .35 4.5 32 5.9 .6 70 2.3 Ref range high 5 12 48 13.1 1.6 180 4.2 uIU/mL ug/dL % uptake ng/dL ng/dL pg/mL [d] Feb 09, 2021 11:30 0.78 SERUM REV T-T4 BIN PTH IN LH FSH PROLAC 3 D T T Ref range low 12.7 10 1 1 Ref range high 25.1 65 9 19 mcg/mL pg/mL mIU/mL mIU/mL ng/mL SERUM GROWTH CORTIS ALDOST ANGIO- TESTOS L E 1 Ref range low 3 9 1.53 Ref range high 16 67 8.92 ug/dL U/L ng/mL SERUM SHBG DHEA-S ESTRAD PROGES B-OHB TESTO, L T TOTAL Ref range low .02 220 Ref range high .27 892 mmol/L ng/dL SERUM LYSOZY PTH(QUEST CAROTE 25 OH GASTRI PTH pr M) N D N o Ref range low 4 20 Ref range high 51 50 mcg/dL ng/mL [d] Feb 09, 2021 11:30 26.0 SERUM PTH,MM PTH IN (Y) T d. Effective 10/16/13 - Vitamin D, Total (Screen) test should not be used when single dose 50,000 IU D2 is administered. *** For test TSH Units: mIU/mL *** Evaluation for TSH: As of Sept.27, 2011, new instrumentation is being used for TSH. Note change in reference range. Evaluation for VIT D: As of May 16, 2012, this test replaces Vit D 25-OH Panel. Results with new assay are comparable to old assay. Unexpectedly high values in patients receiving supplementation may be falsely elevated, and can be confirmed with 25-OH VITAMIN D2/3 (Rx Monitor) test if clinically indicated. Note also reference range change to reflect Institute of Medicine recommendations. See below for Scrum (25 OH) Vitamin D Concentrations vs. Health Status: Vitamin D (ng/mL): Health Status: <12 Associated with Vitamin D deficiency, leading to rickets in infants and osteomalacia in adults. 12-20 Generally considered inadequate for both bone and overall health in healthy individuals. >=20 Generally considered adequate for bone and overall health in healthy individuals. >50 Emerging evidence links potential adverse effects to such levels particularly >60 ng/mL. Ordering Provider: MD Released..: Feb 09, 2021@13:13 Reporting Lab....: Performing Lab...: HEMATOLOGY ----BLOOD Feb 26 Feb 09 Reference 2021 2021 08:45 11:29 Units Ranges---WBC 4.8 8.3 K/cmm4.5 - 11 HCT 34.7 L 36.0 L % 39.2 - 50.4 HGB 11.1 L 11.8 L g/dL 12.8 - 17 RBC 3.53 L 3.69 L M/cmm 4.23 - 5.66 MCV 98.3 97.6 fL 82 - 99 MCH 31.4 32.0 pg 26.2 - 32.6 MCHC 32.0 32.8 g/dL 30.8 - 35.1 RDW 12.7 11.9 L % 12 - 16 RETIC % .8 - 2 RETIC # K/cmm 30 - 90 RET-Hc pg ATY MON % PLT 264 239 K/cmm 140 - 360 MPV 10.5 10.3 fL 9.2 - 12.4 IPF % 1 - 7 IG % 0.2 0.6 % 0 - .7 nRBC 0.0 0.0 %/WBC 0 - 0 Gran 61.8 70.9 % 43.7 - 75.8 Lymph 24.7 16.8 % 14 - 42.3 Mono 10.6 10.1 % 5.1 - 13.7 Eosin 2.1 1.4 % .4 - 6.8 Baso 0.6 0.2 % .1 - 2 AtLym % 0 - 6 Meta % 0 - 1 Myclo % 0 - 0 Promy % 0 - 0 Blast % 0 - 0 MORPH: Ansio Poilkil Ovalo Acanth Teardp Target Polych Hypoch Bastip ToxGrn Schist Sphero ABS NEU 2.97 5.88 K/cmm 2.2 - 7.6 ABS LYM 1.19 1.40 K/cmm 1 - 3.2 PLT.EST Comments: c i c. Ordering Provider: MD Report Released..: Feb 26, 2021@09:56 Reporting Lab....: Performing Lab...: Smear made available for clinician review or clinical pathology E-consult. Ordering Provider: MD Report Released..: Feb 09, 2021@12:25 Reporting Lab....: Performing Lab...: SEDIMENTATION RATE ---- BLOOD SEDRATE ESR(WHAV) Ref range low 0 0 Ref range high 30 30 mm/hr mm/hr [c] Feb 26, 2021 08:45 80H [i] Feb 09, 2021 11:29 95 H c. Evaluation for ESR: Starting January 2016, the Hematology Laboratory will implement a new technology for the measurement of Erythrocyte Sedimentation Rates (ESR). The Laboratory will implement this change beginning July 2017. This new methodology will reduce the sample size required and improve turnaround times. The new platform, is manufactured and distributed by Agency. Normal ranges will not change, though some patient will need to have new baselines established due to increased sensitivity of the test and the fact that this technology may not be affected by low hemoglobin/hematocrit levels as the other methodologies and thus is less likely to cause false elevations in the ESR. Ordering Provider: MD Report Released..: Feb 26, 2021@09:56 Reporting Lab....: Performing Lab...: Smear made available for clinician review or clinical pathology E-consult. Ordering Provider: MD Report Released..: Feb 09, 2021@12:25 Reporting Lab....: Performing Lab...: A1C HEMOGLOBIN ----BLOOD A1C cAG % mg/dL [c] Feb 09, 2021 11:30 5.8 H 120 c. 5.7 - 6.4% Prediabetes .=6.5% Diabetic range. If the patient has not yet been diagnosed with T2DM, see Clinical Practice Guideline for Management of T2DM (dated 4/2017) for more guidance. For patients already diagnosed with T2DM, target HbA1c values should be individualized using a Shared Decision-Making process. *** For test A1C Normals: low: <=5.6 *** Ordering Provider: MD Report Released..: Feb 09, 2021@12:25 Reporting Lab..... Performing Lab...: ANEMIA TESTS-SERUM --- SERUM VIT B12 FOLATE FE TIBC FE SAT Ref range low 200 5.2 40 204 20 Ref range high 900 160 475 50 pg/mL ng/mL ug/dL % [a] Feb 26, 2021 08:45 78 389 [d] Feb 09, 2021 11:30 360 .20.0 70 363 SERUM FERRITN EP TRANSFN Ref range low 20 200 Ref range high 300 360 ng/mL mg/dL [a] Feb 26, 2021 08:45 5 L [d] Feb 09, 2021 11:30 19 L a. Evaluation for FER: Male Reference Range = 20-300 Female Reference Range = 10-200 As of Septt.27, 2011, new instrumentation is being used for FERRITIN. Not change in reference range. Ordering Provider: MD Report Released..: Feb 26, 2021@10:40 Reporting Lab....: Performing Lab...: Effective 10/16/13 - Vitamin D, Total (Screen) test should not be used when single dose 50,000 IU D2 is administered. Evaluation for VIT B12: Minor changes to reference range were implemented on 6/13/12 in order to standardize ranges across the database. Levels above 300 or 400 pg/mL are rarely associated with B12 deficiency induced hematological or neurological disease, respectively. Further testing is suggested for SYMPTOMATIC patients with B12 levels between 100 and 300 pg/mL (hematological abnormalities) and between 100 and 400 pg/mL (neurological abnormalities). *** For test FOLATE Normals: low: >=5.2 *** Evaluation for FOLATE: Minor changes to reference range were implemented on 6/13/12 in order to standardize ranges across the database. Ordering Provider: MD Report Released..: Feb 09, 2021@13:13 Reporting Lab....: Performing Lab...: TUMOR MARKERS ---- SERUM Feb 09 Reference 2021 11:30 Units Ranges--- AFP ng/mL 0 - 10 CEA ng/mL 0 - 5 PSA 0.24 ng/mL 0 - 4 CA125 CA15-3 CA19-9 CA27.29 Comments: d d. Effective 10/16/13 - Vitamin D, Total (Screen) test should not be used when single dose 50,000 IU D2 administered. Ordering Provider: MD Report Released..: Feb 09, 2021@13:13 Reporting Lab....: Performing Lab...: SERUM PROTEIN ELECTROPHORESIS & IFE ---- SERUM PROTEIN ALBUMIN ALPHA-1 ALPHA-2 BETA Ref range low 6 3.13 .19 .46 .56 Ref range high 8.5 5.37 .5 1.2 1.18 g/dL g/dL g/dL g/dL g/dL [f] Feb 09, 2021 11:29 7.4 3.81 0.32 0.95 0.84 SERUM GAMM G M-P M-P% M-P G A/G Ref range low .67 .99 Ref range high 1.67 1.81 g/dL % g/dL [f] Feb 09, 2021 11:29 1.48 1.06 SERUM IFE [g] Feb 09, 2021 11:29 comment f. SER ESSENTIALLY NORMAL SERUM PROTEIN ELECTROPHORESIS. NO PARAPROTEIN BANDS SEEN ON SPEP. SPEP reviewed by MD Ordering Provider: MD Report Released..: Feb 11, 2021@08:44 Reporting Lab....: Performing Lab...: Small M spike IgM lambda observed. Request further SPEP for measurements IEP=IMMUNOELECTROPHORESIS; IFE=IMMUNOFIXATON ELECTROPHORESIS Ordering Provider: MD Report Released..: Feb 11, 2021@08:45 Reporting Lab....: Performing Lab...: SARS-CoV-2 ANTIBODY TESTING ---- SERUM SARS-C SARS-C OV-2 oV-2 I gG Qnt gG Qua 1 Ref range low 0 Negative Ref range high 1.3 Index [b] Feb 26, 2021 08:45 0.0 Negative b. The Abbott SARS-CoV-2 IgG assay has been authorized by the FDA under an Emergency Use Authorization for use by authorized laboratories. It has not been FDA cleared or approved. Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection. Serological testing should not be used at this determine whether an individual has protective immunity or remains contagious. Test results must be considered in the context of other available clinical and laboratory findings. Negative results do not rule out SARS-COV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals. Negative results may occur in scrum collected too soon following infection, in immune suppressed patients, or in some individuals with prior mild illness. Ordering Provider: MD Report Released..: Feb 26, 2021@13:08 Reporting Lab....: Performing Lab....: MISCELLANEOUS TESTS ---- DATE TIME SPECIMEN TEST VALUE Ref ranges Feb 26, 2021@08:45 SERUM CRP,INFLAMMATION: 2.3 mg/L 0.0 - 7.9 Feb 26, 2021@08:45 SERUM TRANSFERRIN: 311 mg/dL 173 - 382 Feb 26, 2021@08:45 SERUM TRANSFERRIN SAT%:20% 15 - 45 Evaluation for CRP,INF: As of Nov 3, 2011 CRP is being performed at facility. Note change in UNITS. Numerical results are considered comparable to old method. Reference range is unchanged. Ordering Provider: MD Report Released..: Feb 26, 2021@10:40 Reporting Lab....: Performing Lab...: Feb 09, 2021@12:50 URINE: *IMMUNOFIXATION,URINE Not Performed: Feb 09, 2021@12:50 *NP Reason: see nb/wr 21 256 upep Ordering Provider: MD Reporting Lab....: Feb 09, 2021@12:11 URINE PROTEIN URINE,SPOT(WRX):<6.8 mg/dL Ref: NOT ESTABLISHED Feb 09, 2021@12:11 URINE UPEP INTERP,SPOT(WRX): No Abnormal protein present protein < 6.8 mg/dL Ordering Provider MD Report Released...: Feb 16, 2021@08:38 Reporting Lab....: Performing Lab...: Feb 09, 2021@11:30 SERUM TRANSFERRIN: 290 mg/dl 17 - 382 Feb 09, 2021@11:30 SERUM TRANSFERRING SAT%: 19 % 15 - 45 Effective 10/16/13 - Vitamin D, Total (Screen) test should not be used when single dose 50,000 IU D2 administered. Ordering Provider: MD Report Released..: Feb 09, 2021@13:13 Reporting Lab....: Performing Lab...: Feb 09, 2021@11:30 BLOOD : *CBC W/ AUTO DIFF Not Performed: Feb 09, 2021@11:52 *NP Reason: duplicate Ordering Provider: MD Reporting Lab....: FREE K/L LC RATIO: 1.94 H 0.26 - 1.65 Feb 09, 2021@11:29 SERUM KAPPA LC FREE SERUM 68.55 H mg/L 3.30 - 22.50 Feb 09, 2021@11:29 SERUM LAMBDA LC FREE SERUM: 35.39 H mg/L 5.71 - 30.50 Small M spike IgM lambda observed. Request further SPEP for measurements IEP=IMMUNOELECTROPHORESIS; IFE= IMMUNOFIXATION ELECTROPHORESIS Ordering Provider: MD Report Released..: Feb 11, 2021@08:45 Reporting Lab....: Performing Lab...: Feb 09, 2021@11:29 SERUM CRP,INFLAMMATION: 8.1 Hmg/L 0.0 - 7.9 *CHEM 7 Not performed: Feb 09, 2021@11:33 *NP Reason: duplicate *LIPASE Not Performed: Feb 09, 2021@11:33 *NP Reason: duplicate Evaluation for CRP,INF: As of Nov 3, 2011 CRP is being performed. Note change in UNITS. Numerical results are considered comparable to old method. Reference range is unchanged. Ordering Provider: MD Report Released..: Feb 09, 2021@12:32 Reporting Lab....: Performing Lab....: Feb 09, 2021@12:25 Reporting Lab....: Performing Lab...: ----BLOOD BANK ---- No ABO/Rh results. ANTIBIODIES IDENTIFIED: No Antibody results. TRANSFUSION REQUIREMENTS No Transfusion Requirements. TRANSFUSION REACTIONS: No Transfusion Reactions. AVAILABLE/ISSUED UNITS: No Available/Issued Units. DIAGNOSTIC TESTS No results. COMPONENT REQUESTS: No Component Requests. TRANSFUSED UNITS No Transfused Units.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1066829

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WA
Alter
88,0
Geschlecht
M
Eingang
02.03.2021
Impfdatum
25.02.2021
Beginn
02.03.2021
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Patient passed away in his sleep that evening after he recieved his COVI vaccine. Patient had not been ill. No other information is known.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
None known
Aktuelle Erkrankungen
-
Vorgeschichte
Atherosclerosis, PAD, CKD, Hypertension, Hyperlipidemia, Systolic Murmur, Hyperplasia fatty tissue, HX prostate cancer
Andere Medikamente
atorvastatin, amlodipine, clopidogrel, metoprolol, losartan,
Allergien
Aspirin
Vorherige Impfungen
-

VAERS 1063887

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
VA
Alter
51,0
Geschlecht
F
Eingang
01.03.2021
Impfdatum
01.03.2021
Beginn
01.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Acute myocardial infarction Dyspnoea Loss of consciousness

Symptomtext

Patient was administered the first dose in the Pfizer COVID vaccine series. During the observation portion, the patient passed out in the observation area approximately 10 minutes after receiving the dose and became non-responsive with ragged breathing. The pharmacy team responded and administered a dose of epinephrine 0.3mg to the patient immediately and called for EMS who arrived on the scene

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1044780

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WI
Alter
73,0
Geschlecht
M
Eingang
21.02.2021
Impfdatum
18.02.2021
Beginn
19.02.2021
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
AST/ALT ratio abnormal Blood lactic acid increased Diarrhoea haemorrhagic Encephalopathy Endotracheal intubation Hypotension Liver injury Septic shock

Symptomtext

SEPTIC SHOCK ACUTE LIVER INJURY ENCEPHALOPATHIC PRESENTED WITH BLOODY DIARRHEA. TRANSAMINASES IN THE 1000S. IN SEPTIC SHOCK. INTUBATED AT PRESENT

Weitere VAERSDATA-Felder
Praegender Schweregrund
Septic shock
Hospital-Tage
2,0
Labordaten
AST/ALT IN 1000 LACTATE 11.0 HYPOTENSIVE.
Aktuelle Erkrankungen
NONE
Vorgeschichte
Ulnar neuropathy (ICD10 = G56.20 / ICD9 = 354.2 / SNOMED = 367399005) Former smoker (ICD10 = Z87.891 / ICD9 = V15.82 / SNOMED = 8517006) Diabetes mellitus with neurological manifesta ... (ICD10 = E11.40 / ICD9 = 250.62 / SNOMED = 421326000) Mixed hyperlipidemia (ICD10 = E78.2 / ICD9 = 272.2 / SNOMED = 267434003) Cervical root neuropathy (ICD10 = M54.12 / ICD9 = 723.4 / SNOMED = 54404000) Chronic lymphocytic leukemia (ICD10 = C91.90 / ICD9 = 204.10 / SNOMED = 92814006) Low back pain (ICD10 = M54.5 / ICD9 = 724.2 / SNOMED = 279039007) Peripheral vascular disease (ICD10 = I73.9 / ICD9 = 443.9 / SNOMED = 400047006) Chronic kidney disease, Stage III (moderate) (ICD10 = N18.30 / ICD9 = 585.3 / SNOMED = 433144002) Chronic lymphoid leukemia (ICD10 = C91.90 / ICD9 = 204.10 / SNOMED = 92814006) Albuminuria (ICD10 = R80.9 / ICD9 = 791.0 / SNOMED = 274769005) Type 2 diabetes with diabetic gastroparesis (ICD10 = E11.43 / ICD9 = 536.3 / SNOMED = 423263001) Diabetes mellitus Type 2 with neurologic comp ... (ICD10 = E11.40 / ICD9 = 250.62 / SNOMED = 421326000) Chronic alcoholism in remission (ICD10 = F10.21 / ICD9 = 303.93 / SNOMED = 191813001) Benign essential hypertension (ICD10 = I10 / ICD9 = 401.1 / SNOMED = 1201005) Diabetes mellitus Type 2 w/ peripheral vascul ... (ICD10 = E11.51 / ICD9 = 250.72 / SNOMED = 422166005)
Andere Medikamente
P1 Current Medications: Rx: INSULIN SYRINGE/NEEDLE 28G X 1/2"0.5 ML N/A Each, Ref: 11 Instructions: Take inject Each N/A AT BEDTIME. for use with Lantus 15u qhs. dx: 250.62 Rx: GLUCOSAMINE 1500MG ORAL Capsule, Ref: 0 Inst
Allergien
NONE
Vorherige Impfungen
-

VAERS 1044569

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

kritisch
Staat
WI
Alter
85,0
Geschlecht
M
Eingang
21.02.2021
Impfdatum
17.02.2021
Beginn
20.02.2021
Tage bis Beginn
3,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Cerebral artery thrombosis Cerebrovascular accident International normalised ratio increased Magnetic resonance imaging brain abnormal Thrombotic stroke

Symptomtext

THROMBOTIC STROKE IN THE DISTRIBUTION OF THE LEFT MCA DISTRIBUTION

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
2,0
Labordaten
MRI OF THE BRAIN DOCUMENTED THE STROKE. INR ON HIS WARFARIN TREATMENT WAS LOW AT 1.7
Aktuelle Erkrankungen
acute inflammatory arthritis elbow.
Vorgeschichte
Venous insufficiency Senile cataract Arm melanoma NEVER SMOKER Obesity Stroke Carpal tunnel syndrome Osteoarthritis of hand Prediabetes Diverticulitis CONG HEART FAIL COMB, CHRON Iron deficiency anemia due to chronic blood loss Benign prostatic hypertrophy w/ urinary obstr ... Cervical degenerative disc disease SKIN CANCER SCALP Osteoarthritis of knee Atrial fibrillation Benign essential hypertension Mixed hyperlipidemia Benign prostatic hypertrophy without urinary ... Albuminuria Stage 3 Obstructive sleep apnea Reflux esophagitis Cerebral atherosclerosis Long-term (current) use of anticoagulants Former smoker Hypothyroidism Major depressive disorder, single episode, mi ... Albuminuria Stage 2 Actinic keratosis Lumbar radiculopathy Inflammatory arthritis Polymyalgia rheumatica Long term use of systemic steroid Seronegative rheumatoid arthritis Anemia, unspecified Osteoarthritis of shoulder Cervical radiculopathy Pseudogout
Andere Medikamente
: FISH OIL 900MG ORAL , Ref: 0 Instructions: Take 1200MG TWICE DAILY. Rx: VITAMIN D3 1000iu ORAL , Ref: 0 Instructions: Take ORAL DAILY. Rx: furosemide 20 mg tablet Ref: 2 Instructions: Take 1 Tablet Oral
Allergien
amoxiccillin and atorvastatin
Vorherige Impfungen
ACUTE INFLAMMATORY ARTHRITS FOLLOWING FIRST PFIZER

VAERS 2720431

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
NY
Alter
52,0
Geschlecht
M
Eingang
03.12.2023
Impfdatum
01.03.2021
Beginn
01.04.2021
Tage bis Beginn
31,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein
Electrocardiogram Syncope

Symptomtext

Late evening of 2nd vaccination shot, fainted at home (10pm) and was taken to the ER by ambulance

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
EKG, Blood Pressure
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Vit C, D, magnesium, zinc
Allergien
None
Vorherige Impfungen
-

VAERS 2697746

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TX
Alter
90,0
Geschlecht
F
Eingang
18.10.2023
Impfdatum
20.02.2021
Beginn
18.01.2022
Tage bis Beginn
332,0
Dosis
2
Route/Site
IM / LA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Bradycardia C-reactive protein increased COVID-19 Chest X-ray abnormal Endotracheal intubation Hypothermia Pleural effusion Pneumonia SARS-CoV-2 test positive Syncope

Symptomtext

Presented after collapsing at home; bradycardic, hypothermic; + covid CXR: bilat pleural effusions and PNA, Intubated in ED; labs: CRP: 11.09; Tx: Maxipime, Rocephin, Decadron, heparin; Initially on epi gtt, weaned off by day 2; family decided on comfort care

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
7,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2687715

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TX
Alter
60,0
Geschlecht
M
Eingang
28.09.2023
Impfdatum
02.03.2021
Beginn
24.12.2021
Tage bis Beginn
297,0
Dosis
2
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Anticoagulant therapy COVID-19 Chest X-ray normal Cough Fibrin D dimer increased Syncope

Symptomtext

Pt presented with syncope d/t coughing; CXR: clear; dx: Covid infection Tx: solumedrol, Vit C, Vit D3, Zinc, Singulair, lovenox; no criteria met for remdesivir or tocilizumab; minimal O2 support with 1 LPM NC; back to room air baseline by d/c; elequis continued at dc due to elevated d-dimer

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2687707

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TX
Alter
65,0
Geschlecht
F
Eingang
28.09.2023
Impfdatum
22.02.2021
Beginn
29.12.2021
Tage bis Beginn
310,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory distress syndrome Atypical pneumonia C-reactive protein increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Fibrin D dimer Headache Hypoxia Oxygen saturation decreased Respiratory tract congestion

Symptomtext

Presented wtih cough, congestion, HA, mild hypoxia; CXR: Atypical PNA Dx: Acute respiratory distress due to COVID-19 virus secondary to COVID-19 pneumonia; Labs: D-dimere 0.79; CRP: 34.61; Tx: oxygen, remdesivir, zinc, vitamin-C, dexamethasone 12/31 still desats with activity on room air; cont remdesivir and low O2; 1/2 normal sats with walking on room air; dc without O2

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory distress syndrome
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2668510

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TX
Alter
79,0
Geschlecht
F
Eingang
09.08.2023
Impfdatum
20.02.2021
Beginn
09.01.2022
Tage bis Beginn
323,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 pneumonia Cough Dyspnoea Exposure to SARS-CoV-2 Hypoxia Respiratory distress Respiratory tract congestion

Symptomtext

Presents to the ED with C/O SOB, Cough, and Congestion for the last 3-4 days, exposed to COVID.Admitted for Acute Respiratory Distress with Hypoxia, Covid Pneumonia, Hypoxia, and SOB and Cough. Tx W/ IV Decadron,Rocephin and azithromycin , Zinc,Vitamin-C, zinc, vitamin D3 replacement. Supplemental Oxygen. Remdesivir. D/C home /HHC

Weitere VAERSDATA-Felder
Praegender Schweregrund
Respiratory distress
Hospital-Tage
6,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2639116

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TX
Alter
68,0
Geschlecht
F
Eingang
31.05.2023
Impfdatum
29.01.2021
Beginn
16.04.2021
Tage bis Beginn
77,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Diplopia Hypoaesthesia Laboratory test Lymphadenopathy Malaise Myalgia Paranasal sinus hypersecretion Pyrexia Rash Secretion discharge Swelling VIth nerve paralysis

Symptomtext

Started getting sick after my second dose of Pfizer EN6198 on 02/26/2021. Head started swelling and felt sick all over my body. My left sinus area and throat was producing excess mucus. Muscle pain and joint pain with fever. Lymph nodes in neck and under arms were swollen. Rash on chest too. Caused 6th nerve palsy and double vision. I had gone to the ER at Hospital on 04/21/2021 and tests were run and I didn't test postive for Covid19. They released me and I continued to feel sick for months. I have also had numbness and tingling in hands and feet. Lots of burning in the feet that continue to present day. My double vision is still present. I continue to have repeating symptoms. Numbness on nose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
VIth nerve paralysis
Hospital-Tage
-
Labordaten
Medical Center on 04/21/2021. Eye Center on 04/28/2021.
Aktuelle Erkrankungen
hashimoto's endrocrine disorder
Vorgeschichte
numbness, tingling and burning in feet. Numbness and tingling in hand. muscle cramping in legs, feet and hands.
Andere Medikamente
synthroid 100mcg; 81mg asprin
Allergien
Leviquin and strong antibiotics if given in too much
Vorherige Impfungen
-

VAERS 2632259

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6198

schwer
Staat
-
Alter
62,0
Geschlecht
F
Eingang
15.05.2023
Impfdatum
27.02.2021
Beginn
27.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Thrombosis Ultrasound scan

Symptomtext

blood clot

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
ultrasound
Aktuelle Erkrankungen
-
Vorgeschichte
Diabetes
Andere Medikamente
-
Allergien
immitrex
Vorherige Impfungen
-

VAERS 2624848

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
67,0
Geschlecht
F
Eingang
02.05.2023
Impfdatum
17.10.2021
Beginn
03.03.2022
Tage bis Beginn
137,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Ischaemic stroke Obstructive sleep apnoea syndrome

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE OBSTRUCTIVE SLEEP APNEA ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY

Weitere VAERSDATA-Felder
Praegender Schweregrund
Ischaemic stroke
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2610194

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6198

schwer
Staat
-
Alter
65,0
Geschlecht
F
Eingang
05.04.2023
Impfdatum
23.02.2021
Beginn
03.04.2023
Tage bis Beginn
769,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Laboratory test Myocarditis

Symptomtext

myocarditis

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
-
Labordaten
MCG 4/3/23
Aktuelle Erkrankungen
na
Vorgeschichte
na
Andere Medikamente
na
Allergien
na
Vorherige Impfungen
-

VAERS 2559523

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
FL
Alter
55,0
Geschlecht
F
Eingang
13.01.2023
Impfdatum
22.03.2021
Beginn
25.03.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test abnormal Feeling abnormal Guillain-Barre syndrome Hypertension Inflammation Pain in extremity Plantar fasciitis Tinnitus

Symptomtext

Tinnitus (ringing in ears), higher than before blood pressure, pain in extremities, brain fog, plantar fasciitis, inflammation. Have been under a doctors care for remedies. Nothing has made substantial difference, however, the pain and inflammation has subsided a bit.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
-
Labordaten
Has full blood panel and subsequent blood testing for Gillian Bar, etc. on 09/28/2022
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2539118

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MI
Alter
89,0
Geschlecht
F
Eingang
21.12.2022
Impfdatum
04.03.2021
Beginn
07.10.2022
Tage bis Beginn
582,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Computerised tomogram normal Confusional state Coronary arterial stent insertion Coronary artery disease Fall COVID-19 Cardiac pacemaker evaluation Catheterisation cardiac abnormal Chest X-ray normal Computerised tomogram head normal Implantable defibrillator insertion Percutaneous coronary intervention Post procedural complication Pyrexia SARS-CoV-2 test positive Skin laceration Syncope Troponin increased

Symptomtext

90y.o. male with multiple medical problems including CAD, dementia, paroxysmal atrial fibrillation, sick sinus syndrome status post permanent pacemaker who presented to ED on 10/7/2022 from a local hospital for cardiology consultation. Patient was evaluated at the hospital after sustaining a fall/syncopal episode. Per notes his wife heard a noise and found patient on the floor. He had a scalp laceration that was repaired at a facility. His PPM was interrogated and showed a 2-minute run of V. tach. Troponin was elevated (175, 378, 504, 663). He underwent cardiac cath on 10/9 which showed multivessel disease, successful PCI and stent placement. Family requested transfer to our facility as this is where he receives most of his care. Patient was placed on IV heparin drip. CT head/cervical spine negative, chest x-ray, pelvic x-ray negative. He is now S/P post pacemaker upgrade to ICD implant by Dr. on 10/11/22. Pts post-operative course was complicated by confusion, fevers due to COVID-19 infection. He is s/p remdesivir and dexamethasone and has since been removed from isolation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
10/13 SARS-CoV-2 -COVID-19 by NAA, Micro -- detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2529310

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
NV
Alter
66,0
Geschlecht
F
Eingang
12.12.2022
Impfdatum
26.02.2021
Beginn
05.09.2022
Tage bis Beginn
556,0
Dosis
1
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Aortic thrombosis Pelvic venous thrombosis Renal vascular thrombosis Surgery Vascular graft

Symptomtext

S/P SURGERGY FOR PELVIC CLOTS AND RENAL CLOTS AND AORTA - AND BYPASS DONE ON THE LOWER EXT.. LEG / FOOT HEALING BETTER WITH IMPROVED VASCULAR FLOW.. PT SUSPECTS THAT THE VACCINE TRIGGERED THE MANY CLOTS.. SUGGESTED TO REPORT TO VAERS.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Aortic thrombosis
Hospital-Tage
4,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2481441

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
89,0
Geschlecht
M
Eingang
14.10.2022
Impfdatum
01.03.2021
Beginn
23.07.2022
Tage bis Beginn
509,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 Febrile neutropenia Intensive care Pneumonia SARS-CoV-2 test positive Sepsis

Symptomtext

Narrative: Fully vaccinated, COVID positive on admission to ICU for neutropenic fever. Patient treated for septic pneumonia and COVID

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2470535

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MI
Alter
-
Geschlecht
F
Eingang
06.10.2022
Impfdatum
22.08.2022
Beginn
28.08.2022
Tage bis Beginn
6,0
Dosis
3
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 pneumonia Drug ineffective Haemodynamic instability Hypoxia Oxygen saturation decreased Pneumothorax Respiratory distress SARS-CoV-2 antibody test

Symptomtext

Haemodynamic instability; Respiratory distress; Hypoxia; Pneumothorax; COVID-19 pneumonia; COVID-19 pneumonia; This is a spontaneous report received from a non-contactable reporter(s) (Consumer). A 68-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Aug2022 as dose 4 (booster), single (Lot number: FK9894) for COVID-19 immunization; BNT162b2 (BNT162B2), on 08Feb2021 as dose 1, single (Lot number: EL9269), as dose 2, single (Lot number: EN6198) and as dose 3 (booster), single (Lot number: FH8028) for COVID-19 immunization. The patient's relevant medical history included: "Seronegative RA" (unspecified if ongoing). The patient's concomitant medications were not reported. The patient had positive SARS-CoV-2 IgG (Anti-Spike) on 23Aug2022. The patient had COVID-19 pneumonia in 2022 (positive SARS-COV-2 antibody test) presented for worsening shortness of breath (SOB). In the emergency room (ER), the patient was hypoxic requiring high flow nasal cannula (HFNC) 100% with Fi02/50 L and a nonrebreather maintaining SP02 in the early 90s. A significant increase in work of breathing was noted and patient was intubated. On 28Aug2022, the patient developed respiratory distress. Patient had a needle decompression and then chest tube placement for right sided tension pneumothorax. Patient was unable to be weaned off ventilator and on 05Sep2022 had a drop in Sp02 with increased WOB. The patient required multiple pressors for hemodynamic instability. She was then transitioned to comfort care and passed peacefully that evening of 06Sep2022. The reported cause of death: "COVID-19 pneumonia", "Haemodynamic instability", "Hypoxia", "Pneumothorax", "Respiratory distress". It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: COVID-19 pneumonia; Haemodynamic instability; Hypoxia; Pneumothorax; Respiratory distress

Weitere VAERSDATA-Felder
Praegender Schweregrund
Respiratory distress
Hospital-Tage
-
Labordaten
Test Date: 2022; Test Name: SP02; Result Unstructured Data: Test Result:Decreased; Comments: in the early 90s; Test Date: 20220905; Test Name: SP02; Result Unstructured Data: Test Result:drop; Test Date: 2022; Test Name: SARS-COV-2 antibody test; Test Result: Positive ; Test Date: 20220823; Test Name: SARS-CoV-2 IgG (Anti-Spike); Test Result: Positive
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Seronegative rheumatoid arthritis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2453564

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MI
Alter
75,0
Geschlecht
F
Eingang
21.09.2022
Impfdatum
03.03.2021
Beginn
24.08.2022
Tage bis Beginn
539,0
Dosis
1
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Asthenia COVID-19 Cardiac monitoring Chest pain Confusional state Cough Dialysis Hypophagia Intensive care Lethargy SARS-CoV-2 test positive

Symptomtext

Patient to ED 8/24 ED for Dialysis from Nursing home. Patient COVID+ 8/24. 8/25 patient remains very weak with infrequent non productive cough. 8/26 Patient A0X4, denies any complaints of CP/SOB. 8/29 patient is resting with no dyspnea, poor oral intake, on nasal cannula. 8/31 patient respirations even and unlabored and chest expansion is symmetrical. Patient placed on cardiac monitor, denies shortness of breath or chest pain. 9/3 patient is A&Ox4, on RA, no signs of respiratory distress noted. 9/7 transferred out of the ICU, is resting and weak. 9/8 patient is A&O x 2-3 with periods of confusion, lethargic, denies any SOB/chest pain, no S/S of acute distress. Patient complaining of chest pain, worsened by cough. 9/14 patient discharged.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
15,0
Labordaten
see above
Aktuelle Erkrankungen
None
Vorgeschichte
Bronchospasm with bronchitis, acute Pulmonary emphysema (CMS/HCC), Acute exacerbation of chronic obstructive pulmonary disease (COPD) (CMS/HCC), Bilateral pleural effusion Adynamic ileus (CMS/HCC), Carotid stenosis, Subclavian artery stenosis, left Subclavian steal syndrome, Claudication of right lower extremity, SOB (shortness of breath), Coronary artery disease of native artery of native heart with stable angina pectoris (CMS/HCC), Mixed hyperlipidemia, Essential hypertension, Mitral valve insufficiency, Aortic ectasia (CMS/HCC), PAD (peripheral artery disease) (CMS/HCC), Obesity (BMI 30-39.9), CKD (chronic kidney disease), stage IV (CMS/HCC), Hyperkalemia Edema of both legs, Pericardial effusion, Paroxysmal atrial fibrillation (CMS/HCC), Iron deficiency anemia due to chronic blood loss A-fib (CMS/HCC), Persistent atrial fibrillation (CMS/HCC), Septic shock (CMS/HCC), Acquired thrombocytopenia (CMS/HCC), Acute urinary retention, Hydronephrosis, right Hypothermia, Atrial fibrillation with RVR (CMS/HCC), ESRD (end stage renal disease) (CMS/HCC)
Andere Medikamente
albuterol (PROVENTIL, VENTOLIN, PROAIR) HFA 108 (90 Base), MCG/ACT INHAL Aero Soln, amiodarone (CORDARONE, PACERONE) 200 MG PO Tab, aspirin (ECOTRIN) 81 MG PO Tablet Delayed Response, atorvastatin (LIPITOR) 40 MG PO Tab, B complex-vitamin c
Allergien
Iodinated Diagnostic Agents, Sulfa Antibiotics, Codeine, Meperidine HCL
Vorherige Impfungen
-

VAERS 2433424

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MI
Alter
65,0
Geschlecht
F
Eingang
08.09.2022
Impfdatum
02.03.2021
Beginn
14.08.2022
Tage bis Beginn
530,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Confusional state Cough Diabetic ketoacidosis Dyspnoea Intensive care Nausea Respiratory distress SARS-CoV-2 test positive Vomiting

Symptomtext

66-year-old female brought into the emergency room history of diabetes difficulty with breathing, nausea and vomiting last 2 to 3 days. Patient a little more awake and alert than on admission. Patient is still confused about how long she has been in the hospital. History of camping with their motor home in Park the week of 24 July. There for 3 to 4 days with her grandchildren. Apparently one of the grandchildren started to feel ill on the way home 27th 28th. Patient has been home with some respiratory distress. Patient was tested at home 8/10 tested positive they called primary care and was given a prescription for Paxlovid. Patient states she took it on the 10th 11th and 12th and on the morning of admission here. Patient had progressive nausea and vomiting over the last 2 to 3 days. Patient was noted to require O2 in the ER placed on 2 L with progression over the next 24 hours. Patient has been evaluated by MICU, currently on 6 to 7 L. Breathing better. Patient maintained on the floor. Infectious diseases been asked to assist. Patient able to call her husband to verify dates. Infectious disease has been asked to assist. Patient has cough shortness of breath does not require home O2 normally. She was found to have COVID and was in DKA. She received dexamethasone 6 mg daily, now complete.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
10,0
Labordaten
8/14 SARS-CoV-2 (COVID-19) by Nucleic Acid Amplification, POC-- detected
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2429798

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6198

schwer
Staat
NY
Alter
68,0
Geschlecht
F
Eingang
06.09.2022
Impfdatum
18.03.2021
Beginn
18.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Loose tooth Loss of consciousness Pain Pain in extremity Pyrexia Sleep disorder Syncope Tremor

Symptomtext

My arm started to hurt in the evening, nothing major. The big problem was that I PASSED OUT a few minutes after I got up the next day, so 03/19/21. I was in the bathroom washing my hands at the sink, and then I woke up on the bathroom floor. I don't know how long I was out, but I felt like it was not very long. PLEASE NOTE, this happened to me again after the Booster shot I had on 10/01/21. I don't know if I can make a second report about that date, so I add it here. My side effects were much worse after the Booster. More pain, fever, chills, shaking, teeth chattering so hard that one tooth was loosened. I could not get to sleep for hours, so I got up later the next day, but again, I PASSED OUT a couple of minutes after I got up the next day. I had been on the landline phone when I passed out, so it was the noise that the phone makes when it isn't hung up that woke me from my faint.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
There were no tests or labs done as a result. I didn't think too much about it the first time it happened, and when I mentioned it to my Primary Care Physician at my annual check up months later, she thought the passing out was not related to the shot. When it happened again after the booster, she didn't know what was going on, and was going to look into it, but I got no information from her, and she has since retired. I went to a new doctor for my annual exam last week, and she has promised to look into it, and gave me this website to report the issue. So I have no information or suggestions, and I am now afraid to get a second booster!
Aktuelle Erkrankungen
None
Vorgeschichte
High Blood Pressure-- controlled. High Cholesterol, still a little high. Thyroid issue controlled.
Andere Medikamente
Levothyroxine 50 mcg, Anastrazole 1 mg, Losartin potassium 50 mg, Pravastatin Sodium 20 mg, Nature's Bounty women's gummy vitamins
Allergien
None that I know of
Vorherige Impfungen
-

VAERS 2335160

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CA
Alter
60,0
Geschlecht
F
Eingang
25.06.2022
Impfdatum
24.02.2021
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Disturbance in attention Guillain-Barre syndrome Muscular weakness Polymerase chain reaction Pyrexia Somnolence

Symptomtext

Giulian-Barre syndrome with fever; Giulian-Barre syndrome with fever; severe muscle weakness; somnolence; difficulties focusing; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient. A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Feb2021 at 15:45 as dose 2, single (Lot number: EN6198) at the age of 60 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Migraine headache" (unspecified if ongoing); "Hypertension intermittent" (unspecified if ongoing), notes: Hypertension intermittent. There were no concomitant medications. Patient did not receive any other vaccine on same day and not receive other vaccine in four weeks. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EN5318, Location of injection: Arm Left, Vaccine Administration Time: 01:30 PM, Route of Administration: Intramuscular), administration date: 04Feb2021, for COVID-19 immunization, reaction(s): "difficulties focusing and completing tasks", "Guillain Barre syndrome", "fever", "severe muscle weakness", "somnolence". The following information was reported: GUILLAIN-BARRE SYNDROME (medically significant), PYREXIA (non-serious), outcome "recovered with sequelae" and all described as "Giulian-Barre syndrome with fever"; MUSCULAR WEAKNESS (non-serious), outcome "recovered with sequelae", described as "severe muscle weakness"; SOMNOLENCE (non-serious), outcome "recovered with sequelae"; DISTURBANCE IN ATTENTION (non-serious), outcome "recovered with sequelae", described as "difficulties focusing". The patient underwent the following laboratory tests and procedures: Polymerase chain reaction: (13Dec2020) Negative, notes: Nasal Swab; (13Jan2022) Negative, notes: Nasal Swab; (07Mar2022) Negative, notes: Nasal Swab; (27Apr2022) Negative, notes: Nasal Swab. Therapeutic measures were taken as a result of guillain-barre syndrome, pyrexia, muscular weakness, somnolence, disturbance in attention with bed rest, valacyclovir 1000 mg PO QID and ibuprofen 400 mg PO TID. Patient received BNT162b2 (BNT162B2), on 06Feb2022 at 15:45 as dose 3, single (Lot number: unknown) intramuscular, in left arm for covid-19 immunisation. Clinical course: It was reported that patient experienced giulian-barre syndrome with fever, severe muscle weakness, somnolence, difficulties focusing and completing tasks for 2 and 3 weeks after 2nd vaccination.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the event guillain-barre syndrome and the use of suspect product BNT162b2 cannot be fully excluded. The case will be reassessed once further information is available The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
-
Labordaten
Test Date: 20201213; Test Name: PCR; Result Unstructured Data: Test Result:Negative; Comments: Nasal Swab; Test Date: 20220113; Test Name: PCR; Result Unstructured Data: Test Result:Negative; Comments: Nasal Swab; Test Date: 20220307; Test Name: PCR; Result Unstructured Data: Test Result:Negative; Comments: Nasal Swab; Test Date: 20220427; Test Name: PCR; Result Unstructured Data: Test Result:Negative; Comments: Nasal Swab
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Hypertension (Hypertension intermittent); Migraine headache
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278293

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
IL
Alter
33,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
04.02.2021
Beginn
05.02.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Asthma Condition aggravated Headache Immunisation reaction Impaired work ability Laboratory test Thrombosis

Symptomtext

First vaccination, I had a headache. Then for the 2nd vaccination, I had ended up in the hospital, the shot triggered my asthma, I had to miss a couple of days of work. The third vaccination, booster, I had a headache. The last booster, I ended up in the emergency room from 2:30pm -3am, they thought I had blood clots, and my asthma was acting up, I had an asthma attack as well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
1,0
Labordaten
Yes, while I was at the hospital (they all said it is the shot)
Aktuelle Erkrankungen
None
Vorgeschichte
Asthma
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2234200

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CT
Alter
65,0
Geschlecht
M
Eingang
14.04.2022
Impfdatum
01.10.2021
Beginn
13.02.2022
Tage bis Beginn
135,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Atrioventricular block complete Cardiac pacemaker insertion Cardiac stress test normal Dyspnoea Electrocardiogram abnormal Electrocardiogram normal Intensive care Nausea Syncope X-ray

Symptomtext

On 2/13, I fainted while sitting on the couch. Went to see Dr on 2/17 who found an abnormal EKG. On 2/18 and 2/23 I had an ECG and Chemical Stress test. Both were normal On 2/27 I woke up during the night unable to breathe, and became nauseous. We were at our daughters in another state at the time. My wife accompanied me to Medical Ctr, where I was found to be in complete heart blockage. My BP on admittance was 156/90 and a pulse of 21. I was put on an external pacemaker immediately and a permanent one was implanted on Monday, 2/28. We flew back to CT on Friday 3/4. I have since followed up with Dr., Dr. (Cardiologist) and will see Dr. on 5/5

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
2,0
Labordaten
Multiple EKGs, XRays related to ER visit first, then admittance to the CCU post implant
Aktuelle Erkrankungen
-
Vorgeschichte
Diabetic, environmental allergies, allergic asthma
Andere Medikamente
Trulicity, Jardiance, Metformin, Pravastatin, Paroxetine, Benezapril, Omeprazole
Allergien
Codeine if injected
Vorherige Impfungen
-

VAERS 2206427

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MI
Alter
95,0
Geschlecht
M
Eingang
30.03.2022
Impfdatum
19.03.2021
Beginn
11.12.2021
Tage bis Beginn
267,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory distress syndrome Asthenia Blood calcium decreased Blood creatinine normal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Culture negative Fatigue Haemoglobin decreased Hypotension Leukocytosis Lung infiltration Pneumonia Procalcitonin SARS-CoV-2 test positive Urine analysis normal White blood cell count increased

Symptomtext

Patient presented to the ER with chief complaint of weakness and fatigue. He was diagnosed with COVID-19 pneumonia on December 11th, he spent 2 days in the hospital during which her received a course of Decadron and supplemental oxygen. He was discharged home on the 12/12/2021. Patient returned 10 days later. In the ER, the patient was hypotensive but improved. Labs were significant for creatinine of 1.1, calcium 7.6, leukocytosis 13.26, hemoglobin 11.1, procalcitonin 0.23. UA was negative for UTI and chest x-ray revealed interval stable patchy bilateral pulmonary infiltrates presumably acute distress disease. Patient was started on empiric cefepime and vancomycin for hospital-acquired pneumonia. Pt improved in strength during his hospital stay and weaned off oxygen. Pt's respiratory cultures did not have any growth and he remained afebrile and no signs of infection were evident, hence antibiotics were discontinued.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory distress syndrome
Hospital-Tage
7,0
Labordaten
Positive COVID 19 test on 12/11/21
Aktuelle Erkrankungen
-
Vorgeschichte
09 11 09 Degenerative disc disease 09 11 09 Spinal stenosis 1998 CAD (coronary artery disease) Date Unknown Arthritis Date Unknown Borderline high cholesterol 03/12/18 Closed displaced transverse fracture of left patella Date Unknown HTN (hypertension) Date Unknown Hypertension
Andere Medikamente
aspirin EC (HALFPRIN) 81 MG PO TBEC isosorbide mononitrate (IMDUR) 60 MG SR tablets metoprolol tartrate (LOPRESSOR) 25 MG tablet Naproxen Sodium 220 MG CAPS tamsulosin (FLOMAX) 0.4 MG CAPS capsule
Allergien
Penicillin, Chlorhexidine.
Vorherige Impfungen
-

VAERS 2148331

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
KY
Alter
80,0
Geschlecht
M
Eingang
28.02.2022
Impfdatum
19.02.2021
Beginn
18.02.2022
Tage bis Beginn
364,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Anaemia Anticoagulant therapy COVID-19 COVID-19 pneumonia Colonoscopy normal Cryptosporidiosis infection Deep vein thrombosis Diarrhoea Gastritis HIV test negative Oesophageal candidiasis Oesophagogastroduodenoscopy abnormal Stool analysis abnormal

Symptomtext

Hospital Course: This elderly man was admitted with diarrhea and anemia. He also had covid pneumonia. He was treated for covid with remdesivir and steroids. He has done well. He is breathing much better and has no wheezing today. He had diarrhea. Stool studies showed cryptosporidium. He was seen by ID and was treated for this. HIV screening negative. Diarrhea has resolved He has been anemic. EGD showed candida esophagitis and gastritis. Colonoscopy was limited due to prep but did not show major pathology. He had DVT while here. He had been on coumadin PTA. He will go home on eliquis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
8,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, PAF, cardiomyopathy, CHF, HLD, COPD, chronic kidney disease
Andere Medikamente
synthroid, proair, D3, Proventil, Flomax, Lipitor,ASA, coreg, Norco,duoneb, protonix, symbicort
Allergien
nka
Vorherige Impfungen
-

VAERS 2129150

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TX
Alter
71,0
Geschlecht
M
Eingang
21.02.2022
Impfdatum
20.02.2021
Beginn
12.09.2021
Tage bis Beginn
204,0
Dosis
2
Route/Site
IM / OT
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute kidney injury Anxiety Bradycardia COVID-19 COVID-19 pneumonia Chest pain Cough Dyspnoea Hypotension Intensive care SARS-CoV-2 test positive

Symptomtext

Presented with CP, anxiety, SOB, nonproductive cough; + Covid-19 in ED; admitted to ICU with hypotension, bradycardia, Covid-19 PNA, AKI; treated with O2, remdesivir, steroids, zinc; TX to tele 9/14. DC home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
9,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2098834

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
82,0
Geschlecht
M
Eingang
09.02.2022
Impfdatum
25.02.2021
Beginn
08.02.2022
Tage bis Beginn
348,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute pulmonary oedema Body temperature increased COVID-19 pneumonia Diarrhoea Dyspnoea Fatigue

Symptomtext

Admitted to hospital on 2/8 with COVID-19 pneumonia. Patient is a 83 y.o. never smoker with a history of ESRD, hypertension, BPH who presents to a local ER chief complaint of fatigue and admitted for acute pulmonary edema. Patient severely hard of hearing; however, answering questions appropriately including orientation reports recent diarrhea for approximately 3 weeks and reportedly noted improvement prior to hospital evaluation. Developed fatigue and shortness of breath beginning 2/8/2022 with reported elevated temperature 99; therefore, sought ER for evaluation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute pulmonary oedema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2050746

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MI
Alter
78,0
Geschlecht
M
Eingang
20.01.2022
Impfdatum
04.10.2021
Beginn
19.01.2022
Tage bis Beginn
107,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Abdominal pain upper Acute respiratory distress syndrome Blood lactic acid increased Bronchitis COVID-19 Chest X-ray abnormal Computerised tomogram thorax abnormal Cough Diarrhoea Dyspnoea Gastroenteritis Hypoxia Intensive care Leukocytosis Lung infiltration Palpitations Pneumonia Respiratory symptom

Symptomtext

Chief Complaint: Difficulty breathing Additional Medical History: Patient presents to the emergency department with complaint of cough and difficulty breathing that has been ongoing since 2022-01-06. Patient was diagnosed with COVID-19 teen on that date. His initial symptoms had been consistent with a gastroenteritis he had come complaining of epigastric pain diarrhea and vomiting he did have some slight cough at the time so he was tested and subsequently found to be positive he was not hypoxic at the time so he was discharged and instructed to get outpatient monoclonal antibody therapy as he was at risk. Patient has developed progressive shortness of breath since presents now with difficulty breathing and palpitations nonproductive cough. I questioned him about his advanced wishes regarding mechanical ventilation, and he does not want to be on a ventilator though he is willing to allow us to try BiPAP.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory distress syndrome
Hospital-Tage
1,0
Labordaten
79-year-old hypertensive, type II diabetic, not a known case of coronary artery disease, known case of chronic lymphocytic leukemia admitted from the emergency room when he presented with worsening of breathing, noted to be hypoxic, appears septic with elevated lactic acid level, leukocytosis and tachycardia. CT scan of the chest evident of right-sided middle and lower lobe pneumonic infiltrate. Patient was initially seen in the emergency room on December 31 with upper respiratory symptoms, was diagnosed with bronchitis, patient revisited emergency room on January 6, 2022, found to have COVID-19 positive, patient was discharged home and was given with monoclonal antibodies as an outpatient. Though at that visit his x-ray did show evidence of extensive pneumonia on the right side. Patient continued to get worse with breathing with persisting cough, came to the emergency room noted to be in acute respiratory distress and hospitalized. Sepsis protocol been initiated and ICU, given with fluid bolus and started with fluid. Started on IV Zosyn. Patient was given with remdesivir to the ER, though pharmacist consider it out of window since patient was diagnosed 10 days ago. Patient requiring high flow oxygen up to 5 to 6 L. Patient have vest not to be intubated. Patient denying for any chest pain, noted to be significantly short of breath and tachycardiac. Patient denies for any fever or chills, denies any nausea or vomiting. Patient is not a smoker, denies for any alcohol or drug use. Past medical history: 1. Chronic lymphocytic leukemia of B-cell type not having achieved remission, diagnosis confirmed January 28, 2021, received chemotherapy by oncologist 5 of planned 6 cycles March 2021 through October 2021. Patient apparently has to be on Acalabrutinib 100 mg twice a day,
Aktuelle Erkrankungen
CLL
Vorgeschichte
CLL DM HTN anxiety arthritis
Andere Medikamente
Current Home Medications 1. atorvastatin 40 mg oral tablet : 1 tab(s) orally once a day (at bedtime) 2. clonazePAM 0.5 mg oral tablet : 2 tab(s) orally 3 times a day 3. hydrochlorothiazide-quinapril 12.5 mg-20 mg oral tablet : 1 tab(s) oral
Allergien
none known
Vorherige Impfungen
-

VAERS 2043569

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge EN6198

schwer
Staat
FL
Alter
48,0
Geschlecht
M
Eingang
18.01.2022
Impfdatum
14.05.2021
Beginn
15.01.2022
Tage bis Beginn
246,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
COVID-19 Intensive care Mechanical ventilation Positive end-expiratory pressure Respiratory distress SARS-CoV-2 test positive Tachypnoea Tracheostomy

Symptomtext

49-year-old male who presented to the emergency department from Hospital for "respiratory distress." Patient tested positive for COVID-19 on January 13, 2022. When EMS arrived at Hospital the patient was satting at 97% and tachypneic. Patient has arrived to the intensive care unit at where he is on ventilator support via tracheostomy, 40% FiO2 and 5 of PEEP without respiratory distress.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, Afib, DM, glaucoma, gout, GERD, urinary retention
Andere Medikamente
-
Allergien
sulfa drugs
Vorherige Impfungen
-

VAERS 2039365

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
KY
Alter
92,0
Geschlecht
M
Eingang
17.01.2022
Impfdatum
18.11.2021
Beginn
15.01.2022
Tage bis Beginn
58,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory distress syndrome COVID-19 SARS-CoV-2 test positive

Symptomtext

COVID-19 infection resulting in hospitalization, ARDS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory distress syndrome
Hospital-Tage
3,0
Labordaten
COVID-19 PCR (+) 1/13/22
Aktuelle Erkrankungen
NONE
Vorgeschichte
Chest pain ? Coronary artery disease involving native coronary artery of native heart with unstable angina pectoris ? Difficulty walking ? Elevated troponin ? Hyperlipidemia ? Hypothyroidism ? Lightheadedness ? Pulmonary edema ? Third degree AV block
Andere Medikamente
acetaminophen (TYLENOL) 325 MG tablet Nursing Home Yes Yes Take 650 mg by mouth Every 4 (Four) Hours As Needed for Mild Pain . aluminum-magnesium hydroxide-simethicone (Antacid) 200-200-20 MG/5ML suspension Nursing Home Yes Yes T
Allergien
Shellfish-derived products, Shrimp flavor, Azithromycin, and Codeine
Vorherige Impfungen
-

VAERS 2028406

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
FL
Alter
85,0
Geschlecht
F
Eingang
12.01.2022
Impfdatum
01.10.2021
Beginn
11.01.2022
Tage bis Beginn
102,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Dyspnoea Intensive care Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

comes to ICU for dyspnea. Patient was beginning to have dyspnea 4 days ago and went to outpatient center for COVID testing. She was vaccinated x3 with pfizer. She came back positive and developed worsening dyspnea calling EMS. Upon arrival, per report, O2 saturations were in 50s and placed on NRB support with improvement in oxygenation. Patient was placed on HHFNC in the ED but still dyspneic and subsequently placed on BiPAP On arrival to ICU, patient was on BiPAP 10/5, 80% with MV around 7-8 and TV in 400s comfortable not in respiratory distress and speaking in full sentences without any drips.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
hypertension, left MCA territory CVA with no residual deficits, coronary artery disease, peripheral artery disease, hy
Andere Medikamente
-
Allergien
Codeine
Vorherige Impfungen
-

VAERS 2022241

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MN
Alter
72,0
Geschlecht
F
Eingang
10.01.2022
Impfdatum
28.02.2021
Beginn
01.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal discomfort Abdominal pain upper Dehydration Diarrhoea Feeding disorder Insomnia Loss of consciousness Nausea Vomiting Weight decreased

Symptomtext

I experienced nausea, vomiting, diarrhea the day after the injection. This lasted for about 6 hours. After that, I experienced excruciating stomach pain so intense that it was impossible to get to sleep. This pain lasted about 3 days. After the pain lessened and I was able to rest, the symptoms of stomach upset endured for 7 days. I was unable to eat and lost 10 pounds. On day 9, I began having blacking out spells because of extreme dehydration. I began to take small amounts of gatorade. My eating intake did not return to normal until about day 13 following the injection.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
I called Nurse line at one point. They recommended I come in to the Urgent Care. I was not able to come in because I was so sick to my stomach.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Cholestoff, Konsyl, Multivitamin
Allergien
None
Vorherige Impfungen
-

VAERS 2021991

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MD
Alter
29,0
Geschlecht
F
Eingang
10.01.2022
Impfdatum
10.03.2021
Beginn
01.04.2021
Tage bis Beginn
22,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Heavy menstrual bleeding Menstruation irregular Muscle spasms Oligomenorrhoea Rash Skin reaction Thrombosis

Symptomtext

Abnormally heavy menstrual cycles that last 8+ days (used to last 5-6 days). Heavy clotting spells that last hours, leading to lightheadedness/the verge of fainting. Bleeding through heavy duty tampons in less than an hour. Extreme breakouts on chin, about 10-20 blemishes when approaching menstrual cycle. Severe cramping, doubled over in pain when approaching menstrual cycle/on menstrual cycle. Period is now either early or late, never on time like it had been since I was 13 (I'm now 30).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2010192

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MI
Alter
77,0
Geschlecht
M
Eingang
06.01.2022
Impfdatum
02.03.2021
Beginn
28.12.2021
Tage bis Beginn
301,0
Dosis
2
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
COVID-19 Cardiomegaly Chest X-ray abnormal Chest pain Dyspnoea Pleural effusion Pulmonary oedema Respiratory distress SARS-CoV-2 test positive Syncope Visceral congestion Vomiting

Symptomtext

12/28/2021: Event occurred after 2nd vaccine. Patient had a syncopal event during his hemodialysis session early today. Patient tested positive for Covid-19 in current admission. Hx of COPD, CAD, post CABG. COPD on 2 to 3 L of oxygen at home, Denies any fever, chills, nausea, vomiting or diarrhea. During evaluation of the patient, he got short of breath and was experiecing increase work of breathing through purse lips. Patient having moderate chest pain. He had an episode of vomiting. Nitro did not improved the chest pain. He was placed on a non rebreather mask and received breathing treatments which mildly improved his respiratory distress and his chest pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary oedema
Hospital-Tage
2,0
Labordaten
12/28/2021: Chest Xray- No significant change in degree of interstitial pulmonary edema with cardiomegaly, bilateral pleural effusions, central vascular congestion and curly B lines. 12/28: SarsCOV2 - positive
Aktuelle Erkrankungen
unknown
Vorgeschichte
End stage renal disease On dialysis, COPD, Diabetes
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2530213

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
75,0
Geschlecht
M
Eingang
04.01.2022
Impfdatum
11.03.2021
Beginn
19.04.2021
Tage bis Beginn
39,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Adverse drug reaction Anticoagulant therapy Deep vein thrombosis Peripheral swelling Platelet count normal

Symptomtext

Narrative: Patient is a 74 year-old male who received his first COVID vaccine on 2/16 and his second dose on 3/11. On 4/19, patient presented to the emergency department with lower extremity swelling, and was found to have bilateral LE DVTs. He was started on apixaban (started with VTE initiation dose) for his event. Per our ID pharmacy evaluation: Vaccine induced thrombosis has been shown to be associated with the Johnson and Johnson vaccine (and Astrazeneca though this is not available for use in this country) which is an adenovirus vaccine. VIT typically occurs within 30 days of vaccine receipt and is often accompanied by low platelets. This association between vaccine and thrombosis has not been shown with the MRNA vaccine (Pfizer or Moderna). It is unlikely that DVT is 2/2 COVID vaccine. Patient received MRNA vaccine which has not been shown to be associated with VIT. Additionally PLTS are wnl and patient has other risk factors for thrombosis such as obesity (BMI ~34), paraplegia (decreased mobility), history of prior thrombosis, and history of cancer. Event is being reported as an ADR given it was within 6 weeks of the vaccine administration.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2500279

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
45,0
Geschlecht
M
Eingang
02.01.2022
Impfdatum
16.03.2021
Beginn
03.04.2021
Tage bis Beginn
18,0
Dosis
UNK
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Pericardial excision Pericarditis

Symptomtext

Narrative: INITALLY ADMITTED ON 03/25 WITH ACUTE PERICARDITIS AND DISCHARGED ON 03/27. THEN RE-ADMITTED ON 04/03 WITH ACUTE PERICARDITIS AND REQUIRED AN EMERGENT PERICARDIAL WINDOW BY CARDIOTHORACIC SURGERY.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pericarditis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1992043

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
-
Geschlecht
M
Eingang
30.12.2021
Impfdatum
23.02.2021
Beginn
18.10.2021
Tage bis Beginn
237,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory distress syndrome Anticoagulant therapy Atrial fibrillation COVID-19 COVID-19 pneumonia Endotracheal intubation Mental status changes Metabolic encephalopathy Renal impairment SARS-CoV-2 test positive

Symptomtext

COVID + on 10/18/2021. Pnuemonia due to COVID 19 virus. Altered menal status. Metabolic encephalopathy. New onset a-fib. ARDS. The patient was treated aggressively with IV steroids, remdesivir, and baricitinib. The patient could not make it on his own. He has to be intubated. He was able to be extubated. The patient was kept on Eliquis 5 mg p.o. twice daily. His kidney function did resolve and came back to normal. Discharged to rehab.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory distress syndrome
Hospital-Tage
30,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1961863

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
FL
Alter
66,0
Geschlecht
F
Eingang
18.12.2021
Impfdatum
03.03.2021
Beginn
04.04.2021
Tage bis Beginn
32,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Antinuclear antibody negative Blood test normal Blood thyroid stimulating hormone Dizziness Dysphagia Electric shock sensation Full blood count normal Gingival discolouration Limb discomfort Lipids normal Magnetic resonance imaging head normal Metabolic function test Neurological examination normal Paraesthesia Paraesthesia oral Rheumatoid factor negative Throat irritation Tinnitus

Symptomtext

April 4, 2021: Prickling like pins and needles/tingling in hands, forearms, lower legs, lips, tongue, roof of mouth, back of throat. Difficulty swallowing. Pale gums. Dizziness. Vertigo. Heavy legs. Tinnitus - severe. Feeling like electrical current moving throughout entire body. Reactions started 4/4/21 and continued throughout 4/30/2021. Reactions came in waves. On April 4, 2021 sudden onset. Called 911; transported to Emergency Room. Symptoms subsided; released. April 8, 2021: again called 911 transported to ER. Waited 3 hours; symptoms subsided so I went home. I have seen my PCP 4 times. 10/27/21 appt. with a Neurologist who said nothing was wrong with me and I should take a second vaccine; consider Moderna. A 11/16/21 appt. with an Immunologist/Allergist with a follow-up appt. in February.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
4/9/2021: tests (ordered by PCP). All results were within Normal range: Blood Panel, Comprehensive Metabolic Panel, Lipid Panel, Standard, TSH, CBC, Vitamin B12, Rheumatoid Factor, ANA Screen, IFA, w/REFL Titer and Pattern. 9/27/2021: Brain MRI - normal.
Aktuelle Erkrankungen
None
Vorgeschichte
SVT. COPD - mild. Allergies to pollen, grasses, dust, cat dander.
Andere Medikamente
Metoprolol ER Succinate 25 mg per day. D-Mannose supplement (Urinary tract health). Omega 3. Calcium 600 mg plus Vit D. Visbiome (probiotic)
Allergien
Sulfa (childhood reaction). Ciprofloxacin - severe reaction in 2016. Possible recent reaction to Latex - October 2021.
Vorherige Impfungen
-

VAERS 1951679

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TX
Alter
63,0
Geschlecht
F
Eingang
15.12.2021
Impfdatum
02.03.2021
Beginn
02.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Aortic thrombosis Blood test Computerised tomogram Electric shock sensation Hypoaesthesia Magnetic resonance imaging Migraine Pain in extremity Transient ischaemic attack

Symptomtext

I felt shot going into corroded artery into head, it numbed left side of face and I developed migraine on right arm. I had 2 episodes since this started. Last event I had to be care flighted from the local hospital to the stroke ward of a different. Blood clot found in aorta at hospital. Classified as TIA which triggers strokes currently.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Aortic thrombosis
Hospital-Tage
3,0
Labordaten
CT Scan; MRI; Blood Panel.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Hydrochlorothiazide; Metformin; Lisinopril; Atorvastatin
Allergien
Tramadol
Vorherige Impfungen
-

VAERS 1936371

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
OH
Alter
67,0
Geschlecht
F
Eingang
09.12.2021
Impfdatum
12.03.2021
Beginn
23.11.2021
Tage bis Beginn
256,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory distress syndrome COVID-19 Pneumonia SARS-CoV-2 test positive

Symptomtext

2019 Novel Coronavirus RNA detected 11/26/2021 Hospitalized 12/3/2021 DX Pneumonia and ARDS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory distress syndrome
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
COPD
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1928838

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CT
Alter
74,0
Geschlecht
F
Eingang
07.12.2021
Impfdatum
08.03.2021
Beginn
10.03.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Atrial fibrillation Cardiac ablation Cardiac monitoring abnormal Chills Dizziness Echocardiogram abnormal Electrocardiogram abnormal Fatigue Fear Head injury Heart rate increased Impaired work ability Ligament sprain Loss of consciousness

Symptomtext

On 03/09/2021, after having my second Covid vaccine, I had chills and was very fatigued but that went away by 2:30 PM. The next day, 03/10/2021, I awoke after sleeping very deep and when I went to walk, I PASSED OUT, hit my head and wrenched my neck. I put on an watch later that morning and within a few hours it alerted me that I was in Atrial Fibrillation. The AFIB came on with a vengeance. My heart rate was high and I headed to the ER about 6:00 PM. I was diagnosed with AFIB and was admitted to the hospital and put on medication. I saw my own cardiologist for a few months. The AFIB continued to get worse during the spring and I went to an electrophysiologist and it was suggested I get an ablation but it but it couldn't be scheduled for three months due to the EP's full schedule. During the summer I had events where I would feel like I was going to pass out unless I sat down. If effected my work because I would have episodes where I just had to sit all day due to how I would feel. I had two (summer & fall 2020) episodes prior to my 2nd Covid shot, but nothing was really ever diagnosed except one time the monitor recorded an SVT - Paroxysmal Supraventricular Tachycardia. The second Covid shot really changed my life and not for the better. I finally had my heart ablation on 11/4/2021. Now I wait, in the blanking period, to see if it was successful or not. I'm very concerned about getting the booster shot -- fearful it will make me have another heart situation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
1,0
Labordaten
3/10/2021 - Heart monitor 3/11/2021 - echocardiogram Various EKG's, echocardiograms & three week monitor on various dates
Aktuelle Erkrankungen
none
Vorgeschichte
hypothryoidism, non-specific autoimmune disease, dupuytren's disease
Andere Medikamente
Synthroid, minocycline, lisinopril, baby aspirin, vitamin D, p, Omega 3, probiotic
Allergien
penicillin, sulfa drugs, macrodantin, demerol
Vorherige Impfungen
-

VAERS 1900057

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
WV
Alter
71,0
Geschlecht
F
Eingang
25.11.2021
Impfdatum
21.10.2021
Beginn
22.11.2021
Tage bis Beginn
32,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Abnormal behaviour Amnesia Angiogram abnormal Angiogram cerebral abnormal Base excess increased Blood glucose normal Cerebral small vessel ischaemic disease Chest X-ray normal Confusional state Facial paralysis Fall Feeling abnormal Haemoglobin decreased Headache Hemiparesis Loss of consciousness Neurological symptom PCO2 increased

Symptomtext

Dr. note- H&P: chief complaint: syncopy & stroke-like symptoms HPI: femail with medical history of hypertension, hyperlipidemia, frequent falls who presents with syncopal event. Patient was at her usual health state as of this morning. She left home to go shopping with her daughter. Her daughter was still at home and when she came out patient was found on the grass, unconscious. EMS was called, patient woke up and had 2 episodes of emesis. According to EMS report it was reported that patient had left-sided facial droop and left-sided weakness. Upon arrival to the ED patient did not have any focal weakness or facial droop. Patient does not remember what happened or how she fell. At the CTA head and neck, she was found to have 2 mm subarachnoid hemorrhage on the right parietal lobe. There is no external signs of head trauma after her fall. Patient does not remember how she was transferred to the hospital. At the time of my exam she is complaining about slight headache. She denies any shortness of breath, chest pain, abdominal pain, focal weakness, numbness, speech abnormality. Husband at the bedside, reports that patient had 2-3 falls within last couple of weeks. However when she fell previously, she did not pass out. Her other falls were related to imbalance and they were mostly mechanical falls. Patient denies any incontinence after today?s event, denies any seizure-like activity. She was confused after the event but got back to her baseline quickly. Will admit for further workup and treatment related to subarachnoid hemorrhage and syncopy. Diagnoses: subarachnoid hemorrhage, hyperlipidemia, major depressive disorder, diabetes mellitus type 2 Dr. note- ED: chief complaint: stroke symptoms HPI: 71 y.o. femail who presents to the ED for stroke symptoms. Patient was getting ready to go shopping with a family member earlier today 11/22/21 and was found on the ground by the car. Per EMS patient?s daughter said that shortly after lunch patient ?wasn?t acting right,? had left sided weakness, and a left facial droop. She had two episodes of emesis while being lifted onto stretcher. Patient says that she is no is any pain but ?feels out of it.? She has had no recent illness but is diabetic and had back surgery in July, 2021. Family member states that she is alert and oriented at baseline. Patient denies chest pain, shortness of breath, abdominal pain, fever, chills, or any other symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
2,0
Labordaten
CT angio intra-extra cranial w IV contrast (head-neck): Impression: no large vessel occlusion, small amount of subarachnoid hemorrhage noted in the right parietal region. Extensive small vessel ischemic changes without evidence of acute territorial infarct. CXR: Impression: normal appearance of lungs. Vital Signs: BP- 148/74, HR- 82, RR- 17, Temp 98.1 F, SpO2- 94% on room air Labs: PCO2 (venous)- 61mm/Hg, Base excess- 6.1mmol/L, HGB- 11g/dL, glucose- 96
Aktuelle Erkrankungen
-
Vorgeschichte
Past Medical History: b12 deficiency, right breast CA, diabetes mellitus type 2, GAD, GERD, HTN, hyperlipidemia, macular degeneration, magnesium deficiency, mass of upper lobe of right lung, major depressive disorder, osteoarthritis of both hands, renal cyst, vitreous hemorrhage of right eye Past Surgical History: De quervain?s release, fixation kyphoplasty, Hx back surgery, Hx breast biopsy, Hx breast lumpectomy, Hx cataract removal, Hx knee arthroscopy, Hx tonsillectomy, Hx dental extraction
Andere Medikamente
Medications: tylenol, fosamax, arimidex, ecotrin, lipitor, betamethasone dipropionate, vitamin b12, cymbalta DR, lexapro, feratab, flonase, zestoretic, mag-ox, glucophage XR, Toprol-XL, prilosec, ozempic, tresiba flextouch, aristocort cream
Allergien
Allergies: Band-Aid Plus Antibiotic, Actos
Vorherige Impfungen
-

VAERS 1894205

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
NY
Alter
75,0
Geschlecht
M
Eingang
23.11.2021
Impfdatum
26.02.2021
Beginn
03.09.2021
Tage bis Beginn
189,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Accessory spleen Anticoagulant therapy Asthenia Colectomy Computerised tomogram head abnormal Condition aggravated Confusional state Constipation Diarrhoea Encephalomalacia Enema administration Facial paralysis Gastrectomy Haematoma Intensive care Laparoscopic surgery Neurological examination Pancreatectomy

Symptomtext

TOTAL HOSPITAL COURSE: Patient is a 76M PMHx of HTN, HLD, CKD, a-fib on Xarelto, h/o CVA 10 years ago, BPH, CHF (EF > 50%) presents with distal pancreatic mass, concerning for malignant mucinous cyst s/p laparoscopic converted to open distal pancreatectomy en bloc resection with splenectomy, partial gastrectomy, and partial colectomy on 11/9. Initially confused post-operatively, improved after pca, Dilaudid and Benadryl dc'd. Admitted to the ICU for required pressor support and post-op monitoring and management.Diarrhea has resolved after Colace dc'd. On 11/17 patient developed weakness and facial droop overnight concerning for stroke/TIA, self-resolved after 1 hr. Pt transferred to medicine, neurology consulted, started on edoxaban, ASA, atorvastatin. Meningococcal, and H.flu vaccines given, PPSV23 given. COVID booster given. CT head 11/19 encephalomalacia of the left cerebellum, otherwise neg. MRI deferred for staples s/p abd surg. Patient had constipation which resolved with docusate and enema. Given deconditioning and prolonged stay in hospital, over weekend patient developed a possible mild pneumonia as evidenced by respiratory symptoms and an elevated WBC(15.6). Patient remains stable and SAR would further assist in clearance of secretions. He was also started on IV Zosyn, and WBCs downtrending to 11.7 today. Will be transitined to Augmentin PO upon discharge to SAR. Excision pathology from Surgery 11/19: - PANCREATIC PSEUDOCYST WITH ORGANIZING MURAL HEMATOMA. - LOW-GRADE PANCREATIC INTRAEPITHELIAL NEOPLASIA. - BACKGROUND CHRONIC PANCREATITIS. - SMALL ACCESSORY SPLEEN. - COLON, SPLEEN, AND STOMACH WITHOUT DIAGNOSTIC ALTERATION. - NO CARCINOMA IDENTIFIED. - NINE BENIGN LYMPH NODES.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
14,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
PMH: Benign essential hypertension Hyperlipidemia Benign prostatic hypertrophy with outflow obstruction Degeneration of lumbar intervertebral disc Vitamin D deficiency History of calculus of kidney Cerebral infarction due to embolism of cerebral arteries Diarrhea History of polyp of colon Anxiety Atrial fibrillation Chronic kidney disease stage 3 Acute exacerbation of chronic congestive heart failure Mass of pancreas
Andere Medikamente
ACTIVE OUTPATIENT MEDICATIONS ******************************************************************************** ATENOLOL 25MG TAB TAKE ONE TABLET BY MOUTH EVERY DAY FOR HEART --
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 1890671

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MI
Alter
55,0
Geschlecht
M
Eingang
22.11.2021
Impfdatum
03.11.2021
Beginn
11.11.2021
Tage bis Beginn
8,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute kidney injury COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chronic kidney disease Dyspnoea Dyspnoea exertional Exposure to SARS-CoV-2 Hypoxia Infection Oxygen saturation decreased Peripheral swelling Pulmonary oedema SARS-CoV-2 test positive Ultrasound Doppler normal Wheezing

Symptomtext

Hospitalized 11/11/2021; COVID 19 positive 11/11/2021; Fully vaccinated plus booster BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: DO Admission Date: 11/11/2021 Discharge Date: Nov 13, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] Chronic kidney disease, unspecified CKD stage [N18.9] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1] HOSPITAL COURSE: Pt is a 55 yr old M with PMHx of NICMP s/p Bi Vent ICD, Chronic systolic CHF, Morbid Obesity, OSA on BiPAP at night, HTN, GERD, Full vaccinated against COVID with recent booster vaccine presented to ED on 11/11 after testing positive for COVID 19. Pt was exposed to his wife - who tested positive on 11/8. Patient noted that he was short of breath and hypoxic (on pulse ox at home) with activity. Upon ED - eval, patient required 2L O2. Chest X ray concerning for mild pulmonary vascular and interstitial prominence - pulmonary edema vs underlying infection. Pt admitted for COVID-19 pneumonia - started on Decadron and Remdesivir. Right leg noted to be enlarged - US lower extremities negative for DVT. patient responded rapidly to remdesivir and dexamethasone. he had a slight AKI for which he was encouraged to hydrate and instructed to hold his entresto for two days, he was also set up with a follow-up lab. when i saw him he was in good spirits with no objections to leaving, he was actually comfortable on room air (was supposed to be wearing his oxygen) though did have some DOE. patient seen by pulmonary rehab prior to discharge and sent out on dexamethasone as well. all questions and concerns addressed, all meds and follow-ups reviewed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary oedema
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
Office visit notes on 11/11/2021: Assessment / Plan: 1. Shortness of breath - DR CHEST 2 VIEWS FRONTAL AND LATERAL; Future 2. Contact with and (suspected) exposure to covid-19 The patient is was visibly short of breath with ambulation with a desaturation of 84% on room air. He has bibasilar wheezing. Chest x-ray is suspicious for pulmonary edema versus infection. The patient is sent to the emergency department via personal vehicle. The patient declines an ambulance for transportation at this time Subjective: Patient ID: The patient is a 55 y.o. male Chief Complaint: BREATHING PROBLEM (Hard to breathe for the past few days. Feels like he has something in his lungs. His wife was diagnosed today with covid ) and COVID-19 HPI The patient presents to the walk-in clinic with a chief complaint of difficulty breathing for the past few days. He states he has had bronchitis in the past and feels very similar. His wife was tested for COVID on Monday and had a positive test result today. He denies any fevers, sore throat, ear pain, or sinus congestion. He is fully vaccinated and received his booster vaccine 8 days ago.
Vorgeschichte
OSA (obstructive sleep apnea) Non-ischemic cardiomyopathy (HCC) HTN (hypertension) ICD (implantable cardioverter-defibrillator) discharge VF (ventricular fibrillation) (HCC) GERD (gastroesophageal reflux disease) Morbid obesity with BMI of 60.0-69.9, adult (HCC) Tubular adenoma of colon COVID-19 Chronic kidney disease (CKD), stage III (moderate) (HCC) Status post laparotomy Primary osteoarthritis of both knees Compliance poor
Andere Medikamente
Ascorbic Acid (VITAMIN C) 500 MG CHEW aspirin (ASPIRIN LOW DOSE) 81 MG tablet carvedilol (COREG) 25 MG tablet Cholecalciferol (VITAMIN D3) 2000 units TABS dexamethasone (DECADRON) 6 MG tablet (Expired) ferrous sulfate 325 (65 Fe) MG tablet
Allergien
NKA
Vorherige Impfungen
-

VAERS 1869612

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
UT
Alter
72,0
Geschlecht
F
Eingang
15.11.2021
Impfdatum
29.09.2021
Beginn
30.10.2021
Tage bis Beginn
31,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Bronchitis Chest discomfort Cough Electric shock sensation Headache Pyrexia SARS-CoV-2 test

Symptomtext

Within 24 hours of having the Booster I became bedridden with a fever, headache, and electrical shocks running from my cranium all the way down to my fingers and toes. After a few days the fever and shocks subsided, but i got a terrible cough was weak. I treated with OTC DayQuil for several days and finally on Oct 18 called my family Dr. near closing time. She told me I should go to Urgent care. I did so and saw a PA-C. I told him I had not felt well since taking the covid booster and now had a painful cough. They did a covid test which was negative and did an X-ray it was determined that I had bronchitis and was Rx'd augmentin and a strong cough medicine. that helped the bronchitis, but I still suffer from weak spells and electrical shocks which leave me weak. It interferes with my ADL and I still don't feel normal.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
Chest x-ray and covid test October 18,2021
Aktuelle Erkrankungen
none
Vorgeschichte
migraine headaches
Andere Medikamente
verapamil, magnesium, multi vitiamin,
Allergien
codeine
Vorherige Impfungen
-

VAERS 1843281

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
WA
Alter
73,0
Geschlecht
F
Eingang
04.11.2021
Impfdatum
28.02.2021
Beginn
28.02.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Electric shock sensation Headache Immediate post-injection reaction Induration Lymph node pain Lymphadenopathy Neck pain Neuralgia Pain Pyrexia Sensation of foreign body Swelling Ultrasound scan abnormal

Symptomtext

Reacted to all 3 doses of the vaccine. For all doses had swollen glands. Dose 1: swollen glands, slight fever, frequent headaches, glands were under chin area and beneath the tongue. Sensation of golf ball underneath throat, did not see the doctor, just waited it out. Dose 2: Similar symptoms to dose 1, except experienced chills, temperature was stable. Dose 3: Swollen glands were underneath the ears in the back like two hard peas, immediately after the dose, the swelling has not gone down. 2 weeks before 11/4 experienced sharp shooting pain behind the ear, felt like unbearable nerve pain, lightning bolts. The pain did not subside, so went to urgent care on recommendation of a consulting nurse. At urgent care, did ultrasound on the neck, and felt that lymph nodes in the neck were swollen (not just under the chin), under the armpits, near the groin. Advised to apply heat on the neck, not given any medication. Then went to lymphatic massage therapist a week later (week before 11/4). Did a massage to try and soothe some of the lymphnode pain, as the nodes were pushing on the nerves causing pain. The entire lymphatic system was swollen overall. Still having some neck pain and swelling.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
Bleeding Disorder (vonwillibram's factor); Asthma (stress-induced mostly); prone to bronchitis and sinusitis
Andere Medikamente
Potassium chloride; atorvastatin; montelukast; amlodipine; hydrochlorothiazide; vitamin D3; probiotics; krill oil; vitamin C; calcium; CENTUM SILVER; melatonin; TYLENOL; diphenhydramine
Allergien
Cephalexin; sulfa drugs; philofolates; aminofytocides; surgical tape; peaches; plums; nectarines; green bananas (unripe); avocados
Vorherige Impfungen
-

VAERS 1775256

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CA
Alter
69,0
Geschlecht
F
Eingang
09.10.2021
Impfdatum
04.03.2021
Beginn
21.09.2021
Tage bis Beginn
201,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Arthralgia Atrial fibrillation Cardiac monitoring Chest pain Computerised tomogram abnormal Dyspnoea Echocardiogram Electrocardiogram Pericardial effusion Pericarditis SARS-CoV-2 test

Symptomtext

Left shoulder and chest pain; shortness of breath starting at 6:00 pm September 21. Rest of day felt fine - had dental appointment and worked normal work day. Early morning September 22, woke about 3:00 am and went to ER with difficulting breathing and increased chest and shoulder pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pericarditis
Hospital-Tage
-
Labordaten
ER did EKG, COVID Test, CT Scan and diagnosed mild pericardial effusion. They said it is pretty common and they are seeing more cases of this condition. Following Monday, the 27th, saw the cardiologist and had an echocardiogram. Started Heart Monitor which ended Oct 8. Thursday, Sep 30, had a Cardiac CT Scan during which I was in Atrial Fibrillation Tests confirmed diagnosis of pericarditis.
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension
Andere Medikamente
Metoprolol ER Succinate 50 mg tablets Lisinopril 40 mg tablets Felodipine 5 mg ER tablets
Allergien
Hydrochlorothiazide
Vorherige Impfungen
tetanus shot at university over 45 years ago

VAERS 1758894

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
PA
Alter
74,0
Geschlecht
F
Eingang
04.10.2021
Impfdatum
26.02.2021
Beginn
11.09.2021
Tage bis Beginn
197,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Adenovirus test Angiogram pulmonary abnormal Aortic arteriosclerosis Arteriosclerosis coronary artery Asthenia Bordetella test negative COVID-19 Cardiac telemetry normal Chest X-ray normal Chlamydia test negative Computerised tomogram thorax abnormal Coronavirus test negative Cough Dizziness Dyspnoea Electrocardiogram normal Emphysema

Symptomtext

ED to Hosp-Admission Discharged 9/13/2021 - 9/15/2021 (2 days) MD Last attending ? Treatment team Syncope and collapse Principal problem Presenting Problem/History of Present Illness/Reason for Admission Syncope and collapse [R55] AKI (acute kidney injury) (CMS/HCC) [N17.9] Syncope, unspecified syncope type [R55] COVID-19 virus infection [U07.1] 74-year-old female past medical history of stable cerebral aneurysm, routinely follows in the outpatient setting, COPD, essential hypertension, polymyalgia rheumatica, vertigo presented to the ER with near syncopal episodes. Still feeling very weak for the past 3 to 4 days she was going to the bathroom she felt dizzy and was about to pass out. In the ED she was tested positive for COVID-19, CT angiogram of the chest was negative for PE given her elevated D-dimer, her orthostatic vitals were positive, she was hydrated her blood pressure medications were adjusted. She was told to follow-up with her PCP in the outpatient setting for further blood pressure medication adjustment if required. Also a Zio patch was placed on her to rule out any arrhythmia while in the hospital telemetry and EKGs were unremarkable. She was discharged home in a stable condition. Patient does not require any oxygen for her COVID-19.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
2,0
Labordaten
09/13/21 1958 Respiratory virus detection panel Collected: 09/13/21 1812 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result Detected Critical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Syncytial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected Procedure Component Value Ref Range Date/Time X-ray chest 1 view - Portable Resulted: 09/14/21 1009 Order Status: Completed Updated: 09/14/21 1009 Narrative: XR CHEST 1 VW PORT IMPRESSION: No acute findings. NB: Radiography can be negative in the early of stage of COVID 19 pneumonia. END OF IMPRESSION: INDICATION: syncope, vomiting, cough Cough. COVID 19 positive 9/13/2021. TECHNIQUE: Portable AP projection of the chest was acquired. COMPARISON: 4/20/2021. 10/20/2017. 11/14/2008. FINDINGS: EKG wires and tubing project over the thorax. An implanted geometric metallic device again projects at the base of the neck on the left, and has been present since 2008. The heart size is normal. The vascular distribution is normal. Aortic calcifications are present. Splenic arterial calcifications including calcified splenic aneurysm are again seen. The lungs are clear. No pleural effusion is identified. There is no evidence of pneumothorax. Mild thoracic dextrocurve and bilateral AC arthrosis are noted. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. CT angiogram chest pulmonary embolism with and without contrast (Abnormal) Resulted: 09/13/21 2247 Order Status: Completed Updated: 09/13/21 2247 Narrative: PROCEDURE INFORMATION: Exam: CTA Chest Without And With Contrast Exam date and time: 9/13/2021 9:03 PM Age: 74 years old Clinical indication: Shortness of breath; Additional info: Syncope, elevated d-dimer covid+. Syncope, covid positive, elevated d-dimer TECHNIQUE: Imaging protocol: Computed tomographic angiography of the chest without and with contrast. 3D rendering (Not supervised by radiologist): MIP and/or 3D reconstructed images were created by the technologist. Radiation optimization: All CT scans at this facility use at least one of these dose optimization techniques: automated exposure control; mA and/or kV adjustment per patient size (includes targeted exams where dose is matched to clinical indication); or iterative reconstruction. Contrast material: Contrast volume: 80 ml; Contrast route: INTRAVENOUS (IV); COMPARISON: CT CHEST WO CONTRAST 11/17/2020 10:57 AM FINDINGS: Pulmonary arteries: Normal. No pulmonary emboli. Aorta: Moderate atherosclerotic changes within the aorta. Lungs: Patchy airspace disease identified at left base as well as both upper lobes, may represent early developing covid pneumonia. Underlying pulmonary emphysema. Pleural spaces: Unremarkable. No pneumothorax. No pleural effusion. Heart: Moderate to severe coronary atherosclerosis. Mediastinal space: Mild hiatal hernia. Lymph nodes: Unremarkable. No enlarged lymph nodes. Bones/joints: Unremarkable. No acute fracture. Soft tissues: Unremarkable. Other findings: No acute filling defect. IMPRESSION: No acute pulmonary emboli. Patchy airspace disease identified at left base as well as both upper lobes, may represent early developing covid pneumonia.
Aktuelle Erkrankungen
-
Vorgeschichte
Nervous Cerebrovascular accident (CVA), unspecified mechanism (CMS/HCC) Lumbar radiculopathy Polymyalgia rheumatica (CMS/HCC) Paralysis of right vocal cord Syncope and collapse Respiratory Chronic obstructive pulmonary disease (CMS/HCC) Circulatory Cerebral arterial aneurysm Benign essential hypertension Genitourinary Left kidney mass Renal cell carcinoma of left kidney (CMS/HCC) CKD (chronic kidney disease), stage III (CMS/HCC) Musculoskeletal Osteoporosis Lumbar herniated disc Lumbar spondylosis Spondylosis of cervical region without myelopathy or radiculopathy Endocrine/Metabolic Hyperlipidemia Hypothyroidism Prerenal azotemia Other Recurrent major depressive disorder (CMS/HCC) Anxiety Depression Ground glass opacity present on imaging of lung Controlled substance agreement signed H/O left nephrectomy
Andere Medikamente
ALPRAZolam (XANAX) 0.5 mg tablet aspirin 81 mg tablet atorvastatin (LIPITOR) 40 mg tablet levothyroxine (SYNTHROID) 88 mcg tablet lisinopriL (ZESTRIL) 5 mg tablet omeprazole (PriLOSEC) 20 mg capsule predniSONE (DELTASONE) 10 mg tablet
Allergien
Keflex [Cephalexin]Other (document details in comments)
Vorherige Impfungen
-

VAERS 1745393

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MN
Alter
67,0
Geschlecht
F
Eingang
29.09.2021
Impfdatum
06.02.2021
Beginn
28.08.2021
Tage bis Beginn
203,0
Dosis
2
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Blood pressure decreased COVID-19 Dyspnoea Endotracheal intubation Intensive care Oxygen saturation decreased Positive airway pressure therapy Respiratory distress SARS-CoV-2 test positive

Symptomtext

Briefly, this patient is a 68 year old female presenting in respiratory distress. She was diagnosed with Covid 4 weeks ago. She has been at home recently with home O2. She notes the gradual onset of increasing work of breathing to where EMS was called. She was satting 60% on their arrival, and CPAP raised her to 80%. She arrived awake and alert, in respiratory distress. We could not get her above 85% despite settings of 18/10 with 100% on BiPap, so we intubated her. She initially had improved Bps but they have now dropped so we are starting a norepi drip. Admitting to the ICU for further care.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
-
Labordaten
Coronavirus 2 PCR Detect, V symptomatic POSITIVE
Aktuelle Erkrankungen
-
Vorgeschichte
Hospital Pneumonia Due To COVID-19 Acute Respiratory Failure With Hypoxia Failure Heart Biventricular Acidosis Metabolic Non-Hospital Major Depressive Disorder Single Episode Unspecified Depressive Disorder Hypertension Diabetes Mellitus Type 2 Exudative Age-Related Macular Degeneration With Active Choroidal Neovascularization Left Intraocular Lens Implant Status Post Detachment Vitreous Posterior Bilateral Exudative Age-Related Macular Degeneration With Active Choroidal Neovascularization Right
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1740946

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MI
Alter
71,0
Geschlecht
M
Eingang
28.09.2021
Impfdatum
23.03.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Chest X-ray Computerised tomogram head Computerised tomogram spine Headache Pneumonia Pyrexia SARS-CoV-2 test Syncope

Symptomtext

syncope, headaches, fever, pneumonia.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
CHEST 2 VIEWS FRONTAL/LATERAL. 9/27/ 2021 COVID test.9/27/ 2021 CT HEAD W/O IV CONTRAST-9/27/ 2021. CT CERVICAL SPINE W/O IV CONTRAST. 9/27/ 2021.
Aktuelle Erkrankungen
None
Vorgeschichte
Subarachnoid hemorrhage. CVA.
Andere Medikamente
atorvastatin, Colestipol, GLUCOSAMINE-CHONDROIT-VIT C-MN PO, Magnesium Lactate, THERAGRAN, PARoxetine, Psyllium, thiamine, KEPPRA.
Allergien
None
Vorherige Impfungen
-

VAERS 1736002

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6198

schwer
Staat
CA
Alter
66,0
Geschlecht
M
Eingang
26.09.2021
Impfdatum
24.02.2021
Beginn
24.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fall Head injury Syncope

Symptomtext

client reported 2 hrs after vaccine had syncope episode lasting a few seconds. Per client fell and hit head. Client stated followed up with medical provider.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
hypertension, diabetes, high cholesterol
Andere Medikamente
unable to recall names
Allergien
none
Vorherige Impfungen
-

VAERS 1708573

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MI
Alter
71,0
Geschlecht
M
Eingang
17.09.2021
Impfdatum
04.02.2021
Beginn
05.09.2021
Tage bis Beginn
213,0
Dosis
2
Route/Site
SYR / AR
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Pyrexia Respiratory distress

Symptomtext

The patient has multiple health issues, so exact time of onset and symptoms are hard to diagnose, but patient presents with respiratory distress, fever (may be due to sepsis)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Respiratory distress
Hospital-Tage
13,0
Labordaten
-
Aktuelle Erkrankungen
Type 2 Diabetes, prostate cancer, multiple myeloma, atrial fibrilation, chronic diastolic heart failure, end stage renal disease on dialysis, stroke, hypertension, hypothyroid, left ventrical hypertrophy
Vorgeschichte
Type 2 Diabetes, prostate cancer, multiple myeloma, atrial fibrilation, chronic diastolic heart failure, end stage renal disease on dialysis, stroke, hypertension, hypothyroid, left ventrical hypertrophy
Andere Medikamente
Allopurinol 100 mg Tab 100 mg 1 tab(s), PO (oral), qDay Amiodarone 200 mg Tab 400 mg 2 tab(s), PO (oral), bid Aspirin 81 mg Chew 81 mg 1 tab(s), PO (oral), qDay Atorvastatin 40 mg Tab 80 mg 2 tab(s), PO (oral), at bedtime Calcium Carbon
Allergien
NKA
Vorherige Impfungen
-

VAERS 1708482

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
WA
Alter
47,0
Geschlecht
F
Eingang
17.09.2021
Impfdatum
13.03.2021
Beginn
13.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Chest pain Contusion Disorientation Immediate post-injection reaction Loss of consciousness Malaise Pain in extremity

Symptomtext

Immediately following the injection, I stood up and a sharp, painful shooting pain shot from my arm across my chest on the left side. I remember saying I don't feel good, then lost consciousness. I have vague recollection of someone slapping my face, yelling I can't get a pulse, get an AED, and I lost consciousness again. When I came to I was surrounded by multiple staff and very disoriented. One nurse apologized to me saying I might have a bruise on my chest because she thumped me when they couldn't get a pulse. I'd never opened my eyes till after that. They called for an ambulance and called my husband who was close by. Paramedics arrived and assessed me ready to take me to the hospital, but I refused just wanting to go home and to bed. I was, and still am, very shaken by the event. Now I don't know what to do about being fully vaccinated. Can I get the Janssen, I asked my rheumatologists and they said absolutely not to the 2nd mRNA and that there's little research about the risk of the JJ as a second. What are people like me to do as we are ostracized from society unable to get a 2nd shot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Lupus
Andere Medikamente
Plaquenil 200mg
Allergien
None
Vorherige Impfungen
-

VAERS 1693621

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
WA
Alter
41,0
Geschlecht
F
Eingang
12.09.2021
Impfdatum
09.03.2021
Beginn
12.03.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Asthenia Blood test Central nervous system lesion Clonic convulsion Condition aggravated Inflammation Laboratory test Magnetic resonance imaging abnormal Multiple sclerosis Multiple sclerosis relapse Tremor Visual impairment Weight decreased

Symptomtext

I haven't had a MS relapse in 6 years, I went of of my copaxone in March 2020 I wasn't on any MS at time of Vaccine, I had an MRI 2019 that was normal. After the vaccine I clinic seizures, it happened out of blue in morning when I got up. The ambulance was called I went To clinic had an MRI My original lesion load doubled and all new ones were active, new lesions on brain and cervical spine. I was put on IV solumedrol for 3 days to bring down the inflammation . I was having weakness, shakiness, visual issues lost about 20lbs in 3 weeks. I went to primary care could not do anything because he had no experience. I'm seeing a new MS specialist. Dr. started me on ocrevus , before he went on a leave.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Clonic convulsion
Hospital-Tage
3,0
Labordaten
MRI, blood work, and more I can't even remember.
Aktuelle Erkrankungen
-
Vorgeschichte
MS
Andere Medikamente
tylenol
Allergien
penicillin
Vorherige Impfungen
-

VAERS 1682870

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
FL
Alter
69,0
Geschlecht
M
Eingang
08.09.2021
Impfdatum
06.03.2021
Beginn
06.09.2021
Tage bis Beginn
184,0
Dosis
2
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
COVID-19 Chills Decreased appetite Musculoskeletal discomfort Pyrexia SARS-CoV-2 test positive Syncope

Symptomtext

Patient presented to facility with syncope, neck pressure, decreased appetite, chills, fevers. Pt was admitted to facility.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
COVID PCR test was performed no 9/6/21 and was positive.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1648862

UNKNOWN MANUFACTURER · PNEUMO (NO BRAND NAME) · Charge EN6198

schwer
Staat
DE
Alter
69,0
Geschlecht
M
Eingang
28.08.2021
Impfdatum
01.02.2012
Beginn
03.03.2021
Tage bis Beginn
3.318,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Chest X-ray Computerised tomogram thorax Lumbar puncture Lymphadenectomy Magnetic resonance imaging head Seizure Vomiting

Symptomtext

The initial case was missing the following minimum criteria: no adverse effect (unspecified). Upon receipt of follow-up information on 27Jul2021, this case now contains all required information to be considered valid. This is a spontaneous report from the contactable consumers (including patient's wife) and physician. A 69-year-old male patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PNEUMOCOCCAL 13-VAL CONJ VAC (DIPHT CRM197 PROTEIN)), in Feb2012 (Batch/Lot Number: EN6198) as DOSE 1, SINGLE, and on 03Mar2021 17:45 (Batch/Lot number was not reported) as DOSE 2, SINGLE both given via an unspecified route of administration for COVID-19 and cefalexin (KEFLEX), via an unspecified route of administration from 10Mar2021 (Batch/Lot number was not reported) to 10Mar2021, at unspecified dose and for an unspecified indication. Medical history and concomitant medications were not reported. The patient had pneumonia vaccine in Feb2012 and he ended up in hospital because he had a reaction (unspecified) from it. On 03Mar2021 17:45, the patient had the 2nd dose of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) for COVID 19 (as reported- pending clarification). It was also mentioned that the patient had COVID vaccines, the first was 10Feb2021 and the second was on 03Mar2021 at 6pm (AER 2021311937). It was reported that on 05Mar2021 the patient had a small cut patient procedure done to remove lymph node under left arm (noted on unknown date). On 10Mar2021, the surgeon put the patient on cefalexin. Half hour after taking cefalexin, the patient started seizing, then vomiting uncontrollably. The patient was rushed to hospital by ambulance/emergency room and was admitted on 10Mar2021. The patient had numerous labs including chest X-ray, chest CT scan, brain MRI, and lumbar puncture in 2021 with unknown results. The patient was then discharged on 13Mar2021. Outcome of the events were unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
3,0
Labordaten
Test Date: 2021; Test Name: Chest X ray; Result Unstructured Data: Test Result:UNKNOWN; Test Date: 2021; Test Name: Chest CT scan; Result Unstructured Data: Test Result:UNKNOWN; Test Date: 2021; Test Name: Lumbar puncture; Result Unstructured Data: Test Result:UNKNOWN; Test Date: 2021; Test Name: Brain MRI; Result Unstructured Data: Test Result:UNKNOWN
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
KEFLEX [CEFALEXIN]
Allergien
-
Vorherige Impfungen
-

VAERS 1623679

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6198

schwer
Staat
OH
Alter
80,0
Geschlecht
M
Eingang
23.08.2021
Impfdatum
05.02.2021
Beginn
20.08.2021
Tage bis Beginn
196,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
COVID-19 Computerised tomogram thorax abnormal Intensive care Lung opacity Respiratory failure SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

breakthrough covid infection with admission to ICU for respiratory failure

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
4,0
Labordaten
covid + 8-20; ct+ for ground glass opacities
Aktuelle Erkrankungen
-
Vorgeschichte
hypertension, copd
Andere Medikamente
unclear - this was 6 months ago. Has been maintained on amlodipine, spiriva, potassium, hydrochlorothiazide, losartan, and breo-ellipta
Allergien
nkda
Vorherige Impfungen
-

VAERS 1578609

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
PA
Alter
56,0
Geschlecht
F
Eingang
17.08.2021
Impfdatum
04.03.2021
Beginn
05.08.2021
Tage bis Beginn
154,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Acute respiratory distress syndrome Coronavirus infection SARS-CoV-2 test positive

Symptomtext

Encounter for screening laboratory testing for severe acute respiratory syndrome coronavirus 2

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory distress syndrome
Hospital-Tage
-
Labordaten
08/05/21 1206 POCT COVID-19 PCR Collected: 08/05/21 1204 | Final result | Specimen: Swab from Nares POC COVID-19 PCR DetectedAbnormal Lot # m159923 Point of Care COVID-19 PCR Testing Lot Expiration Date 11/14/21
Aktuelle Erkrankungen
-
Vorgeschichte
Neck pain
Andere Medikamente
cetirizine (ZyrTEC) 10 mg tablet fluticasone propionate (FLONASE ALLERGY RELIEF) 50 mcg/actuation nasal spray
Allergien
NKA
Vorherige Impfungen
-

VAERS 1574184

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TN
Alter
83,0
Geschlecht
F
Eingang
16.08.2021
Impfdatum
13.03.2021
Beginn
14.08.2021
Tage bis Beginn
154,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Bilevel positive airway pressure Brain natriuretic peptide increased Chest X-ray abnormal Fibrin D dimer Intensive care Lung infiltration Mental status changes Respiratory distress Troponin T increased

Symptomtext

Patient hospitalized beginning 8/14/2021..Symptoms:altered mental status, respiratory distress; Nonrebreather mask; BiPAP setting above 90%; Treatment: dexathasone and remdesivir, Vancomycin and Rocephin. Hospitalization ongoing in CCU.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
3,0
Labordaten
8/14/21 Laborary results: BNP 1260, D-dimer 1.1, troponin T of 36. Chest x ray: multifocal infiltrates
Aktuelle Erkrankungen
Unknown;
Vorgeschichte
A-Fib, COPD, HTN, Obesity; Hyperglycemia; Heart failure; Fibromyalgia; DM;
Andere Medikamente
Unknown;
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1546328

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
NJ
Alter
57,0
Geschlecht
M
Eingang
11.08.2021
Impfdatum
20.03.2021
Beginn
03.04.2021
Tage bis Beginn
14,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Anticoagulant therapy Blood test Dyspnoea Intensive care Pulmonary thrombosis Sleep disorder Thrombosis

Symptomtext

evening of 3 Apr 21 woke up from sleep with sense that I could not breath; something wrong. i drove to local ER where I was admitted to ICU fo2 days, with numerous blood clots in both lungs and one on my right upper leg. I was not in any vehicle accident nor suffered any fall or injury prior to this diagnosis. I was in complete shock. No family history of blood clots.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
2,0
Labordaten
4 Apr 21, blood work and put on blood thinner (I cannot recall names and amount)
Aktuelle Erkrankungen
none
Vorgeschichte
pTSD and lower back herniated disk
Andere Medikamente
indomathacin as needed
Allergien
none
Vorherige Impfungen
-

VAERS 1540551

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TN
Alter
86,0
Geschlecht
F
Eingang
10.08.2021
Impfdatum
03.03.2021
Beginn
09.08.2021
Tage bis Beginn
159,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Asthenia COVID-19 Chills Decreased appetite Diarrhoea Illness Nasal congestion Productive cough Pyrexia SARS-CoV-2 test positive Sputum discoloured Syncope

Symptomtext

PATIENT PRESENTED TO MEDICAL CENTER ER ON 8/9/2021 WITH APPROXIMATELY 5-6 DAYS OF GENERAL ILLNESS TO INCLUDE NASAL CONGETSTION, COUGH PRODUCTIVE WITH WHITISH SPUTUM. SUBJECTIVE FEVERS AND CHILLS, GENERALIZED WEAKNESS AND DECREASE APPETITE, MULTIPLE SYNCOPAL EPISODES, SOME DIARRHEA. DENIES ANY KNOWN SICK CONTACTS OR RECENT TRAVEL. TOOK HOME COVID TEST REPORTED IT WAS POSITIVE. RETESTED AT HOSPITAL. COVID19 SARSCoV2 = DETECTED ON8/9/21

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
8/9/21 SARSCoV2 = DETECTED
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
UNKNOWN
Andere Medikamente
UNKNOWN
Allergien
NO KNOWN ALLERGIES
Vorherige Impfungen
-

VAERS 1531673

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MD
Alter
31,0
Geschlecht
F
Eingang
06.08.2021
Impfdatum
08.03.2021
Beginn
20.03.2021
Tage bis Beginn
12,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Asthenia Blood test Computerised tomogram Dizziness Echocardiogram Electrocardiogram Electroencephalogram Fatigue Heart rate increased Lumbar puncture Magnetic resonance imaging Migraine Nausea Syncope Urine analysis Vomiting

Symptomtext

6 months: dizziness, weakness, lightheadedness, fainting, fast heartrate, fatigue, migraine, nausea, vomiting

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
2 MRI, 24 hour EEG, EKG, echocardiogram, 3 CT scans, bloodwork, 24 hour urine test, spinal tap
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
gabapentin, zyrtec d, flonase
Allergien
none
Vorherige Impfungen
-

VAERS 1523026

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CA
Alter
33,0
Geschlecht
M
Eingang
03.08.2021
Impfdatum
20.03.2021
Beginn
22.03.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Magnetic resonance imaging Seizure

Symptomtext

experienced seizures for the first time in my life two nights after the second vaccination. Conducted several neurology tests/studies (MRIs,etc.) and they could not locate anything that would allude to epilepsy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
None
Allergien
Ceflacor
Vorherige Impfungen
-

VAERS 1515345

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TN
Alter
66,0
Geschlecht
F
Eingang
30.07.2021
Impfdatum
06.03.2021
Beginn
22.07.2021
Tage bis Beginn
138,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Blood pH decreased Chest X-ray abnormal Endotracheal intubation Hypercapnia Hypoxia Ill-defined disorder Laboratory test Lung opacity PO2 decreased Seizure White blood cell count increased

Symptomtext

Not aware of adverse event at time of vaccination. Hospitalized later

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
9,0
Labordaten
7/22 HR 124, oxygen saturation 90%, LabsWBC 13.5, ABC pH 7.19, pCOX 66.5, PO2 Bicarb 26, Chest x ray ill-defined opacities in mid to lower lung zones. intubated due to seizure activity, hypercapnia and hypoxia.
Aktuelle Erkrankungen
Unknown
Vorgeschichte
HTN, DM, Small bowel obstruction, Hep C, Obesity
Andere Medikamente
Unknown
Allergien
NKA
Vorherige Impfungen
-

VAERS 1504930

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TX
Alter
63,0
Geschlecht
F
Eingang
27.07.2021
Impfdatum
21.02.2021
Beginn
22.02.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Areflexia Asthenia Back pain Chest X-ray Computerised tomogram Computerised tomogram abdomen Computerised tomogram head Computerised tomogram pelvis Cough Diabetic neuropathy Dizziness Dysphagia Fall Hypoaesthesia Loss of consciousness Muscle spasms Pain in extremity Paraesthesia

Symptomtext

passed out and fell; Peripheral Diabetic Neuropathy; upper back pain the radiated from side to side; spasm; numbness in hands and feet; numbness in hands and feet; passed out and fell; dizzy; legs began to tingle; lost my ability to swallow correctly; weak; had no gag reflex and couldn't cough; blow my nose; My legs hurt; had no gag reflex and couldn't cough,; This is a spontaneous report from contactable consumer (Patient herself). A 63-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EN6198; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 21Feb2021 11:30 as single dose for COVID-19 immunization. Medical history included diabetes mellitus, lupus-like syndrome, atrial, guillain-barre syndrome, food allergy, contrast media allergy from an unknown date and unknown if ongoing. Concomitant medications included metformin (METFORMIN), metoprolol tartrate (METOPROLOL TARTRATE), fenofibrate (FENOFIBRATE) taken for an unspecified indication. The patient previously took penicilin g, potassium, chantix and experienced hypersensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19. On 22Feb2021 11:00 it was reported that, 24 hours after vaccination she started having upper back pain the radiated from side to side. 3 days later she saw PCP who ordered chest x-ray and prescribed muscle relaxer. 4th day pain was worse at night and went to ER, given different medication for spasm. 5th day, pain continued to get worse at night and went to ER had CT of abdomen/Pelvis and given different medication for spasm. 6th day pain worse, returned to ER, had back pain, numbness in hands and feet. Diagnosed with Peripheral Diabetic Neuropathy, given Gabapentin. All this time she had been running on 2 hours a sleep a day. On 10th day, she passed out and fell. On 11th day, she was dizzy and legs began to tingle so went to ER, where she was admitted over the weekend. A CT of Brain and Spine and Doppler were done. Discharged with same diagnosis. Saw Neurologist 6 weeks after onset. During this ordeal on an unspecified dates she lost her ability to swallow correctly and had no gag reflex and couldn't cough, blow her nose. Her legs hurt and she was weak. Diagnosed with GBS. The patient was hospitalized for upper back pain the radiated from side to side, spasm, numbness in hands and feet, numbness in hands and feet for 3 days. Therapeutic measures were taken as a result of weak, upper back pain the radiated from side to side, spasm, numbness in hands and feet, numbness in hands and feet, peripheral diabetic neuropathy, passed out and fell, passed out and fell, dizzy, legs began to tingle, lost my ability to swallow correctly as patient had received pain medication and physical therapy evaluation. Since the vaccination, the patient was not tested for COVID-19. The outcome of all events was not recovered. Follow-up actions are needed. Further information has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
3,0
Labordaten
Test Name: Chest X-ray; Result Unstructured Data: Test Result:NA; Test Name: CT of Spine; Result Unstructured Data: Test Result:NA; Test Name: CT of Abdomen; Result Unstructured Data: Test Result:NA; Test Name: CT of Brain; Result Unstructured Data: Test Result:NA; Test Name: CT of Pelvis; Result Unstructured Data: Test Result:NA; Test Name: Doppler; Result Unstructured Data: Test Result:NA
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Atrial fibrillation; Contrast media allergy; Diabetes mellitus; Guillain Barre syndrome; Lupus-like syndrome; Shellfish allergy
Andere Medikamente
METFORMIN; METOPROLOL TARTRATE; FENOFIBRATE
Allergien
-
Vorherige Impfungen
-

VAERS 1466580

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
AR
Alter
90,0
Geschlecht
M
Eingang
13.07.2021
Impfdatum
23.03.2021
Beginn
27.03.2021
Tage bis Beginn
4,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Computerised tomogram head Eyelid function disorder Facial paralysis

Symptomtext

Droopy face, eye wouldn?t close

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
-
Labordaten
Ct scan to rule out stroke, exam at ER
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Eliquis, atorvastatin, nexium
Allergien
None
Vorherige Impfungen
-

VAERS 1449988

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
PA
Alter
41,0
Geschlecht
M
Eingang
06.07.2021
Impfdatum
19.05.2021
Beginn
22.05.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Arthralgia Back pain Blood test Chest pain Computerised tomogram thorax Dizziness Dyspnoea Headache Magnetic resonance imaging head Paraesthesia Renal pain Syncope

Symptomtext

Started with Tingling in Upper Right Leg, Chest Pain and Shortness of Breath, Constant Headaches. Passing out, Light headed and dizziness. Joint Pain and All Day Headaches. More recently Been having Sharp pain in kidney areas and back pain and Constant headaches. Tingling throughout whole body at times.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
6-5-21 Chest CT and bloodwork 7-1-21 Brain MRI
Aktuelle Erkrankungen
-
Vorgeschichte
HPV; Asthma
Andere Medikamente
Lansoprazole
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 1381304

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MN
Alter
-
Geschlecht
U
Eingang
01.07.2021
Impfdatum
26.02.2021
Beginn
05.03.2021
Tage bis Beginn
7,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal pain upper Pyrexia Abdominal X-ray Dysstasia Thrombosis

Symptomtext

fever; stomach pain; This is a spontaneous report from a contactable consumer (patient). A 68-years-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: EN6198 or EN6208), via an unspecified route of administration, administered in arm on 26Feb2021 at 11:00 AM (at the age of 68 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 05Mar2021, the patient woke up with severe stomach pain at 2:00 am morning it lasted till 07:00 am it eased up, pain they lasted 4 or 5days, experienced fever on an unspecified date and it went away for about 4days then it set up. Outcome of the events was recovered on an unspecified date.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1432888

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
AL
Alter
20,0
Geschlecht
M
Eingang
29.06.2021
Impfdatum
12.06.2021
Beginn
13.06.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Headache Investigation Malaise Seizure Vomiting

Symptomtext

Feeling sick; Feeling dizzy; Seizure; vomiting; bad Headache; This is a spontaneous report from a contactable consumer. A 20-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via intramuscular, administered in arm right on 12Jun2021 (Lot Number: EN6198) as dose 2, single (at the age of 20 years old) for COVID-19 immunization. Medical history included asthma, attention deficit hyperactivity disorder (ADHD), Blood pressure high; all from an unknown date. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for an unspecified indication, start and stop date were not reported and inhaler medication for asthma. No prior vaccinations (within 4 weeks). The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, LOT#EW0170), via intramuscular administered in right arm on 17May2021 (also reported as 07May2021) as dose 1, single for COVID-19 immunization and experienced no adverse effect. It was stated that it was just when he got the second dose of the COVID-19 Pfizer on 12Jun2021, it was supposed to be on 07Jun2021, but patient didnt go back in. Further stated that patient just started feeling sick just while ago (on unspecified date), but he started feeling dizzy on 13Jun2021. It was reported that patient got his second dose and on 13Jun2021, his vomiting could not stop and having bad headache, he could not stop vomiting. Consumer stated that he was trying to have like seizure or something on 13Jun2021. Reporter stated no treatment for the event. The patient had lab test at a hospital. They were checking out the Vitamin levels. The patient underwent lab tests and procedures which included checking out the vitamin levels: unknown results on 11May2021. The outcome of the events seizure, vomiting, bad headache was not recovered and outcome of feeling sick and feeling dizzy was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
Test Date: 20210511; Test Name: Vitamin levels; Result Unstructured Data: Test Result:unknown results
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: ADHD; Asthma; Blood pressure high
Andere Medikamente
ADDERALL
Allergien
-
Vorherige Impfungen
-

VAERS 1420142

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
PA
Alter
66,0
Geschlecht
M
Eingang
23.06.2021
Impfdatum
07.02.2021
Beginn
06.05.2021
Tage bis Beginn
88,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Activated partial thromboplastin time Angiogram Anti-thyroid antibody Antineutrophil cytoplasmic antibody Antinuclear antibody Arterial catheterisation Atrial fibrillation Bacterial test Bilirubin conjugated Blood calcium Blood creatinine Blood glucose Blood lactate dehydrogenase Blood lactic acid Blood magnesium Blood phosphorus Blood test Body fluid analysis

Symptomtext

myocarditis and pericarditis Afib pericardial window cardioversion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
-
Labordaten
Copied from hospital site: ? RHEUMATOID FACTOROrdered by MDJun 2, 2021 ? C3 COMPLEMENTOrdered by MDJun 2, 2021 ? C4 COMPLEMENTOrdered by MDJun 2, 2021 ? RIBONUCLEIC PROTEIN ANTIBODY, IGGOrdered by MDJun 2, 2021 ? ANTI DNA, DOUBLE STRANDED, WITH REFLEX TO TITEROrdered by MDJun 2, 2021 ? ANTI SCLERODERMAOrdered by MDJun 2, 2021 ? THYROID PEROXIDASE ABOrdered by MDJun 2, 2021 ? SJOGRENS SYNDROME-A EXTRACTABLE NUCLEAR ABOrdered by MDJun 2, 2021 ? SJOGRENS SYNDROME-B EXTRACTABLE NUCLEAR ABOrdered by MDJun 2, 2021 ? PROTEINASE 3 ANTIBODYOrdered by MDJun 2, 2021 ? ANTI MYELOPEROXIDASE ANTIBODYOrdered by MDJun 2, 2021 ? ANTI-SMITH ANTIBODYOrdered by MDJun 2, 2021 ? THYROGLOBULIN ANTIBODYOrdered by MDJun 2, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by CRNPYour provider left a comment on this result Jun 2, 2021 ? BILIRUBIN DIRECTOrdered by CRNPYour provider left a comment on this result Jun 2, 2021 ? CBC WITH DIFFERENTIALOrdered by CRNPJun 2, 2021 ? CBC W/ AUTO DIFFERENTIALOrdered by CRNPYour provider left a comment on this result Jun 2, 2021 ? POCT GLUCOSE METEROrdered by MDMay 23, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by CRNPMay 23, 2021 ? POCT GLUCOSE METEROrdered by MDMay 23, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 23, 2021 ? MAGNESIUMOrdered by MDMay 23, 2021 ? PHOSPHORUSOrdered by MDMay 23, 2021 ? CALCIUM IONIZEDOrdered by MDMay 23, 2021 ? CBCOrdered by MDMay 23, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by CRNPMay 22, 2021 ? POCT GLUCOSE METEROrdered by MDMay 22, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by CRNPMay 22, 2021 ? POCT GLUCOSE METEROrdered by MDMay 22, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by MDMay 22, 2021 ? POCT GLUCOSE METEROrdered by MDMay 22, 2021 ? POCT GLUCOSE METEROrdered by MDMay 22, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 22, 2021 ? MAGNESIUMOrdered by MDMay 22, 2021 ? PHOSPHORUSOrdered by MDMay 22, 2021 ? CALCIUM IONIZEDOrdered by MDMay 22, 2021 ? CBCOrdered by MDMay 22, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by CRNPMay 22, 2021 ? POCT GLUCOSE METEROrdered by MDMay 21, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by CRNPMay 21, 2021 ? POCT GLUCOSE METEROrdered by MDMay 21, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by MDMay 21, 2021 ? ELECTROPHYSIOLOGY PROCEDUREOrdered by CRNPMay 21, 2021 ? CT ANGIOGRAM LEFT ATRIAL APPENDAGENSTRUCTIONOrdered by CRNPMay 21, 2021 ? CT ANGIOGRAM LEFT ATRIAL APPENDAGE CARDIOLOGYOrdered by CRNPMay 21, 2021 ? POCT GLUCOSE METEROrdered by MDMay 21, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 21, 2021 ? MAGNESIUMOrdered by MDMay 21, 2021 ? PHOSPHORUSOrdered by MDMay 21, 2021 ? CALCIUM IONIZEDOrdered by MDMay 21, 2021 ? CBC WITH DIFFERENTIALOrdered by CRNPMay 21, 2021 ? APTTOrdered by CRNPMay 21, 2021 ? PROTIME-INROrdered by CRNPMay 21, 2021 ? CBC W/ AUTO DIFFERENTIALOrdered by CRNPMay 21, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by CRNPMay 21, 2021 ? POCT GLUCOSE METEROrdered by MDMay 20, 2021 ? POCT GLUCOSE METEROrdered by MDMay 20, 2021 ? POCT GLUCOSE METEROrdered by MDMay 20, 2021 ? POCT GLUCOSE METEROrdered by MDMay 20, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 20, 2021 ? MAGNESIUMOrdered by MDMay 20, 2021 ? PHOSPHORUSOrdered by MDMay 20, 2021 ? CALCIUM IONIZEDOrdered by MDMay 20, 2021 ? CBCOrdered by MDMay 20, 2021 ? POCT GLUCOSE METEROrdered by MDMay 19, 2021 ? POCT GLUCOSE METEROrdered by MDMay 19, 2021 ? POCT GLUCOSE METEROrdered by MDMay 19, 2021 ? POCT GLUCOSE METEROrdered by MDMay 19, 2021 ? TRANSTHORACIC ECHO (TTE) LIMITEDOrdered by MDMay 19, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 19, 2021 ? MAGNESIUMOrdered by MDMay 19, 2021 ? PHOSPHORUSOrdered by MDMay 19, 2021 ? CALCIUM IONIZEDOrdered by MDMay 19, 2021 ? CBCOrdered by MDMay 19, 2021 ? POCT GLUCOSE METEROrdered by MDMay 18, 2021 ? POCT GLUCOSE METEROrdered by MDMay 18, 2021 ? TRANSTHORACIC ECHO (TTE) LIMITEDOrdered by CRNPMay 18, 2021 ? XR CHEST 1 VWOrdered by MDMay 18, 2021 ? POCT GLUCOSE METEROrdered by MDMay 18, 2021 ? TISSUE EXAMOrdered by MDMay 18, 2021 ? ANESTHESIA ARTERIAL LINE PLACEMENTOrdered by MDMay 18, 2021 ? POCT GLUCOSE METEROrdered by MDMay 18, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 18, 2021 ? MAGNESIUMOrdered by MDMay 18, 2021 ? PHOSPHORUSOrdered by MDMay 18, 2021 ? CALCIUM IONIZEDOrdered by MDMay 18, 2021 ? PROTIME-INROrdered by MDMay 18, 2021 ? CBCOrdered by MDMay18, 2021 ? POCT GLUCOSE METEROrdered by MDMay 17, 2021 ? POCT GLUCOSE METEROrdered by MDMay 17, 2021 ? POCT GLUCOSE METEROrdered by MDMay 17, 2021 ? TRANSTHORACIC ECHO (TTE) LIMITEDOrdered by MDMay 17, 2021 ? POCT GLUCOSE METEROrdered by MDMay 17, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 17, 2021 ? MAGNESIUMOrdered by MDMay 17, 2021 ? PHOSPHORUSOrdered by MDMay 17, 2021 ? CBCOrdered by MDMay 17, 2021 ? CALCIUM IONIZEDOrdered by MDMay 17, 2021 ? PROTIME-INROrdered by MDMay 17, 2021 ? POCT GLUCOSE METEROrdered by MDMay 16, 2021 ? POCT GLUCOSE METEROrdered by MDMay 16, 2021 ? POCT GLUCOSE METEROrdered by MDMay 16, 2021 ? POCT GLUCOSE METEROrdered by MDMay 16, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 16, 2021 ? MAGNESIUMOrdered by MDMay 16, 2021 ? PHOSPHORUSOrdered by MDMay 16, 2021 ? CALCIUM IONIZEDOrdered by MDMay 16, 2021 ? PROTIME-INROrdered by MDMay 16, 2021 ? CBCOrdered by MDMay 16, 2021 ? POCT GLUCOSE METEROrdered by MDMay 15, 2021 ? POCT GLUCOSE METEROrdered by MDMay 15, 2021 ? POCT GLUCOSE METEROrdered by MDMay 15, 2021 ? POCT GLUCOSE METEROrdered by DOMay 15, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 15, 2021 ? MAGNESIUMOrdered by MDMay 15, 2021 ? PHOSPHORUSOrdered by MDMay 15, 2021 ? CALCIUM IONIZEDOrdered by MDMay 15, 2021 ? PROTIME-INROrdered by MDMay 15, 2021 ? CBCOrdered by MDMay 15, 2021 ? POCT GLUCOSE METEROrdered by DOMay 14, 2021 ? POCT GLUCOSE METEROrdered by DOMay 14, 2021 ? POCT GLUCOSE METEROrdered by DOMay 14, 2021 ? TRANSTHORACIC ECHO (TTE) LIMITEDOrdered by DOMay 14, 2021 ? POCT GLUCOSE METEROrdered by DOMay 14, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 14, 2021 ? MAGNESIUMOrdered by MDMay 14, 2021 ? PHOSPHORUSOrdered by MDMay 14, 2021 ? CALCIUM IONIZEDOrdered by MDMay 14, 2021 ? PROTIME-INROrdered by MDMay 14, 2021 ? CBCOrdered by MDMay 14, 2021 ? POCT GLUCOSE METEROrdered by DOMay 13, 2021 ? POCT GLUCOSE METEROrdered by DOMay 13, 2021 ? TRANSTHORACIC ECHO (TTE) LIMITEDOrdered by CRNPMay 13, 2021 ? POCT GLUCOSE METEROrdered by DOMay 13, 2021 ? ANA, WITH REFLEX TO TITEROrdered by MDMay 13, 2021 ? ANA TITER, REFLEX ONLY - DO NOT ORDEROrdered by MDMay 13, 2021 ? POCT GLUCOSE METEROrdered by DOMay 13, 2021 ? CALCIUM IONIZEDOrdered by MDMay 13, 2021 ? CBC WITH DIFFERENTIALOrdered by MDMay 13, 2021 ? CBC W/ AUTO DIFFERENTIALOrdered by MDMay 13, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 13, 2021 ? MAGNESIUMOrdered by MDMay 13, 2021 ? PHOSPHORUSOrdered by MDMay 13, 2021 ? PROTIME-INROrdered by MDMay 13, 2021 ? SEDIMENTATION RATE, AUTOMATEDOrdered by MDMay 13, 2021 ? C-REACTIVE PROTEINOrdered by MDMay 13, 2021 ? CREATININE SERUMOrdered by MDMay 13, 2021 ? HEPATIC FUNCTION PANELOrdered by CRNPMay 13, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 13, 2021 ? POCT GLUCOSE METEROrdered by DOMay 13, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by DOMay 12, 2021 ? POCT GLUCOSE METEROrdered by DOMay 12, 2021 ? POCT GLUCOSE METEROrdered by DOMay 12, 2021 ? TRANSTHORACIC ECHO (TTE) DURING PERICARDIOCENTESISOrdered by DOMay 12, 2021 ? CARDIAC CATHETERIZATIONOrdered by CRNPMay 12, 2021 ? CYTOLOGY, NON-GYNECOLOGICOrdered by DOMay 12, 2021 ? BODY FLUID CELL COUNT WITH DIFFOrdered by DOMay 12, 2021 ? FUNGAL CULTUREOrdered by DOMay 12, 2021 ? BODY FLUID CELL COUNTOrdered by DOMay 12, 2021 ? BODY FLUID CELL COUNT DIFFERENTIAL INSTRUMENTOrdered by DOMay 12, 2021 ? CULTURE, FLUIDOrdered by DOMay 12, 2021 ? GLUCOSE BODY FLUIDOrdered by DOMay 12, 2021 ? LACTATE DEHYDROGENASE BODY FLUIDOrdered by DOMay 12, 2021 ? PROTEIN BODY FLUIDOrdered by DOMay 12, 2021 ? CULTURE, FLUIDOrdered by DOMay 12, 2021 ? CULTURE, ANAEROBICOrdered by DOMay 12, 2021 ? POCT GLUCOSE METEROrdered by DOMay 12, 2021 ? POCT GLUCOSE METEROrdered by DOMay 12, 2021 ? CREATININE SERUMOrdered by MDMay 12, 2021 ? APTTOrdered by DOMay 12, 2021 ? POCT GLUCOSE METEROrdered by DOMay 11, 2021 ? POCT GLUCOSE METEROrdered by DOMay 11, 2021 ? POCT GLUCOSE METEROrdered by DOMay 11, 2021 ? TRANSTHORACIC ECHO (TTE) LIMITEDOrdered by CRNPMay 11, 2021 ? POCT GLUCOSE METEROrdered by DOMay 11, 2021 ? BASIC METABOLIC PANELOrdered by DOMay 11, 2021 ? APTTOrdered by DOMay 11, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by DOMay 11, 2021 ? APTTOrdered by DOMay 10, 2021 ? POCT GLUCOSE METEROrdered by DOMay 10, 2021 ? POCT GLUCOSE METEROrdered by DOMay 10, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by DOMay 10, 2021 ? CARDIAC CATHETERIZATIONOrdered by MD PhDMay 10, 2021 ? POCT ACTIVATED CLOTTING TIMEOrdered by DOMay 10, 2021 ? POCT GLUCOSE METEROrdered by DOMay 10, 2021 ? POCT GLUCOSE METEROrdered by DOMay 10, 2021 ? APTTOrdered by MDMay 10, 2021 ? CREATININE SERUMOrdered by MDMay 10, 2021 ? BASIC METABOLIC PANELOrdered by CRNPMay 10, 2021 ? MAGNESIUMOrdered by CRNPMay 10, 2021 ? APTTOrdered by MDMay 9, 2021 ? POCT GLUCOSE METEROrdered by MDMay 9, 2021 ? POCT GLUCOSE METEROrdered by MDMay 9, 2021 ? CBCOrdered by MDMay 9, 2021 ? APTTOrdered by MDMay 9, 2021 ? PROTIME-INROrdered by MDMay 9, 2021 ? POCT GLUCOSE METEROrdered by MDMay 9, 2021 ? POCT GLUCOSE METEROrdered by MDMay 9, 2021 ? POCT GLUCOSE METEROrdered by MDMay 9, 2021 ? CBC W/ AUTO DIFFERENTIALOrdered by MDMay 9, 2021 ? CBC WITH DIFFERENTIALOrdered by MDMay 9, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 9, 2021 ? MAGNESIUMOrdered by MDMay 9, 2021 ? PHOSPHORUSOrdered by MDMay 9, 2021 ? CALCIUM IONIZEDOrdered by MDMay 9, 2021 ? POCT GLUCOSE METEROrdered by MDMay 8, 2021 ? POCT GLUCOSE METEROrdered by MDMay 8, 2021 ? POCT GLUCOSE METEROrdered by MDMay 8, 2021 ? POCT GLUCOSE METEROrdered by MDMay 8, 2021 ? CBC WITH DIFFERENTIALOrdered by MDMay 8, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 8, 2021 ? MAGNESIUMOrdered by MDMay 8, 2021 ? PHOSPHORUSOrdered by MDMay 8, 2021 ? CALCIUM IONIZEDOrdered by MDMay 8, 2021 ? CBC W/ AUTO DIFFERENTIALOrdered by MDMay 8, 2021 ? POCT GLUCOSE METEROrdered by MDMay 7, 2021 ? POCT GLUCOSE METEROrdered by MDMay 7, 2021 ? PET CT MYOCARD PERF W REGAOrdered by CRNPMay 7, 2021 ? STRESS ECGOrdered by CRNPMay 7, 2021 ? TRANSTHORACIC ECHO (TTE) COMPLETEOrdered by MDMay 7, 2021 ? POCT GLUCOSE METEROrdered by MDMay 7, 2021 ? URINALYSIS AUTO W/SCOPEOrdered by MDMay 7, 2021 ? URINALYSIS CULTURE IF INDICATED, CHEMICAL DIPSTICKOrdered by DOMay 7, 2021 ? URINALYSIS CULTURE IF INDICATED, AUTOMATED UMICOrdered by DOMay 7, 2021 ? POCT GLUCOSE METEROrdered by MDMay 7, 2021 ? APTTOrdered by MDMay 7, 2021 ? LIPID PANELOrdered by MDMay 7, 2021 ? CBC WITH DIFFERENTIALOrdered by MDMay 7, 2021 ? COMPREHENSIVE METABOLIC PANELOrdered by MDMay 7, 2021 ? PHOSPHORUSOrdered by MDMay 7, 2021 ? CALCIUM IONIZEDOrdered by MDMay 7, 2021 ? CBC W/ AUTO DIFFERENTIALOrdered by MDMay 7, 2021 ? MAGNESIUMOrdered by CRNPMay 7, 2021 ? RBC MORPHOLOGY ONLY (INTERFACED)Ordered by MDMay 7, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by MDMay 7, 2021 ? TROPONIN IOrdered by MDMay 6, 2021 ? CBCOrdered by MDMay 6, 2021 ? APTTOrdered by MDMay 6, 2021 ? PROTIME-INROrdered by MDMay 6, 2021 ? POCT GLUCOSE METEROrdered by MDMay 6, 2021 ? CT ANGIOGRAM CHEST W WO CONTRASTOrdered by DOMay 6, 2021 ? LACTIC ACID, SERUMOrdered by DOMay 6, 2021 ? TROPONIN IOrdered by MDMay 6, 2021 ? C-REACTIVE PROTEINOrdered by MDMay 6, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by DOMay 6, 2021 ? ED ULTRASOUND CARDIAC LIMITEDOrdered by MDMay 6, 2021 ? LACTIC ACID, SERUMOrdered by DOMay 6, 2021 ? CULTURE, BLOODOrdered by DOMay 6, 2021 ? CULTURE, BLOODOrdered by DOMay 6, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by DOMay 6, 2021 ? Influenza A&B/RSV/COVID-19Ordered by DOMay 6, 2021 ? XR CHEST 1 VWOrdered by DOMay 6, 2021 ? ED ULTRASOUNDOrdered by MDMay 6, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by MDMay 6, 2021 ? TROPONIN IOrdered by MDMay 6, 2021 ? CBC WITH DIFFERENTIALOrdered by MDMay 6, 2021 ? BASIC METABOLIC PANELOrdered by MDMay 6, 2021 ? CBC W/ AUTO DIFFERENTIALOrdered by MDMay 6, 2021 ? MAGNESIUMOrdered by DOMay 6, 2021 ? APTTOrdered by DOMay 6, 2021 ? PROTIME-INROrdered by DOMay 6, 2021 ? HEPATIC FUNCTION PANELOrdered by DOMay 6, 2021 ? HEMOGLOBIN A1COrdered by MDMay 6, 2021 ? ECG 12-LEAD: HOSPITAL OR TEST FACILITYOrdered by MDMay 6, 2021
Aktuelle Erkrankungen
Pollen - Runny nose and coughing
Vorgeschichte
Liver transplant - Alpha-1 at Hospital, transplant performed on 12/31/2005-1/1/2006
Andere Medikamente
Medications Aspirin 81 MG 1X DAILY Atorvastatin 80 MG 1X DAILY Empagliflozin 25 mg 1 / Daily Humalog Insulin Sliding Scale Lantus Insulin 30 unit 1X Daily Lisinopril 20 Mg 1 Daily Mycophenolate 500 mg 2X Daily Nitrostat Sublingual 0.4 MG PR
Allergien
None
Vorherige Impfungen
-

VAERS 1417327

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
PA
Alter
84,0
Geschlecht
M
Eingang
22.06.2021
Impfdatum
05.03.2021
Beginn
06.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Balance disorder Blood test Dysstasia Facial paralysis SARS-CoV-2 test negative Transient ischaemic attack

Symptomtext

The next day after the vaccine, I could not stand, no balance and drooping on right side of face. My spouse called 911 and thought I was having a stroke. I was admitted to the hospital. I had numerous blood work done and tests done and was diagnosed with TIA transient ischaemic attack and to follow up with a neurologist. I was in the hospital 3 days. I am being followed by the neurologist. I still have balance issues and the facial drooping is gone.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
3,0
Labordaten
Covid test in hospital-negative
Aktuelle Erkrankungen
none
Vorgeschichte
diabetes, hypertension, high cholesterol, alzheimer, atherosclerosis,
Andere Medikamente
Vitamin B, Vitamin D, Fish oil, Metformin, Glipizide, Atorvastatin, Metoprolol, Namzaric, Plavix,
Allergien
none
Vorherige Impfungen
-

VAERS 1406787

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
VA
Alter
67,0
Geschlecht
M
Eingang
17.06.2021
Impfdatum
21.03.2021
Beginn
20.05.2021
Tage bis Beginn
60,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Physical examination Thrombosis Ultrasound scan

Symptomtext

8 weeks after second shot, I developed 2 superficial blood clots in my left leg. At the time, I was taking a daily low-dose of aspirin as recommended by my doctor for people my age. I experienced a little over a week of pain before the clots dissolved. I have no history of blood clots.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
Ultra-sound scan and physical exam.
Aktuelle Erkrankungen
None, other than long term management of high blood pressure and pre-diabetic.
Vorgeschichte
Only those mentioned in Item 11 and pain management for 2 botched foot surgeries and scar tissue from old back surgery.
Andere Medikamente
Metformin, Losartan, Hydralazine, Exalgo, Vitamin D, low dose aspiring
Allergien
None
Vorherige Impfungen
-

VAERS 1398544

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
IN
Alter
67,0
Geschlecht
F
Eingang
15.06.2021
Impfdatum
18.03.2021
Beginn
18.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Thrombosis Ultrasound scan

Symptomtext

Had thrombosis, Blood clots in leg; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received bnt162b2 (Lot Number: EN6198; Expiration Date: Jun2021), dose 1 via an unspecified route of administration, administered in arm left on 18Mar2021 at the age of 67-year-old as single dose for covid-19 immunisation. Medical history included diabetes. The patient's concomitant medications were not reported. Three days after vaccination, the patient had thrombosis, blood clots in her leg and had gone to the Emergency room on 21Mar2021. It started at night but she didn't know what it was, may be the same day she got vaccine (18Mar2021). The patient was taking "blood thinners" (medication name not clarified) for the Blood clots. The patient underwent lab tests and procedures which included ultrasound: unknown results on an unknown date. The outcome of event was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
Test Name: Ultrasound; Result Unstructured Data: Test Result:Unknown results
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Diabetic
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1394676

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
IL
Alter
58,0
Geschlecht
M
Eingang
13.06.2021
Impfdatum
29.01.2021
Beginn
03.05.2021
Tage bis Beginn
94,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Blood test Chest discomfort Chest pain Electrocardiogram Pericarditis

Symptomtext

Pericarditis Chest discomfort/pain and left shoulder pain began on 5/3/21. Went to emergency room on 5/5/21 and EKG showed that this was thought to be Pericarditis. I was admitted for one night.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pericarditis
Hospital-Tage
-
Labordaten
5/5/21 EKG, blood work
Aktuelle Erkrankungen
-
Vorgeschichte
I have had afib a couple of times, no underlying condition that they could detect. Only have an episode approximately once per year for a few minutes. This started in 2019. No episodes in 2020, one episode in 2021.
Andere Medikamente
Metoprolol ER Succinate 50mg (1x day), Flecainide 50 mg (2x day), Pantoprazole 40 mg (1x day)
Allergien
none
Vorherige Impfungen
-

VAERS 1388450

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TX
Alter
37,0
Geschlecht
M
Eingang
10.06.2021
Impfdatum
27.01.2021
Beginn
29.01.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute cardiac event Catheterisation cardiac Electrocardiogram abnormal Magnetic resonance imaging abnormal Magnetic resonance imaging heart Pericarditis Troponin increased

Symptomtext

I developed pericarditis, was sent to the hospital where they treated me with the use of anti-inflammatory medication.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pericarditis
Hospital-Tage
2,0
Labordaten
Troponin levels were highly elevated EKG/MRI indicated a cardiac event Cath was performed
Aktuelle Erkrankungen
None
Vorgeschichte
Prior myocarditis
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1382537

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
IN
Alter
81,0
Geschlecht
F
Eingang
08.06.2021
Impfdatum
03.02.2021
Beginn
05.02.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Abnormal behaviour Aphasia Asthenia Computerised tomogram normal Dysarthria Fall Glassy eyes Loss of consciousness

Symptomtext

Two days after patient's first vaccine@ about 4 pm, I could tell that something was wrong with her. Every day she and I play cards, but this day she was really struggling. She couldn't figure out where any of the cards went, and was missing every play. I tool her up to lay down. At about 6pm, her eyes looked really glassy and she was unable to speak clearly. Her words were very slurred, and her sentences did not make any sense. I called 911, and they came and took her to the ER. The doctors said that she had a small stroke. She was put on a low dosage of blood pressure medicine, and was hospitalized for 6 days to monitor her. During that time many tests were run on her. 2nd Vaccine- 2-24-21 Two hours after returning from getting the second vaccine, the patient went upstairs to go to the bathroom and she passed out onto the bathroom floor. Again, when talking to her, her words were slurred. She was very weak. I called 911 again. Initially they were not going to take her, but when she went to get up she fell back down. She was too weak to walk, so they took her to the ER again. She was released to go home that evening. Sher saw her primary doctor and was referred by her oncologist to see a hematologist. She endured a three month waiting period until she could be tested for APLS. She will go this Friday to find out the reslts of that test. Additionally, she saw her vascular neurologist, Dr. He looked at her scans and said it was NOT a stroke. He said that her body basically had a surge as a result of trying to fight off the vaccine. He said that the CAT scan that was done at the time she went to the ER the first time did NOT indicate signs of a new stroke, but that what they were seeing on the scans was from her past stroke. Dr. said that he saw no indication that she had another stroke and that her body was just reacting to the vaccine. He said that all of the symptoms that she had were all things that could happen because of the surge.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
6,0
Labordaten
Unsure of the test that were ran on her on these two seperate occasions.
Aktuelle Erkrankungen
N/A
Vorgeschichte
Neuropathy in her feet Cancer- Multiple Myloma- in remission Stroke on two seperate instances
Andere Medikamente
Fluoxetine=1@1x/day-20mg NeuRemedy=1@2x/day Centrum Silver=1@1x/day B12(time release)=1@1x/day-1000mcg D3=1@1x/day-125mcg Metanx=1@2x/day B Complex=1@1x/day Atorvastatin=1@1x/day-40mg Clopidogrel=1@1x/day-75mg Eliquis=1@2x/day-5mg
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1375067

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
PA
Alter
26,0
Geschlecht
F
Eingang
04.06.2021
Impfdatum
04.06.2021
Beginn
04.06.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Loss of consciousness Syncope

Symptomtext

Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: The patient fainted roughly 5 min after vaccine administration and became responsive again in less than a minute. She was monitored for 30 min with frequent blood pressure checks and took two glucose tablets while drinking plenty of water.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1374267

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
77,0
Geschlecht
F
Eingang
04.06.2021
Impfdatum
12.03.2021
Beginn
14.03.2021
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Seizure like phenomena

Symptomtext

R56.9 - Seizure-like activity (CMS/HCC)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure like phenomena
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1368535

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
WV
Alter
73,0
Geschlecht
M
Eingang
02.06.2021
Impfdatum
06.03.2021
Beginn
20.03.2021
Tage bis Beginn
14,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein
Bell's palsy Gait disturbance Hypoaesthesia Laboratory test Mobility decreased Neurological symptom Thrombosis Walking aid user

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA States exactly 2 weeks after received 2nd dose of Pfizer vaccine, lost feeling in his right leg. Went to the hospital. Continued to have neurological symptoms. States was diagnosed with Bell's Palsy and blood clot in right leg. States cannot ambulate without walker now. States doctors are unsure of cause of neurological issues.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
states several tests and labs over past 3 months
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
unknown
Vorherige Impfungen
-

VAERS 1355808

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CA
Alter
75,0
Geschlecht
F
Eingang
27.05.2021
Impfdatum
05.03.2021
Beginn
07.03.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Anticoagulant therapy Chest X-ray normal Deep vein thrombosis Electrocardiogram normal Peripheral swelling Ultrasound Doppler abnormal

Symptomtext

swollen leg first noticed 3/7/21, Saw my doctor on 3/11/21. Doctor sent me to get Ultrasound next day. After she got results by phone, she had me go directly to nearest ER that same day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
-
Labordaten
Diagnosed with Extensive Deep Vein Thrombosis on 3/12/21 with Arterial Ultrasound; Had chest x-ray, EKG, etc. at ER (good); prescribed Eliquis, another Arterial ultrasound on 4/30/21; met virtually with Hematologist on 4/5/21, had a venous ultrasound 5/27/21; have appointment with Hematologist on 6/3/21.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Amlodipine Besylate, Estradiol vaginal inserts, 1MD probiotic caps, Benefiber prebiotic, calcium tabs. Daily fiber caps, Biotin, Fish Oil caps, Vitamin C, Chia seeds, ground Flaxseed, Organic Prebiotic Fiber powder
Allergien
Cantaloupe
Vorherige Impfungen
-

VAERS 1349563

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
SC
Alter
70,0
Geschlecht
F
Eingang
26.05.2021
Impfdatum
19.02.2021
Beginn
02.04.2021
Tage bis Beginn
42,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Generalised tonic-clonic seizure SARS-CoV-2 test Seizure Weight Weight decreased

Symptomtext

She keeps losing more and more weight; Petite mal seizures/frequency of seizures increased; Grand mal convulsion/ One clonic tonic or grand mal seizure; This is a spontaneous report from a contactable Nurse (patient). A 70-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 administered in Arm Left on 19Feb2021 08:45 (Lot Number: EN6198) as 2ND DOSE, SINGLE for covid-19 immunisation. Medical history included epilepsy (diagnosed since age 6), guillain-barre syndrome (she cannot get the flu vaccine anymore because of her history of with Guillain-Barre Syndrome), she had COVID-19 in AUG2020 and has been having increased seizures since then as well, Seizures. She was positive on her COVID test, she forgets what was that it said when it came back, it didn't say positive, it said something else, she went back and forth after that first COVID test. She says it said detected, it didn't say anything else. She says after that she came home and self quarantined for 14 days, then went back for piece of mind to get a negative test, but they said positive, so then she quarantined 21 days that time. She says she went back and they tested her with the gold test which takes longer to her understanding to study that, and that came back negative. She says after 21 days she built up enough antibodies for it to be negative. She clarifies that she had COVID and COVID testing done before getting the doses of the Pfizer COVID-19 vaccine, before she got her her vaccinations. She had no other vaccinations on the dates she got her Pfizer COVID-19 vaccine doses or in the four weeks prior. She uses Lysol wipes and Clorox to clean her house and her door knobs. She says she uses hand sanitizer and wears 1-2 masks. She says in 1990 she had an airborne virus that put her in intensive care for 21 days and she was paralyzed, so she is thankful to be alive, and that she is no longer paralyzed. She says this came along, and it brought back a lot of horrible memories. Caller says she had to live with something, and her mask, and a lot of handwashing. Call handler attempted to clarify this statement with the caller. Concomitant medications included clobazam (Manufacturer: Microlabs. NDC: 4271-315-01, EXP: 09Aug2021) 10mg tablets, two twice a day taken for seizure; levetiracetam (LEVETIRACETAM 1A FARMA) 500mg, four tablets in the morning and four at night, taken for seizure. The patient previously received first doe of bnt162b2 administered in Arm Left on 22Jan2021 08:45AM (Lot Number: EL3249) for covid-19 immunisation . The patient would like to know if the COVID-19 infection increases seizure activity. She has a history of epilepsy and has received both dose of her vaccine. She states that she petite mal seizures and has One clonic tonic or grand mal seizure on 2APR2021 at 12:35AM. She also reports that she keeps losing more and more weight and does not know why. She states that in JUL2020 she was 196 pounds and today she weighs 177 pounds. About frequency of seizures increased, the patient says that her seizures had been pretty well been controlled, for 6 months. She says that there were a couple times she had months seizure free, but now can't get through the day without multiple seizures. She says they are petit mal, but she is also having grand mal seizures. She clarifies that her seizures increased last July, after she got out of rehab, they got worse during the month of August. She confirms that she was diagnosed with COVID-19 in August 2020. She clarifies her seizures increased before she got the doses of the vaccine this year. She says she had convulsions on 2Apr2021, a grand mal seizure, at 12:35 in the morning. She was just wondering if there was any connection between COVID-19 and increased seizure activity. She says her neurologist and she are both hitting their heads on the floor and trying to think of what combination of meds could stop her seizures and convulsions to get her down to where she is not having multiple petit mal every day. She says she used to see her neurologist every 2-3 months, now she sees him every month. She says every 2-3 months he changes her medication. She says he has her on two drugs now, and he increased them both, they are hoping to get answers, if her seizures have not calmed down and gone away he is going to take her off Keppra. She is taking the Keppra generic, named Levetiracetam, she takes 500mg, four tablets in the morning and four at night. She says the other anti seizure medication is Clobazam, she takes two pills a day. She says each time he puts her on a different drug it is another chemical change to her body and another expense to be constantly changing drugs. She says her neurologist might change her medications again when she goes back May 20th for her follow up. She says there could be drug interactions and stuff that her neurologist might not be aware of, she is not having a fun time. She says her neurologist tried to put her on two different drugs to good take care of the problem, one was Keppra and her insurance denied that one so he said let's try this one and put it thru her insurance for authorization and it was accepted but they said they don't carry it and get her private pharmacist. The outcome of Petite mal seizures and Grand mal seizure was not recovered, of other event was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Generalised tonic-clonic seizure
Hospital-Tage
-
Labordaten
Test Name: COVID Test; Test Result: Positive ; Comments: COVID testing done before getting the doses of the Pfizer COVID-19 vaccine; Test Name: COVID Test; Test Result: Negative ; Comments: COVID testing done before getting the doses of the Pfizer COVID-19 vaccine; Test Name: weight; Result Unstructured Data: Test Result:177 lbs; Test Date: 202007; Test Name: weight; Result Unstructured Data: Test Result:196 lbs
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19; Epilepsy (diagnosed since age 6); Guillain-Barre syndrome; Paralyzed (She says in 1990 she had an airborne virus that put her in intensive care for 21 days and she was paralyzed,); Seizures; Viral infection NOS (She says in 1990 she had an airborne virus that put her in intensive care for 21 days and she was paralyzed,)
Andere Medikamente
CLOBAZAM; LEVETIRACETAM 1A FARMA
Allergien
-
Vorherige Impfungen
-

VAERS 1347569

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
72,0
Geschlecht
F
Eingang
25.05.2021
Impfdatum
01.03.2021
Beginn
02.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Arterial thrombosis Peripheral ischaemia Surgery Ultrasound Doppler

Symptomtext

3/2 MHC, admitted day after covid vaccine with arterial clot. Patient seen for left lower extremity arterial occlusion with critical limb ischemia. The patient was transferred immediately post-operatively to the Progressive Care Unit for observation. The next morning the patient was discharged home with stable vital signs, clean, dry, and intact wounds, good pain control, and vascular exam of +BLE PT and DP doppler signals.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arterial thrombosis
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1341201

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
NY
Alter
72,0
Geschlecht
M
Eingang
22.05.2021
Impfdatum
19.03.2021
Beginn
18.05.2021
Tage bis Beginn
60,0
Dosis
1
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia COVID-19 COVID-19 pneumonia Cough Fatigue Fibrin D dimer normal Haemoglobin decreased Lung opacity Metabolic function test Platelet count normal Pneumonia Positron emission tomogram abnormal Red blood cell sedimentation rate increased SARS-CoV-2 test positive Syncope White blood cell count normal

Symptomtext

Pt is a fully vaccinated individual as of 3/19/2021 when he had his 2nd Pfizer covid 19 vaccine. He presented to the Emergency room on 5/18/2021 with concerns for covid 19 pneumonia. He is a 72-year-old male undergoing chemotherapy for follicular lymphoma through cardiology center who stated he had a PET scan done at other facility earlier today and stated the oncologist did not like the results and sent him to the emergency room. They were concerned about Covid pneumonia and sent him to be evaluated and admitted as well as treated. Patient stated he has been having trouble over the past several weeks where he has been weaker and more tired, just the week prior he had a syncopal episode. He has since felt more tired than usual and he has had a chronic nonproductive cough. He was admitted to the hospital after testing positive on nasopharyngeal PCR for covid 19 with PET scan findings of ground glass opacities and b/l pneumonia. He was treated with remdesivir and decadron and sent home on 5/19 to recover. He did not require oxygen during his hospital stay or on discharge.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
2,0
Labordaten
New PET positive activity within the lungs with basilar and peripheral predominance in areas of ground glass opacities, most likely COVID pneumonia d dimer was normal blood cx were normal wbc 1.1 hgb 9.2, platelets normal esr 111 cmp normal
Aktuelle Erkrankungen
None
Vorgeschichte
Follicular lymphoma on chemo, atrial fibrillation, DM-2, depression, CAD, hypothyroidism, gerd
Andere Medikamente
Eliquis, vit D, Hydrocodone, Victoza, levothyroxine, Celexa, Metformin, Protonix, Predmisone, Toujeo, Depakote, ferrous sulfate, coreg
Allergien
terbinafine
Vorherige Impfungen
-

VAERS 1341201

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
NY
Alter
72,0
Geschlecht
M
Eingang
22.05.2021
Impfdatum
19.03.2021
Beginn
18.05.2021
Tage bis Beginn
60,0
Dosis
2
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia COVID-19 COVID-19 pneumonia Cough Fatigue Fibrin D dimer normal Haemoglobin decreased Lung opacity Metabolic function test Platelet count normal Pneumonia Positron emission tomogram abnormal Red blood cell sedimentation rate increased SARS-CoV-2 test positive Syncope White blood cell count normal

Symptomtext

Pt is a fully vaccinated individual as of 3/19/2021 when he had his 2nd Pfizer covid 19 vaccine. He presented to the Emergency room on 5/18/2021 with concerns for covid 19 pneumonia. He is a 72-year-old male undergoing chemotherapy for follicular lymphoma through cardiology center who stated he had a PET scan done at other facility earlier today and stated the oncologist did not like the results and sent him to the emergency room. They were concerned about Covid pneumonia and sent him to be evaluated and admitted as well as treated. Patient stated he has been having trouble over the past several weeks where he has been weaker and more tired, just the week prior he had a syncopal episode. He has since felt more tired than usual and he has had a chronic nonproductive cough. He was admitted to the hospital after testing positive on nasopharyngeal PCR for covid 19 with PET scan findings of ground glass opacities and b/l pneumonia. He was treated with remdesivir and decadron and sent home on 5/19 to recover. He did not require oxygen during his hospital stay or on discharge.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
2,0
Labordaten
New PET positive activity within the lungs with basilar and peripheral predominance in areas of ground glass opacities, most likely COVID pneumonia d dimer was normal blood cx were normal wbc 1.1 hgb 9.2, platelets normal esr 111 cmp normal
Aktuelle Erkrankungen
None
Vorgeschichte
Follicular lymphoma on chemo, atrial fibrillation, DM-2, depression, CAD, hypothyroidism, gerd
Andere Medikamente
Eliquis, vit D, Hydrocodone, Victoza, levothyroxine, Celexa, Metformin, Protonix, Predmisone, Toujeo, Depakote, ferrous sulfate, coreg
Allergien
terbinafine
Vorherige Impfungen
-

VAERS 1333584

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6198

schwer
Staat
NY
Alter
15,0
Geschlecht
M
Eingang
20.05.2021
Impfdatum
19.05.2021
Beginn
19.05.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Confusional state Dizziness Fall Head injury Syncope Unresponsive to stimuli

Symptomtext

Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: possibly seizure related. patient fainted and hit head on wall upon fall. came to and went in and out a couple times. stable until EMS arrival

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1332784

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CO
Alter
66,0
Geschlecht
M
Eingang
20.05.2021
Impfdatum
29.03.2021
Beginn
01.04.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Thrombosis Ultrasound scan

Symptomtext

Blood clot in leg; This is a spontaneous report from a contactable consumer (patient). A 66 year old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration on 29Mar2021 at 12:45 (Batch/Lot Number: EN6198) as a single dose for COVID-19 immunisation. Medical history included COVID-19 from Nov2020 to an unknown date: came down with COVID virus in November and it felt like mild flu symptoms. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 08Mar2021 at 12:45 (Batch/Lot Number: EN6198) as a single dose in the right shoulder for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have any adverse events following prior vaccinations. The patient's medical history included: father had a blood clot in his 50s. Concomitant medication (other medications taken in two weeks) were none. On an unspecified date in Apr2021, the patient experienced blood clot in leg. Relevant test included: ultrasound on 15Apr2021 showed blood clot. The clinical course was as follows: On 04Apr2021 or 05Apr2021 he started to notice a problem on his right leg. He went to see the doctor and it was determined he has a vascular problem. This problem got worse and ended up in the emergency room and was informed he had a blood clot in his leg. The clot started down by his ankle and had moved up towards half way to knee. Then moved up higher. He went to the emergency room on 15Apr2021and was diagnosed with a blood clot with an ultrasound scan that was done. He was then prescribed a blood thinner. He was informed it is a superficial thrombosis. The patient clarified the problem he started to notice with his right leg as it was like a bump, and sore. He was not sure what it was. He thought at first he may have banged his leg. Then he noticed it was sore and getting higher. He went to see his physician who referred him to a vascular surgeon. It took a while to get in to be seen by the vascular surgeon because so busy. A few days after that he went to the hospital, the emergency room because he was not getting better. That is when he found out he had a blood clot. Treatment for the blood clot in leg included, patient was prescribed rivaroxaban (XARELTO) 10mg once a day. The patient confirmed the blood clot was getting better. The outcome of the event blood clot was recovering. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
Test Date: 20210415; Test Name: Ultrasound scan; Result Unstructured Data: Test Result:blood clot
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Clot blood (Father had a blood clot in his 50s); COVID-19
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1331283

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CA
Alter
79,0
Geschlecht
M
Eingang
19.05.2021
Impfdatum
01.02.2021
Beginn
01.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Computerised tomogram Magnetic resonance imaging Thrombosis X-ray

Symptomtext

Blood clots

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
4,0
Labordaten
CT scan, x-rays MRI
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1316528

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6198

schwer
Staat
NY
Alter
24,0
Geschlecht
M
Eingang
14.05.2021
Impfdatum
13.05.2021
Beginn
13.05.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Fall Flushing Hyperhidrosis Loss of consciousness Pallor Syncope Unresponsive to stimuli

Symptomtext

Systemic: Chills-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Additional Details: patient blacked out and fell off observation chair to floor He awoke almost immediately and started to sweat and was very pale. EMS was called and patient denied care.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1307856

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
72,0
Geschlecht
F
Eingang
11.05.2021
Impfdatum
25.02.2021
Beginn
08.03.2021
Tage bis Beginn
11,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Seizure

Symptomtext

R56.9 - Seizure

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1303393

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
69,0
Geschlecht
M
Eingang
10.05.2021
Impfdatum
27.02.2021
Beginn
18.04.2021
Tage bis Beginn
50,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Acute kidney injury Bell's palsy

Symptomtext

This 69 year old black male received the Covid shot on 2/27/21 and went to the ED and admitted on 4/18/21 with the following diagnoses listed below. G51.0 - Bell's palsy N17.9 - Acute kidney failure, unspecified

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1297806

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
86,0
Geschlecht
M
Eingang
07.05.2021
Impfdatum
16.03.2021
Beginn
19.04.2021
Tage bis Beginn
34,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Bell's palsy

Symptomtext

This 86 year old male received the Covid shot on 3/16/21 and went to the ED on 04/19/21 and was admitted on 4/21/21 with the following diagnoses listed below. G51.0 - Bell's palsy

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1294726

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TN
Alter
67,0
Geschlecht
F
Eingang
07.05.2021
Impfdatum
02.03.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Computerised tomogram Dizziness Dysphemia Feeling jittery Laboratory test Malaise Seizure Tremor

Symptomtext

seizure; Feel woozy; felt even weaker; jittery feeling; shaky; doesn't feel well; It has left her with a stutter; This is a spontaneous report received from contactable consumer (patient). A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6198), dose 1 via an unspecified route of administration on 02Mar2021 (at the age of 67years) as single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she got her first shot on 02Mar2021 and the second shot 25Mar2021. She took the first shot and she wanted to say a day or so after that she got up and did some things around the house and she went to the cloth store. She clarified that she went to the fabric store and came out she had a jittery feeling. Then she began to feel woozy and stated she may need to eat. She drove up to by (withheld) and there was a cookout restaurant in the same vicinity as (withheld). When she went to turn into the lot, she was "shaky" and pulled into the parking space. She added that the best thing is for her to go home. She didn't want to take the interstate and went to the back way just in case something happened. She went home and it was approximately 10 miles away. When she got home, she felt even weaker. Her husband was outside because he fishes and was working on his boat. She told him that she doesn't feel well and was shaky. He told her to go in the house and he would come in. She went in through the basement and when she got to the step her foot wouldn't come up, so she crawled up the steps. When her husband came in, she went into a seizure and had no control. She could hear her husband speaking but couldn't speak so he called. They told him to give her four 81 mg of aspirin. So, he gave her some aspirin. She could hear them when they came in to get her, but she couldn't respond. They took her to the hospital. At the hospital they did two CAT scans and another unspecified test. The patient added that she was concerned because she is a very active person, and this is not her normal talk. Before the shot she did a lot of sewing and that's her business. But a few days after the shot she began to have a lot of seizures and went to the hospital. And when she came home it continued. Before she left the hospital, she had not spoken to anyone. When her husband came in, she couldn't get her words out. It has left her with a stutter, and she decided to go to speech therapy. She went in and a few days it seemed like it had helped. The patient further stated that she is not getting back to normal and needs a walker or cane and she's 68 and healthy. The outcome of events was unknown. Information on lot/batch number was available. Additional information has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
Test Name: CAT scan; Result Unstructured Data: Test Result:unknown result; Test Name: Laboratory test; Result Unstructured Data: Test Result:unknown result
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1130525

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
AR
Alter
47,0
Geschlecht
M
Eingang
07.05.2021
Impfdatum
16.03.2021
Beginn
16.03.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Asthenia Guillain-Barre syndrome Back pain Blood test CSF test Deafness Chills Electroencephalogram normal Fatigue Headache Hypoaesthesia Hemiparesis Hypertension Loss of consciousness Hyporesponsive to stimuli Lumbar puncture normal Magnetic resonance imaging head normal Malaise

Symptomtext

Guillain Barre syndrome; Doesn't feel from his waist down on left side; Doesn't feel from his waist down on right side; Weakness on right side; Weakness on left side; Passed out; High blood pressure; Lost hearing on right side; Headache; Fever; Pain in back; Pain in neck that went up to his head; This is a spontaneous report from a contactable consumer. A 47-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 16Mar2021 at 15:00 or 15:10 (at the age of 47-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history was reported as none. It was reported that the patient had no pre-existing conditions and was "100% healthy and normally ran every day for 2-3 miles." Concomitant medications were reported as none. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. The patient did not have a history of adverse events that followed prior vaccinations. The patient previously received the flu shot in Sep2020 (at the age of 47-years-old) for immunization and experienced no side effects. It was reported that the patient received a flu shot every year and experienced no side effects. On 16Mar2021 the patient experienced fever, pain in back and pain in neck that went up to his head; on 17Mar2021 the patient experienced headache; on 18Mar2021 the patient experienced does not feel from his waist down on left side, does not feel from his waist down on right side, weakness on right side, weakness on left side, passed out and on unspecified dates the patient experienced Guillain Barre syndrome, lost hearing on right side and high blood pressure. The events does not feel from his waist down on left side, does not feel from his waist down on right side, weakness on right side, weakness of left side and passed out (911 was called) required an emergency room visit; does not feel from his waist down on left side, does not feel from his waist down on right side, weakness on right side, weakness on left side and Guillain Barre syndrome also required a physician office visit. The patient was hospitalized for the events passed out, does not feel from his waist down on left side, does not feel from his waist down on right side, Guillain Barre syndrome, weakness of right side and weakness of left side from 18Mar2021 to 08Apr2021 (also reported as "for 22 days"). The reporter (friend of the patient) called to file a report for his friend, who did not speak any English. The reporter wanted to make Pfizer aware of the adverse event that the patient experienced. The reporter stated that the hospital staff stated that they reported the patient's adverse event to Pfizer, the local health department and the CDC, but the patient's family and friends were not sure if the report was filed, thus the reporter was calling. The clinical course was reported as follows: "6-7 hours after getting home from getting the vaccine on 16Mar2021, the patient started to feel fever, pain in his back, and pain in his neck that went up to his head. The hospital had given the patient Tylenol and the hospital staff informed the patient that if he felt a fever or pain after the COVID-19 vaccine, he should take the Tylenol. The hospital staff also informed the patient that if his symptoms got worse to call 911 and go to the emergency room. The patient took the Tylenol and his fever came down a bit and the patient went to sleep. On the next day, 17Mar2021, the patient's neck pain started going up more like a headache. On the morning of Thursday, 18Mar2021, the patient got weak. The patient could barely move his hand or neck or leg. After the weakness began, "it was like 1-2-3" and the patient was passed out. After the patient passed out, 911 was called and when emergency personnel arrived, the emergency personnel thought that the patient had had a stroke. When the patient woke up on 18Mar2021, the patient was unable to feel from the waist to all the way down. The medical staff at the hospital did a lot of testing on the patient, MRIs and all that stuff, and all of the test results were coming back negative. The medical staff took some fluid from the patient's back after the patient was in the hospital for 2-3 days. The results came back negative until 2 weeks later when the patient's friends and family were informed that the patient had Guillain-Barre Syndrome. The patient's left side got a little improvement with medicine, but the patient's right side did not get any improvement." The patient's fever was treated for the first few days while hospitalized, the patient no longer had a fever. The patient was also treated for high blood pressure for the first few days that he was hospitalized. The reporter was informed of the patient's hearing loss "after the patient started speaking good, about 3-4 days after the patient had the first dose of the COVID-19 vaccine on 16Mar2021. The patient was losing hearing before that, but the patient was not able to talk to the caller or family a lot." (as reported). The reporter did not provide details on medications administered during the patient's hospital stay. The reporter stated that the patient was just discharged from the hospital and sent home. The reported believed that the patient needed more care and more medicine and that he was not finished with treatment. The reporter stated that the patient should have been back to normal health before having been discharged from the hospital. He did not know why the patient was discharged. The reporter stated that the patient was sent home without any medicine and was still experiencing daily headaches. The patient took Advil Migraine for his headaches which did not work, or only worked for 10 minutes and then the pain would come back. The hospital referred the patient to a different facility. The reporter stated that the patient could not get an appointment with this facility for up to 2 months from now. The patient could not wait 2 months for relief. He could not be like that with a headache and no feeling on his right side for 2 months. According to a different doctor the patient needed "more IVIG, immunoglobulin and needed to get attention from a neurologist to watch him until he got better." The patient had an appointment scheduled with a neurologist for Monday 26Apr2021 at 08:00. The clinical outcome of the event fever was recovered/resolved on an unspecified date; does not feel from his waist down on left side and weakness on left side were recovering/resolving; does not feel from his waist down on right side, weakness on right side, lost hearing on right side, pain in back, pain in neck that went up to his head and headache were not recovered/not resolved and passed out, Guillain Barre syndrome and high blood pressure were unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
21,0
Labordaten
Test Name: Bloodwork; Result Unstructured Data: Test Result:Normal; Test Name: Checked spinal fluid; Result Unstructured Data: Test Result:unknown; Test Name: Checked spinal fluid; Result Unstructured Data: Test Result:Guillain-Barre Syndrome; Test Name: MRI; Result Unstructured Data: Test Result:Normal; Test Name: Weight; Result Unstructured Data: Test Result:170 to 180, maybe 190 lbs
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1293389

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
WI
Alter
18,0
Geschlecht
M
Eingang
06.05.2021
Impfdatum
08.04.2021
Beginn
08.04.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Chills Confusional state Gaze palsy Hyperhidrosis Loss of consciousness Nausea Pallor

Symptomtext

Patient received 1st dose of COVID-19 vaccination and immediately after became pale with upward eye deviation and loss of consciousness for approximately 10 seconds. Patient aroused and was noted by nurse to be nauseous, confused, sweating, and shivering. Patient's vitals were obtained and patient was given Gatorade and a snack. Patient was monitored for an additional 30 minutes and repeat vitals obtained. Patient was discharged in stable condition to mother.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1288353

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CA
Alter
83,0
Geschlecht
F
Eingang
05.05.2021
Impfdatum
22.02.2021
Beginn
12.03.2021
Tage bis Beginn
18,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthropathy Muscle strain Thrombosis

Symptomtext

may be blood clot; Something happened with my knee and it has just got worse; I was thinking maybe it is a pulled muscle or something but it is very bad now; This is a spontaneous report received from a contactable consumer (patient). An 83-year-old female patient (5 feet 1 inches, about 120 pounds) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN6198, patient was not sure) via an unspecified route of administration at left arm on 22Feb2021 (83-year-old at time of vaccination), at single dose; the second dose of BNT162B2 (lot number: unknown) via an unspecified route of administration on 15Mar2021 (83-year-old at time of vaccination), at single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient stated she has got both the shots of Pfizer (Covid-19 vaccine) and at the end of the first one or it is like eighteen days, just before the second shot, something happened with her knee and it has just got worse (from 12Mar2021). She did not connect that with the Pfizer shot and I was thinking maybe it is a pulled muscle or something but it is very bad now. She would like to know what she can do. Also, she is thinking may be blood clot at this point and she would like to have it checked. She thinks that she should be able to contact somebody to actually get some physical test on this. She tried heat and cold alternate and Absorbine Jr. and Aspirin. It varied with the days, she thinks she has taken Aspirin about twice a day and it is a tablet and it was 325 mg and she took two of those, orally. Therapeutic measures were taken as a result of the event and included "heat and cold alternate and Absorbine Jr. and Aspirin". The outcome of the event was not recovered. Information on the lot/batch number has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1277200

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
OH
Alter
64,0
Geschlecht
F
Eingang
01.05.2021
Impfdatum
08.03.2021
Beginn
08.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Condition aggravated Discomfort Dysphonia Electric shock sensation Fear Gait disturbance Neuralgia Oropharyngeal pain Pain Skin burning sensation Throat tightness

Symptomtext

she has been having some sore throat or tightness of the throat issues that she felt should be looked at.; she has been having some sore throat or tightness of the throat issues that she felt should be looked at.; she feels like her voice is getting either strange or raspy or something and had worsened; events are getting worse/Feels like she is going downhill/debilitating; Discomfort; She is in pain constantly and is scared and had worsened; Burning skin; She is in pain constantly and is scared and had worsened; electrical sensation/electrical sensations on most of the left side of the body and had worsened; severe neurological burning pain and getting worse; She can't walk straight, has a rocking feeling when she walks which is really weird; it is not a balance problem it's more like something is not firing telling her left side to work, which is very strange and was worsened; This is a spontaneous report from a contactable consumer. A 64-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in Right Arm on 08Mar2021 14:00 (Batch/Lot Number: EN6198) as SINGLE DOSE (at the age of 64 years) for covid-19 immunisation. Patient had first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), on 17Feb2021 for covid-19 Immunization Batch/lot number EN9804, as single dose into right arm. Medical history included hypersensitivity from an unknown date and unknown if ongoing , allergy to animal from an unknown date, skin burning sensation and paraesthesia from an unknown date following unspecified brand shingles vaccine following first dose, Lot/NDC/Expiry: unknown. Concomitant medications included loratadine (LORATADINE) taken for an unspecified indication and flecainide acetate (FLECAINIDE ACETATE) taken for an unspecified indication. The patient experienced severe neurological burning pain and getting worse (medically significant) on 08Mar2021 23:00 with outcome of not recovered , she can't walk straight, has a rocking feeling when she walks which is really weird; it is not a balance problem it's more like something is not firing telling her left side to work, which is very strange and was worsened (medically significant) on 08Mar2021 23:00 with outcome of not recovered , she has been having some tightness of the throat issues that she felt should be looked at (medically significant) on an unspecified date with outcome of unknown , she is in pain constantly and is scared and had worsened (medically significant) on 08Mar2021 23:00 with outcome of not recovered , electrical sensation/electrical sensations on most of the left side of the body and had worsened on 08Mar2021 23:00 with outcome of not recovered , she has been having some sore throat that she felt should be looked at on an unspecified date with outcome of unknown , burning skin on 08Mar2021 23:00 with outcome of not recovered , she feels like her voice is getting either strange or raspy or something and had worsened on an unspecified date with outcome of not recovered , she is in pain constantly and is scared and had worsened on 08Mar2021 23:00 with outcome of not recovered , and discomfort (discomfort) (non-serious) on an unspecified date with outcome of not recovered. The events are getting worse/feels like she is going downhill/debilitating and she is not recovered. She has been trying to get help for these events for about a month, but events are getting worse and no one seems to know what to do. Therapeutic measures were taken as a result of she is in pain constantly. She has seen several doctors and no one can seem to help her. She is trying to get into a neurologist as referred by caller's primary care physician, but the neurologist can't see her for 5 weeks. She was seen in the hospital emergency room last night, 13Apr2021 but not admitted to the hospital. No one there seems to know what to do. ER did some blood work which turned out fine in the hospital and put her on Gabapentin. They told her to take Gabapentin 300mg 3 times daily for 2 weeks. She mentioned that next Tuesday, 20Apr2021 they are sending her in for a thyroid ultrasound but that was at her own request. Blood work done in the hospital on 13Apr2021 came back fine. The patient is not in a study or programme. No additional vaccine was administered on same date of the Pfizer Suspect. She has not taken any other vaccinations within four weeks prior to the first administration date of the suspect vaccine. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Allergic to cats; Allergy; Burning skin (Following unspecified brand shingles vaccine following first dose, Lot/NDC/Expiry: unknown.); Tingling (Following unspecified brand shingles vaccine following first dose, Lot/NDC/Expiry: unknown.)
Andere Medikamente
LORATADINE; FLECAINIDE ACETATE
Allergien
-
Vorherige Impfungen
-

VAERS 1258192

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
LA
Alter
63,0
Geschlecht
M
Eingang
26.04.2021
Impfdatum
17.03.2021
Beginn
13.04.2021
Tage bis Beginn
27,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Angiogram pulmonary normal Chest pain Echocardiogram Electroconvulsive therapy Pericarditis

Symptomtext

Acute pericarditis, severe chest pain, colchicine 0.6 mg tablet 2 times per day for 10 days, asprin 81 mg

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pericarditis
Hospital-Tage
2,0
Labordaten
CT angiogram pulmonary - negative ECT 12 lead ECHO Complete
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
propranolol 10 mg,, multi vitamin, omeprazole , claritin
Allergien
none
Vorherige Impfungen
-

VAERS 1257145

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
AR
Alter
65,0
Geschlecht
F
Eingang
25.04.2021
Impfdatum
25.04.2021
Beginn
25.04.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Chills Colitis ischaemic Dehydration Gastrointestinal haemorrhage Hallucination Pyrexia Renal failure Thrombosis

Symptomtext

Fever. Chills, hallucinations, renal failure, ischemic colitis, gi bleed, blood clot,, dehydration

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
25,0
Labordaten
I don't have these but they're from end of March until this date 042521
Aktuelle Erkrankungen
None
Vorgeschichte
Diabetes. COPD, fibromyalgia, degenerative disk disease with spinal stenosis, PAD, anxiety, depression After shot was sick for a week then ended up in hospital for 10 days, sent home for 5, then back to hospital for 14 days and counting. Deep vein thrombosis, colitis, kidney failure
Andere Medikamente
Aspirin, motropol, lisenpril, tramadol. Wellbrutron, astorvastan, dexilent, duloxtenine, metformin, lantus, breo enhaler, alprazolam, tizandine
Allergien
Morphine, Codeine, Predisone
Vorherige Impfungen
-

VAERS 1255247

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
ME
Alter
71,0
Geschlecht
F
Eingang
25.04.2021
Impfdatum
05.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Electric shock sensation Headache Herpes zoster Muscle spasms Tourette's disorder

Symptomtext

severe pain across the front of her stomach/ rash/ shingles; severe pain in her head/it hurt to touch; severe pain in her head, it hurt to touch and had shocks and her whole body would cramp up; her whole body would cramp up; Tourette's; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6198, expiration date: 30Jun2021) at the age of 71-years-old, via an unspecified route of administration in right shoulder on 05Mar2021 at 10:30 at single dose for COVID-19 immunization. Medical history included neuropathy in feet caused Tamoxifen (chemotherapy), anal cancer stage IV, breast cancer, double mastectomy, chemotherapy, and lymph node in left arm. Concomitant medications included gabapentin, meloxicam, and vitamins. There were no additional vaccines administered on the same date with the COVID-19 vaccine as well as within 4 weeks. The patient previously took tamoxifen as chemotherapy and experienced neuropathy in feet. The patient received her first COVID-19 vaccine on 05Mar2021 and on 13Mar2021, she experienced severe pain across the front of her stomach. On 19Mar2021, she said she has something, and it was a rash. She went to care facility on 20Mar2021 and was told she has shingles. The patient stated that the doctor just looked at her and said she has shingles, no testing was done. They told her it was ok for her to get the second shot, but she was worried about that. She experienced shingles since 13Mar2021, she still has it. She was supposed to have the shingles vaccine 4 years ago, but it was expensive. Her son heard on the radio that the shot may cause shingles, it may or may not be related but she wanted to let Pfizer know. The rash was starting to go away, and the pain was not, but the pain was far better. She ended up going to the doctor on 24Mar2021 with severe pain in her head since Mar2021, and she didn't know why. It hurt to touch and had shocks and her whole body would cramp up. Her daughter told her she looked like she had Tourette's, it was happening every 2-5 minutes. The doctor couldn't do anything and told her what she could take. It was an additional thing and the doctor said it was probably from shingles but she did not have a rash there. It was completely gone now. She received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8727, expiration date: 31Jul2021), via an unspecified route of administration in right shoulder on 26Mar2021 at noon and stated that it was getting better then, and by 27Mar2021 it was gone completely. She was petrified this was going to happen while she was there to get the second vaccine and they would say she couldn't do it. The outcome of the event shingles was recovering and recovered on 27Mar2021 for all other events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electric shock sensation
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Anal cancer stage IV; Breast cancer; Chemotherapy; Lymph nodes enlarged; Mastectomy; Neuropathy
Andere Medikamente
GABAPENTIN; MELOXICAM
Allergien
-
Vorherige Impfungen
-

VAERS 1254765

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
NJ
Alter
66,0
Geschlecht
F
Eingang
25.04.2021
Impfdatum
26.02.2021
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Joint swelling Thrombosis Ultrasound scan Varicose vein

Symptomtext

blood clot in her right ankle; varicose vein in her right ankle and it started to hurt; varicose vein in her right ankle and it started to hurt; ankle on her right side started swelling; This is a spontaneous report from a contactable consumer (patient). A 66-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on arm left on 26Feb2021 14:00 (Batch/Lot Number: EN6198) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809 and expiry date: 30Jun2021) on left arm on 05Feb2021 for covid-19 immunisation. The patient experienced blood clot in her right ankle, varicose vein in her right ankle and it started to hurt, ankle on her right side started swelling, all on an unknown date. All events caused patient physician office visit. Treatment received for all events. It is reported that she is calling about the Covid 19 vaccine. She wanted to report that she developed a blood clot in her right ankle. She went to the doctor yesterday on 06Apr2021. She would like to add she has no prior history of any type of blood issues. The doctor she saw thought that the blood clot and the Covid 19 vaccine could be related but would not commit to saying so directly. She started having issues about 6 days after the second Covid 19 vaccine. She doesn't exactly remember when, maybe the 04Mar2021 or 05Mar2021. She ignored the issues attributing them to over exercising. She reached a point where she couldn't ignore the issues anymore and went to the doctor. Caller clarifies she has a varicose vein in her right ankle and it started to hurt then her ankle on her right side started swelling. She only payed attention to her ankle when it got worse. The last 3 weeks have been awful. She would like it known that she does not lead a sedimentary lifestyle. She rides her bike 60 miles a week and walks 10 miles a week. She's always moving. This is unusual for her. The doctor she saw diagnosed her with a blood clot and he did a sonogram in his office. She has been prescribed Xarelto 15mg tablets. Take 2 tablets twice daily for the first 21 days then on the 22nd day start taking one 20mg tablet once daily. The patient underwent lab tests and procedures which included sonogram: unknown result on 06Apr2021. The outcome of the all events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
Test Date: 20210406; Test Name: sonogram; Result Unstructured Data: Test Result:Unknown result
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1248373

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6198

schwer
Staat
AR
Alter
57,0
Geschlecht
F
Eingang
23.04.2021
Impfdatum
05.03.2021
Beginn
09.03.2021
Tage bis Beginn
4,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pain in extremity Skin warm Thrombosis

Symptomtext

hurting warm leg, blood clot

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1242428

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
71,0
Geschlecht
F
Eingang
22.04.2021
Impfdatum
25.02.2021
Beginn
28.02.2021
Tage bis Beginn
3,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Asthenia Cellulitis Condition aggravated Encephalopathy Erythema Fatigue Intensive care Pyrexia Sepsis

Symptomtext

admitted due to fatigue, weakness, right lower ext redness, acute encephalopathy secondary to fever notes document patient states cellulitis flares after any vaccination Severe sepsis requiring ICU treatment, treated with supportive care and antibiotics for 5 days and discharged on oral antibiotics

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
5,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Morbid obesity, bilateral stasis dermatitis, venous insufficiency, lymphedema, hypothyroidism, hypertension, type 2 diabetes. chronic suppression therapy for cellultitis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1240173

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
OR
Alter
76,0
Geschlecht
F
Eingang
21.04.2021
Impfdatum
27.02.2021
Beginn
28.02.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Angiogram normal Cerebral infarction Cerebral small vessel ischaemic disease Electrocardiogram normal Facial paralysis Fibrin D dimer increased Hemiparesis Magnetic resonance imaging head abnormal

Symptomtext

Patient dreamt she was having a stroke around midnight (estimated) the night of her vaccine. Woke with LUE/LLE weakness and facial droop. Did not immediately report, but after persistent symptoms presented to ED 3/10 for evaluation. MRI showed early infarct right frontal lobe in setting of extensive chronic ischemic small vessel disease throughout the periventricular and subcortical white matter. MRA head/neck negative. EKG: NSR

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
4,0
Labordaten
MRI:3/10/21, EKG 3/10/21-ER Report, Providence D Dimer 3/12: 506 MRI Brain 4/20:Enlargement of MCA territory ischemic area compared to 3/10. No new infarct or hemorrhagic conversion.
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, h/o breast cancer, Hyperlipidemia, Depression, ADD, BMI, Arthritis
Andere Medikamente
Abilify, Metoprolol, Desvenlafaxine, Irbesartan-hctz, myrbetriq 50, simvastatin , zolpidem, ASA, Miralax, Vit D3, Voltaren gel Methylphenidate
Allergien
Radicav, oxycodone
Vorherige Impfungen
-

VAERS 1235816

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
DE
Alter
74,0
Geschlecht
M
Eingang
21.04.2021
Impfdatum
19.03.2021
Beginn
21.03.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Guillain-Barre syndrome Paraplegia

Symptomtext

guillain barre syndrome; Paralysis from the waist down; This is a spontaneous report from a contactable consumer (patient). A 74-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 19Mar2021 09:00 (Batch/Lot Number: EN6198) as single dose for covid-19 immunisation. The COVID-19 vaccine was administered at Hospital. Medical history reported as none. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced Guillain-Barre syndrome and Paralysis from the waist down on 21Mar2021 13:00. Adverse event (AE) resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage. Therapeutic measures were taken as a result of events included Intravenous immunoglobulin (IVIG) and now needing long term care. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, it was unknown if the patient was tested for COVID-19. The outcome of the events was recovering.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1231390

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6198

schwer
Staat
MI
Alter
93,0
Geschlecht
M
Eingang
20.04.2021
Impfdatum
25.02.2021
Beginn
27.02.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: ja
Peripheral swelling Thrombosis

Symptomtext

After first shot some swelling in lower leg, after shot 2 severe swelling and blood clots both legs

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
28,0
Labordaten
Ended up in Hospital March 10th
Aktuelle Erkrankungen
-
Vorgeschichte
Heart disease Kidney disease Diabetes Neuropathy
Andere Medikamente
Levothyroxine, Furosemide, B12, Vit. D, melatonin, aspirin 81mg
Allergien
Sulfa drugs, citrus oil
Vorherige Impfungen
-

VAERS 1950973

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
FL
Alter
70,0
Geschlecht
F
Eingang
19.04.2021
Impfdatum
03.03.2021
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Adverse event Angiogram peripheral abnormal Anticoagulant therapy Aortic thrombosis Arthralgia Computerised tomogram abnormal Condition aggravated Coronary artery thrombosis Deep vein thrombosis Gait inability Inappropriate schedule of product administration Intensive care Intervertebral disc protrusion Limb discomfort Pain Pain in extremity Peripheral artery occlusion Peripheral artery thrombosis

Symptomtext

To it may Concern: April 14, 2021 We are writing this letter to explain the adverse event that happened to my wife. I feel it important to inform you of this event in order to prevent this event from happing to others. We feel your form is not user friendly and does not lend itself to the reporting a COVID Vaccination event. It does not address reporting both dose information and does not provide sufficient space to describe a complicated event. I will attempt to fill in the items that were left blank as follows: Patient and My Thoughts: We believe my vascular occlusion was caused by my Phizer vaccination, the time line and other problems of blood clots caused by other manufactures led me to believe so. When in the hospital some doctors thought it might be true, and many of my medical friends also agree with me. I am in the process of making an appointment with a hematologist, and hope that he may have insight to my blood clot problem. I feel you should investigate my event in order to save others, I am lucky to survive this event and do not know what future issues lay ahead for me. Regards: Patient Time Line of Events Vascular Occlusion April 1, 2021 February 13-First Dose Coivd 19 Vaccination Phizer EC9269 at County Clinic Site March 3 -Second Dose Covid 19 Vaccination Phizer EN6198 at County Clinic Site March 11- Pedicure-Complained that it hurt, later that evening had pain in right hip and down leg to calf, pain became progressivity worse. March 20- Pain in the right leg. Went to walk in Clinic, advised doctor of past pulmonary embolism. Because it was Saturday, they were unable to x ray, suggested we go to emergency. At the emergency we asked the doctor if there was a possibility of a blood clot. His reply was no, a very small percentage chance, less than 1% chance because of taking Elquis. The doctor stated he could order a ultura sound test for blood clots, but it would be a waste of time and money to do so but he could do so if we wanted. We requested he do the test, we wanted to know that there were no clots present. After the test, the doctor stated I told you so, no clots present. A cat scan was made, herniated disk present, a condition we knew was present. The problem was diagnosed as scintica nerve issue. Was given a shot for pain, prescription for steroids and Lidocaine patch written. Discharged with instructions for treatment. When at home the pain continued and progressively became worse, decided that I needed to return to the emergency site. March 29- Returned to emergency. Doctor suspected that I had a herniated disc (sciatica) after hearing all my systems. The doctor stated the only way that he could be certain of his suspicions would be to have a MRI, I elected not to have it done today. The doctor encouraged me to follow up with my primary care physician (I did not have one) for further treatment. Also suggested that I could make an appointment for pain management. I made a appointment Internal Medicine for April 1st. Prescriptions written for acetaminophen, cyelobenzaprine, naproxen, discharge instructions given and discharged. April 1st-In the morning, preparing for my appointment with internal group at 11am, after my shower, I could not walk on my left leg, I felt the pain was at a 10 level. like my leg was in a vise, the pain was higher than 10 if possible, maybe a 30, then I told my husband that he should call 911. My husband was like a deer in a head light, very confused, I had to tell two additional times before he did so. The 911 Fire Truck arrived in approximately ten minutes, ambulance shortly after. I was transported to the emergency facility. Upon arrival the doctor examined me and felt that I might have an aneurysm. Meds were given, I was then transported by ambulance, right light and siren to the Hospital Emergency, the nurse from the emergency facility traveled with me. Upon arrival I was examined immediately and was given a CT Angiography, and it was determined that I had vascular occlusion with a white foot. Dr., a Vascular Surgeon told me that I needed immediate surgery to remove extensive intraluminal thrombus in the thoracic, proximal abdominal aorta as well as in the bilateral profunda femoris artery, as well as the femoral arteries, superficial femoral arteries, popliteal arteries with single vessel runoff present to the right ankle and no definite flow identified in the left runoff vessel. After a 4 Hr. surgery and recovery I was transferred to the CCU unit staying there for two days, transfer to a normal room and discharged on April 4th. My care throughout stay and treatment was excellent, beyond my expeditions, the staff and doctors are great! Hospital is exceptional. Additional Thoughts of Husband- My wife has been very healthy throughout our marriage of 57 years. The discovery of Brest Cancer in 2018, successfully treated, and her Pulmonary Embolism in 2019 and near-death experience also successfully treated as an eye opener to me. When the events of April 1st happened, I was overwhelmed, what is going on, I thought wife's sciatica diagnosis could be causing pain, but not to the extent to call 911, maybe I should take her back to Emergency. Thank God she was correct in telling me to call 911. The issue I have is why did she have Vascular Occlusion? Blood clots can not happen when taking Eliquis, I have been told that by Medical friends in addition to physicians. All of these opinions have ruled out blood clots in my mind and could have caused me to be responsible for my wife's death, thank God again. I wonder if the COVID-19 Vaccination could be a cause. I have searched this thought and found many articles stating blood clots a side effect with people with Covid. Also there have been blood clot side effects with vaccinations such as in AstraZeneca. My fear is will blood clots return. I wonder will we ever know what caused wife's issue. I would encourage physicians not to discount the possibility of blood clots being present no matter what medicine is being taken. I feel we were in the right place when this event happened, thank God that were. The Doctors, Nurses at the hospital have saved my wife's life, and I am grateful for their care. April-4 Discharged Hospital. Discharge papers written 11 pages. April-6 Home visitation. Field ed out paperwork and took vitals April-9 Visited Dr DO at Physician Group. Described the events of 4/1/2021. Doctor examined, took vitals, and wrote prescriptions. Patient and I were very comfortable and pleased with her deminer and knowledge. We decided Dr would be patient's primary physician. April-13 Home visitation, PT, filled out paperwork, took vitals, preformed physical therapy. The plan is for two visits per week for two weeks and one other visit after that.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Aortic thrombosis
Hospital-Tage
4,0
Labordaten
See Attached Letter for Items 19,20,21,22,23,27
Aktuelle Erkrankungen
None
Vorgeschichte
Left Breast Cancer 9/18/2018, Pulmonary Embolism 4/8/2019, Right Knee Replacement 9/23/2014
Andere Medikamente
Eliquis 5MG,Levothyroxine .025MG,Prozac 20MG,Vytorin 10-20MG
Allergien
Sulfa
Vorherige Impfungen
-

VAERS 1228987

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
OH
Alter
36,0
Geschlecht
F
Eingang
19.04.2021
Impfdatum
26.02.2021
Beginn
26.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Feeling hot Flushing Loss of consciousness Nausea

Symptomtext

After approximately 10-15 minutes from receiving vaccine patient felt hot and experienced flushing in her face. She felt nauseous and dizzy and alerted the nurse. Patient was then to be taken to a separate room and patient reports upon standing she blacked out because the next thing she remembered was lying on a couch in a separate room at the clinic site. She took 50 mg of oral Benadryl and also Tylenol. Patient was given something to eat and drink and sat on the couch for an hour, and then she felt fine. Vitals: BP 112/70 mmHg, HR 84 beats per min, PO2 98%

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Thyroid cancer and thyroidectomy 2006, anemia, hysterectomy
Andere Medikamente
Armor Thyroid 300 mg, Iron 130 mg, Multivitamin, Biotin 5,000 units, Vitamin D3 50,000 units (taken weekly and last dose taken day before vaccine), Celexa 20 mg, Adderall XR 20 mg
Allergien
Penicillin, erythromycin, ciprofloxacin, Macrobid
Vorherige Impfungen
-

VAERS 1227970

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
OH
Alter
88,0
Geschlecht
F
Eingang
19.04.2021
Impfdatum
03.03.2021
Beginn
09.03.2021
Tage bis Beginn
6,0
Dosis
1
Route/Site
- / LA
Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Brain stem stroke

Symptomtext

Mom died of a Brain Stem stroke; This is a spontaneous report from a contactable consumer (who reported for the mother). An 88-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the left arm on 03Mar2021 at 11:30 (at the age of 88-year-old) (Lot Number: EN6198) as single dose for COVID-19 immunisation. The patient was not tested for COVID-19 after vaccination. Relevant medical history included COVID-19 prior of vaccination. Concomitant medication included atorvastatin (LIPITOR) taken for an unspecified indication, start and stop date were not reported. On 09Mar2021 at 09:45, the patient experienced a brain stem stroke; the event required emergency room visit, the patient was hospitalized on 09Mar2021 and the event was considered serious also as life-threatening and causing disability. The patient received unspecified corrective treatments. The patient died due to brain stem stroke on 11Mar2021. An autopsy was not performed.; Reported Cause(s) of Death: Brain stem stroke

Weitere VAERSDATA-Felder
Praegender Schweregrund
Brain stem stroke
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19 (prior of vaccination)
Andere Medikamente
LIPITOR [ATORVASTATIN]
Allergien
-
Vorherige Impfungen
-

VAERS 1227205

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
AR
Alter
68,0
Geschlecht
F
Eingang
18.04.2021
Impfdatum
22.03.2021
Beginn
22.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Atrioventricular block complete Heart rate Heart rate abnormal Malaise Oxygen saturation Oxygen saturation decreased Syncope Vomiting

Symptomtext

19 second pause of no heartbeat and in third degree heart block; 19 second pause of no heartbeat and in third degree heart block; Awoke to throw up; Thinks she fainted; Oxygen level of 93 on oximeter; she wasn't feeling well; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in left arm on 22Mar2021 at 15:00 (Lot Number: EN6198) as single dose for covid-19 immunization. Medical history included mild stroke from 18Jan2020 and not ongoing, suspected she had atrial fibrillation and she had a heart monitor placed 21Feb2020. Her heart monitor never showed Atrial Fibrillation after one year of being monitored. Ongoing low thyroid/hypothyroidism and blood cholesterol increased from an unknown date. Concomitant medications included levothyroxine taken for low thyroid/hypothyroidism from an unspecified start date (started probably been 10 years) and ongoing; atorvastatin taken for reduce cholesterol from 2020 (started right after she had stroke, either Jan2020 or Feb2020) and ongoing. No additional vaccines administered on same date of the Pfizer suspect. No prior Vaccinations (within 4 weeks). The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in left arm on 01Mar2021 (at age of 68 years old, Lot Number: EN6200) as single dose for covid-19 immunization. She was fine right after the first dose. She only had a sore arm for 3 days. Just last week, she had a severe adverse reaction right after her vaccine. With the second dose, she had everything possible. Twelve hours after, on 23Mar2021 at 03:00, she awoke to throw up. She thinks she fainted. She had to throw up 2 more times that night. She had been wearing a heart monitor. On 24Mar2021 her cardiologist called her and told her she had a 19 second pause of no heartbeat and was in a 3rd degree heart block. The very next morning, they put in a pacemaker. She was overall healthy and athletic. She was a runner and golfs all the time. She had an outpatient procedure for the pacemaker placement at the hospital on 25Mar2021. She was still recovering but improving. Caller added it was scary when your heart stops. Caller added she did not see this as a possible related side effect, but that evening when she was not feeling well, 22Mar2021, she checked her oxygen level with her oximeter. It was 93 and usually runs around 99. It is back to normal now. She checked it the night she was vomiting. Stated this was before the third degree heart block by a few hours. She did not think it was related. All her symptoms are gone other than the placement of her pacemaker. The outcome of the events " 19 second pause of no heartbeat and in third degree heart block" was recovering. The outcome of the event " Oxygen saturation decreased" was recovered. The outcome of other events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
Test Date: 20210324; Test Name: Heartbeat; Result Unstructured Data: Test Result:19 second pause of no heartbeat; Test Date: 20210322; Test Name: Oxygen level; Result Unstructured Data: Test Result:93; Comments: usually runs around 99
Aktuelle Erkrankungen
Blood cholesterol increased; Hypothyroidism
Vorgeschichte
Medical History/Concurrent Conditions: Atrial fibrillation (She had a heart monitor placed 21Feb2020.); Stroke
Andere Medikamente
LEVOTHYROXINE; ATORVASTATIN
Allergien
-
Vorherige Impfungen
-

VAERS 1223652

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
VA
Alter
71,0
Geschlecht
F
Eingang
17.04.2021
Impfdatum
27.02.2021
Beginn
04.03.2021
Tage bis Beginn
5,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Aortic thrombosis Computerised tomogram Computerised tomogram abnormal Pain in extremity Peripheral artery thrombosis Subclavian artery thrombosis Surgery Ultrasound Doppler

Symptomtext

Patient developed what I though was Raynaud's in right hand. Later that day began having pain. I advised her to go to ED. Evaluated in ED and felt to have Raynaud's as well. Approximately 36 hours later developed severe pain in right arm. Went back to ED and CT scan showed thrombus extending from Aortic arch to subclavian artery and down brachial artery. Underwent emergency surgery to remove thrombus.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Aortic thrombosis
Hospital-Tage
5,0
Labordaten
Cat scan of chest. Doppler ultrasound
Aktuelle Erkrankungen
-
Vorgeschichte
Hypertension, diet controlled diabetes, asthma, hypercholesterolemia, Hx of breast cancer
Andere Medikamente
Anastrozole, atorvastatin, bisoprolol, celebrex, Citracal, lorazepam, omeprazole, Singulair.
Allergien
NKA
Vorherige Impfungen
-

VAERS 1221459

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CO
Alter
41,0
Geschlecht
F
Eingang
16.04.2021
Impfdatum
04.03.2021
Beginn
04.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Anxiety Arthralgia Atrial septal defect Body temperature increased Cardiac aneurysm Chest X-ray normal Chills Computerised tomogram thorax normal Crying Dyschezia Echocardiogram abnormal Fibrin D dimer increased Hyperaesthesia Hyperhidrosis Loss of personal independence in daily activities Musculoskeletal discomfort Night sweats Pain

Symptomtext

he evening of 3-4-21 when I got home from work, I ate dinner, then started shivering badly with temp of 100.5. The shivering quickly changed to more of a convulsing and temp got up to 104.7F. When I woke the next morning, temp was back down to 101-102F and most of shakes were subsiding. But I noticed that I had a deep, cutaneous pain reaction from head to toe when I awoke on 3-5-21. I could not brush my hair because my scalp was too tender. I couldn't let anything touch me and put pressure against any part of my body. Then at 3:30 that afternoon, I went to bathroom and had a bowel movement. It was so excruciating that I truly though my colon might have come partially out. I was in too much pain to flush, so I crawled across the house to my bed and laid on my side for an hour, crying. When I was finally able to go back to the bathroom to flush, I was expecting a large BM. It was not. It was about 2" x 1" and soft. There was no blood. It just felt like it tore me up. ****Then at 7:30 PM on 3-5-21 was when things got very serious. I was sitting down watching TV after a light meal. Suddenly, I started noticing discomfort deep in my upper back, between my shoulder blades. Within 5 minutes, it was at its worst....I was have rated it 11/10 pain. The pain was just very deep, behind the spine, about palm sized radius and unrelenting. My first thought was "maybe this is musculoskeletal since I've been in bed a lot because of the pain today." So I looked in my medicine cabinet for what I had and took 5 mg of Oxycodone and 10 mg of Cyclobenzaprine. An hour later, these meds hadn't touched it. I was beginning to really worry about an MI, or aortic dissection or pulmonary embolism (though I had no SOB). Lying flat on my back on a hard surface seemed to provide the only relief (though minimal relief, 9/10 pain). I called another provider who was on call and told her. She said that I could try taking 800 mg of Ibuprofen, but if I wasn't relieved in 1 hour, I needed to call 911 or have someone take me to the ER. I was asleep in an hour. I took it easy the next two days but started feeling back to normal during the days. I continued to sweat throughout the nights and skin pain continued so much that I had to cut some of my hair out. That following Tuesday, the deep upper back pain returned.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
had a slightly positive D-Dimer, borderline Troponin. Went for Chest Xray which was negative. CT scan of chest negative. But 7 days after the vaccine, I had vision disturbances to my R eye. Asked for further workup to r/o PFO. Echo of heart done shows Atrial Septal Aneurysm and R to L atrial shunting. I am awaiting Cardiology consult 4-28-21 to see if anything can be done. The pain I continue to feel is apparently the aneurysm :0(
Aktuelle Erkrankungen
None
Vorgeschichte
Hypothyroidism, Raynauds, Monoclonic Jerks, PMS exacerbated by elevated Estrogen and low Testosterone Hx of inguinal Hernia Hx of Geographic tongue Cervical Radiculopathy
Andere Medikamente
NP Thyroid 45 mg QD Keppra 750 mg BID Fluoxetine 10 mg QD Vitamin D 5000 IU 3 x's per week, Vitamin C, DIM, Chaste Tree Berry, Probiotic Magnesium Glycerinate 525 mg Q AM Magnesium Lactate 500 mg Q HS
Allergien
Stainless Steel Latex Tree Nuts Avocado Browned Bananas Jalape?os seeds
Vorherige Impfungen
-

VAERS 1203491

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MN
Alter
56,0
Geschlecht
F
Eingang
13.04.2021
Impfdatum
10.03.2021
Beginn
12.03.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Angiogram Anticoagulant therapy Cerebral artery thrombosis Computerised tomogram head Endotracheal intubation Extubation Mechanical ventilation Thrombectomy Visual impairment

Symptomtext

Pt reported to the ER two days after vaccination on 03/12/21 with complaints of visual difficulties and gaze abnormalities. Stroke code was activated at 1445. After CT, pt was flown to Hospital for work up by neurology. Underwent CTA, throbus in right PCA. Underwent thrombectomy. Complications from stroke and difficult airway led to intubation and mechanical intervention, extubated the next day. Pt discharged from hospital 03/17 on Eliquis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebral artery thrombosis
Hospital-Tage
5,0
Labordaten
03/12/21 CT head w/o contrast 03/12/21 CTA brain with perfusion 03/12/21 CTA neck 03/13/21 CT head w/o contrast
Aktuelle Erkrankungen
no acute illness
Vorgeschichte
hypertension, NSTEMI 08/2016 and 01/2017, hypertrophic cardiomyopathy, COPD, obesity, type 2 diabetes, hyperlipidemia, depression, tobacco use, peripheral neuropathy, noncompliance with medications
Andere Medikamente
aspirin 81mg QD, diltiazem ER 240mg QD, lisinopril 20mg QD, metformin 500mg BID, metoprolol tartrate 100mg BID, nitrostat 0.4mg PRN, omeprazole 20mg QD, KCl 20 mEq QD, rosuvastatin 40mg QD, venlafaxine 100mg BID
Allergien
codeine
Vorherige Impfungen
-

VAERS 1201807

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
VA
Alter
44,0
Geschlecht
M
Eingang
13.04.2021
Impfdatum
26.02.2021
Beginn
27.02.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Activated partial thromboplastin time prolonged Bell's palsy Computerised tomogram Computerised tomogram neck Full blood count Headache Metabolic function test

Symptomtext

Severe headache the day after the vaccine, followed by a regular headache until present, worsening intensity. Then on 4/10/2021, he developed changes on the right side of his face that were diagnosed in ED as Bell's Palsy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
4/10/21 CMP, CBC, PT/PTT, CT scan of neck and head
Aktuelle Erkrankungen
none
Vorgeschichte
ulcerative colitis
Andere Medikamente
xyzal, vitamin D
Allergien
none
Vorherige Impfungen
-

VAERS 1201376

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CA
Alter
55,0
Geschlecht
M
Eingang
13.04.2021
Impfdatum
19.03.2021
Beginn
22.03.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Scan Thrombosis

Symptomtext

blood clot formed in left leg in surface vein, at intersection with deep vein.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
3/30/21 scan performed confirmed blood clot
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Anastrozole; Testosterone
Allergien
none
Vorherige Impfungen
-

VAERS 1112775

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MN
Alter
56,0
Geschlecht
F
Eingang
12.04.2021
Impfdatum
10.03.2021
Beginn
12.03.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Angiogram cerebral Angiogram pulmonary Basilar artery thrombosis Computerised tomogram head Ischaemic stroke Asthenia Cerebral thrombosis Dizziness Gait disturbance Speech disorder Brain stem stroke Chest pain Dyspnoea Endotracheal intubation Thrombosis Visual acuity reduced Vomiting

Symptomtext

1. Acute ischemic stroke (HCC) 2. Basilar artery thrombosis

Weitere VAERSDATA-Felder
Praegender Schweregrund
Brain stem stroke
Hospital-Tage
5,0
Labordaten
CT head 3/12/21, CTA brain 3/12/21, CTA Neck 3/12/21, CT head 3/13/21, CTA chest 3/13/21, CT head 3/24/21
Aktuelle Erkrankungen
none
Vorgeschichte
hypertension, COPD, obesity, Diabetes, hyperlipidemia, hypertrophic cardiomyopathy
Andere Medikamente
Aspirin 81 mg, atorvastatin, diltiazem, lisinopril, metformin, metoprolol, nitroglycerin Sl, omeprazole, potassium chloride, rosuvastatin ,venlafaxine
Allergien
Codeine
Vorherige Impfungen
-

VAERS 1192115

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
IN
Alter
66,0
Geschlecht
M
Eingang
10.04.2021
Impfdatum
17.03.2021
Beginn
18.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Blood pressure decreased Blood pressure increased Blood pressure measurement Blood test Cystoscopy Diarrhoea Loss of consciousness Nausea SARS-CoV-2 test

Symptomtext

Second Dose: blood pressure went to high; Second Dose: started to black out, if his partner had not been there for him he might be dead right now; Second Dose: blood pressure dropped to 89/56; Second Dose: too weak to walk very far; Second Dose: diarrhea; Second Dose: Nausea; This is a spontaneous report from a contactable consumer (patient). A 66-year-old male consumer received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 17Mar2021 at 09:00 at single dose for COVID-19 immunisation at the age of 66-year-old. Lot number was EN6198. Medical history included ongoing hypertension (10-15 years), ongoing degenerative arthritis since 2010, ongoing Rheumatoid arthritis since 2015, pain, prostate infection (treated with antibiotic; stopped taking the antibiotic and all of his medications), pneumonia in Sep2020 (unrelated to the Covid 19 virus, hospitalization). Patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Feb2021 at single dose in left arm for COVID-19 immunisation at the age of 66-year-old and he experienced nausea, slight diarrhea, tiredness; lot number was EM9810. Concomitant medications included adalimumab (HUMIRA), methotrexate, hydrocodone. On 18Mar2021, the patient experienced nausea and diarrhea. The patient received ondansetron 4mg tablets, take 1 by mouth every 4 hours as needed for nausea. On 20Mar2021, the patient experienced black out, if his partner had not been there for him he might be dead right at the time of report, it was a bad, bad experience (life-threatening), blood pressure dropped to 89/56 and too weak to walk very far. The patient drank lots of fluids and they were able to get his blood pressure back up, the doctor almost sent him to the hospital to get fluids. Then his blood pressure went to high and he had to get it down. The patient had gone to pick up some groceries and he started to black out. He had to ride in the motorized cart around since he was too weak to walk very far. The patient has had to ride the motorized cart before because he has degenerative arthritis and rheumatoid arthritis. The patient got into his van to leave and he could not drive home. It was only 7 miles but he felt like he would have blacked out and it would have been dangerous; he called his partner and he came to get him. On 21Mar2021, the patient experienced blood pressure went to high. On unknown date, blood pressure resulted high, cystoscopy (urine came back positive for infection), Covid 19 virus test (negative). On 20Mar2021, blood pressure dropped to 89/56. On 22Mar2021, blood work was performed (unknown results). Doctor recommended that he should stop taking his arthritis medications and pain medication. The doctor told him those medications might interfere in getting the Covid 19 vaccine; the patient took immune depressors. The patient did not recover from weakness and nausea, the patient recovered from diarrhea; the outcome of other events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
Test Name: blood pressure; Result Unstructured Data: Test Result:High; Test Date: 20210320; Test Name: blood pressure; Result Unstructured Data: Test Result:89/56; Test Date: 20210322; Test Name: blood work; Result Unstructured Data: Test Result:Unknown results; Test Name: cystoscopy; Result Unstructured Data: Test Result:urine came back positive for infection; Test Name: Covid 19 virus test; Test Result: Negative
Aktuelle Erkrankungen
Hypertension (10-15 years); Osteoarthritis; Rheumatoid arthritis
Vorgeschichte
Medical History/Concurrent Conditions: Pain; Pneumonia (in the hospital with pneumonia unrelated to the Covid 19 virus; diagnosed with pneumonia in Sep2020); Prostate infection (treated with antibiotic. He stopped taking the antibiotic and all of his medications.)
Andere Medikamente
HUMIRA; METHOTREXATE; HYDROCODONE
Allergien
-
Vorherige Impfungen
-

VAERS 1190936

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
WA
Alter
67,0
Geschlecht
M
Eingang
10.04.2021
Impfdatum
16.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood pressure measurement Hypertensive crisis Thrombosis Vertigo

Symptomtext

Hypertensive crisis at 180/95; Vascular thrombosis; Head is spinning; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6198), via an unspecified route of administration in left arm, on 16Mar2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered in a hospital facility. In Mar2021, the patient's head was spinning, there was a hypertensive crisis at 180/95 for 2 times, and there may be a vascular thrombosis. It was unknown if treatment was received for the adverse events. The events were considered non-serious by the patient. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
Test Name: Blood pressure; Result Unstructured Data: Test Result:180/95
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1179414

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MI
Alter
34,0
Geschlecht
F
Eingang
08.04.2021
Impfdatum
08.04.2021
Beginn
08.04.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Asthenia Dizziness Hyperhidrosis Hypertension Nausea Presyncope

Symptomtext

5-1 minutes after 1st injection patient became very nauseous and had near syncopal episode. She as diaphoretic and complained of feeling very weak and lightheaded. She almost collapsed to the ground. She was severely hypertensive. EMS was called and patient transported to nearest ER. Denied any diffciulty in breathing, chest pain, or any other signs of allergic reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1178928

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MI
Alter
71,0
Geschlecht
F
Eingang
07.04.2021
Impfdatum
02.03.2021
Beginn
09.03.2021
Tage bis Beginn
7,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Back injury Contusion Loss of consciousness

Symptomtext

I'm not sure this was the cause, I blacked out from standing to the floor. Woke up on floor, hurt back, took Motrin 800 mg, used Ice and Heat for Pain. Did not report to Dr., just though I brused Back Badly

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
none done yet
Aktuelle Erkrankungen
NONE
Vorgeschichte
HIGH BLOOD PRESSURE, HIGH URIC ACID, DEPRESSION, UNDER-ACTIVE THYROID DISEASE
Andere Medikamente
HCTZ 25 MG,NORVACE 5MG,PROZAC 80MG,COZZAR 25G,NEXIUM25MG,SYNTHROID 125 MCG,FOLIC ACID 1MG,ALLOURINAL 100MG,BIOTIN 1 MG, CRANBERRY 25,000,VIT D 10,000UNITS,
Allergien
SULFA DRUGS, ALL ACE INHIBITORS
Vorherige Impfungen
-

VAERS 1178472

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TX
Alter
60,0
Geschlecht
M
Eingang
07.04.2021
Impfdatum
24.02.2021
Beginn
26.02.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bell's palsy Ear pain Headache

Symptomtext

earache, headache and Bell's Palsy on left side of fac

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1177972

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
NE
Alter
73,0
Geschlecht
M
Eingang
07.04.2021
Impfdatum
01.04.2021
Beginn
04.04.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Bell's palsy Facial paralysis Lacrimation increased Mastication disorder

Symptomtext

On late afternoon of 4/4/2021 spouse noticed slight paralysis on the right side of face (mouth) and sagging of check/neck. No other symptom was felt. On 4/5/2021 paralysis was still obvious and right eye was tearing. Still no other issues. On 4/6/2021 paralysis seems to interrupt chewing on right side. Went to emergency thinking maybe it was a slight stroke. Diagnosis was Bell palsy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1166770

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
IA
Alter
21,0
Geschlecht
M
Eingang
04.04.2021
Impfdatum
01.04.2021
Beginn
01.04.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fall Loss of consciousness

Symptomtext

Patient was in medical observation fell on floor and passed out. Moved back to cc part of building where we kept for 30 plus minutes. Asked patient if he hit his head he stated no- no neck problems just right knee was hit when he fell. BP 115/72 mmHg, pulse 72 bpm, pulse ox 99%, RR 16 brpm. Patient was monitored for 30 minutes and then discharged home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1102517

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
DE
Alter
69,0
Geschlecht
M
Eingang
04.04.2021
Impfdatum
03.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Angiogram Chest X-ray Computerised tomogram head Computerised tomogram thorax Culture Aspiration Blood culture Body temperature Computerised tomogram Electroencephalogram Lumbar puncture Magnetic resonance imaging Magnetic resonance imaging head Laboratory test Magnetic resonance imaging neck Lipoma Peripheral swelling Pneumonia aspiration

Symptomtext

Seizure; a fever that was 101.4; Aspiration Pneumonia, due to aspirating or vomiting during the seizure; Aspiration Pneumonia, due to aspirating or vomiting during the seizure; Aspiration Pneumonia, due to aspirating or vomiting during the seizure; arm on the left side at the armpit was swollen; This is a spontaneous report from a contactable consumer. This consumer (patient's wife) reported for a 69-year-old male patient (husband) who received second dose of BNT162B2 (Pfizer-BiONtech COVID-19 vaccine, formulation: solution for injection), via an unspecified route of administration, administered in Arm Left on 03Mar2021 18:00 (Batch/Lot Number: EN6198) as single dose for Covid-19 immunization; cephalexin hcl (Capsule, 500 mg), via an unspecified route of administration from 10Mar2021 to 10Mar2021, at 500 mg, once daily, (He only had the 1 dose) for protection. Medical history included Diabetes Type 2 and lymph node was removed from the left armpit on 05Mar2021. Historical vaccine included BNT162B2 (Pfizer-BiONtech COVID-19 vaccine), (First Dose: Lot EL8982, No Expiry written, administered on the Left Arm) for COVID-19 immunisation on 10Feb2021 and experienced lymph node was removed from the left armpit, Pneumonia vaccine on Feb2012 for Immunization and experienced he had a reaction from it. Pneumonia vaccine Feb2012 and he ended up in Hospital because he had a reaction from it, she does not know Name, Lot number, or Expiry of the pneumonia Vaccine, had a reaction with the pneumonia vaccine in the past. Concomitant medications were not reported. Patient experienced Seizure, a stroke, convulsing on 10Mar2021, a fever that was 101.4 on 09Mar2021 and Aspiration Pneumonia, due to aspirating or vomiting during the seizure, arm on the left side at the armpit was swollen on Mar2021. She was calling about the Covid Vaccine. She was calling on behalf of her husband. They got both covid vaccines, the first was 10Feb2021 and the second was on 03Mar2021 at 6 pm. On 10Mar2021 her husband had a seizure, he was 69 years old, and he has never had a seizure before. She was wonder if this could be any relation to the vaccine or other things leading up to it. She has already called and reported this on the site but no one has called her from the (Public agency name). Reporter was a Medical Secretary, but she retired 8 years ago. His First Dose was on 10Feb2021 at 6 PM. The Second Dose was on 03Mar2021 at 6 PM, the Seizure happened on the 10Mar2021. Facility of vaccine administration: It was apart of "(name withheld)" it was like a pop up clinic but offered by (name withheld). It was in (address withheld). She confirms this was a Medical facility, not Military facility, it took place in a physician office suite. The Seizure was a 1 time event, he was not still experiencing seizures. It lasted about a minute, more or less, but she called #, she screamed because she was scared. He was then taken to the hospital, admitted, and then discharged. At the Hospital they did everything, they ruled out a stroke, ruled out everything. They said this was not due to any epileptic nature, her husband had Brain EEG, MRI, MRA, Chest X ray, Head CT, Ct Scan of the Head, Ct Scan of the Chest, Spinal Tap, Blood Culture for Sepsis. Caller was queried if there was any known results she would like to share, she states that everything was normal. Outcome: He ended up with Aspiration Pneumonia, due to aspirating or vomiting during the seizure. Caller was queried on what the current status of the Aspiration Pneumonia was, she stated that he was good, he had a Follow Up yesterday with the doctor, he was pretty good at the moment, he was coughing a lot but that's related to the aspiration pneumonia, he does have another Chest X ray in 4 weeks to a month. First Dose: Lot EL8982, No Expiry written, administered on the Left Arm. Second Dose: Lot EN6198, No Expiry written, administered on the Left Arm. Concomitant Medication: It was questionable and dark. On 03Mar2021 he had his second dose, then on 05Mar2021 at 9 AM he had a procedure in which a lymph node was removed from the left armpit. This procedure was actually scheduled after the first covid vaccine dose. It was done in the doctors office, by Tuesday afternoon 09Mar2021 he was running a fever that was 101.4 late in the day. They initially thought it was a lipoma. Caller was queried if she knew what the actual procedure name was, she stated Left. It was some proper medical name for arm pit. They called the general surgeon that did this surgery, their doctor actually referred her husband to him, he said bring him in the morning and give him Tylenol or Advil, it helped the fever and it came down but the arm on the left side at the armpit was swollen. Her husband went to the doctor in the morning 10Mar2021, he had a 10:30 AM appointment, he saw Physician Assistant and she removed 22 cc's of a light red fluid, when it was removed her husband was like oh my god what a relief! For protection, her husband was prescribed an antibiotic, caller initially said Keflex but then confirms that it is actually generic Cephlaxin 500 mg twice a day. He was fine when he left the office, they even stopped at the store, and then when they pulled into the driveway the Physician Assistant called to ask if he feels okay, this was at 12:50 noon. The Cephlaxin was started, they then walked into the house made a sandwich had a drink and he took the first pill, then at 1:36 PM she was on the phone. It was in between 12:50 and 1:36 PM that he had the seizure, it just right before 1:36 PM. Prior to seizure, her husband was sitting down, and he said "my eyes, the light is blinding his eyes, he cant see" She then looked over at him and he was seizing and convulsing. Cephalexin: Dispensed in an amber orange brownish color pharmacy vial, it is capsules, oblong, light green, it says 219 on the capsule. The Manufacture is (Manufacturer name). He only had the 1 dose on 10Mar2021, and did not take anymore, it was stopped. Medical conditions: Caller was queried if there are any Allergies, she stated No, however in 2012 he had a Pneumonia vaccine Feb2012 and he ended up in Hospital because he had a reaction from it, she did not know Name, Lot number, or Expiry of the pneumonia Vaccine. Her husband has had no other vaccines on the same day as the covid vaccine or in the 4 weeks prior. This experience did cause him to go to the ER and Physician Office, as she mentioned yesterday he had a follow up on 18Mar2021 and he has another this coming Monday 22Mar20221, it was a follow up with the surgeon. Treatment: He came home, they called in a medication which he took his last dose last night of Augmentin. He was on IV medication in the Hospital. When speaking with the family doctor he said that it could be multiple things, he doesn't know what to think as there is no conclusive answer. He said this could be the cephalexin or the covid vaccine considering her husband had a reaction with the pneumonia vaccine in the past. The doctor said for now, no more vaccines, nothing for him. She was given a case number through the the site, she doesn't if she will hear from the (Public agency name). The patient underwent lab tests and procedures which included blood culture: normal on Mar2021, temperature: 101.4 fahrenheit on 09Mar2021, chest x-ray: normal on Mar2021, CT scan: normal on Mar2021, Head CT: normal on Mar2021, Brain EEG: normal on Mar2021, Spinal tap: normal on Mar2021, MRI: normal on Mar2021, MRA: normal on Mar2021.The action taken in response to the events for cephalexin hcl was permanently withdrawn on 10Mar2021. The outcome of the events, for Seizure was Recovered/Resolved with Sequel, for Aspiration Pneumonia, due to aspirating or vomiting during the seizure, arm on the left side at the armpit was swollen, outcome was unknown, for a fever that was 101.4, outcome was recovering, for a stroke outcome was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
3,0
Labordaten
Test Date: 202103; Test Name: Blood culture; Result Unstructured Data: Test Result:Normal; Test Date: 20210309; Test Name: temperature; Result Unstructured Data: Test Result:101.4 Fahrenheit; Test Date: 202103; Test Name: Chest X-ray; Result Unstructured Data: Test Result:Normal; Test Date: 202103; Test Name: CT scan; Result Unstructured Data: Test Result:Normal; Test Date: 202103; Test Name: Head CT; Result Unstructured Data: Test Result:Normal; Test Date: 202103; Test Name: Brain EEG; Result Unstructured Data: Test Result:Normal; Test Date: 202103; Test Name: Spinal tap; Result Unstructured Data: Test Result:Normal; Test Date: 202103; Test Name: MRI; Result Unstructured Data: Test Result:Normal; Test Date: 202103; Test Name: MRA; Result Unstructured Data: Test Result:Normal
Aktuelle Erkrankungen
Lymph node excision
Vorgeschichte
Medical History/Concurrent Conditions: Type 2 diabetes mellitus
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1102517

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
DE
Alter
69,0
Geschlecht
M
Eingang
04.04.2021
Impfdatum
03.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Angiogram Chest X-ray Computerised tomogram head Computerised tomogram thorax Culture Aspiration Blood culture Body temperature Computerised tomogram Electroencephalogram Lumbar puncture Magnetic resonance imaging Magnetic resonance imaging head Laboratory test Magnetic resonance imaging neck Lipoma Peripheral swelling Pneumonia aspiration

Symptomtext

Seizure; a fever that was 101.4; Aspiration Pneumonia, due to aspirating or vomiting during the seizure; Aspiration Pneumonia, due to aspirating or vomiting during the seizure; Aspiration Pneumonia, due to aspirating or vomiting during the seizure; arm on the left side at the armpit was swollen; This is a spontaneous report from a contactable consumer. This consumer (patient's wife) reported for a 69-year-old male patient (husband) who received second dose of BNT162B2 (Pfizer-BiONtech COVID-19 vaccine, formulation: solution for injection), via an unspecified route of administration, administered in Arm Left on 03Mar2021 18:00 (Batch/Lot Number: EN6198) as single dose for Covid-19 immunization; cephalexin hcl (Capsule, 500 mg), via an unspecified route of administration from 10Mar2021 to 10Mar2021, at 500 mg, once daily, (He only had the 1 dose) for protection. Medical history included Diabetes Type 2 and lymph node was removed from the left armpit on 05Mar2021. Historical vaccine included BNT162B2 (Pfizer-BiONtech COVID-19 vaccine), (First Dose: Lot EL8982, No Expiry written, administered on the Left Arm) for COVID-19 immunisation on 10Feb2021 and experienced lymph node was removed from the left armpit, Pneumonia vaccine on Feb2012 for Immunization and experienced he had a reaction from it. Pneumonia vaccine Feb2012 and he ended up in Hospital because he had a reaction from it, she does not know Name, Lot number, or Expiry of the pneumonia Vaccine, had a reaction with the pneumonia vaccine in the past. Concomitant medications were not reported. Patient experienced Seizure, a stroke, convulsing on 10Mar2021, a fever that was 101.4 on 09Mar2021 and Aspiration Pneumonia, due to aspirating or vomiting during the seizure, arm on the left side at the armpit was swollen on Mar2021. She was calling about the Covid Vaccine. She was calling on behalf of her husband. They got both covid vaccines, the first was 10Feb2021 and the second was on 03Mar2021 at 6 pm. On 10Mar2021 her husband had a seizure, he was 69 years old, and he has never had a seizure before. She was wonder if this could be any relation to the vaccine or other things leading up to it. She has already called and reported this on the site but no one has called her from the (Public agency name). Reporter was a Medical Secretary, but she retired 8 years ago. His First Dose was on 10Feb2021 at 6 PM. The Second Dose was on 03Mar2021 at 6 PM, the Seizure happened on the 10Mar2021. Facility of vaccine administration: It was apart of "(name withheld)" it was like a pop up clinic but offered by (name withheld). It was in (address withheld). She confirms this was a Medical facility, not Military facility, it took place in a physician office suite. The Seizure was a 1 time event, he was not still experiencing seizures. It lasted about a minute, more or less, but she called #, she screamed because she was scared. He was then taken to the hospital, admitted, and then discharged. At the Hospital they did everything, they ruled out a stroke, ruled out everything. They said this was not due to any epileptic nature, her husband had Brain EEG, MRI, MRA, Chest X ray, Head CT, Ct Scan of the Head, Ct Scan of the Chest, Spinal Tap, Blood Culture for Sepsis. Caller was queried if there was any known results she would like to share, she states that everything was normal. Outcome: He ended up with Aspiration Pneumonia, due to aspirating or vomiting during the seizure. Caller was queried on what the current status of the Aspiration Pneumonia was, she stated that he was good, he had a Follow Up yesterday with the doctor, he was pretty good at the moment, he was coughing a lot but that's related to the aspiration pneumonia, he does have another Chest X ray in 4 weeks to a month. First Dose: Lot EL8982, No Expiry written, administered on the Left Arm. Second Dose: Lot EN6198, No Expiry written, administered on the Left Arm. Concomitant Medication: It was questionable and dark. On 03Mar2021 he had his second dose, then on 05Mar2021 at 9 AM he had a procedure in which a lymph node was removed from the left armpit. This procedure was actually scheduled after the first covid vaccine dose. It was done in the doctors office, by Tuesday afternoon 09Mar2021 he was running a fever that was 101.4 late in the day. They initially thought it was a lipoma. Caller was queried if she knew what the actual procedure name was, she stated Left. It was some proper medical name for arm pit. They called the general surgeon that did this surgery, their doctor actually referred her husband to him, he said bring him in the morning and give him Tylenol or Advil, it helped the fever and it came down but the arm on the left side at the armpit was swollen. Her husband went to the doctor in the morning 10Mar2021, he had a 10:30 AM appointment, he saw Physician Assistant and she removed 22 cc's of a light red fluid, when it was removed her husband was like oh my god what a relief! For protection, her husband was prescribed an antibiotic, caller initially said Keflex but then confirms that it is actually generic Cephlaxin 500 mg twice a day. He was fine when he left the office, they even stopped at the store, and then when they pulled into the driveway the Physician Assistant called to ask if he feels okay, this was at 12:50 noon. The Cephlaxin was started, they then walked into the house made a sandwich had a drink and he took the first pill, then at 1:36 PM she was on the phone. It was in between 12:50 and 1:36 PM that he had the seizure, it just right before 1:36 PM. Prior to seizure, her husband was sitting down, and he said "my eyes, the light is blinding his eyes, he cant see" She then looked over at him and he was seizing and convulsing. Cephalexin: Dispensed in an amber orange brownish color pharmacy vial, it is capsules, oblong, light green, it says 219 on the capsule. The Manufacture is (Manufacturer name). He only had the 1 dose on 10Mar2021, and did not take anymore, it was stopped. Medical conditions: Caller was queried if there are any Allergies, she stated No, however in 2012 he had a Pneumonia vaccine Feb2012 and he ended up in Hospital because he had a reaction from it, she did not know Name, Lot number, or Expiry of the pneumonia Vaccine. Her husband has had no other vaccines on the same day as the covid vaccine or in the 4 weeks prior. This experience did cause him to go to the ER and Physician Office, as she mentioned yesterday he had a follow up on 18Mar2021 and he has another this coming Monday 22Mar20221, it was a follow up with the surgeon. Treatment: He came home, they called in a medication which he took his last dose last night of Augmentin. He was on IV medication in the Hospital. When speaking with the family doctor he said that it could be multiple things, he doesn't know what to think as there is no conclusive answer. He said this could be the cephalexin or the covid vaccine considering her husband had a reaction with the pneumonia vaccine in the past. The doctor said for now, no more vaccines, nothing for him. She was given a case number through the the site, she doesn't if she will hear from the (Public agency name). The patient underwent lab tests and procedures which included blood culture: normal on Mar2021, temperature: 101.4 fahrenheit on 09Mar2021, chest x-ray: normal on Mar2021, CT scan: normal on Mar2021, Head CT: normal on Mar2021, Brain EEG: normal on Mar2021, Spinal tap: normal on Mar2021, MRI: normal on Mar2021, MRA: normal on Mar2021.The action taken in response to the events for cephalexin hcl was permanently withdrawn on 10Mar2021. The outcome of the events, for Seizure was Recovered/Resolved with Sequel, for Aspiration Pneumonia, due to aspirating or vomiting during the seizure, arm on the left side at the armpit was swollen, outcome was unknown, for a fever that was 101.4, outcome was recovering, for a stroke outcome was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
3,0
Labordaten
Test Date: 202103; Test Name: Blood culture; Result Unstructured Data: Test Result:Normal; Test Date: 20210309; Test Name: temperature; Result Unstructured Data: Test Result:101.4 Fahrenheit; Test Date: 202103; Test Name: Chest X-ray; Result Unstructured Data: Test Result:Normal; Test Date: 202103; Test Name: CT scan; Result Unstructured Data: Test Result:Normal; Test Date: 202103; Test Name: Head CT; Result Unstructured Data: Test Result:Normal; Test Date: 202103; Test Name: Brain EEG; Result Unstructured Data: Test Result:Normal; Test Date: 202103; Test Name: Spinal tap; Result Unstructured Data: Test Result:Normal; Test Date: 202103; Test Name: MRI; Result Unstructured Data: Test Result:Normal; Test Date: 202103; Test Name: MRA; Result Unstructured Data: Test Result:Normal
Aktuelle Erkrankungen
Lymph node excision
Vorgeschichte
Medical History/Concurrent Conditions: Type 2 diabetes mellitus
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1158684

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6198

schwer
Staat
OH
Alter
73,0
Geschlecht
F
Eingang
02.04.2021
Impfdatum
01.03.2021
Beginn
02.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Eye pain Facial paralysis Fatigue Feeling abnormal Hyperacusis Lacrimation increased Magnetic resonance imaging Memory impairment Pain Sleep disorder Somnolence Speech disorder Tremor Visual impairment

Symptomtext

Bell's Palsy partial facial paralysis on both sides; Eyesight is dimmed; throbbing pain mostly in right eye/ Occasional shooting pain in eye; Eyes watering; Groggy; Dizzy; Extreme fatigue; Brain foggy; Forgetful; Sleep cycle distorted; Essential tremors in hands; Dull pain in back of head near neck; slightly garbled/ voice difficult to understand; Sensitive to loud noises; This is a spontaneous report from a contactable Other-HCP (patient). A 73-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), at same age, via an unspecified route of administration, administered in arm left on 01Mar2021 16:30 (Batch/Lot Number: en6198; Expiration Date: 01Mar2021) as single dose for covid-19 immunisation. Medical history included COPD. Concomitant medication included salbutamol (VENTOLIN [SALBUTAMOL]);and fluticasone propionate/ salmeterol xinafoate (ADVAIR). The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: em9809) on 07Feb2021 04:00 PM, in left arm for covid-19 immunisation at age of 73 years old. The patient experienced eyesight was dimmed, even when she can manage to open her eyelids, occasional shooting pain in eye, eyes watering, throbbing pain mostly in right eye, Bell's Palsy partial facial paralysis on both sides: can't smile, voice difficult to understand, slightly garbled, groggy, dizzy, brain foggy, forgetful, extreme fatigue, sensitive to loud noises like dog's bark, sleep cycle distorted, essential tremors in hands are greater than usual, and dull pain in back of head near neck and all on 02Mar2021 05:00 PM. AE resulted in Doctor or other healthcare professional office/clinic visit. Patient is not pregnant. The treatment was received. No covid prior vaccination and no covid tested post vaccination. The patient underwent lab tests and procedures which included MRI (magnetic resonance imaging): unknown result on unspecified date. The outcomes of events were recovering.; Sender's Comments: Based on a plausible temporal association, the company cannot completely rule out a causative role of BNT162B2 to the onset of facial paralysis. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
-
Labordaten
Test Name: MRI; Result Unstructured Data: Test Result:Unknown result
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: COPD
Andere Medikamente
VENTOLIN [SALBUTAMOL]; ADVAIR
Allergien
-
Vorherige Impfungen
-

VAERS 1157628

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MI
Alter
63,0
Geschlecht
F
Eingang
01.04.2021
Impfdatum
26.02.2021
Beginn
27.02.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Body temperature Dizziness Head injury Influenza like illness Loss of consciousness Nausea Pyrexia

Symptomtext

passed out; Unfortunately hit my head.; felt light headed; slightly nauseous; intense right knee pain; temperature of 99.6; flu-like symptoms; This is a spontaneous report from a contactable Other Health Professional (patient). A 63-year-old non-pregnant female patient received bnt162b2 (Pfizer Brand COVID 19), dose 2 intramuscular, administered in left arm on 26Feb2021 12:00 (Lot Number: EN6198) as single dose for COVID-19 immunisation. Medical history included hypothyroidism from an unknown date and unknown if ongoing. The patient was not diagnosed of Covid prior vaccination and has not been tested for Covid post vaccination. The patient has no known allergies. Concomitant medication included levothyroxine, liothyronine (NP THYROID) taken for an unspecified indication, start and stop date were not reported. The patient previously received bnt162b2 (Pfizer Brand COVID 19), dose 1 intramuscular, administered in left arm on 05Feb2021 11:30 AM, (Lot Number: EM9810) for COVID-19 immunisation. There was no other vaccine in four weeks. On 27Feb2021 07:45, the patient passed out, unfortunately hit head, felt light headed and slightly nauseous. It was also reported that patient had intense right knee pain, a temperature of 99.6 and flu-like symptoms. The events were also described as follows: 18hrs after the injection, I had intense right knee pain that lasted for 24hrs. Also in that same time period, I felt a huge rush of energy come over me and passed out. Unfortunately hit my head. I had a temperature of 99.6 and flu-like symptoms that lasted 24hrs. For 4 days I felt light headed and slightly nauseous but that could have been due to hitting my head. Called 911, EMT evaluation and the patient received treatment for events. Outcome of the events was recovered on an unspecified date.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events and other events. There is limited information provided in this report. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
Test Date: 20210227; Test Name: temperature; Result Unstructured Data: Test Result:99.6
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Hypothyroidism
Andere Medikamente
NP THYROID
Allergien
-
Vorherige Impfungen
-

VAERS 1155211

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MD
Alter
52,0
Geschlecht
M
Eingang
01.04.2021
Impfdatum
08.03.2021
Beginn
10.03.2021
Tage bis Beginn
2,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Condition aggravated Imaging procedure abnormal Inflammatory marker increased Pericarditis

Symptomtext

Pt experienced an episode of pericarditis 2 days after receiving vaccine; had been dealing with on and off pericarditis but this was worst episode he had experienced

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pericarditis
Hospital-Tage
9,0
Labordaten
imaging and inflammatory marker confirmed pericarditis
Aktuelle Erkrankungen
hx of pericarditis, was under control prior to vaccine
Vorgeschichte
afib, pericarditis
Andere Medikamente
atorvastatin, nexium, metoprolol
Allergien
colchicine, latex
Vorherige Impfungen
-

VAERS 1154101

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
NH
Alter
67,0
Geschlecht
F
Eingang
01.04.2021
Impfdatum
08.03.2021
Beginn
08.03.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Anaphylactic reaction Dyspnoea Heart rate irregular Palpitations Pharyngeal swelling

Symptomtext

anaphylactic reaction; Throat swelling; heart racing; irregular heart rate; gasping for air; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot Number: EN6198) via an unspecified route of administration in Right buttocks, at the age of 67-year-old, on 08Mar2021 10:00 as SINGLE DOSE, for covid-19 immunisation. Medical history allergies: Sulfites, urinary tract disorder, Birth defect bladder w/ recurrent kidney stones, kidney infection, Grave's disease, and lyme disease. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination and was not tested post vaccination. Concomitant medications included levothyroxine and epinephrine. The patient previously took sulfur dioxide and experienced drug hypersensitivity. The patient experienced anaphylactic reaction with throat swelling, heart racing, irregular heart rate, gasping for air on 08Mar2021 10:45. Therapeutic measures taken in response to the events included self administration of epinephrine. The events were assessed as serious (life threatening). Outcome was recovering at the time of the report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
Test Date: 20210308; Test Name: Heart rate; Result Unstructured Data: Test Result:irregular
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Graves' disease (Grave's disease); Kidney infection; Kidney stones; Lyme's disease; Sulfonamide allergy; Urinary tract disorder
Andere Medikamente
LEVOTHYROXINE; EPINEPHRINE
Allergien
-
Vorherige Impfungen
-

VAERS 1153320

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
KY
Alter
64,0
Geschlecht
F
Eingang
31.03.2021
Impfdatum
13.03.2021
Beginn
01.03.2021
Tage bis Beginn
-
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Cough Diarrhoea Dyspnoea Respiratory distress Nervousness Tremor Vomiting

Symptomtext

Chills; Vomiting; Diarrhea; shakes; Shortness of breath; Coughing; respiratory distress; This is a spontaneous report from a contactable retired nurse. A 64-year-old female patient received the first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EN6198; expiration date: unknown), at vaccination age 64-year-old via an unspecified route of administration in the right arm on 13Mar2021 09:30 as a single dose for covid-19 immunisation. The patient medical history was none. There were no concomitant medications. The patient reported that she had side effects after getting her first dose of the Pfizer COVID-19 vaccine Saturday morning (13Mar2021) at 09:30am. She mentioned that she developed side effects Monday (15Mar2021) night that she also had all day Tuesday (16Mar2021), it was pretty significant. She mentioned that she is concerned about getting the second dose, and she is thinking that she is not going to get that after having her first dose. She stated that her side effects lasted all night Monday night, she had shortness of breath and coughing. She added that on Tuesday morning she started having chills, shakes, throwing up or vomiting, and having massive diarrhea all day long. She also mentioned that she thought it was serious, and she was going to have to go to the hospital soon. She wasn't going to have a choice if it hadn't gotten better. She reported that all her side effects are better, and that for treatment, she took some Delsym cough medicine and diarrhea medicine, Imodium, she thinks it was called. She says she took one dose of the cough medicine yesterday morning, and she has taken 3 doses of Imodium today. She wondered if she should take the second shot or if she would get the same symptoms again. She says she is hesitant to take second one because she doesn't want respiratory distress again (Mar2021), it was horrible, and she has never had massive diarrhea before to where she couldn't get to the bathroom, it was the worst thing she has went through. The outcome of the events was recovering.; Sender's Comments: The contributory role of the suspect productbnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EN6198; expiration date: unknown), to reported events is possible.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Respiratory distress
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1152778

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
IL
Alter
73,0
Geschlecht
M
Eingang
31.03.2021
Impfdatum
01.03.2021
Beginn
08.03.2021
Tage bis Beginn
7,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein
Acute kidney injury Asthenia Blood culture Chest X-ray Computerised tomogram abdomen Computerised tomogram head Confusional state Culture urine Dizziness Electrocardiogram Full blood count Haematuria Hallucination Metabolic function test Somnolence Syncope Urine analysis

Symptomtext

Syncope, weakness, lightheadedness, somnolense, confusion, hallucination, acute kidney injury, gross hematuria

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
5,0
Labordaten
BMP, CBC,urinalysis, blood and urine cultures, chest x-ray, CT scan abdomen, head, EKG
Aktuelle Erkrankungen
HTN, DM II, PVD, Depression
Vorgeschichte
HTN, DM II, PVD, Depression, s/p CVA
Andere Medikamente
Cloipdogrel 75 daily, Citalopram 20 daily, Carvedilol 12.5 mg bid, Gabapentin 300 mg bid, Hydrochlorothiazide 25 mg daily, Lisinopril 40 mg daily, Metformin 500 bid, Rosuvastatin 40 mg qhs, Melatonin 3 mg qhs
Allergien
No Known Allergies
Vorherige Impfungen
-

VAERS 1150954

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CA
Alter
30,0
Geschlecht
F
Eingang
31.03.2021
Impfdatum
09.02.2021
Beginn
28.02.2021
Tage bis Beginn
19,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Asthenia Concussion Loss of consciousness Syncope

Symptomtext

fainted; lost consciousness; weakness; concussion; This is a spontaneous report from a contactable consumer. A 30-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6198) on 09Feb2021 in left arm at single dose for COVID-19 immunisation. Medical history was none, unknown if known allergies. No covid prior vaccination. Concomitant medications were none (no other medications in two weeks). No other vaccine in four weeks. The patient was not pregnant, was not pregnant at time of vaccination. No covid tested post vaccination. The patient received first dose on 09Feb2021, on 28Feb2021 05:00 PM, experienced weakness fainted, lost consciousness, diagnosed with concussion. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, life threatening illness (immediate risk of death from the event). The patient was hospitalized for one day. Unknown if treatment for the events. Outcome of the event was not recovered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1150913

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
FL
Alter
65,0
Geschlecht
F
Eingang
31.03.2021
Impfdatum
04.03.2021
Beginn
04.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Anaphylactic reaction Asthenia Chest discomfort Confusional state Dizziness Dyspnoea Fatigue Headache Lip swelling Paraesthesia oral Speech disorder Swollen tongue Thinking abnormal Throat irritation Throat tightness

Symptomtext

Gasping for air; Tongue swelling; Swollen lips; Throat closing/restriction in her throat; tickle in the throat; Headache; Dizzy; couldn't think clearly/her thinking wasn't clear; Confused; sensation in her chest; weak; fatigued; she had a full tongue which effecting her talking; tingling in her lips; anaphylactic reaction; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Lot Number: EN6198; Expiration Date: Jun2021), as single dose in left shoulder on 04Mar2021 at noon for COVID-19 immunisation. Medical history included Hashimoto's disease from May2012 and ongoing (autoimmune condition), ongoing undifferentiated connective tissue disease (UCTD) (autoimmune condition, unsure when diagnosed, started with polymyalgia rheumatica, then it went to rheumatoid arthritis (RA), then it went between Lupus and undifferentiated connective tissue disease), hospitalization: she had to go hospital twice in last 4 months, one was for Amlodipine which has polyethylene glycol and another time for Lisinopril as another blood pressure medication, she had 2 mild anaphylactic reactions in the last 4 months from amlodipine and Lisinopril, patient thought they all have PEG in the ingredients; underwent colonoscopy unknown results. There were no concomitant medications. On 04Mar2021 the patient experienced anaphylactic reaction, gasping for air, headache, dizzy, could not think clearly/her thinking was not clear, tongue swelling, swollen lips, throat closing/restriction in her throat, confused , sensation in her chest, weak, fatigued, she had a full tongue which effecting her talking, tickle in the throat, tingling in her lips. Course of events was as follows: The patient drove two hours to get the vaccine. The patient was vaccinated on 04Mar2021 at noon. The reaction started immediately, the caller had a severe headache within seconds, a little bit of sensation in her chest. The patient's thoughts were getting mixed up, she was not thinking clearly. This was one of first things that happened. The patient stumbled a little bit and the nurses were there around her and said she better sit down now. Then the sensation in her throat was starting to feel like it was closing up, her lips were swollen; so she would say she was a little bit confused. The patient started getting dizzy and her thinking was not clear, her tongue swelled, she had a full tongue which effecting her talking, she was gasping for air, she needed a moment to regulate her breathing. In regards to swollen lips she added at first she had a tickle in the throat, tingling in her lips, restriction in her throat, then she started slurring her words before the ambulance got there. On site they responded and watched her because she did not know if the symptoms were going to get worse. The paramedics gave the caller oxygen and an IV, since she had a mild experience she wanted to see what she did not take any medications before taking the vaccine so she could see what it would do, she did not take an ibuprofen or Tylenol. Patient commented, she knew it was not recommended, but some people do it. The patient mentioned started speaking very badly and very fast, she started gulping for air, and was informed the histamines are hitting her. She felt like she was going to faint, she thought if she was able to count back from ten she was going to be knocked out. Once she counted back she started to feel better. Like she would not faint. She did not faint often. She mentioned counting backwards from ten when getting a colonoscopy or something like don't get passed five and then knocked out, so she knows the sensation that can occur. After 1.5 hours they decided to call the emergency number and that was when the ambulance came. The ambulance service was the one who did everything for the patient. Because the patient got in the ambulance, they required her to go to the hospital, she was in a bed in the hall, by the time her doctor had looked at her, her throat had opened up and was feeling reasonably well after an hour an half. Confirmed she was not admitted just in the Emergency Room. On 04Mar202 the patient was at the hospital and was gasping for breath. The patient was on an IV and they gave her 125 mg of Solu-Medrol, 50 mg of Benadryl, and 5 mg of nausea medicine, phedrol the caller thought it was called. They did a good job and that helped the patient down from the most severe symptoms and she wanted to report her symptoms. The patient has been looking around and she thought this reaction it was from the polyethylene glycol. She mentioned historically she had a minor reaction. She had to go hospital twice in last four months. One was for Amlodipine which has polyethylene glycol and another time for Lisinopril which is another blood pressure medication. She confirmed she visited the emergency room for all 3 of these cases. The patient was still very confused on 09Mar2021 and over the weekend, she had to rest, she was weak and fatigued. On 09Mar2021 it was first real day she went back to work. She worked and asked her brother to watch out for her. On 10Mar2021 she was starting to feel a little bit better as regarded anaphylactic reaction, she has recovered with residual effects from the anaphylactic reaction. Confusion was improved but stull a concern. The outcome of anaphylactic reaction was recovered with sequelae, of headache, swollen lips, confused was recovering, of gasping for air, dizzy, could not think clearly/her thinking was not clear, tongue swelling, throat closing/restriction in her throat, sensation in her chest, weak, fatigued, she had a full tongue which effecting her talking, tickle in the throat, tingling in her lips was unknown. Patient asked if there was a conclusion about the PEG and her anaphylactic reaction. Her second dose was scheduled on 25Mar2021. Patient stated that her PCP and the CDC recommend to not get the second dose. Caller wanted to know if the anaphylaxis could be worse in the second dose. The patient wanted to know if she should she get the next dose. She was very concerned about COVID as well but did not know if it's worth her risking her life. Patient wanted to know if she can get the Johnson and Johnson vaccine after a certain amount of time after receiving the Pfizer COVID 19 vaccine, caller cannot get the second dose of the Pfizer COVID vaccine due to a reaction. As of 12Mar2021 patent stated she does not wish to be contacted any further. A Product Complaint was filed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Hashimoto's disease (Autoimmune condition.); Undifferentiated connective tissue disease (autoimmune, unsure when diagnosed, polymyalgia rheumatica, then RA, then Lupus + UCTD)
Vorgeschichte
Medical History/Concurrent Conditions: Anaphylactic reaction to drug (she had two mild anaphylactic reactions in the last four months from amlodipine and Lisinopril); Colonoscopy; Hospitalization (twice in last 4 months. One was for Amlodipine which has PEG and for Lisinopril for blood pressure)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1150393

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
UT
Alter
-
Geschlecht
M
Eingang
31.03.2021
Impfdatum
10.03.2021
Beginn
10.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Fall Loss of consciousness Nausea Pain in extremity

Symptomtext

I passed out, fell to floor and was unresponsive for multiple minutes; fell to floor; Momentary feeling of nausea and lightheadedness before passing out; Momentary feeling of nausea and lightheadedness before passing out; mild sore arm; This is a spontaneous report from a contactable consumer reporting for himself. A 52-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EN6198/expiration date: not provided), via an unspecified route of administration, on 10Mar2021 at 14:00 (as a single dose in the right arm for COVID-19 IMMUNIZATION. The patient had known allergies to statins and aspirin. The patient had no other medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication (other medications taken in two weeks) were none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Mar2021, the patient experienced a mild sore arm. On 13Mar2021 at 17:30, the patient experienced nausea and lightheadedness before passing out. The clinical course was as follows: On 10Mar2021 afternoon, the patient received the first dose of COVID-19 vaccine. No overt signs of illness or other symptoms beyond mild sore arm. On 13Mar2021, in the afternoon, the patient passed out, fell to floor and was unresponsive for multiple minutes. Momentary feeling of nausea and lightheadedness before passing out. No other signs of illness at time. Paramedics and subsequence ER visit did not find any signs of physical symptoms that would have attributed to syncope. Lightheadedness lasted for awhile and was still occurring on and off during ER visit. The adverse events resulted in a doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient did not receive any treatment for these events. The outcome of the events mild sore arm, passed out, nausea and lightheadedness was recovered on an unspecified date in Mar2021. Since the vaccination, the patient had not been tested for COVID-19.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Drug allergy
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1093422

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CA
Alter
42,0
Geschlecht
F
Eingang
30.03.2021
Impfdatum
04.03.2021
Beginn
04.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Arthralgia Asthenia Dizziness Erythema Fatigue Influenza like illness Joint swelling Gout Headache Hypokinesia Neck pain Mobility decreased Musculoskeletal stiffness Pain in extremity Syncope Pain Tremor Visual impairment

Symptomtext

extreme pain in left side of neck with difficulty moving; fainted; dizziness; Extreme pain in left side of neck with difficulty moving; gout-like reaction in feet; arm pain; fatigue; weakness; body aches; left hand knuckles swelled turned red stiff and painful; left hand knuckles swelled turned red stiff and painful; left hand knuckles swelled turned red stiff and painful; headache; vision disturbances; shakiness; This is a spontaneous report from a contactable other health care professional (patient). A 42-year-old female patient (non-pregnant) received first dose BNT162B2 (Solution for injection, COVID 19, Pfizer, lot number: EN6198) via Intramuscular in Left arm on 04Mar2021 at 10: 45 at single dose for COVID-19 immunisation. Patient medical history included Gluten allergy. Concomitant medications included Phentermine, hydrochlorothiazide, ibuprofen. On 04Mar2021 at 16:00, patient had extreme pain in left side of neck with difficulty moving, gout-like reaction in feet, arm pain, fatigue, weakness, body aches, left hand knuckles swelled turned red stiff and painful, fainted, headache, vision disturbances, shakiness, dizziness. Adverse events was not resulted in Emergency room/department or urgent care. treatment was not given. No covid prior vaccination and no covid tested post vaccination. Outcome of events were not recovered.; Sender's Comments: Based on temporal assosciation, the causal relationship between BNT162B2 and the serious event, syncope cannot be completely ruled out.The impact of this report on benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Gluten sensitivity
Andere Medikamente
PHENTERMINE; HYDROCHLOROTHIAZIDE; IBUPROFEN
Allergien
-
Vorherige Impfungen
-

VAERS 1093422

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CA
Alter
42,0
Geschlecht
F
Eingang
30.03.2021
Impfdatum
04.03.2021
Beginn
04.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Arthralgia Asthenia Dizziness Erythema Fatigue Influenza like illness Joint swelling Gout Headache Hypokinesia Neck pain Mobility decreased Musculoskeletal stiffness Pain in extremity Syncope Pain Tremor Visual impairment

Symptomtext

extreme pain in left side of neck with difficulty moving; fainted; dizziness; Extreme pain in left side of neck with difficulty moving; gout-like reaction in feet; arm pain; fatigue; weakness; body aches; left hand knuckles swelled turned red stiff and painful; left hand knuckles swelled turned red stiff and painful; left hand knuckles swelled turned red stiff and painful; headache; vision disturbances; shakiness; This is a spontaneous report from a contactable other health care professional (patient). A 42-year-old female patient (non-pregnant) received first dose BNT162B2 (Solution for injection, COVID 19, Pfizer, lot number: EN6198) via Intramuscular in Left arm on 04Mar2021 at 10: 45 at single dose for COVID-19 immunisation. Patient medical history included Gluten allergy. Concomitant medications included Phentermine, hydrochlorothiazide, ibuprofen. On 04Mar2021 at 16:00, patient had extreme pain in left side of neck with difficulty moving, gout-like reaction in feet, arm pain, fatigue, weakness, body aches, left hand knuckles swelled turned red stiff and painful, fainted, headache, vision disturbances, shakiness, dizziness. Adverse events was not resulted in Emergency room/department or urgent care. treatment was not given. No covid prior vaccination and no covid tested post vaccination. Outcome of events were not recovered.; Sender's Comments: Based on temporal assosciation, the causal relationship between BNT162B2 and the serious event, syncope cannot be completely ruled out.The impact of this report on benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Gluten sensitivity
Andere Medikamente
PHENTERMINE; HYDROCHLOROTHIAZIDE; IBUPROFEN
Allergien
-
Vorherige Impfungen
-

VAERS 1062885

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CT
Alter
65,0
Geschlecht
F
Eingang
30.03.2021
Impfdatum
27.02.2021
Beginn
27.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Anaphylactic reaction Pharyngeal hypoaesthesia Electrocardiogram Throat irritation

Symptomtext

My throat felt like it was going numb. A nurse gave me an injection of my epi pen, then a shot of Benadryll. I was taken to the ER via ambulance and given two 24 hour steroids. I was in the ER for about 4.5 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
Dr said I suffered from anaphylaxis.
Aktuelle Erkrankungen
None
Vorgeschichte
Over weight
Andere Medikamente
Vitamin D Vitamin B complex Both under doctors' orders
Allergien
Wasp venom Neosporin (sp?) Sulfur drugs Codine Pencillin Trimethobenzamide Hcl Polymyxin B
Vorherige Impfungen
-

VAERS 1062885

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CT
Alter
65,0
Geschlecht
F
Eingang
30.03.2021
Impfdatum
27.02.2021
Beginn
27.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Anaphylactic reaction Pharyngeal hypoaesthesia Electrocardiogram Throat irritation

Symptomtext

My throat felt like it was going numb. A nurse gave me an injection of my epi pen, then a shot of Benadryll. I was taken to the ER via ambulance and given two 24 hour steroids. I was in the ER for about 4.5 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
Dr said I suffered from anaphylaxis.
Aktuelle Erkrankungen
None
Vorgeschichte
Over weight
Andere Medikamente
Vitamin D Vitamin B complex Both under doctors' orders
Allergien
Wasp venom Neosporin (sp?) Sulfur drugs Codine Pencillin Trimethobenzamide Hcl Polymyxin B
Vorherige Impfungen
-

VAERS 1143929

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MN
Alter
69,0
Geschlecht
F
Eingang
29.03.2021
Impfdatum
26.02.2021
Beginn
23.03.2021
Tage bis Beginn
25,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Asthenia Blood test Fatigue Hypoaesthesia Loss of control of legs Loss of personal independence in daily activities Magnetic resonance imaging Seizure Urinary incontinence

Symptomtext

Patient states that she had numbness in both feet and legs. Several days later these symptoms were getting worse and she went into a seizure, lost control of her use of her legs, arms and her bladder. She called 911 and transported to y Hospital ER. She had MRI w/ negative results and was given fluids. She was released to go home. Pt has appt w PCP and will discuss her symptoms w/ them. Pt is still weak, has fatigue but can use her arms and legs. She is not able to do normal activities. She had her 2nd Covid dose on 3/26/21 @ 9:20 am in her right arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
MRI; Blood work.
Aktuelle Erkrankungen
No
Vorgeschichte
Hypertension, Fibromyalgia.
Andere Medikamente
Lisinopril 20mg bds , Atenolol 20mg bds,
Allergien
Latex, many allergies to prescription medications.
Vorherige Impfungen
-

VAERS 1140678

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CA
Alter
75,0
Geschlecht
M
Eingang
29.03.2021
Impfdatum
02.03.2021
Beginn
02.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Muscular weakness Paralysis

Symptomtext

Paralyzed in his arms and legs; Legs were weak; Severe shivers; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EN6198), via an unspecified route of administration in the right arm on 02Mar2021 at 09:30 (at the age of 75-years old) as a single dose for COVID-19 immunization. Medical history included dizziness, hyperuricemia (he produces too much uric acid and it causes kidney stones), back pain, COVID-19 in Dec2020 and was cleared by the end of Dec2020. Ongoing concomitant medications included diazepam for dizziness since 1978, allopurinol for hyperuricemia, oxycodone hydrochloride/paracetamol (PERCOCET) for back pain since 7-8 years ago. There were no other vaccines administered on the same day or within 4 weeks prior to the vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL9262) on 09Feb2021 at 09:30 (at the age of 75-years-old) in the left arm and experienced muscle aches. On 02Mar2021 at 21:00, the patient experienced severe shivers. On 03Mar2021 at 02:30, the patient woke up to go to the bathroom and noticed his legs were weak. On 03Mar2021 at 07:00 he was paralyzed in his arms and legs- he could feel his muscles but couldn't make them move. He just laid there for ten hours, and it was scary, and he thought that over a period of time the vaccine would get filtered out. After that, he was fully recovered and able to move. The events did not require a visit to the physician or the emergency room. The patient was concerned that he got the second shot too soon after having COVID-19 in Dec2020. The clinical outcome of legs were weak and paralyzed in his arms and legs was resolved on 03Mar2021, severe shivers was resolved on 04Mar2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paralysis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Back pain; COVID-19; Dizziness; Hyperuricemia; Kidney stones
Andere Medikamente
DIAZEPAM; ALLOPURINOL; PERCOCET [OXYCODONE HYDROCHLORIDE;PARACETAMOL]
Allergien
-
Vorherige Impfungen
-

VAERS 1321567

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
UT
Alter
66,0
Geschlecht
M
Eingang
27.03.2021
Impfdatum
25.03.2021
Beginn
26.03.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Headache Myalgia Pyrexia Syncope

Symptomtext

Fevers, diffuse myalgias and headache Syncope

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1139620

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
IA
Alter
73,0
Geschlecht
F
Eingang
27.03.2021
Impfdatum
24.02.2021
Beginn
27.02.2021
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Angiogram pulmonary abnormal Bradycardia COVID-19 Computerised tomogram thorax Condition aggravated Culture urine positive Dizziness Echocardiogram abnormal Escherichia infection Fall Haemorrhage Head injury Hypovolaemia Interleukin level increased Lung infiltration Presyncope SARS-CoV-2 test positive Skin laceration

Symptomtext

Pfizer COVID-19 EUA Vaccine Pt received first COVID vaccine 2/25/21. Tested positive for COVID late February. Reported to ED 3/5/21 with near syncope. Patient was seen emergency department laying in bed. The patient had a noticeable scalp laceration to posterior parietal area. After being symptomatic with COVID-19 for a few days, the patient reports getting up at 5:00 a.m. to use the bathroom, feeling lightheaded, then ended up on the floor, she reports sitting on the floor and then hit her head at some point, but was not entirely sure of this timeline. She states she ended up moving to the living room when she noticed that her head was bleeding a lot and her fiance called 911. She reports a history of syncopal episode in 2001 when she had influenza and apparently the story was much the same as this time, but she actually lost consciousness in 2001. Admitted to observation. 3/7: 73-year-old female recent COVID-19 infection admitted on 03/05/2021 for an episode of syncope probably secondary to bradycardia versus volume depletion. Paramedic on arrival at home reported bradycardia with heart rate in the 30s but has been normal since admission. The CT angiogram of the chest done at the emergency room showed bilateral infiltrates compatible with recent COVID-19 infection. No PE. However patient has no respiratory symptoms and O2 saturation is perfectly normal. Urinalysis was suggestive of infection and subsequent culture was positive for E coli and it is pansensitive. She was admitted to hospital for overnight observation. She was commenced on IV Rocephin and azithromycin. The EP cardiologist was consulted and she recommended and echocardiogram and it revealed mild global hypokinesis with LVEF of 45-50% but patient denied any prior history of cardiac problem. On re-evaluation this morning the vital signs remains normal. Patient has not had any episode of bradycardia since she presented to the emergency room. She will be discharged home follow up with the EP cardiologist for further evaluation. Patient does not need outpatient oral antibiotics as IV Rocephin for 3 days should be adequate for uncomplicated UTI.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
2,0
Labordaten
See above
Aktuelle Erkrankungen
-
Vorgeschichte
Glaucoma
Andere Medikamente
Bimatoprost
Allergien
Levofloxacin - anxiety Sulfa drugs - unknown
Vorherige Impfungen
-

VAERS 1138587

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
WA
Alter
68,0
Geschlecht
F
Eingang
26.03.2021
Impfdatum
06.03.2021
Beginn
06.03.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Facial paralysis Muscle twitching Paraesthesia Paraesthesia oral

Symptomtext

#Tingling in face - Ongoing intermittently since 6 Mar 2021 - Notes that symptoms started immediately after she received her COVID vaccine and have progressively become more noticeable since then - She did not notify the post-observer that she was experiencing symptoms - Tingling starts in right eye and goes down into right lower lip with occasional twitching - slight facial droop on right lower cheek/mouth - Denies facial pain or eyelid drooping - Denies shortness of breath, chest pain/tightness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Facial paralysis
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
- + sore throat, mild dry cough - + fatigue, chills
Vorgeschichte
Patient Active Problem List Diagnosis ? Osteoporosis [M81.0] July 23, 2020 DEXA scan ? Groin swelling [R19.09] L side, Hernia US 4/18 - she did not show for scan . ? Family history of breast cancer [Z80.3] Bellcross score = 2 Sister with breast CA, diagnosed ~ age 50, recurred MGM, Paternal Aunt, Daughter Plans to do yearly Mammo In KP study, using website. Ends 2018 . ? Atypical chest pain [R07.89] B died at age 37 after viral myocarditis Low risk ETT 3/17 No early FHx of CAD PFTs nl 4/09 . Low risk ETT 08/19/2020: Slight hypertensive response to exercise but normal resting blood pressure. ? OSA (obstructive sleep apnea) [G47.33] ? PPD positive [R76.11] ? Adjustment disorder with mixed anxiety and depressed mood [F43.23] ? Prolapse of anterior vaginal wall [N81.10] PAPs nl, Neg HPV age 63 in 2015 . ? Nuclear senile cataract [H25.10] ? Vitamin D deficiency [E55.9] ? Degenerative arthritis of knee [M17.10] ? Special screening for malignant neoplasms, colon [Z12.11] Colonoscopy June 2008, negative, only one hyperplastic polyp. Repeat 2018::::::::::::::::::: . ? ADHD (attention deficit hyperactivity disorder) [F90.9] ? Hypothyroidism [E03.9] ? ANXIETY STATE [F41.1]
Andere Medikamente
Levothyroxine 0.112mg daily Vitamin D 2,000mg daily
Allergien
Sulpha
Vorherige Impfungen
-

VAERS 1137173

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
IA
Alter
72,0
Geschlecht
M
Eingang
26.03.2021
Impfdatum
12.03.2021
Beginn
12.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / UN
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Coagulation test Mesenteric vein thrombosis

Symptomtext

Superior mesenteric vein thrombosis. No known cause at this time. Hypercoag panel negative. patient hospitalized and currently on Xarelto for 6 months. Received vaccination dose 2 1 week prior.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mesenteric vein thrombosis
Hospital-Tage
2,0
Labordaten
Hypergoa panel, COVID testing, CT abdomen/pelvis
Aktuelle Erkrankungen
none reported
Vorgeschichte
CAD, type 2 diabetes with polyneuropathy, hyperlipidemia, HTN, OSA, peripheral neuropathy, Renal stones, MI, anxiety
Andere Medikamente
Unknown. I do not see patient regularly. I saw as hospital follow up for potential complications
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1135763

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
KS
Alter
37,0
Geschlecht
F
Eingang
26.03.2021
Impfdatum
06.03.2021
Beginn
07.03.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bell's palsy Chills Headache Muscular weakness Pyrexia Swelling face

Symptomtext

Fever; Chills; Bell's Palsy; Swelling and muscle weakness on the left side of the face; Swelling and muscle weakness on the left side of the face; Headache; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EN6198, first dose) solution for injection intramuscular in the left arm on 06Mar2021 at 08:45 (at the age of 37-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included diagnosed with Covid-19 on 26Jul2020 and penicillin allergy. Family medical history included diabetes. There were no concomitant medications. Past drug history included known allergies to codeine. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. The patient experienced Bell's Palsy, swelling and muscle weakness on the left side of the face on 07Mar2021 at 05:00. It started with left arm swelling and muscle weakness on the left side of the face, left face pain diagnosed as Bell's palsy and developed headache (07Mar2021). The next day (08Mar2021) at 1pm started with fever and chills. The was no emergency room or physician office visit. No treatment was provided for the events Bell's Palsy, swelling and muscle weakness on the left side of the face. The outcome of the events Bell's Palsy, swelling and muscle weakness on the left side of the face was recovering. The outcome of the events headache, fever and chills was unknown. Since the vaccination, the patient has not been tested for COVID-19.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19; Diabetes; Penicillin allergy
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1135578

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CO
Alter
68,0
Geschlecht
F
Eingang
25.03.2021
Impfdatum
06.03.2021
Beginn
07.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Computerised tomogram Deep vein thrombosis Echocardiogram Pulmonary thrombosis Ultrasound scan

Symptomtext

Developed DVT blood clots in legs and clots in lungs.; Developed DVT blood clots in legs and clots in lungs.; This is a spontaneous report from a contactable consumer. This 68-year-old female consumer reported that she received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EN6198) on 06Mar2021 12:30 PM at left arm for COVID-19 immunisation. Medical history included known allergies: Clindamycin and high blood pressure. Historical vaccine was 1st dose of BNT162B2 (lot number EN6201) on 14Feb2021 01:15 PM at left arm for COVID-19 immunisation. Concomitant drugs included hydrochlorothiazide, triamterene (TRIAMTERENE AND HYDROCHLOROTHIAZIDE), omeprazole, nortriptyline hydrochloride (NORTRIPTYLIN). The patient developed DVT blood clots in legs and clots in lungs on 07Mar2021 08:00 AM. Event resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). Patient was hospitalized for 3 days and received treatment. The patient had computerised tomogram (CAT) scan, ultrasound, echocardiogram. Event outcome was not resolved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
3,0
Labordaten
Test Name: CAT scan; Result Unstructured Data: Test Result:Unknown results; Test Name: echocardiogram; Result Unstructured Data: Test Result:Unknown results; Test Name: ultrasound; Result Unstructured Data: Test Result:Unknown results
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Blood pressure high
Andere Medikamente
TRIAMTERENE AND HYDROCHLOROTHIAZIDE; OMEPRAZOLE; NORTRIPTYLIN
Allergien
-
Vorherige Impfungen
-

VAERS 1133021

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
FL
Alter
54,0
Geschlecht
F
Eingang
25.03.2021
Impfdatum
23.02.2021
Beginn
23.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Alopecia Anaphylactic reaction Fatigue Headache Lip pruritus Ocular hyperaemia Pruritus Pyrexia Skin discolouration Throat irritation Urticaria

Symptomtext

severe fatigued/fatigue; red eyes; fever; Darkened skin in face; Itchy scalp and subsequent hair; hair loss; headaches; Anaphylaxis; hives; itching breathing, lips, throat impacted; itching breathing, lips, throat impacted; This is a spontaneous report from a contactable consumer (patient). A 54-year-old female patient not pregnant received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Left arm on 23Feb2021 at 01:00 PM (at age of 54-year-old) as SINGLE DOSE for covid-19 immunisation, Lot Number: EN6198. First vaccine dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) was administered on 03Feb2021 in Left arm for COVID-19 immunisation, Lot number: EL8982. Medical history was not reported. Patient did not receive any other medications within two weeks prior to the vaccination. Patient did not receive other vaccine in four weeks prior to the COVID vaccine. Patient had no COVID prior vaccination. Patient was not tested for Covid post vaccination. On 23Feb2021 within 20 mins patient experienced anaphylaxis, hives, itching breathing, lips, throat impacted. On 23Feb2021 at 02:00 PM (also reported as over next week) patient experienced severe fatigued; red eyes; fever; darkened skin in face; subsequent results, Itchy scalp and subsequent hair; seeing hair loss continuing and fatigue, headaches ongoing thus far. Events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatments received included Anaphylaxis medicine, intravenous (Iv) administration; prescript. Patient had not recovered from the events, at the time of the report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1130077

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
FL
Alter
80,0
Geschlecht
M
Eingang
24.03.2021
Impfdatum
20.03.2021
Beginn
21.03.2021
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Bell's palsy Dry eye Eye irritation

Symptomtext

Pt presented to the ED with right-sided facial drooping and was diagnosed with Ball's Palsy. Pt was prescribed prednisone in the ED. Evaluated today at our office and was prescribed valtrex. Currently experiencing right eye dryness and irritation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1129587

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MD
Alter
34,0
Geschlecht
M
Eingang
24.03.2021
Impfdatum
05.03.2021
Beginn
06.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Chills Headache Pain Pain in extremity Syncope

Symptomtext

fainted; severe headache; Chills; body aches; arm pain; This is a spontaneous report received from from a contactable consumer (patient). A 34-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 05Mar2021 at 14:00 (Lot Number: EN6198) (at 34-year-old) at single dose in arm left for COVID-19 immunization. The patient's medical history was not reported. No allergy to medications, food, or other products. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications within 2 weeks of vaccination included testosterone cypionate, chorionic gonadotrophin (HCG), rosuvastatin, and tadalafil (CIALIS), all taken for an unspecified indication, start and stop date were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 12Feb2021 at 14:00 (Lot Number: EN6201) at single dose in arm left for COVID-19 immunization. He woke up in the middle of the night (4:00 am on 06Mar2021) after getting his second vaccine with severe headache, chills, body aches and arm pain. After getting up and using the bathroom, he went to take his temperature and fainted. The events were reported as non-serious, while resulted in emergency room/department or urgent care, treatment included intravenous (IV) fluids, paracetamol (TYLENOL). The outcomes of the events were resolved on an unspecified date in Mar2021. Information on the expiration date of vaccine has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
TESTOSTERONE CYPIONATE; HCG; ROSUVASTATIN; CIALIS
Allergien
-
Vorherige Impfungen
-

VAERS 1129259

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
WA
Alter
-
Geschlecht
F
Eingang
24.03.2021
Impfdatum
05.03.2021
Beginn
05.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Chills Fatigue Inappropriate schedule of product administration Loss of consciousness Nausea Off label use Pyrexia

Symptomtext

Passed out; Chills during the night; Weak/weakness; Fever in the morning; Nausea; fatigue; dose 1 on 16Feb2021 15:00 and dose 2 on 05Mar2021 15:00; dose 1 on 16Feb2021 15:00 and dose 2 on 05Mar2021 15:00; This is a spontaneous report from a contactable consumer (patient). An adult female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 (lot number EN6200) on 16Feb2021 15:00 and dose 2 (Lot Number: EN6198) on 05Mar2021 15:00 both via an unspecified route of administration in arm left as single dose for COVID-19 immunisation. Medical history included allergy to Thimerosal. The patient was not pregnant at the time of vaccination. Concomitant medication received within 2 weeks of vaccination included estradiol (ESTRADIOL TRANSDERMAL) 0.05 mg per day, Multivitamin and colecalciferol (D3 5000). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Symptoms after the second vaccine on 06Mar2021 04:00 included chills during the night, weak, fever in the morning, fatigue. Took 2 extra strength Tylenol at 9:00 am, back to bed. Up at 12:00 pm and overwhelmed with weakness, nausea, passed out, when she woke up she was laying on the floor. She did not know how long she was out, but she did not think it was more than 5-10 minutes. No treatment was received for the adverse event. The outcome of events chills, weakness, nausea, passed out, fever and fatigue was recovered, other events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Drug allergy (Thimerosal)
Andere Medikamente
ESTRADIOL TRANSDERMAL; D3 5000
Allergien
-
Vorherige Impfungen
-

VAERS 1128860

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
-
Geschlecht
U
Eingang
24.03.2021
Impfdatum
01.03.2021
Beginn
01.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Flushing Hyperhidrosis Loss of consciousness Movement disorder Pain in extremity Tremor

Symptomtext

sweaty; flushing; Hardly move; Passing out; Chills; shakes; My arm started hurting; This is a spontaneous case received from a contactable consumer (patient reported for herself). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot EN6198, expiry date not reported), via an unspecified route of administration on 01Mar2021 at a single dose for Covid-19 Immunization. Medical history included Covid and been in the hospital because of that, from Nov2020 to an unknown date. The patient's concomitant medications were not reported. Patient just had a question here about the shot, first shot on 01Mar2021 and arm started hurting, no big deal, 7 o' clock at night, patient got shot in the morning, and took Tylenol then about 9:30 at night, patient got chills and the shakes and at 3:30, the next morning (02Mar2021), patient got all sweaty and flushing everything. On 02Mar32021, patient was passing out, and son was trying to give patient the stuff. Patient did have Covid back in Nov2020 and had "rubbed out swab and the passing out stuff". Patient actually had been in the hospital because of that. It was exactly the same symptoms that patient had when patient got the shot. Patient did not know if patient should get the second shot and asked if those were going to happen again. Patient said that it was so scary when passing out like that. Patient just did not know what to do and then called the next day cannot, "hardly move" (02Mar2021). Patient asked if it was alright if patient just talk to the physician and will just call doctor. Patient asked if patient should get the second shot or if it was going to happen again. Therapeutic measure were taken as a result of the events arm started hurting and passing out. The outcome of the events reported was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19; Hospitalization
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1125931

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6198

schwer
Staat
VA
Alter
53,0
Geschlecht
F
Eingang
23.03.2021
Impfdatum
02.03.2021
Beginn
02.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity Peripheral swelling Thrombosis Ultrasound scan

Symptomtext

Left leg started hurting, and swoll up from my knee to my foot, and the next day was told to go to hospital. They found a blood clot in my leg .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
Ultra sound
Aktuelle Erkrankungen
None
Vorgeschichte
High blood pressure
Andere Medikamente
Hydrochlorothiazide,25mg, clonidine, 0.1mg, Amlodipine besylate 10 mg, Corey CR 40mg.
Allergien
Penicillin, codene, morphine
Vorherige Impfungen
-

VAERS 1122738

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
WV
Alter
62,0
Geschlecht
F
Eingang
22.03.2021
Impfdatum
27.02.2021
Beginn
05.03.2021
Tage bis Beginn
6,0
Dosis
1
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Thrombosis

Symptomtext

blood clot formed in left arm; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient, not pregnant at time of vaccination, received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6198), via an unspecified route of administration, on right Arm on 27Feb2021 0100, SINGLE DOSE for covid-19 immunisation. Medical history included Diabetic, High blood pressure, both from an unknown date. Concomitant medications included glipizide, metformin, fenofibrate. The patient previously took sumatriptan succinate (IMITREX) and experienced drug allergy. After vaccination 6 days later (05Mar2021) a blood clot formed in left arm. Shot was given in right arm. Hospitalization followed and now on blood thinners. AE resulted in: Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). The patient was hospitalized for 2 days. The outcome of the event was not recovered. Eliquis was given as treatment for the event. No covid prior vaccination. Not covid tested post vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Blood pressure high; Diabetic
Andere Medikamente
GLIPIZIDE; METFORMIN; FENOFIBRATE
Allergien
-
Vorherige Impfungen
-

VAERS 1266167

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
73,0
Geschlecht
M
Eingang
19.03.2021
Impfdatum
12.03.2021
Beginn
17.03.2021
Tage bis Beginn
5,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 Intensive care SARS-CoV-2 test positive

Symptomtext

COVID+ICU admission Patient received first COVID-19 Vaccination on 3/12/21. On3/18/2021, Was alerted that patient was COVID+ and admitted to ICU

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1116753

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
OR
Alter
65,0
Geschlecht
M
Eingang
19.03.2021
Impfdatum
04.03.2021
Beginn
17.03.2021
Tage bis Beginn
13,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Deep vein thrombosis Ultrasound scan abnormal

Symptomtext

Developed a DVT in right calf on 03/17/2021. Doctor told me it was a significant clot that had developed , after review of ultrasound exam

Weitere VAERSDATA-Felder
Praegender Schweregrund
Deep vein thrombosis
Hospital-Tage
-
Labordaten
03/18/2021 (1) First exam at Family Practice (2) Confirmed with ultrasound examination at Hospital same day
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension controlled w/ meds diabetes 2 controlled w/ diet, meds
Andere Medikamente
Niacin ER, Metformin, Allopurinal, Folic Acid, Telmisartan, Ezetimbe low dose aspirin, mulit vitamin
Allergien
Penicillin, Tetracycline, statins
Vorherige Impfungen
-

VAERS 1108587

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CO
Alter
69,0
Geschlecht
F
Eingang
17.03.2021
Impfdatum
08.03.2021
Beginn
10.03.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Chest discomfort Ear pain Fall Head injury Lymphadenopathy Palpitations Pyrexia Syncope

Symptomtext

Presents to PCP 2 days after 2nd covid vaccine with fevers, chest heaviness, palpitations, syncope (fell and hit head), swollen lymph node under arm, bilateral ear pain. Sncyope thought to be vasovagal and not related to vaccine. OTC treatment for symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
augmentin,
Vorherige Impfungen
-

VAERS 1108505

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
FL
Alter
70,0
Geschlecht
F
Eingang
17.03.2021
Impfdatum
04.03.2021
Beginn
05.03.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Body temperature increased Dizziness Hypotension Loss of consciousness

Symptomtext

103 temperature, loss of consciousness, low BP. Dizziness.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
2,0
Labordaten
Contact hospital.
Aktuelle Erkrankungen
Post concussion syndrome acute
Vorgeschichte
IBS,DDD, Neuropathy.
Andere Medikamente
Synthyroid,Neurotin,Librax,Premarin.
Allergien
Flagyl
Vorherige Impfungen
-

VAERS 1107260

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
VA
Alter
79,0
Geschlecht
F
Eingang
17.03.2021
Impfdatum
27.02.2021
Beginn
28.02.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Balance disorder Dizziness Loss of consciousness

Symptomtext

Dizziness; feels unsteady at times; nearly passed out/totally passed out; This is a spontaneous report from a contactable consumer. A 79-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EN6198), via an unspecified route of administration, administered in Arm Left on 27Feb2021 as SINGLE DOSE for covid-19 immunisation. The patient's medical history was reported as none. There were no concomitant medications. It was reported that the patient received first COVID shot Saturday. She confirms the Pfizer COVID 19 Vaccine. She says 24 hours after she had the shot she nearly passed out, she got really dizzy and someone asked, are you okay, and she said no and they caught her before she totally passed out and she sat down. She is still having waves of dizziness and she feels unsteady at times, not every second but she is a little scared to drive a car. She just thought someone should know that. It was reported that dizziness began the next day on 28Feb2021 around 3pm. She closes her eyes and says she doesn't want to look at that. It is ongoing but it is not so bad after she gets up. It seems to have lessened after about 3 pm yesterday it is bothersome. She confirms it is ongoing but improved a little since it began. The outcome of the event dizziness was recovering, while unknown for the other events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None, Comment: Patient History: No
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1105675

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TN
Alter
63,0
Geschlecht
F
Eingang
16.03.2021
Impfdatum
16.03.2021
Beginn
16.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Paraesthesia oral Seizure

Symptomtext

Pt received vaccine at 15:25. At 15:33 pt. reported her lips felt tingly. At 15:38 patient began seizing and was lowered to the ground by 2 staff members. Oxygen was placed on patient at 5L via nonrebreather mask. Initial BP 160/80 manually on right arm, Heart rate 26, oxygen saturation 84%. Oxygen increased to 10L and EPI 0.5 mg administered IM into right anterolateral by, APN at 15:43. 15:44 vitals: BP 182/90 manual R arm, 110 heart rate, 99% 02. Oxygen decreased to 8L. Seizure ended at 15:45. Vitals at 15:45 180/105 BP, 115 heart rate, 98% O2.Vitals at 15:48 185/100, HR 102, oxygen 99%. EMS arrived at 15:50 & 2nd seizure began at 15:50. 15:50 vitals BP 245/110, 131 HR, 99% O2. 15:52 vitals 240/110 BP, 107 HR, 99% 02. Pt. left via ambulance at 15:55.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
pt. unable to report; denied "feeling sick today" on vaccination questionnaire.
Vorgeschichte
history of grand mal seizures
Andere Medikamente
pt. unable to report
Allergien
Cipro, IVP dye, Chantex, moose, lobster.
Vorherige Impfungen
-

VAERS 1103351

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MI
Alter
57,0
Geschlecht
M
Eingang
15.03.2021
Impfdatum
10.03.2021
Beginn
10.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Cardiac monitoring normal Chest discomfort Computerised tomogram thorax normal Depressed level of consciousness Dizziness Echocardiogram normal Electrocardiogram normal Fall Feeling cold Headache Malaise Myalgia Nausea Presyncope Syncope Tremor Troponin normal Urine analysis normal

Symptomtext

PRESENTING PROBLEM: Syncope and collapse [R55] HOSPITAL COURSE: History of Present Illness: 57-year-old man known to me for bilateral lung transplant for bronchoalveolar cell carcinoma complicated by bilateral pleural effusions of unknown etiology and mild decrease in pulmonary mechanics, DVT on Eliquis who came to the Emergency Room 3/12/21 with a chief complaint of near syncope. Patient and woke up in the early morning hours of 3/12/21 to use the restroom. While urinating, he became very dizzy and nauseated and had a sense like he needed to lay down to rest. Other than nausea he did not have any other symptoms. He returned to his bed and fell upon his wife and had decreased level of consciousness but without total loss of consciousness (he was able to hear his wife talking to him but was unable to respond). This lasted about a minute and slowly he came back to his senses. After this he felt quite cold and did have some shaking but is not clear whether these were true rigors. He did not have any preceding fevers nor did he have any fevers in the emergency room. After about 5-10 minutes he was feeling back to his normal self but want to come into the hospital to get checked out. He has never had anything like this before.The patient has had chest pressure since his COVID vaccine which he had on Wednesday. This is been intermittent, mostly positional and better with laying on his side and leaning forward, worse with recumbency. It is not pleuritic in nature. No associated shortness of breath. No other fevers chills sweats. No sick contacts. Evaluation in the emergency room was done and a CT scan was done and no pulmonary embolus was found. No parenchymal abnormalities. The patient's pleural effusions remain, and her mildly worsened, personally reviewed. Baseline labs were unremarkable for anemia, kidney injury.EKG personally reviewed, normal sinus rhythm. High sensitivity troponin was done and negative. Family otherwise feels well, no sick contacts, eating well no nausea vomiting diarrhea blood in his stool. Pt admitted for observation. Continued to feel well VSS, ekg stable, ECHO without acute findings (see below), UA neg, cardiac monitoring uneventful, orthostatics negative, walking in halls and eating well. Appears to have had vaso vagal episode. Will be getting routine head imaging in the coming month with cancer history See below testing Care plan upon discharge > To call if any return of symptoms > To hold metformin until Monday due to recent dye load > Blood cultures Pending, low clinical suspicion > To change H2 blocker to PPI due to GERD on 3 month esophagram > Follow up in clinic when return from break > Dr discussing with pulmonary team most recent CT (see below) and treatment plan moving forward Brief exam: awake, alert, oriented, not in any distress. PERRL, EMOI, tongue midline. Upper and lower extremities at full strength 5/5 in the arms, hands, dorsi flex and flexion at the ankles, knees and legs. Sensation not tested. Brief history and medical decision making: s/p bilateral lung transplant for bronchoalveolar cell carcinoma complicated by bilateral loculated pleural effusion, DVT on eliquis presenting post syncopal event. Syncopal event without evidence of seizure like activity, fast recovery, and no sudden changes consistent with an acute cardiac event. Thus symptoms were likely due to vasovagal event possibly post COVID_19 related side effect (headache, achy muscles, not feeling well overall). He has no neurologic deficit, CTA thorax without PE, negative EKG, troponin and echocardiogram. He is not on antihypertensives and blood pressures have been normal. Given his initial diagnosis of BAC, there may be concern for metastatic disease, though symptoms have not persisted and he has no focal deficit. He also received contrast for his CTA today, thus will defer further imaging for now. Syncope: - defer 2nd dose of COVID-19 vaccine as its effectiveness in transplant patient is not established and patient potentially had an adverse event. - oral hydration encouraged - monitor for additional ongoing neurologic symptoms such as headaches, vision changes, neck stiffness, fevers, night sweats, weight loss, weakness or paraesthesias - patient advised to avoid driving until further evaluation - consider MRI brain with and without contrast if any symptoms persist or reoccur Complex loculated pleural effusion

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Lung Cancer (adenocarcinoma L Lung, lung nodules, bronchoalveolar carcinoma); S/P Lung transplant; GERD; high cholesterol; history antineoplastic therapy, hemoptysis, hydropneumothorax, steroid induced hyperglycemia, DVT, abnormal thyroid
Andere Medikamente
acyclovir, cetirizine, chloecalciferol, eliquis, everolimus, fluconazole, magnesium oxide, metformin-XR, pantoprazole, pravastatin, predniSONE, MVI, Bactrim, tacrolimus, tamsulosin
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1049695

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
NM
Alter
30,0
Geschlecht
F
Eingang
15.03.2021
Impfdatum
29.01.2021
Beginn
29.01.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood glucose normal Cardiac flutter Syncope Feeling abnormal Pruritus

Symptomtext

fell faint(fainted); heart flutters; This is a spontaneous report from a contactable pharmacist. A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose, lot number: EL3246, intramuscular on 29Jan2021 14:15 at a single dose for COVID-19 immunization. Medical history included MVA (motor vehicle accident), TBI (traumatic brain injury) in 2007, vagovasal and Hypotension post TBI (traumatic brain injury), Celiac Disease. The patient had known allergies: ibuprofen and milk products. Concomitant medication included famotidine, methylphenidate, fludrocortisone, omeprazole, desvenlafaxine succinate (PRISTIQ), brexpiprazole (REXULTI), folic acid, ibuprofen and progesterone. On 29Jan2021 14:15, the patient experienced heart flutters and "fell faint" (fainted) and assisted safely to the ground. Patient was monitored and released. No treatment given. The patient had no other vaccines in the last four weeks. The patient has not tested positive for COVID post vaccination. The outcome of the events was recovered on Jan2021. The events were assessed as serious- medically significant.; Sender's Comments: Based on the information currently available, a causal association between the reported events and BNT162B2 cannot be fully excluded.This case will be re-evaluated upon receipt of additional information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Automobile accident; Celiac disease; Hypotension; Milk allergy (known allergies: ibuprofen, milk products (unknown reactions for both)); Traumatic brain injury (TBI in 2007)
Andere Medikamente
FAMOTIDINE; METHYLPHENIDATE; FLUDROCORTISONE; OMEPRAZOLE; PRISTIQ; REXULTI; FOLIC ACID; IBUPROFEN; PROGESTERONE
Allergien
-
Vorherige Impfungen
-

VAERS 1098030

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
VA
Alter
44,0
Geschlecht
F
Eingang
14.03.2021
Impfdatum
27.02.2021
Beginn
09.03.2021
Tage bis Beginn
10,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity Tenderness Thrombosis Ultrasound scan

Symptomtext

Woke up with sore upper right thigh Tuesday March 9. Very tender to the touch. Visited Dr. Wednesday March 10, ordered ultrasound which was completed on Thursday March 11 and diagnosed a superficial blood clot. Prescribed Xarelto 10mg.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Thrombosis
Hospital-Tage
-
Labordaten
Ultrasound at Hospital March 11. Result - superficial blood clot
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Low Ogestrel; birth control pill Zyrtec
Allergien
None
Vorherige Impfungen
-

VAERS 1093694

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
VA
Alter
35,0
Geschlecht
M
Eingang
12.03.2021
Impfdatum
09.03.2021
Beginn
09.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

Syncopal episode following vaccination

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
unknown
Vorgeschichte
None known
Andere Medikamente
unknown
Allergien
No known allergies
Vorherige Impfungen
Patient reports prior syncopal events with vaccination and venipuncture

VAERS 1090776

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
FL
Alter
71,0
Geschlecht
F
Eingang
11.03.2021
Impfdatum
23.02.2021
Beginn
23.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Ear pain Facial pain Fatigue Headache Heart rate Heart rate increased Hypoaesthesia Hypoaesthesia oral Lip disorder Myalgia Pain in extremity Paralysis Somnolence Tinnitus

Symptomtext

beeps, noise in her ears; muscle and joint pain; muscle and joint pain; tongue was a little numb; face lips; felt paralyzed/Felt like I couldn't move it like paralyzed a little bit; whole left side of body started going numb/Left side was numb around 7 or 8 that night/all left side was numb; pains in all of her face; pain and soreness in arm/arm was painful; tachycard, high heart rate; very tired, sleepy; very tired, sleepy; headache, heavy in her head; pain in both ears; This is a spontaneous report from a contactable consumer (patient). This 71-years-Old female patient received the first dose of (Pfizer Biontech Covid 19 Vaccine, Lot No. EN6198) intramuscularly at single dose on 23Feb2021 for COVID-19 immunisation. Relevant history and concomitant drugs were unknown. Past dug included flu vaccine in Sep2020. The patient received her first dose of Covid 19 vaccine on 23Feb2021 at 3:30 in the afternoon. She came home and felt, not bad at any time but more or less towards 6:00 or 7:00 at night she started feeling bad. Her whole left side of body started going numb around 7 or 8 that night. Her arm was painful, face lips and all left side was numb. Felt like she couldn't move it like paralyzed a little bit. Clarified as whole left side, even her leg, her feet everything on that left side. She started feeling pains in bones of head, especially her face, clarified all of her face and her left side was numb even her lips on the left side were numb. Her tongue was a little numb. She had muscle and joint pain. The pain, of course, in the arm, but that was normal. Clarified pain in the arm as the injection site. She didn't feel any swell there. She did not take medication for anything. She used a lotion. The lotion was trividol aloe vera arnica caleudula and helped to relive the pain. The arm was still a little painful but it's not bad but that feeling made her tachycard, clarified as high heart rate, feeling like boom boom boom, but she did not have any shortness of breath. The high heart rate was gone the same day. She had no fever or chills. She felt very tired and slept for about 10 hours but during the sleepy she started feeling a headache she couldn't get up because she was so tired and she felt pain in both ears. She had not been to the doctor in a while. She was still old fashioned so she carries everything in a little telephone book. While trying to read information caller states she had to change her eyes. She still felt numbness in left side of left leg but she thought it might be because she had not been exercising. When she was waking up around 9am in the morning, it was yesterday that she felt better in regards to the paralyzed feeling. When pains in her face came she felt and she thought what is this? It only lasted for a little while. It was during the night. The pain and soreness in arm at injection site is still there, she did not feel any swelling, or hot at that site. She confirmed she still felt a little tired, sleepy. It's getting better. She may feel a little heavy in her head and would like to go to sleep, but she was not sleeping. She had many things to do and knew she had to be up. The headache went away and was gone on 24Feb2021. It was persisting for a while, not too hard or heavy, but it resolved by 2 or 3 in the afternoon on the 24th. In regarding to pain in ears she mentioned she no longer had. She had beeps, noise in her ears even at the time she went to bed it was better. The outcome of events paralyzed, pain in arm, tired, sleepy, was recovering, the outcome of events tachycard, pains in all of her face, pain in both ears was resovled, the outcome of other events was unknown.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paralysis
Hospital-Tage
-
Labordaten
Test Name: heart rate; Result Unstructured Data: Test Result:high; Test Name: heart rate; Result Unstructured Data: Test Result:normal
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1090400

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
FL
Alter
19,0
Geschlecht
M
Eingang
11.03.2021
Impfdatum
09.03.2021
Beginn
09.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope Tremor

Symptomtext

Systemic: Fainting / Unresponsive-Mild, Systemic: Shakiness-Mild, Additional Details: THE PATIENT RECEIVED THE VACCINE AND WAS SEATED IN THE WAITING AREA . AFTER A FEW MINUTES, THE PATIENT BEGAN TO FAINT. THE PHARMACIST AND TECHNICIAN HELPED HIM TO THE FLOOR. HE STATED THAT THIS HAS HAPPENED TO HIM BEFORE WHEN HE HAD BLOOD DRAWN. HE ALSO CALLED HIS MOTHER AND SHE CONFIRMED THAT HE HAS A HISTORY OF SYNCOPE WHEN RECEIVING SHOTS. THE PATIENT DID NOT GO TO THE HOSPITAL, BUT HAD A FRIEND COME TO GET HIM. HE WAS CALLED LATER THAT NIGHT AND STATED THAT EVERYTHING WAS BACK TO NORMAL.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1088187

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
FL
Alter
76,0
Geschlecht
F
Eingang
10.03.2021
Impfdatum
04.03.2021
Beginn
04.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Blood glucose normal Chest pain Dizziness Electrocardiogram normal Full blood count normal Hypertension Hypoglycaemia Metabolic function test normal Nausea Orthostatic hypotension Presyncope

Symptomtext

Within 15-minutes of vaccination, the patient reported dizziness, nausea, and chest pain. EMS evaluated the patient on-site. Patient was found to have orthostatic hypotension, hypoglycemia, and was near-syncopal. EMS administered 400mL of normal saline and 15g oral glucose. EMS transported the patient to Emergency Department. In the ED, the patient was hypertensive (163/73). EKG demonstrated NSR, rate 67 bpm, no ST-T changes, no ectopy, normal PR & QRS intervals. CBC/CMP was unremarkable. Patient noted improvement and was discharged with a diagnosis of a probable vasovagal event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
FSBG (3/4): 68 mg/dL EKG (3/4): NSR, rate 67 bpm, no ST-T changes, no ectopy, normal PR & QRS intervals CBC/CMP (3/4): unremarkable
Aktuelle Erkrankungen
None Reported
Vorgeschichte
Cardiac arrhythmia, Hypercholesterolemia
Andere Medikamente
Aspirin, Leustatin, Levothyroxine
Allergien
Cat dander, Azithromycin
Vorherige Impfungen
-

VAERS 1087983

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
MN
Alter
81,0
Geschlecht
F
Eingang
10.03.2021
Impfdatum
02.03.2021
Beginn
05.03.2021
Tage bis Beginn
3,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Angiocardiogram C-reactive protein increased Echocardiogram Pericarditis Red blood cell sedimentation rate

Symptomtext

Acute inflammatory pericarditis with hospitalization from 3/7-3/10.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pericarditis
Hospital-Tage
3,0
Labordaten
Echo, ESR,CRP (elevated), CTCA
Aktuelle Erkrankungen
UTI, completed course of gentamicin (completed end of Feb)
Vorgeschichte
CHF, hyperlipidemia, Afib, hypertension, obesity, sleep apnea, DM type 2, osteoarthritis
Andere Medikamente
Acetaminophen, Vitamin D3, Enalapril, Lexapro, Estradiol cream, Furosemide, Glimepiride, Probiotic, Imodium, Metoprolol, nystatin ointment and powder, potassium chloride, Trulicity, Rosuvastatin., Warfarin
Allergien
Soma, Equagesic
Vorherige Impfungen
-

VAERS 1087857

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
27,0
Geschlecht
F
Eingang
10.03.2021
Impfdatum
08.03.2021
Beginn
08.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Presyncope

Symptomtext

mild vasovagal reaction

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1086896

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
NM
Alter
30,0
Geschlecht
F
Eingang
10.03.2021
Impfdatum
19.02.2021
Beginn
19.02.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Abdominal distension Auscultation Blood glucose Blood pressure measurement Feeling abnormal Heart rate Oxygen saturation Pruritus Respiratory rate Syncope

Symptomtext

syncopal episode; itching; fullness; feeling funny; This is a spontaneous report from a contactable pharmacist. A 30-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6198), intramuscular on 19Feb2021 14:15 at single dose for COVID-19 immunisation. Medical history included manual vacuum aspiration (MVA), traumatic brain injury (TBI) from 2007 to an unknown date, vagovasal and hypotension post TBI, Celiac disease, allergy to milk products, diagnosed with COVID-19 from Aug2020 to an unknown date prior to vaccination. It was unknown if the patient was pregnant at the time of vaccination. Concomitant medication included famotidine, methylphenidate, fludrocortisone, omeprazole, desvenlafaxine succinate (PRISTIQ), brexpiprazole (REXULTI), and folic acid. The patient was previously vaccinated with the first dose of bnt162b2 (lot number: EL3246) at the age of 30-year-old, intramuscularly for COVID-19 immunisation on 19Jan2021 at 14:15 and experienced heart flutters and "fell faint" (fainted). The patient also previously took ibuprofen and experienced allergies. After approximately 5 minutes after the patient had the second dose of vaccine (19Feb2021 14:20), the patient had syncopal episode, itching/ fullness. Covering physician present and assessed with EMS on Duty: VS: 110/80-BP, 18-RR, 96-HR, SaO2-98% on RA, CBG: 138. Patient awakened and reported "feeling funny" on 19Feb2021, but was A &Ox4, MAEW x4 with equal strength, Lungs Clear to auscultation. At 14:20 the patient was given Benadryl liquid PO given along with 8oz of water. Patient able to drink without issues. At 15:00, EMS called for ER transport to due prolonged recovery. The events resulted in emergency room/department or urgent care. The outcome of the events was unknown.; Sender's Comments: Based on the very close temporal association, there was a reasonable possibility that the vaccination with BNT162B2 played a contributory role in triggering the onset of the reported events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
Test Name: Auscultation; Result Unstructured Data: Test Result:lungs clear; Test Name: CBG; Result Unstructured Data: Test Result:138; Test Name: Blood pressure; Result Unstructured Data: Test Result:110/80; Test Name: HR; Result Unstructured Data: Test Result:96; Test Name: SaO2; Test Result: 98 %; Test Name: RR; Result Unstructured Data: Test Result:18
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Celiac disease; COVID-19; Hypotension; Manual vacuum aspiration; Milk allergy; Traumatic brain injury; Vagal reaction
Andere Medikamente
FAMOTIDINE; METHYLPHENIDATE; FLUDROCORTISONE; OMEPRAZOLE; PRISTIQ; REXULTI; FOLIC ACID
Allergien
-
Vorherige Impfungen
-

VAERS 1086108

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CA
Alter
20,0
Geschlecht
M
Eingang
09.03.2021
Impfdatum
09.03.2021
Beginn
09.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Electrocardiogram Loss of consciousness Presyncope Syncope

Symptomtext

After vaccine was administered patient stated feeling a little dizzy and then patient fainted out of chair and came back to for a few seconds, hten passed out again and came back seconds after. Patient was then transported to the Emergency Room where EKG was done. Diagnosed with Syncope, Vasovagal.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
EKG
Aktuelle Erkrankungen
None
Vorgeschichte
history of fainting or passing out around needles
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
Mother said faints whenever around needles

VAERS 1085891

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
TN
Alter
62,0
Geschlecht
F
Eingang
09.03.2021
Impfdatum
01.03.2021
Beginn
01.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Diarrhoea Dizziness Fatigue Headache Injection site pain Lymph node pain Nausea Syncope

Symptomtext

Within minutes after receiving shot I became completely dizzy, lightheaded and started to faint. EMT came to my aid and took vitals all looked OK. I stayed in place until I felt better about 30 minutes. For the rest of that day and the next day I was extremely tired, a little nauseous, and kind of out of it. The third day I had very sore left arm at site and very sore and tender lymph notes on left side of Arm and trunk. Six days after the shot I came suddenly down with a massive headache and diarrhea. Al has since resolved and I am on day eight.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Anxiety, arthritis
Andere Medikamente
Lexapro Turmeric
Allergien
Bees, wasps, oil paint , codeine, penacillin, Sudafed
Vorherige Impfungen
-

VAERS 1085741

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
IN
Alter
57,0
Geschlecht
F
Eingang
09.03.2021
Impfdatum
01.03.2021
Beginn
06.03.2021
Tage bis Beginn
5,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Anaphylactic reaction Chest pain Dyspnoea Full blood count Metabolic function test Pruritus Rash Troponin T Tryptase Urticaria

Symptomtext

Anaphylaxis - rash and hives from head to toes, severe itching, difficulty breathing, and chest pain. Oxygen Saturation was at 87 when I arrived. Treated with dexamethasone sod phosphate PF last given at 5:45 PM, diphenhydrAMINE (Benadryl) last given at 5:45 PM, EPINEPHrine last given at 5:45 PM, famotine last given at 6:08 PM, GI cocktail oral suspension last given at 6:44 PM, hydrocortisone last given at 8:18 PM, LORazepam last given at 5:48 and 6:45 PM, ondansetron last given at 5:48.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
CBC W AUTO DIFF, COMPREHENSIVE METABOILIC PANEL, TROPONIN T performed 2 times, TRYPTASE
Aktuelle Erkrankungen
None
Vorgeschichte
Elevated BP, seasonal allergies, depression
Andere Medikamente
Aspirin 81 MG EC tablet 1 po qd; buPropion 300 MGXL tablet 1 po qd; cholecalciferol 1000 UNIT tablet po qd; escitalopram 10 MG 1 po qd; estradiol 0.5 MG tablet 1 po qd, fish oil omega-e fatty acids 1000 MG capsule, lisinopril 10 MG tablet
Allergien
IV Contrast Dye and Prilosec (years ago)
Vorherige Impfungen
-

VAERS 1083287

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
VA
Alter
51,0
Geschlecht
F
Eingang
08.03.2021
Impfdatum
23.02.2021
Beginn
24.02.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Computerised tomogram Concussion Fall Head injury Injection site pain Nausea Spinal X-ray Syncope

Symptomtext

I felt fine after the vaccine. That night, I had a sore injection site, but no other symptoms. I woke up at 1:15 a.m., felt okay, walked to the bathroom, and suddenly felt extremely nauseous and thought I might vomit. After walking a few steps, I fainted unexpectedly and got a concussion from the fall. Note: I had hit my head earlier that day on something while standing up, but that had not caused any symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
CT scan and neck x-ray due to concussion.
Aktuelle Erkrankungen
-
Vorgeschichte
Gastroparesis Dumping syndrome Atypical Meniere's disease (I don't get dizzy with it)
Andere Medikamente
Pepcid 40 mg Gaviscon
Allergien
-
Vorherige Impfungen
-

VAERS 1082751

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
63,0
Geschlecht
F
Eingang
08.03.2021
Impfdatum
08.03.2021
Beginn
08.03.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Fall Seizure

Symptomtext

Patient finished observation, then suffered a seizure and fall on the way out of the clinic. Paramedics were called and the patient was monitored and transferred to the hospital on site

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1081311

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
OR
Alter
38,0
Geschlecht
F
Eingang
08.03.2021
Impfdatum
27.02.2021
Beginn
28.02.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blindness transient Flushing Hyperhidrosis Presyncope Syncope Tremor Unresponsive to stimuli

Symptomtext

Patient experienced three episodes of syncope between 1000-1100 on Sunday, 2/28 after receiving the vaccine on Saturday, 2/27 at approximately 1810. Loss of responsiveness ranged from approximately three to twenty seconds. Two of the three episodes were witnessed. Episode one occurred when patient attempted to sit up after waking. Episodes two and three occurred while attempting to change position from sitting to standing. Episodes were preceded by flushing, diaphoresis, graying/blackening vision, and tremulousness. Patient had not experienced syncope prior to these events. Patient recovered at home with increased fluids and rest on Sunday, 2/28 and outpatient infusion of normal saline at a naturopathic clinic on Monday, 3/1. Patient experience no further episodes of syncope as of 3/8 but did have multiple episodes of near-syncope in the week following vaccination. Syncope started at approximately 10 am on Sunday after having received the vaccine on Saturday at approximately 6:10 pm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
no medical testing was performed
Aktuelle Erkrankungen
none
Vorgeschichte
Hashimoto's thyroiditis Ehlers-Danlos Syndrome - Hypermobile Type Postural Orthostatic Tachycardia Syndrome Attention-Deficit Hyperactivity Disorder Asthma - mild Mast Cell Activation Disorder / High Histamine (per Afrin & Moldering's MCAD criteria)
Andere Medikamente
T3-T4 compound, 17.5mcg-70mcg daily PO low dose naltrexone, 4.5 mg daily PO gabapentin 100 mg BID PO acetaminophen 1000 mg BID PO and 1000 mg daily PRN levocetirizine, 5 mg TID PO diamine oxidase 2-4 times daily PRN mixed amphetamine salts
Allergien
no anaphylactic allergies lactose intolerance causing bloating, diarrhea, abdominal pain gluten intolerance causing rash, abdominal pain, and constipation/diarrhea codeine causing full body hives and rash ciprofloxacin causing protracted vomiting
Vorherige Impfungen
-

VAERS 1081208

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CA
Alter
18,0
Geschlecht
M
Eingang
08.03.2021
Impfdatum
04.03.2021
Beginn
06.03.2021
Tage bis Beginn
2,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Chest pain Cold sweat Electrocardiogram ST segment elevation Human rhinovirus test positive Malaise Myocarditis Nausea Pain Pericarditis Pyrexia SARS-CoV-2 test negative Sleep disorder Troponin increased

Symptomtext

This is a 18 y.o. male who is generally healthy. He received a second dose of the SARS2-COV vaccine on 3/4. The following morning he felt feverish and achy with malaise. He stayed home, drank fluids and rested and felt well enough to come up to ski this weekend. During skiing he had some anterior chest pain, it resolved and he went about his day. Tonight at 2245 the pain became sharp and awakened him from sleep. He felt nauseated and clammy as well. Father brought him to the ER for evaluation. His emergency department evaluation showed ST elevations most notably in the inferior and lateral leads as well as in the lateral precordium.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myocarditis
Hospital-Tage
-
Labordaten
Molecular testing was negative for COVID-19 but positive for a rhinovirus. His troponin was initially elevated to 11.98. A subsequent troponin reached 22. Pt was transferred medical facility for cardiac MRI. Final diagnosis at medical center: Pericarditis, myocarditis, positive rhino virus testing
Aktuelle Erkrankungen
diagnosed in ED with Rhinovirus
Vorgeschichte
Asthma
Andere Medikamente
Albuterol inhaler
Allergien
Gluten, Legumes
Vorherige Impfungen
-

VAERS 1080558

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
NH
Alter
57,0
Geschlecht
F
Eingang
08.03.2021
Impfdatum
06.03.2021
Beginn
06.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Dyspnoea Nausea Seizure Loss of consciousness

Symptomtext

Passed out within 10 minutes of getting the shot Went into a seizure An EpiPen was administered within a few minutes Transported to the hospital via ambulance and monitored at the hospital for about an hour after that.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Digestive issues
Andere Medikamente
Benadryl
Allergien
polyethylene glycol
Vorherige Impfungen
-

VAERS 1080558

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
NH
Alter
57,0
Geschlecht
F
Eingang
08.03.2021
Impfdatum
06.03.2021
Beginn
06.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Dyspnoea Nausea Seizure Loss of consciousness

Symptomtext

Passed out within 10 minutes of getting the shot Went into a seizure An EpiPen was administered within a few minutes Transported to the hospital via ambulance and monitored at the hospital for about an hour after that.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Digestive issues
Andere Medikamente
Benadryl
Allergien
polyethylene glycol
Vorherige Impfungen
-

VAERS 1079455

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
RI
Alter
75,0
Geschlecht
F
Eingang
07.03.2021
Impfdatum
25.02.2021
Beginn
02.03.2021
Tage bis Beginn
5,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope Tachycardia

Symptomtext

Tachycardia. I fainted

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Hypothroidism
Andere Medikamente
Synthroid 88 mcg once daily D3 supplement 25mcg once daily
Allergien
None known
Vorherige Impfungen
-

VAERS 1078566

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
WA
Alter
68,0
Geschlecht
M
Eingang
06.03.2021
Impfdatum
05.03.2021
Beginn
05.03.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Hyperhidrosis Hypotension Seizure like phenomena

Symptomtext

sweating seizure like symptom hypotensive

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure like phenomena
Hospital-Tage
-
Labordaten
unknown
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 1078295

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
-
Alter
24,0
Geschlecht
F
Eingang
06.03.2021
Impfdatum
06.03.2021
Beginn
06.03.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Condition aggravated Guillain-Barre syndrome Livedo reticularis Musculoskeletal stiffness

Symptomtext

Hx Guillain-Barr? 5-10 minutes after vaccination had mottled appearance of hands and muscle stiffness of neck, no CP or SOB, given IM benadryl and sent to ED 911 for observation

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hx of Guillain-Barr? like symptoms in the past
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1077920

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
DC
Alter
30,0
Geschlecht
M
Eingang
06.03.2021
Impfdatum
06.03.2021
Beginn
06.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Presyncope Syncope

Symptomtext

Pt had vagal reaction, near syncopal event which had prolonged symptoms brought to medical area and placed in cot

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
NOne
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, Hx of vagal reactions to blood draw in the past
Andere Medikamente
HTN meds
Allergien
Pineapple
Vorherige Impfungen
-

VAERS 1075375

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6198

schwer
Staat
CA
Alter
43,0
Geschlecht
M
Eingang
06.03.2021
Impfdatum
04.03.2021
Beginn
04.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Blood test Computerised tomogram Dizziness Electrocardiogram Fatigue Laboratory test normal Loss of consciousness Nervousness Road traffic accident Nausea Vomiting X-ray

Symptomtext

Light headed followed by losing consciousness for about a minute. Then nausea and throwing up. Fatigue rest of the day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
CAT scan, EKG, X-ray, blood work at hospital
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Daily multi-vitamin
Allergien
None
Vorherige Impfungen
-

VAERS 1075375

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6198

schwer
Staat
CA
Alter
43,0
Geschlecht
M
Eingang
06.03.2021
Impfdatum
04.03.2021
Beginn
04.03.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Blood test Computerised tomogram Dizziness Electrocardiogram Fatigue Laboratory test normal Loss of consciousness Nervousness Road traffic accident Nausea Vomiting X-ray

Symptomtext

Light headed followed by losing consciousness for about a minute. Then nausea and throwing up. Fatigue rest of the day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
CAT scan, EKG, X-ray, blood work at hospital
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Daily multi-vitamin
Allergien
None
Vorherige Impfungen
-